US20160089317A1 - Antiperspirant and deodorant compositions comprising malodor reduction compositions - Google Patents

Antiperspirant and deodorant compositions comprising malodor reduction compositions Download PDF

Info

Publication number
US20160089317A1
US20160089317A1 US14/865,048 US201514865048A US2016089317A1 US 20160089317 A1 US20160089317 A1 US 20160089317A1 US 201514865048 A US201514865048 A US 201514865048A US 2016089317 A1 US2016089317 A1 US 2016089317A1
Authority
US
United States
Prior art keywords
methyl
dimethyl
acetate
isopropyl
prop
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/865,048
Inventor
Jonathan Robert Cetti
Gayle Marie Frankenbach
Steven Anthony Horenziak
Judith Ann Hollingshead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to US14/865,048 priority Critical patent/US20160089317A1/en
Assigned to THE PROCTER & GAMBLE COMPANY reassignment THE PROCTER & GAMBLE COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HORENZIAK, STEVEN ANTHONY, CETTI, JONATHAN ROBERT, FRANKENBACH, GAYLE MARIE, HOLLINGSHEAD, JUDITH ANN
Publication of US20160089317A1 publication Critical patent/US20160089317A1/en
Priority to US15/597,376 priority patent/US20170249407A1/en
Priority to US15/597,391 priority patent/US20170249408A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/01Deodorant compositions
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F30/00Computer-aided design [CAD]
    • G06F30/20Design optimisation, verification or simulation
    • G06F30/23Design optimisation, verification or simulation using finite element methods [FEM] or finite difference methods [FDM]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966Triazines or their condensed derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18Liquid substances or solutions comprising solids or dissolved gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/01Deodorant compositions
    • A61L9/012Deodorant compositions characterised by being in a special form, e.g. gels, emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/12Apparatus, e.g. holders, therefor
    • A61L9/122Apparatus, e.g. holders, therefor comprising a fan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/12Apparatus, e.g. holders, therefor
    • A61L9/127Apparatus, e.g. holders, therefor comprising a wick
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/14Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/24Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0007Aliphatic compounds
    • C11B9/0015Aliphatic compounds containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0007Aliphatic compounds
    • C11B9/0015Aliphatic compounds containing oxygen as the only heteroatom
    • C11B9/0019Aliphatic compounds containing oxygen as the only heteroatom carbocylic acids; Salts or esters thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0026Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/003Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing less than six carbon atoms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0026Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/0034Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing six carbon atoms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0026Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/0038Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing more than six carbon atoms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0042Essential oils; Perfumes compounds containing condensed hydrocarbon rings
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0042Essential oils; Perfumes compounds containing condensed hydrocarbon rings
    • C11B9/0046Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings
    • C11B9/0049Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0042Essential oils; Perfumes compounds containing condensed hydrocarbon rings
    • C11B9/0046Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings
    • C11B9/0049Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms
    • C11B9/0053Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms both rings being six-membered
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0061Essential oils; Perfumes compounds containing a six-membered aromatic ring not condensed with another ring
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0069Heterocyclic compounds
    • C11B9/0073Heterocyclic compounds containing only O or S as heteroatoms
    • C11B9/0076Heterocyclic compounds containing only O or S as heteroatoms the hetero rings containing less than six atoms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0069Heterocyclic compounds
    • C11B9/0073Heterocyclic compounds containing only O or S as heteroatoms
    • C11B9/008Heterocyclic compounds containing only O or S as heteroatoms the hetero rings containing six atoms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0069Heterocyclic compounds
    • C11B9/0092Heterocyclic compounds containing only N as heteroatom
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0043For use with aerosol devices
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/04Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
    • C11D17/041Compositions releasably affixed on a substrate or incorporated into a dispensing means
    • C11D17/042Water soluble or water disintegrable containers or substrates containing cleaning compositions or additives for cleaning compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/04Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
    • C11D17/041Compositions releasably affixed on a substrate or incorporated into a dispensing means
    • C11D17/047Arrangements specially adapted for dry cleaning or laundry dryer related applications
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/06Powder; Flakes; Free-flowing mixtures; Sheets
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/001Softening compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0068Deodorant compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/18Hydrocarbons
    • C11D3/184Hydrocarbons unsaturated
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2003Alcohols; Phenols
    • C11D3/2006Monohydric alcohols
    • C11D3/2034Monohydric alcohols aromatic
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2068Ethers
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2072Aldehydes-ketones
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2075Carboxylic acids-salts thereof
    • C11D3/2079Monocarboxylic acids-salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2093Esters; Carbonates
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2096Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • C11D3/222Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/30Amines; Substituted amines ; Quaternized amines
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/43Solvents
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50Perfumes
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50Perfumes
    • C11D3/502Protected perfumes
    • C11D3/505Protected perfumes encapsulated or adsorbed on a carrier, e.g. zeolite or clay
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06BTREATING TEXTILE MATERIALS USING LIQUIDS, GASES OR VAPOURS
    • D06B1/00Applying liquids, gases or vapours onto textile materials to effect treatment, e.g. washing, dyeing, bleaching, sizing or impregnating
    • D06B1/02Applying liquids, gases or vapours onto textile materials to effect treatment, e.g. washing, dyeing, bleaching, sizing or impregnating by spraying or projecting
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10Complex mathematical operations
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10Complex mathematical operations
    • G06F17/11Complex mathematical operations for solving equations, e.g. nonlinear equations, general mathematical optimization problems
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q99/00Subject matter not provided for in other groups of this subclass
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C10/00Computational theoretical chemistry, i.e. ICT specially adapted for theoretical aspects of quantum chemistry, molecular mechanics, molecular dynamics or the like
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/40Searching chemical structures or physicochemical data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2209/00Aspects relating to disinfection, sterilisation or deodorisation of air
    • A61L2209/10Apparatus features
    • A61L2209/13Dispensing or storing means for active compounds
    • A61L2209/133Replaceable cartridges, refills
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2209/00Aspects relating to disinfection, sterilisation or deodorisation of air
    • A61L2209/10Apparatus features
    • A61L2209/13Dispensing or storing means for active compounds
    • A61L2209/134Distributing means, e.g. baffles, valves, manifolds, nozzles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2209/00Aspects relating to disinfection, sterilisation or deodorisation of air
    • A61L2209/20Method-related aspects
    • A61L2209/21Use of chemical compounds for treating air or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/02Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air by heating or combustion
    • A61L9/03Apparatus therefor
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/10Objects to be cleaned
    • C11D2111/12Soft surfaces, e.g. textile

Definitions

  • the present invention relates to antiperspirant and deodorant compositions comprising malodor reduction compositions and methods of making and using such antiperspirant and deodorant compositions.
  • Unscented or scented products are desired by consumers as they may be considered more natural and discreet than scented products.
  • Manufacturers of unscented or scented products for controlling malodors rely on malodor reduction ingredients or other technologies (e.g. filters) to reduce malodors.
  • malodor reduction ingredients or other technologies e.g. filters
  • effectively controlling malodors for example, amine-based malodors (e.g. fish and urine), thiol and sulfide-based malodors (e.g. garlic and onion), C 2 -C 12 carboxylic acid based malodors (e.g. body and pet odor), indole based malodors (e.g. fecal and bad breath), short chain fatty aldehyde based malodors (e.g.
  • malodor control technologies typically cover up the malodor with a stronger scent and thus interfere with the scent of the perfumed or unperfumed situs that is treated with the malodor control technology.
  • limited nature of the current malodor control technologies is extremely constraining.
  • a malodor control technology in addition to blocking a malodor's access to a sensory cell, in order to achieve the desired goal, a malodor control technology must leave such sensor cell open to other molecules, for example scent molecules.
  • antiperspirant and deodorant compositions comprising the malodor control technologies disclosed herein provide malodor control without leaving an undesirable scent and when perfume is used to scent such compositions, such scent is not unduely altered by the malodor control technology.
  • the present invention relates to antiperspirant and deodorant compositions comprising malodor reduction compositions and methods of making and using such antiperspirant and deodorant compositions.
  • Such antiperspirant and deodorant compositions comprising the malodor control technologies disclosed herein provide malodor control without leaving an undesirable scent and when perfume is used to scent such compositions, such scent is not unduely altered by the malodor control technology.
  • “Ambient” refers to surrounding conditions at about one atmosphere of pressure, 50% relative humidity and about 25° C.
  • “Anhydrous” refers to compositions and/or components which are substantially free of added or free water.
  • Antiperspirant composition refers to antiperspirant compositions, deodorant compositions, and the like. For example, antiperspirant creams, gels, soft solid sticks, body sprays, and aerosols.
  • Soft solid refers to a composition with a static yield stress of about 200 Pa to about 1,300 Pa.
  • solid includes granular, powder, bar and tablet product forms.
  • fluid includes liquid, gel, paste and gas product forms.
  • itus includes paper products, fabrics, garments, hard surfaces, hair and skin.
  • substantially free of refers to about 2% or less, about 1% or less, or about 0.1% or less of a stated ingredient. “Free of refers to no detectable amount of the stated ingredient or thing.
  • MORV is the calculated malodor reduction value for a subject material.
  • a material's MORV indicates such material's ability to decrease or even eliminate the perception of one or more malodors.
  • a material's MORV is calculated in accordance with method found in the test methods section of the present application.
  • malodor refers to compounds generally offensive or unpleasant to most people, such as the complex odors associated with bowel movements.
  • neutralize refers to the ability of a compound or product to reduce or eliminate malodorous compounds. Odor neutralization may be partial, affecting only some of the malodorous compounds in a given context, or affecting only part of a malodorous compound. A malodorous compound may be neutralized by chemical reaction resulting in a new chemical entity, by sequestration, by chelation, by association, or by any other interaction rendering the malodorous compound less malodorous or non-malodorous. Neutralization is distinguishable from odor masking or odor blocking by a change in the malodorous compound, as opposed to a change in the ability to perceive the malodor without any corresponding change in the condition of the malodorous compound. Malodor neutralization provides a sensory and analytically measurable (e.g. gas chromatograph) malodor reduction. Thus, if a malodor reduction composition delivers genuine malodor neutralization, the composition will reduce malodors in the vapor and/or liquid phase.
  • odor blocking refers to the ability of a compound to dull the human sense of smell.
  • odor masking refers to the ability of a compound with a non-offensive or pleasant smell that is dosed such that it limits the ability to sense a malodorous compound. Odor-masking may involve the selection of compounds which coordinate with an anticipated malodor to change the perception of the overall scent provided by the combination of odorous compounds.
  • the term “perfume” does not include malodor reduction materials.
  • the perfume portion of a composition does not include, when determining the perfume's composition, any malodor reduction materials found in the composition as such malodor reduction materials are described herein.
  • a material has a malodor reduction value “MORV” that is within the range of the MORV recited in the subject claim, such material is a malodor reduction material for purposes of such claim.
  • component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.
  • Tables 1-3 A non-limiting set of suitable malodor reduction materials are provided in the tables below.
  • each material in Tables 1-3 is assigned a numerical indentifier which is found in the column for each table that is designated Number.
  • Table 4 is a subset of Table 1
  • Table 5 is a subset of Table 2
  • Table 6 is a subset of Table 3 and there for Tables 4, 5 and 6 each use the same numerical identifier as found, respectively, in Tables 1-3.
  • Vapor Pressure>0.1 torr B Vapor Pressure is between 0.01 torr and 0.1 torr
  • MORV MORV Value MORV Material value for for MORV Value value for No. Equation a.) Equation b.) for Equation c.) Equation d.) 1 0.548223914 0.876283261 1.22018588 ⁇ 0.41901144 2 1.520311929 3.493450446 2.70657265 5.11342862 3 2.267801995 ⁇ 0.81712657 0.43218875 1.595983683 4 ⁇ 0.591063369 ⁇ 0.48283571 0.16199804 1.210497701 7 1.437444636 2.131822996 3.81633465 1.318339345 9 2.151445882 ⁇ 0.46189495 0.56090469 1.206360803 10 2.5733592 ⁇ 0.58780849 1.39751471 1.258361951 11 3.052627325 1.008519135 ⁇ 0.30475953 0.076323462 12 0.683776599 ⁇ 0.01157903 0.82853231
  • An antiperspirant and/or deodorant composition comprising, based on total composition weight,
  • said sum total of malodor reduction materials has a Blocker Index of less than 3, more preferable less than about 2.5 even more preferably less than about 2 and still more preferably less than about 1 and most preferably 0 and/or a Blocker Index average of 3 to about 0.001.
  • each of said malodor reduction materials has a MORV of at least 0.5, preferably from 0.5 to 10, more preferably from 1 to 10, most preferably from 1 to 5, and preferably each of said malodor reduction materials has a Universal MORV.
  • said sum total of malodor reduction materials has a Fragrance Fidelity Index average of 3 to about 0.001 Fragrance Fidelity Index, preferably each malodor reduction material in said sum total of malodor reduction materials has a Fragrance Fidelity Index of less than 3, preferably less than 2, more preferably less than 1 and most preferably each malodor reduction material in said sum total of malodor reduction materials has a Fragrance Fidelity Index of 0.
  • said sum total of malodor reduction materials has an average boiling point, based on the weight percent of each malodor reduction material in said sum total of malodor reduction materials, of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.; preferably 25%, more preferably 50%, more preferably 75%, most preferably each of said malodor reduction materials in said sum total of malodor reduction materials has a of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.
  • said composition comprises a malodor reduction material is selected from the group consisting of Table 1 materials and mixtures thereof; preferably said material is selected from the group consisting of Table 1 materials 1, 2, 3, 4, 7, 9, 10, 11, 13, 14, 16, 17, 18, 21, 22, 23, 25, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 42, 43, 47, 48, 49, 50, 52, 57, 61, 62, 63, 64, 65, 67, 68, 69, 70, 71, 74, 75, 76, 77, 78, 79, 80, 82, 83, 85, 91, 92, 93, 98, 100, 101, 102, 103, 104, 105, 106, 108, 109, 110, 112, 113, 114, 117, 119, 120, 122, 123, 126, 128, 130, 134, 135, 137, 140, 141, 142, 143, 145,
  • said sum total of malodor reduction materials has an average boiling point, based on the weight percent of each malodor reduction material in said sum total of malodor reduction materials, of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.; preferably 25%, more preferably 50%, more preferably 75%, most preferably each of said malodor reduction materials in said sum total of malodor reduction materials has a of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.
  • said composition comprises one or more perfume raw materials.
  • said combination of said sum total of malodor reduction materials and said one or more perfume raw materials combined has an average boiling point, based on the weight percent of each malodor reduction material in said sum total of malodor reduction materials, of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.; preferably 25%, more preferably 50%, more preferably 75%, most preferably each of said malodor reduction materials in said sum total of malodor reduction materials and each of said one or more perfume raw materials has a boiling point of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.
  • the ratio of said one or more perfume raw materials to said sum total of malodor reduction material is from about 500:1 to about 1:1, preferably from about 50:1 to about 1:1, more preferably from about 20:1 to about 1:1, most preferably from about 2:1 to about 1:1.
  • less than 10%, preferably less than 5%, more preferably less than 1% of said malodor reduction materials and said one or more perfume raw materials, based on total combined weight of malodor reduction materials and said one or more perfume raw materials comprise an ionone moiety.
  • said malodor reduction materials are not selected from the group consisting of Table 1-3 materials 302; 288; 50; 157; 1017; 888; 64; 1054; 832; 375; 390; 745; 504; 505; 140; 1012; 498; 362; 103; 356; 1074; 908; 1127; 475; 918; 687; 611; 317; 9; 141; 550; 602; 913; 1005; 521; 10; 215; 370; 335; 378; 1121; 360; 565; 1136; 1129; 655; 369; 1065; 914; 757; 601; 478; 889; 891; 358; 973; 162; 554; 522; 312; 125; 26; 418; 92; 586; 1026; 218; 31; 828; 871; 829; 1066; 287; 269; 769; 701;
  • said said antiperspirant and/or deodorant composition is a antiperspirant composition that comprises a total of, based on total antiperspirant composition weight, from about 0.1% to about 7% of one or more of said malodor reduction materials and, optionally, from about 1% to about 25% of an aluminum salt antiperspirant active.
  • said composition is an anhydrous antiperspirant composition
  • said anhydrous antiperspirant composition comprising a total of, based on total anhydrous antiperspirant composition weight, from about 0.1% to about 7% of one or more of said malodor reduction materials and from about 1% to about 25% of an antiperspirant actives selected from the group consisting of astringent metallic salts, preferably inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof, more preferably aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof.
  • said composition comprises an adjunct ingredient selected from the group consisting of clay mineral powders, pearl pigments, organic powders, emulsifiers, distributing agents, pharmaceutical active, topical active, preservatives, surfactants and mixtures thereof.
  • a method of controlling malodors comprising: contacting a situs comprising a malodor and/or a situs that may become malodorous with an antiperspirant or deodorant composition selected from the group consisting of the antiperspirant and/or deodorant composition disclosed herein, is disclosed.
  • said situs is an underarm and said contacting step comprises contacting said underarm with a sufficient amount of Applicants' antiperspirant and/or deodorant composition containing said sum of malodor reduction materials to provide said underarm with a level of malodor reduction materials of at least 0.0001 mg of malodor reduction material per underarm, preferably from about 0.0001 mg of malodor reduction material per underarm to about 10 mg of malodor reduction material per underarm, more preferably from about 0.001 mg of malodor reduction material per underarm about 5 mg of malodor reduction material per underarm, most preferably from about 0.01 of malodor reduction material per underarm to about 0.2 mg of malodor reduction material per underarm.
  • Antiperspirant compositions can be formulated in many forms.
  • an antiperspirant composition can be, without limitation, a roll on product, a body spray, a stick including soft solid sticks and invisible solids, or an aerosol.
  • Each of the antiperspirant compositions described below can include perfume materials as described herein.
  • a roll-on antiperspirant composition can comprise, for example, water, emollient, solubilizer, deodorant actives, antioxidants, preservatives, or combinations thereof.
  • a clear gel antiperspirant composition can comprise, for example, water, emollient, solubilizer, deodorant actives, antioxidants, preservatives, ethanol, or combinations thereof.
  • the roll-on composition can include water.
  • Water can be present in an amount of about 1% to about 99.5%, about 25% to about 99.5%, about 50% to about 99.5%, about 75% to about 99.5% about 80% to about 99.5%, from about 15% to about 45%, or any combination of the end points and points encompassed within the ranges, by weight of the deodorant composition.
  • Roll-on compositions can comprise an emollient system including at least one emollient, but it could also be a combination of emollients. Suitable emollients are often liquid under ambient conditions. Depending on the type of product form desired, concentrations of the emollient(s) in the deodorant compositions can range from about 1% to about 95%, from about 5% to about 95%, from about 15% to about 75%, from about 1% to about 10%, from about 15% to about 45%, or from about 1% to about 30%, by weight of the deodorant composition.
  • Emollients suitable for use in the roll-on compositions include, but are not limited to, propylene glycol, polypropylene glycol (like dipropylene glycol, tripropylene glycol, etc.), diethylene glycol, triethylene glycol, PEG-4, PEG-8, 1,2 pentanediol, 1,2 hexanediol, hexylene glycol, glycerin, C2 to C20 monohydric alcohols, C2 to C40 dihydric or polyhydric alcohols, alkyl ethers of polyhydric and monohydric alcohols, volatile silicone emollients such as cyclopentasiloxane, nonvolatile silicone emollients such as dimethicone, mineral oils, polydecenes, petrolatum, and combinations thereof.
  • a suitable emollient comprises PPG-15 stearyl ether.
  • suitable emollients include dipropylene glycol and propylene glycol.
  • Suitable deodorant actives can include any topical material that is known or otherwise effective in preventing or eliminating malodor associated with perspiration.
  • Suitable deodorant actives may be selected from the group consisting of antimicrobial agents (e.g., bacteriocides, fungicides), malodor-absorbing material, and combinations thereof.
  • antimicrobial agents may comprise cetyl-trimethylammonium bromide, cetyl pyridinium chloride, benzethonium chloride, diisobutyl phenoxy ethoxy ethyl dimethyl benzyl ammonium chloride, sodium N-lauryl sarcosine, sodium N-palmethyl sarcosine, lauroyl sarcosine, N-myristoyl glycine, potassium N-lauryl sarcosine, trimethyl ammonium chloride, sodium aluminum chlorohydroxy lactate, triethyl citrate, tricetylmethyl ammonium chloride, 2,4,4′-trichloro-2′-hydroxy diphenyl ether (triclosan), 3,4,4′-trichlorocarbanilide (triclocarban), diaminoalkyl amides such as L-lysine hexadecyl amide, heavy metal salts of citrate, salicylate, and piroc
  • the composition can include an odor entrapper.
  • Suitable odor entrappers for use herein include, for example, solubilized, water-soluble, uncomplexed cyclodextrin.
  • the term “cyclodextrin” includes any of the known cyclodextrins such as unsubstituted cyclodextrins containing from six to twelve glucose units, especially, alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and/or their derivatives and/or mixtures thereof.
  • the alpha-cyclodextrin consists of six glucose units, the beta-cyclodextrin consists of seven glucose units, and the gamma-cyclodextrin consists of eight glucose units arranged in a donut-shaped ring.
  • the specific coupling and conformation of the glucose units give the cyclodextrins a rigid, conical molecular structure with a hollow interior of a specific volume.
  • the “lining” of the internal cavity is formed by hydrogen atoms and glycosidic bridging oxygen atoms, therefore this surface is fairly hydrophobic.
  • the unique shape and physical-chemical property of the cavity enable the cyclodextrin molecules to absorb (form inclusion complexes with) organic molecules or parts of organic molecules which can fit into the cavity.
  • Cyclodextrin molecules are described in U.S. Pat. No. 5,714,137, and U.S. Pat. No. 5,942,217. Suitable levels of cyclodextrin are from about 0.1% to about 5%, alternatively from about 0.2% to about 4%, alternatively from about 0.3% to about 3%, alternatively from about 0.4% to about 2%, by weight of the composition.
  • the composition can include a buffering agent which may be alkaline, acidic or neutral.
  • the buffer can be used in the composition for maintaining the desired pH.
  • the composition may have a pH from about 3 to about 10, from about 4 to about 9, from about 5 to about 8, from about 6 to about 7, or it may have a pH of about 6.5.
  • One unique feature of the polyvinyl amine malodor control polymers is its ability to maintain active nitrogen sites at high pH levels which can help enhance the antibacterial effect which comes, at least in part, from the nitrogen sites.
  • Suitable buffering agents include, for example, hydrochloric acid, sodium hydroxide, potassium hydroxide, and combinations thereof.
  • compositions can contain at least about 0%, alternatively at least about 0.001%, alternatively at least about 0.01%, by weight of the composition, of a buffering agent.
  • the composition may also contain no more than about 1%, alternatively no more than about 0.75%, alternatively no more than about 0.5%, by weight of the composition, of a buffering agent.
  • the composition can contain a solubilizer.
  • a suitable solubilizer can be, for example, a surfactant, such as a no-foaming or low-foaming surfactant.
  • Suitable surfactants are nonionic surfactants, cationic surfactants, amphoteric surfactants, zwitterionic surfactants, and mixtures thereof.
  • Suitable solubilizers include, for example, hydrogenated castor oil, polyoxyethylene 2 stearyl ether, polyoxyethylene 20 stearyl ether, and combinations thereof.
  • One suitable hydrogenated castor oil that may be used in the present composition is polyoxyethylene hydrogenated castor oil.
  • solubilizing agent When the solubilizing agent is present, it is typically present at a level of from about 0.01% to about 5%, alternatively from about 0.01% to about 3%, alternatively from about 0.05% to about 1%, alternatively from about 0.01% to about 0.05%, by weight of the composition.
  • the composition can include a preservative.
  • the preservative is included in an amount sufficient to prevent spoilage or prevent growth of inadvertently added microorganisms for a specific period of time, but not sufficient enough to contribute to the odor neutralizing performance of the composition.
  • the preservative is not being used as the antimicrobial compound to kill microorganisms on the surface onto which the composition is deposited in order to eliminate odors produced by microorganisms. Instead, it is being used to prevent spoilage of the composition in order to increase shelf-life.
  • the preservative can be any organic preservative material which will not cause damage to fabric appearance, e.g., discoloration, coloration, bleaching.
  • Suitable water-soluble preservatives include organic sulfur compounds, halogenated compounds, cyclic organic nitrogen compounds, low molecular weight aldehydes, parabens, propane diol materials, isothiazolinones, quaternary compounds, benzoates, low molecular weight alcohols, dehydroacetic acid, phenyl and phenoxy compounds, or mixtures thereof.
  • Non-limiting examples of commercially available water-soluble preservatives include a mixture of about 77% 5-chloro-2-methyl-4-isothiazolin-3-one and about 23% 2-methyl-4-isothiazolin-3-one, a broad spectrum preservative available as a 1.5% aqueous solution under the trade name Kathon® CG by Rohm and Haas Co.; 5-bromo-5-nitro-1,3-dioxane, available under the tradename Bronidox L® from Henkel; 2-bromo-2-nitropropane-1,3-diol, available under the trade name Bronopol® from Inolex; 1,1′-hexamethylene bis(5-(p-chlorophenyl)biguanide), commonly known as chlorhexidine, and its salts, e.g., with acetic and digluconic acids; a 95:5 mixture of 1,3-bis(hydroxymethyl)-5,5-dimethyl-2,4-imidazolidinedione
  • Suitable levels of preservative can range from about 0.0001% to about 0.5%, alternatively from about 0.0002% to about 0.2%, alternatively from about 0.0003% to about 0.1%, by weight of the composition.
  • a body spray can contain, for example, a carrier, perfume, a deodorant active, odor entrappers, propellant, or combinations thereof.
  • the body spray compositions can be applied as a liquid.
  • a carrier suitable for use in a body spray can include, water, alcohol, or combinations thereof.
  • the carrier may be present in an amount of about 1% to about 99.5%, about 25% to about 99.5%, about 50% to about 99.5%, about 75% to about 99.5% about 80% to about 99.5%, from about 15% to about 45%, or any combination of the end points and points encompassed within the ranges, by weight of the composition.
  • a suitable example of an alcohol can include ethanol.
  • compositions described herein can include a propellant.
  • propellants include compressed air, nitrogen, inert gases, carbon dioxide, and mixtures thereof.
  • Propellants may also include gaseous hydrocarbons like propane, n-butane, isobutene, cyclopropane, and mixtures thereof.
  • Halogenated hydrocarbons like 1,1-difluoroethane may also be used as propellants.
  • propellants include 1,1,1,2,2-pentafluoroethane, 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, trans-1,3,3,3-tetrafluoroprop-1-ene, dimethyl ether, dichlorodifluoromethane (propellant 12), 1,1-dichloro-1,1,2,2-tetrafluoroethane (propellant 114), 1-chloro-1,1-difluoro-2,2-trifluoroethane (propellant 115), 1-chloro-1,1-difluoroethylene (propellant 142B), 1,1-difluoroethane (propellant 152A), monochlorodifluoromethane, and mixtures thereof.
  • propellants suitable for use include, but are not limited to, A-46 (a mixture of isobutane, butane and propane), A-31 (isobutane), A-17 (n-butane), A-108 (propane), AP70 (a mixture of propane, isobutane and n-butane), AP40 (a mixture of propane, isobutene and n-butane), AP30 (a mixture of propane, isobutane and n-butane), and 152A (1,1 diflouroethane).
  • A-46 a mixture of isobutane, butane and propane
  • A-31 isobutane
  • A-17 n-butane
  • A-108 propane
  • AP70 a mixture of propane, isobutane and n-butane
  • AP40 a mixture of propane, isobutene and n-butane
  • AP30 a mixture of propane, isobutane and
  • the propellant may have a concentration from about 15%, 25%, 30%, 32%, 34%, 35%, 36%, 38%, 40%, or 42% to about 70%, 65%, 60%, 54%, 52%, 50%, 48%, 46%, 44%, or 42%, or any combination thereof, by weight of the total fill of materials stored within the container.
  • Invisible solid antiperspirant compositions as described herein can contain a primary structurant, an antiperspirant active, a perfume, and additional chassis ingredient(s).
  • the antiperspirant composition can further comprise other optional ingredient(s).
  • the compositions can be in the form of a solid stick.
  • the compositions can have a product hardness of about 600 gram force or more.
  • the compositions may be free of dipropylene glycol, added water, castor wax, or any combination thereof.
  • the antiperspirant composition may be anhydrous.
  • the antiperspirant composition may be free of added water.
  • the invisible solid can have a product hardness of least about 600 gram ⁇ force, more specifically from about 600 gram ⁇ force to about 5,000 gram ⁇ force, still more specifically from about 750 gram ⁇ force to about 2,000 gram ⁇ force, and yet more specifically from about 800 gram ⁇ force to about 1,400 gram ⁇ force.
  • product hardness or “hardness” as used herein is a reflection of how much force is required to move a penetration cone a specified distance and at a controlled rate into an antiperspirant composition under the test conditions described herein below. Higher values represent harder product, and lower values represent softer product. These values are measured at 27° C., 15% relative humidity, using a TA-XT2 Texture Analyzer, available from Texture Technology Corp., Scarsdale, N.Y., U.S.A.
  • the product hardness value as used herein represents the peak force required to move a standard 45-degree angle penetration cone through the composition for a distance of 10 mm at a speed of 2 mm/second.
  • the standard cone is available from Texture Technology Corp., as part number TA-15, and has a total cone length of about 24.7 mm, angled cone length of about 18.3 mm, and a maximum diameter of the angled surface of the cone of about 15.5 mm.
  • the cone is a smooth, stainless steel construction and weighs about 17.8 grams.
  • the invisible solid can comprise a suitable concentration of a primary structurant to help provide the antiperspirant with the desired viscosity, rheology, texture and/or product hardness, or to otherwise help suspend any dispersed solids or liquids within the composition.
  • solid structurant means any material known or otherwise effective in providing suspending, gelling, viscosifying, solidifying, and/or thickening properties to the composition or which otherwise provide structure to the final product form.
  • These solid structurants include gelling agents, and polymeric or non-polymeric or inorganic thickening or viscosifying agents.
  • Such materials will typically be solids under ambient conditions and include organic solids, crystalline or other gellants, inorganic particulates such as clays or silicas, or combinations thereof.
  • the concentration and type of solid structurant selected for use in the antiperspirant compositions will vary depending upon the desired product hardness, rheology, and/or other related product characteristics.
  • the total structurant concentration ranges from about 5% to about 35%, more typically from about 10% to about 30%, or from about 7% to about 20%, by weight of the composition.
  • Non-limiting examples of suitable primary structurants include stearyl alcohol and other fatty alcohols; hydrogenated castor wax (e.g., Castorwax MP80, Castor Wax, etc.); hydrocarbon waxes include paraffin wax, beeswax, carnauba, candelilla, spermaceti wax, ozokerite, ceresin, baysberry, synthetic waxes such as Fischer-Tropsch waxes, and microcrystalline wax; polyethylenes with molecular weight of 200 to 1000 daltons; solid triglycerides; behenyl alcohol, or combinations thereof.
  • hydrogenated castor wax e.g., Castorwax MP80, Castor Wax, etc.
  • hydrocarbon waxes include paraffin wax, beeswax, carnauba, candelilla, spermaceti wax, ozokerite, ceresin, baysberry, synthetic waxes such as Fischer-Tropsch waxes, and microcrystalline wax
  • the antiperspirant stick compositions can comprise a particulate antiperspirant active suitable for application to human skin.
  • concentration of antiperspirant active in the composition should be sufficient to provide the desired perspiration wetness and odor control from the antiperspirant stick formulation selected.
  • the antiperspirant stick compositions can comprise an antiperspirant active at concentrations of from about 0.5% to about 60%, and more specifically from about 5% to about 35%, by weight of the composition. These weight percentages are calculated on an anhydrous metal salt basis exclusive of water and any complexing agents such as, for example, glycine, and glycine salts.
  • the antiperspirant active as formulated in the composition can be in the form of dispersed particulate solids having an average particle size or equivalent diameter of less than about 100 microns, more specifically less than about 20 microns, and even more specifically less than about 10 microns.
  • the antiperspirant active for use in the anhydrous antiperspirant compositions of the present invention can include any compound, composition or other material having antiperspirant activity. More specifically, the antiperspirant actives may include astringent metallic salts, especially inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof. Even more specifically, the antiperspirant actives may include aluminum-containing and/or zirconium-containing salts or materials, such as, for example, aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof.
  • Aluminum salts for use in the anhydrous antiperspirant stick compositions include those that conform to the formula:
  • Zirconium salts for use in the anhydrous antiperspirant stick compositions include those which conform to the formula:
  • zirconium salts are described in Belgian Patent 825,146, Schmitz, issued Aug. 4, 1975, which description is incorporated herein by reference.
  • Zirconium salts that additionally contain aluminum and glycine commonly known as “ZAG complexes,” are believed to be especially beneficial.
  • ZAG complexes contain aluminum chlorohydroxide and zirconyl hydroxy chloride conforming to the above-described formulas.
  • Such ZAG complexes are described in U.S. Pat. No. 3,792,068; Great Britain Patent Application 2,144,992; and U.S. Pat. No. 4,120,948, disclosures of which are incorporated herein by reference for the limited purpose of describing ZAG complexes.
  • n is 2.0 to 10.0, preferably 3.0 to 8.0
  • m is about 0.48 to about 1.11 (which corresponds to M:Cl approximately equal to 2.1-0.9), preferably about 0.56 to about 0.83 (which corresponds to M:Cl approximately equal to 1.8-1.2)
  • q is about 0.8 to about 4.0, preferably about 1.0 to 2.0
  • AA is an amino acid such as glycine, alanine, valine, serine, leucine, isoleucine, ⁇ -alanine, cysteine, ⁇ -amino-n-butyric acid, or y-amino-n-butyric acid, preferably glycine.
  • These salts also generally have some water of hydration associated with them, typically on the order of 1 to 5 moles per mole of salt (typically, about 1% to about 16%, more typically about 4% to about 13% by weight).
  • These salts are generally referred to as aluminum-zirconium trichlorohydrex or tetrachlorohydrex when the Al:Zr ratio is between 2 and 6 and as aluminum-zirconium pentachlorohydrex or octachlorohydrex when the Al:Zr ratio is between 6 and 10.
  • the term “aluminum-zirconium chlorohydrex” is intended to embrace all of these forms.
  • the preferred aluminum-zirconium salt is aluminum-zirconium chlorohydrex-glycine.
  • suitable high efficacy antiperspirant actives can include Aluminum Zirconium Pentachlorohydrex Glycine, Aluminum Zirconium Octachlorohydrex Glycine, or a combination thereof. These high efficacy actives are more fully described in U.S. App. Pub. No. 2007/0003499 by Shen et al. filed Jun. 30, 2005.
  • the antiperspirant composition can further comprise an additional structurant.
  • the additional structurant may be present in an amount from 1% to about 10%, by weight of the composition.
  • the additional structurant(s) will likely be present at an amount less than the primary structurant.
  • Non-limiting examples of suitable additional structurants include stearyl alcohol and other fatty alcohols; hydrogenated castor wax (e.g., Castorwax MP80, Castor Wax, etc.); hydrocarbon waxes include paraffin wax, beeswax, carnauba, candelilla, spermaceti wax, ozokerite, ceresin, baysberry, synthetic waxes such as Fisher-Tropsch waxes, and microcrystalline wax; polyethylenes with molecular weight of 200 to 1000 daltons; and solid triglycerides; behenyl alcohol, or combinations thereof.
  • hydrogenated castor wax e.g., Castorwax MP80, Castor Wax, etc.
  • hydrocarbon waxes include paraffin wax, beeswax, carnauba, candelilla, spermaceti wax, ozokerite, ceresin, baysberry, synthetic waxes such as Fisher-Tropsch waxes, and microcrystalline wax
  • the antiperspirant composition can comprise a solvent at concentrations ranging from about 20% to about 80%, and more specifically from about 30% to about 70%, by weight of the composition.
  • the solvent can be a volatile silicone which may be cyclic or linear.
  • Volatile silicone refers to those silicone materials that have measurable vapor pressure under ambient conditions. Non-limiting examples of suitable volatile silicones are described in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976), which descriptions are incorporated herein by reference.
  • the volatile silicone can be a cyclic silicone having from 3 to 7, and more specifically from 5 to 6, silicon atoms, and still more specifically 5, like cyclopentasiloxane. These cyclic silicone materials will generally have viscosities of less than about 10 centistokes at 25° C. Linear volatile silicone materials suitable for use in the antiperspirant compositions include those represented by the formula:
  • n is from 1 to 7, and more specifically from 2 to 3.
  • These linear silicone materials will generally have viscosities of less than about 5 centistokes at 25° C.
  • volatile silicone solvents suitable for use in the antiperspirant compositions include, but are not limited to, Cyclomethicone D-5; GE 7207 and GE 7158 (commercially available from General Electric Co.); Dow Corning 344; Dow Corning 345; Dow Corning 200; and DC1184 (commercially available from Dow Corning Corp.); and SWS-03314 (commercially available from SWS Silicones).
  • Non-volatile organic fluids may be present, for example, in an amount of about 15% or less, by weight of the composition.
  • Non-limiting examples of nonvolatile organic fluids include mineral oil, PPG-14 butyl ether, isopropyl myristate, petrolatum, butyl stearate, cetyl octanoate, butyl myristate, myristyl myristate, C12-15 alkylbenzoate (e.g., FinsolvTM), octyldodecanol, isostearyl isostearate, octododecyl benzoate, isostearyl lactate, isostearyl palmitate, and isobutyl stearate.
  • mineral oil PPG-14 butyl ether
  • isopropyl myristate petrolatum
  • butyl stearate cetyl octanoate
  • butyl myristate butyl myristate
  • myristyl myristate myristyl myristate
  • C12-15 alkylbenzoate e.
  • the anhydrous antiperspirant compositions can further comprise any optional material that is known for use in antiperspirant and deodorant compositions or other personal care products, or which is otherwise suitable for topical application to human skin.
  • clay mineral powders such as talc, mica, sericite, silica, magnesium silicate, synthetic fluorphlogopite, calcium silicate, aluminum silicate, bentonite and montomorillonite
  • pearl pigments such as alumina, barium sulfate, calcium secondary phosphate, calcium carbonate, titanium oxide, finely divided titanium oxide, zirconium oxide, zinc oxide, hydroxy apatite, iron oxide, iron titrate, ultramarine blue, Prussian blue, chromium oxide, chromium hydroxide, cobalt oxide, cobalt titanate, titanium oxide coated mica
  • organic powders such as polyester, polyethylene, polystyrene, methyl methacrylate resin, cellulose, 12-nylon, 6-nylon, styrene-acrylic acid copolymers, poly propylene, vinyl chloride polymer, tetrafluoroethylene polymer, boron nitride, fish scale guanine, laked tar
  • Talc if used at higher levels can produce a significant amount of white residue which has been found to be a consumer negative for product acceptance. Therefore it is best to limit the composition to less than 10%, less than about 8%, less than about 6%, or less than about 3%, by weight of the composition.
  • Nonlimiting examples of other optional materials include emulsifiers, distributing agents, antimicrobials, pharmaceutical or other topical active, preservatives, surfactants, and so forth. Examples of such optional materials are described in U.S. Pat. No. 4,049,792; U.S. Pat. No. 5,019,375; and U.S. Pat. No. 5,429,816; which descriptions are incorporated herein by reference.
  • Soft solid composition can comprise volatile silicone, antiperspirant active, gellant, residue masking material, or combinations thereof.
  • soft solids generally have a hardness value after dispensing of about 500 gram force or less.
  • the soft solid can comprises a volatile silicone solvent at concentrations ranging from about 20% to about 80%, preferably from about 30% to about 70%, more preferably from about 45% to about 70%, by weight of the composition.
  • the volatile silicone of the solvent may be cyclic or linear.
  • Volatile silicone refers to those silicone materials which have measurable vapor pressure under ambient conditions.
  • suitable volatile silicones are described in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976), which descriptions are incorporated herein by reference.
  • Preferred volatile silicone materials are those having from about 3 to about 7, preferably from about 4 to about 5, silicon atoms.
  • Cyclic volatile silicones are preferred for use in the antiperspirant compositions herein, and include those represented by the formula:
  • n is from about 3 to about 7, preferably from about 4 to about 5, most preferably 5.
  • These cyclic silicone materials will generally have viscosities of less than about 10 centistokes at 25° C.
  • Linear volatile silicone materials suitable for use in the antiperspirant compositions include those represented by the formula:
  • n is from about 1 to about 7, preferably from about 2 to about 3.
  • These linear silicone materials will generally have viscosities of less than about 5 centistokes at 25° C.
  • volatile silicone solvents suitable for use in the antiperspirant compositions include, but are not limited to, Cyclomethicone D-5 (commercially available from G. E. Silicones), Dow Corning 344, Dow Corning 345 and Dow Corning 200 (commercially available from Dow Corning Corp.), GE 7207 and 7158 (commercially available from General Electric Co.) and SWS-03314 (commercially available from SWS Silicones Corp.).
  • the soft solid can include a gellant material comprising fatty alcohols having from about 20 to about 60 carbon atoms, or combinations thereof, at concentrations ranging from about 0.1% to about 8% by weight of the composition.
  • the gellant material when combined with the volatile silicone solvent described hereinbefore, provides the composition with a physically stable structure within which the particulate antiperspirant materials are dispersed, and maintained as such over an extended period of time.
  • the gellant material can comprise saturated or unsaturated, substituted or unsubstituted, fatty alcohols or mixtures of fatty alcohols having from about 20 to about 60 carbons atoms, preferably from about 20 to about 40 carbon atoms. Preferred are combinations of the fatty alcohols.
  • the fatty alcohol gellants are preferably saturated, unsubstituted monohydric alcohols or combinations thereof, which have a melting point of at less than about 110° C., more preferably from about 60° to about 110° C., even more preferably between about 100° C. and 110° C.
  • this fatty alcohol-based gellant material when combined with volatile silicone solvents provides a stable structure for maintaining a dispersion of particulate antiperspirant material in a topical formulation without the necessity of using conventional particulate thickening agents.
  • This gellant material is especially useful in maintaining the physical stability of particulate dispersions containing higher concentrations of volatile silicone solvents.
  • penetration force values for the antiperspirant compositions can be controlled by adjusting total fatty alcohol concentrations.
  • organic solvents or thickening agents to control penetration force values, which solvents or thickening agents often add cost to the formulation, introduce additional compatibility issues, and often contribute undesirable cosmetics such as prolonged stickiness, difficulty in ease of spreading, increased dry-down times and reduced dry feel after application.
  • Specific concentrations of the gellant materials can be selected according to the desired penetration force value.
  • gellant material concentrations preferably range from about 0.1% to about 3% , preferably from about 1.5% to about 3%, by weight of the antiperspirant composition.
  • gellant material concentrations preferably range from about 3% to about 8%, preferably from about 3% to about 6%, by weight of the antiperspirant composition.
  • fatty alcohol gellants for use in the antiperspirant compositions include, but are not limited to, Unilin® 425, Unilin® 350, Unilin® 550 and Unilin® 700 (supplied by Petrolite)
  • the soft solid compositions can further comprise a nonvolatile emollient as a residue masking material
  • a nonvolatile emollient as a residue masking material
  • any such material may be incorporated into the composition of the present invention, provided that such optional material is compatible with the essential elements of the composition, or does not unduly impair product performance or cosmetics.
  • Concentrations of the optional residue masking material can range from about 0.1% to about 40%, preferably from about 1% to about 10%, by weight of the antiperspirant composition.
  • These optional materials can be liquid at ambient temperatures, and can be nonvolatile.
  • the term “nonvolatile” as used in this context refers to materials which have a boiling point under atmospheric pressure of at least about 200° C.
  • suitable residue masking materials for use in the antiperspirant products include butyl stearate, diisopropyl adipate, petrolatum, nonvolatile silicones, octyldodecanol, phenyl trimethicone, isopropyl myristate, C12-15 ethanol benzoates and PPG-14 Butyl Ether. Residue masking materials are described, for example, in U.S. Pat. No. 4,985,238, which description is incorporated herein by reference.
  • the soft solid compositions can further comprise one, or more, other materials which modify the physical characteristics of the compositions or serve as additional “active” components when deposited on the skin.
  • materials are known in the antiperspirant art and can be used in the antiperspirant compositions herein, provided that such optional materials are compatible with the essential materials described herein, or do not otherwise unduly impair product performance.
  • Non limiting examples of materials can include active components such as bacteriostats and fungiostats, and “non-active” components such as colorants, perfumes, cosmetic powders, emulsifiers, chelants, distributing agents, preservatives, and wash-off aids. Examples of such optional materials are described in U.S. Pat. No. 4,049,792; Canadian Patent 1,164,347; U.S. Pat. No. 5,019,375; and U.S. Pat. No. 5,429,816; which descriptions are incorporated herein by reference.
  • An aerosol composition can comprise a concentrate, a propellant, or a combination thereof.
  • Alcohol is a predominant component of the concentrates provided herein.
  • Useful alcohols include C 1 -C 3 alcohols, with the preferred alcohol being ethanol.
  • the alcohol is employed at a concentration level of from at least about 40%, 50% or 55% to about 80%, by weight of the concentrate.
  • An antiperspirant active is dissolved in the alcohol, at a level of from about 1% to about 15%, by weight of the concentrate.
  • Various antiperspirant actives can be employed, including, for example, aluminum chloride, aluminum chlorohydrate, aluminum chlorohydrex, aluminum chlorohydrex PG, aluminum chlorohydrex PEG, aluminum dichlorohydrate, aluminum dichlorohydrex PG, aluminum dichlorohydrex PEG, aluminum sesquichlorohydrate, aluminum sesquichlorohydrex PG, aluminum sesquichlorohydrex PEG, aluminum sulfate, aluminum zirconium octachlorohydrate, aluminum zirconium octachlorohydrex GLY, aluminum zirconium pentachlorohydrate, aluminum zirconium pentachlorohydrex GLY, aluminum zirconium tetrachlorohydrate, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate GLY, and aluminum zirconium trichloro
  • the antiperspirant concentrates can also include an oil or a mixture of two or more oils.
  • Useful oils include, for example, volatile silicone oils and non-volatile organic oils.
  • Volatile silicone refers to those silicone materials that have measurable vapor pressure under ambient conditions. Non-limiting examples of suitable volatile silicones are described in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976).
  • the volatile silicone can be a cyclic silicone having from at least about 3 silicone atoms or from at least about 5 silicone atoms but no more than about 7 silicone atoms or no more than about 6 silicone atoms.
  • volatile silicones can be used which conform to the formula:
  • n is from about 3 or from about 5 but no more than about 7 or no more than about 6.
  • volatile cyclic silicones generally have a viscosity of less than about 10 centistokes at 25° C.
  • Suitable volatile silicones for use herein include, but are not limited to, Cyclomethicone D5 (commercially available from G. E. Silicones); Dow Corning 344, and Dow Corning 345 (commercially available from Dow Corning Corp.); and GE 7207, GE 7158 and Silicone Fluids SF-1202 and SF-1173 (available from General Electric Co.).
  • Suitable volatile silicone oils can also include linear silicone oils such as, for example, DC200 (1 cSt), DC200 (0.65 cSt), and DC2-1184, all of which are available from Dow Corning Corp.
  • the volatile silicone oil can have a viscosity of less than 10 centistokes at 25° C.
  • Non-volatile organic, emollient oils can also be employed.
  • a representative, non-limiting list of emollient oils includes CETIOL CC (dicaprylyl carbonate), CETIOL OE (dicaprylyl ether), CETIOL S (diethylhexylcyclohexane), and CETIOL B (dibutyl adipate), all of which are available from Cognis, and LEXFEEL 7 (neopentyl glycol diheptanoate) from Inolex.
  • the organic emollient oils have a viscosity of less than 50 centistokes at 25° C.
  • organic emollient oil as used herein means silicon-free emollient oils that are liquid at 25° C., and that are safe and light to skin and can be miscible with volatile silicone oils (as described above) and the antiperspirant active-alcohol solution in the concentration ranges described below.
  • the oil or mixture of oils is generally included in the concentrate formulas at a level of from about 5% to about 45%, by weight of the concentrate.
  • This viscosity ranges noted above in connection with the different classes of oil can facilitate desired spray rates and patterns, and can help minimize nozzle clogging.
  • the ratio of alcohol to volatile silicone oil is preferably greater than 1.0, 1.35, or 1.5.
  • the ratio of alcohol to total oil is preferably greater than or equal to about 0.90.
  • the oils in certain examples are miscible with the alcohol and antiperspirant active solution. Although various levels of miscibility are acceptable, the oils are preferably miscible enough with the alcohol and antiperspirant active solution to yield a concentrate having a clear appearance.
  • the antiperspirant compositions can also include residue-masking agents and propellants as discussed above.
  • Malodor reduction materials may be separated from mixtures, including but not limited to finished products such as consumer products and identified, by analytical methods that include GC-MS and/or NMR.
  • the saturation Vapour Pressure (VP) values are computed for each PRM in the perfume mixture being tested.
  • the VP of an individual PRM is calculated using the VP Computational Model, version 14.02 (Linux) available from Advanced Chemistry Development Inc. (ACD/Labs) (Toronto, Canada) to provide the VP value at 25° C. expressed in units of torr.
  • the ACD/Labs' Vapor Pressure model is part of the ACD/Labs model suite.
  • the value of the log of the Octanol/Water Partition Coefficient (log P) is computed for each PRM in the perfume mixture being tested.
  • the log P of an individual PRM is calculated using the Consensus log P Computational Model, version 14.02 (Linux) available from Advanced Chemistry Development Inc. (ACD/Labs) (Toronto, Canada) to provide the unitless log P value.
  • the ACD/Labs' Consensus log P Computational Model is part of the ACD/Labs model suite.
  • the starting information required includes the identity, weight percent, and molar percent of each PRM in the perfume being tested, as a proportion of that perfume, wherein all PRMs in the perfume composition are included in the calculations. Additionally for each of those PRMs, the molecular structure, and the values of various computationally-derived molecular descriptors are also required, as determined in accordance with the Test Method for the Generation of Molecular Descriptors described herein.
  • CAS Chemical Abstract Service
  • PRMs For each PRM in a perfume mixture or composition, its molecular structure is used to compute various molecular descriptors.
  • the molecular structure is determined by the graphic molecular structure representations provided by the Chemical Abstract Service (“CAS”), a division of the American Chemical Society, Columbus, Ohio, U.S.A. These molecular structures may be obtained from the CAS Chemical Registry System database by looking up the index name or CAS number of each PRM. For PRMs, which at the time of their testing are not yet listed in the CAS Chemical Registry System database, other databases or information sources may be used to determine their structures.
  • CAS Chemical Abstract Service
  • the molecular descriptor computations are conducted using the molecular structure of only one of the isomers, which is selected to represent that PRM.
  • the selection of isomer is determined by the relative amount of extension in the molecular structures of the isomers. Of all the isomers of a given PRM, it is the isomer whose molecular structure that is the most prevalent which is the one that is selected to represent that PRM. The structures for other potential isomers of that PRM are excluded from the computations.
  • the molecular structure of the isomer that is the most prevalent is paired with the concentration of that PRM, where the concentration reflects the presence of all the isomers of that PRM that are present.
  • a molecule editor or molecular sketching software program such as ChemDraw (CambridgeSoft/PerkinElmer Inc., Waltham, Mass., U.S.A.), is used to duplicate the 2-dimensional molecular structure representing each PRM.
  • Molecular structures should be represented as neutral species (quaternary nitrogen atoms are allowed) with no disconnected fragments (e.g., single structures with no counter ions).
  • the winMolconn program described below can convert any deprotonated functional groups to the neutral form by adding the appropriate number of hydrogen atoms and will discard the counter ion.
  • the molecular sketching software is used to generate a file which describes the molecular structure of the PRM.
  • the file(s) describing the molecular structures of the PRMs is subsequently submitted to the computer software program winMolconn, version 1.0.1.3 (Hall Associates Consulting, Quincy, Mass., U.S.A., www.molconn.com), in order to derive various molecular descriptors for each PRM.
  • winMolconn version 1.0.1.3 (Hall Associates Consulting, Quincy, Mass., U.S.A., www.molconn.com)
  • MACCS SDF formatted file i.e., a Structure-Data File
  • Simplified Molecular Input Line Entry Specification i.e., a SMILES string structure line notation
  • the SDF file represents each molecular structure in the format of a multi-line record, while the syntax for a SMILES structure is a single line of text with no white space.
  • the winMolconn software program is used to generate numerous molecular descriptors for each PRM, which are then output in a table format. Specific molecular descriptors derived by winMolconn are subsequently used as inputs (i.e., as variable terms in mathematical equations) for a variety of computer model test methods in order to calculate values such as: saturation Vapour Pressure (VP); Boiling Point (BP); logarithm of the Octanol/Water Partition Coefficient (log P); Odour Detection Threshold (ODT); Malodour Reduction Value (MORV); and/or Universal Malodour Reduction Value (Universal MORV) for each PRM.
  • VP saturation Vapour Pressure
  • BP Boiling Point
  • log P logarithm of the Octanol/Water Partition Coefficient
  • ODT Odour Detection Threshold
  • MORV Malodour Reduction Value
  • Universal MORV Universal Malodour Reduction Value
  • the molecular descriptor labels used in the models' test method computations are the same labels reported by the winMolconn program, and their descriptions and definitions can be found listed in the winMolconn documentation. The following is a generic description of how to execute the winMolconn software program and generate the required molecular structure descriptors for each PRM in a composition.
  • Blocker materials suitable for use in consumer products of the present invention are chosen for their ability to decrease malodor, while not interfering with perception of a fragrance.
  • Material selection is done by assigning two indices to a test sample material from two reference scales in order to rank odor strengths.
  • the two reference scales are the Fragrance Fidelity Index (FFI) scale and the Blocker Index (BI) scale.
  • FFI ranks the ability of the test sample material to impart a perceivable odor which could cause interference when combined with another fragrance
  • the BI ranks the ability of the test sample material to reduce malodor perception.
  • the two methods for assigning the indices to a test sample on the FFI and the BI reference scales are given below.
  • the first step in the method for assigning an FFI on the FFI reference scale is to create the FFI reference swatches.
  • the swatches for the scale are created by treating clean fabrics swatches with a known amount of a known concentration of an ethyl vanillin solution.
  • Fabric swatches for this test are white knit polycotton (4 inch ⁇ 4 inch) swatches from EMC ordered as PC 50/50. The supplier is instructed to strip the swatches first, stripping involves washing twice with a fragrance-free detergent and rinsing three times.
  • a clean untreated swatch is also included as the lowest anchor point of reference for odor strength on the FFI scale.
  • the FFI reference scale swatches should be used within 0.5 to 12 hours and discarded after 12 hours.
  • the swatches are used as scale anchor points when graders evaluate a test sample(s) and are assigned a Fragrance Fidelity Index (FFI) as show in Table 7.
  • FFI Fragrance Fidelity Index
  • At least four perfumers/expert graders are used to rank the ethyl vanillin swatches in the FFI scale.
  • the perfumer/expert grader needs to demonstrate adequate discrimination on the scale.
  • the perfumer/expert panel is asked to rank order swatches according to a scale between 0 and 3. The panel must demonstrate statistical differences between the swatches as seen in Table 7.
  • the expert graders must demonstrate a full range of 2.5 over the 4 swatches to be acceptably discriminating.
  • Grader 2 in table 1 has a range of only 2 and is eliminated from the panel.
  • the panel of expert graders must also demonstrated the ability to statistically discriminate between swatches in the scale.
  • the reference swatches represent the 0, 1, 2, and 3 FFIs on the FFI reference scale, Table 9.
  • the expert grader should familiarize them self with the strength of the odor on the FFI reference swatches by sniffing each one starting at 0 (the lowest odor strength) and ending at 3 (the highest odor strength). This should be done prior to evaluating the test sample material treated swatch.
  • a clean swatch is treated with 13 ⁇ L of a known concentration of a test sample material resulting in an about 1 cm of the solution on the clean swatch.
  • the test sample material swatch is dried in a vented hood for 30 minutes and then wrapped in aluminum foil to prevent contamination.
  • the test material swatches and the FFI reference swatches should be made within 2 hrs. of each other.
  • the test material swatch must be used within 0.5 to 12 hours and discarded after 12 hours.
  • At least two perfumers/expert graders are used to assign an FFI grade to a test sample.
  • the perfumer/expert grader smells the test sample swatch by holding that swatch 1 inch from their nose with their nose centered over the area where the test sample was pipetted on to the fabric and then assigns the test sample an FFI grade using the FFI reference scale anchor swatches as references.
  • the test sample swatch is assigned an FFI grade at or between numbers on the FFI scale shown in Table 9. In cases where the test sample material is graded greater than 3, the test material is not a blocker material or the concentration of the material needs to be lowered and reevaluated to determine if a lower level has a malodor blocker functionality.
  • the first step in the method for assigning a BI to a test sample material on the BI reference scale is to create the BI reference swatches.
  • the swatches for the scale are created by treating clean fabrics swatches with a known amount of a known volume of isovaleric acid solution at a known concentration.
  • Fabric swatches for this test are white knit polycotton (4 inch ⁇ 4 inch) swatches from EMC ordered as PC 50/50. The supplier is instructed to strip the swatches first, stripping involves washing twice with a fragrance-free detergent and rinsing three times.
  • At least four perfumers/expert graders are used to rank the isovaleric acid swatches in the BI scale.
  • the perfumer/expert grader needs to demonstrate adequate discrimination on the scale.
  • the perfumer/expert grader is asked to rank order swatches according to a scale between 0 and 3.
  • the panel of graders must demonstrate statistical differences between the swatches as seen in Table 10.
  • the expert graders must demonstrate a full range of 2.5 over the 4 swatches to be acceptably discriminating.
  • the panel of expert graders must also demonstrated the ability to statistically discriminate between swatches in the scale.
  • Expert grader #2 did not demonstrate the ability to discriminate between the swatches and is eliminated from the panel, see Table 11.
  • the reference swatches represent the 0, 1, 2, and 3 BIs on the BI reference scale, Table 12.
  • the expert grader should familiarizes him/herself with the strength of the odor on the BI reference swatches by sniffing each one starting at 0 (the lowest odor strength) and ending at 3 (the highest odor strength). This should be done prior to evaluating the swatch treated with the test material.
  • the test material is applied to a malodorous swatch to determine how well the test material blocks the malodor.
  • the malodorous swatch is made by treating a clean swatch with 20 ⁇ L of a 0.08% solution of isovaleric acid. Dry the malodorous swatch treated with isovaleric acid in a vented hood for 30 minutes. After drying the malodorous swatch a known concentration of test material solution, between 1 ppm and 100 ppm is pipetted onto the malodorous swatch. Apply the test material solution right on top of the spot where the isovaleric acid solution was applied making an about 1 cm diameter spot.
  • the isovaleric acid+test material swatch is dried in a vented hood for 30 minutes and then wrapped in aluminum foil to prevent contamination.
  • the isovaleric acid+test material swatches and the BI reference swatches should be made within 2 hrs. of each other.
  • the isovaleric acid+test material swatch must be used between 1-12 hours just like the reference swatches. It is sometimes necessary to evaluate several levels of the test material between about 1 and about 100 ppm to determine the BI.
  • At least two perfumers/expert graders are used to assign the BI to the test sample.
  • the expert grader smells the isovaleric acid+test material swatch by holding that swatch one inch from their nose with their nose centered over the area where the Test sample was pipetted on to the fabric and then assigns the isovaleric acid+test material swatch a BI based on ranking its odor strength against the odor strength of the swatches in the BI reference scale.
  • the test sample swatch is assigned a BI at or between numbers on the BI in table. In cases where the isovaleric acid+test material swatch odor is greater than 3 on the BI reference scale, this indicates the material is not a blocker or the concentration of the test material needs to be lowered to achieve its blocker functionality.
  • compositions Comprising Malodor Reduction Compounds
  • blends enable more potent malodor reduction because blends are useful at a higher % of the product composition before becoming olfactively noticeable.
  • malodor reduction compounds include
  • Active Component CAS# A B C D E 2,2,8,8-tetramethyl-octahydro-1H- 29461-14-1 35-45 15-25 5-20 10-30 15-25 2,4a-methanonapthalene-10-one 1H-Indene-ar-propanal, 2,3- 300371-33-9 10-20 1-30 NIL 5-10 1-5 dihydro-1,1-dimethyl- Hexadecanoic acid, (2E)-3,7- 3681-73-0 35-45 10-25 NIL 30-40 35-50 dimethyl-2,6-octadien-1-yl ester 1-Pentanol-3-methyl-5-phenyl 55066-48-3 10-20 10-25 2-10 5-17 10 4,7-Methano-1H-inden-5-ol, 171102-41-3 0-5 10-25 NIL 1-6 1-5 3a,4,5,6,7,7a-hexahydro-, 5-acetate 4,8-dimethyl-1-(methylethyl)-7-
  • compositions Comprising Malodor Reduction Compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Theoretical Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Computing Systems (AREA)
  • Mathematical Physics (AREA)
  • Data Mining & Analysis (AREA)
  • Dispersion Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mathematical Analysis (AREA)
  • Computational Mathematics (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Software Systems (AREA)
  • Algebra (AREA)
  • Databases & Information Systems (AREA)

Abstract

The present invention relates to antiperspirant and deodorant compositions comprising malodor reduction compositions and methods of making and using such antiperspirant and deodorant compositions. Such antiperspirant and deodorant compositions comprising the malodor control technologies disclosed herein provide malodor control without leaving an undesirable scent and when perfume is used to scent such compositions, such scent is not unduely altered by the malodor control technology.

Description

    FIELD OF THE INVENTION
  • The present invention relates to antiperspirant and deodorant compositions comprising malodor reduction compositions and methods of making and using such antiperspirant and deodorant compositions.
  • BACKGROUND OF THE INVENTION
  • Unscented or scented products are desired by consumers as they may be considered more natural and discreet than scented products. Manufacturers of unscented or scented products for controlling malodors rely on malodor reduction ingredients or other technologies (e.g. filters) to reduce malodors. However, effectively controlling malodors, for example, amine-based malodors (e.g. fish and urine), thiol and sulfide-based malodors (e.g. garlic and onion), C2-C12 carboxylic acid based malodors (e.g. body and pet odor), indole based malodors (e.g. fecal and bad breath), short chain fatty aldehyde based malodors (e.g. grease) and geosmin based malodors (e.g. mold/mildew) may be difficult, and the time required for a product to noticeably reduce malodors may create consumer doubt as to the product's efficacy on malodors. Often times, manufacturers incorporate scented perfumes to help mask these difficult malodors.
  • Unfortunately, malodor control technologies typically cover up the malodor with a stronger scent and thus interfere with the scent of the perfumed or unperfumed situs that is treated with the malodor control technology. Thus, limited nature of the current malodor control technologies is extremely constraining. Thus what is needed is a broader palette of malodor control technologies so the perfume community can deliver the desired level of character in a greater number of situations/applications. Surprisingly, Applicants recognized that in addition to blocking a malodor's access to a sensory cell, in order to achieve the desired goal, a malodor control technology must leave such sensor cell open to other molecules, for example scent molecules. Thus, antiperspirant and deodorant compositions comprising the malodor control technologies disclosed herein provide malodor control without leaving an undesirable scent and when perfume is used to scent such compositions, such scent is not unduely altered by the malodor control technology.
  • SUMMARY OF THE INVENTION
  • The present invention relates to antiperspirant and deodorant compositions comprising malodor reduction compositions and methods of making and using such antiperspirant and deodorant compositions. Such antiperspirant and deodorant compositions comprising the malodor control technologies disclosed herein provide malodor control without leaving an undesirable scent and when perfume is used to scent such compositions, such scent is not unduely altered by the malodor control technology.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Definitions
  • “Ambient” refers to surrounding conditions at about one atmosphere of pressure, 50% relative humidity and about 25° C.
  • “Anhydrous” refers to compositions and/or components which are substantially free of added or free water.
  • “Antiperspirant composition” refers to antiperspirant compositions, deodorant compositions, and the like. For example, antiperspirant creams, gels, soft solid sticks, body sprays, and aerosols.
  • “Soft solid” refers to a composition with a static yield stress of about 200 Pa to about 1,300 Pa. The term “solid” includes granular, powder, bar and tablet product forms.
  • The term “fluid” includes liquid, gel, paste and gas product forms.
  • The term “situs” includes paper products, fabrics, garments, hard surfaces, hair and skin.
  • The term “substantially free of refers to about 2% or less, about 1% or less, or about 0.1% or less of a stated ingredient. “Free of refers to no detectable amount of the stated ingredient or thing.
  • As used herein “MORV” is the calculated malodor reduction value for a subject material. A material's MORV indicates such material's ability to decrease or even eliminate the perception of one or more malodors. For purposes of the present application, a material's MORV is calculated in accordance with method found in the test methods section of the present application.
  • As used herein, “malodor” refers to compounds generally offensive or unpleasant to most people, such as the complex odors associated with bowel movements.
  • As used herein, “neutralize” or “neutralization” refers to the ability of a compound or product to reduce or eliminate malodorous compounds. Odor neutralization may be partial, affecting only some of the malodorous compounds in a given context, or affecting only part of a malodorous compound. A malodorous compound may be neutralized by chemical reaction resulting in a new chemical entity, by sequestration, by chelation, by association, or by any other interaction rendering the malodorous compound less malodorous or non-malodorous. Neutralization is distinguishable from odor masking or odor blocking by a change in the malodorous compound, as opposed to a change in the ability to perceive the malodor without any corresponding change in the condition of the malodorous compound. Malodor neutralization provides a sensory and analytically measurable (e.g. gas chromatograph) malodor reduction. Thus, if a malodor reduction composition delivers genuine malodor neutralization, the composition will reduce malodors in the vapor and/or liquid phase.
  • As used herein, “odor blocking” refers to the ability of a compound to dull the human sense of smell.
  • As used herein, “odor masking” refers to the ability of a compound with a non-offensive or pleasant smell that is dosed such that it limits the ability to sense a malodorous compound. Odor-masking may involve the selection of compounds which coordinate with an anticipated malodor to change the perception of the overall scent provided by the combination of odorous compounds.
  • As used herein, the term “perfume” does not include malodor reduction materials. Thus, the perfume portion of a composition does not include, when determining the perfume's composition, any malodor reduction materials found in the composition as such malodor reduction materials are described herein. In short, if a material has a malodor reduction value “MORV” that is within the range of the MORV recited in the subject claim, such material is a malodor reduction material for purposes of such claim.
  • As used herein, the terms “a” and “an” mean “at least one”.
  • As used herein, the terms “include”, “includes” and “including” are meant to be non-limiting.
  • Unless otherwise noted, all component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.
  • All percentages and ratios are calculated by weight unless otherwise indicated. All percentages and ratios are calculated based on the total composition unless otherwise indicated.
  • It should be understood that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this specification will include every higher numerical limitation, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this specification will include every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.
  • Malodor Reduction Materials
  • A non-limiting set of suitable malodor reduction materials are provided in the tables below. For ease of use, each material in Tables 1-3 is assigned a numerical indentifier which is found in the column for each table that is designated Number. Table 4 is a subset of Table 1, Table 5 is a subset of Table 2 and Table 6 is a subset of Table 3 and there for Tables 4, 5 and 6 each use the same numerical identifier as found, respectively, in Tables 1-3.
  • Codes
  • A=Vapor Pressure>0.1 torr
    B=Vapor Pressure is between 0.01 torr and 0.1 torr
  • C=LogP<3 D=LogP>3 E=Probability of Ingredient Color Instability=0% F=Probability of Ingredient Color Instability<71%
  • G=Odor Detection Threshold less than p.ol=8
    H=Odor Detection Threshold greater than p.ol=8
    I=Melamine formaldehyde PMC Headspace Response Ratio greater than or equal to 10
    J=Melamine formaldehyde PMC leakage less than or equal to 5%
    K=Log of liquid dish neat product liquid-air partition coefficient greater than or equal to -7
    L=Log of liquid dish neat product liquid-air partition coefficient greater than or equal to -5
  • TABLE 1
    List of materials with at least one MORV from 1 to 5
    Num- CAS Comment
    ber Material Name Number Code
    1 2-ethylhexyl (Z)-3-(4- 5466-77-3 DEFHJ
    methoxyphenyl)acrylate
    2 2,4-dimethyl-2-(5,5,8,8-tetramethyl- 131812-67-4 DFHJ
    5,6,7,8-tetrahydronaphthalen-2-yl)-
    1,3-dioxolane
    3 1,1-dimethoxynon-2-yne 13257-44-8 ACEFHJK
    4 para-Cymen-8-ol 1197-01-9 BCGIJK
    7 3-methoxy-7,7-dimethyl-10- 216970-21-7 BDEFHJK
    methylenebicyclo[4.3.1]decane
    9 Methoxycyclododecane 2986-54-1 DEFHJK
    10 1,1-dimethoxycyclododecane 950-33-4 DEFHJK
    11 (Z)-tridec-2-enenitrile 22629-49-8 DEFHJK
    13 Oxybenzone 131-57-7 DEFGJ
    14 Oxyoctaline formate 65405-72-3 DFHJK
    16 4-methyl-1-oxaspiro[5.5]undecan-4- 57094-40-3 CFGIJK
    ol
    17 7-methyl-2H-benzo[b][1,4]dioxepin- 28940-11-6 CGIK
    3(4H)-one
    18 1,8-dioxacycloheptadecan-9-one 1725-01-5 DGJ
    21 4-(tert-pentyl)cyclohexan-1-one 16587-71-6 ADFGIJKL
    22 o-Phenyl anisol 86-26-0 DEFHJK
    23 3a,5,6,7,8,8b-hexahydro- 823178-41-2 DEFHJK
    2,2,6,6,7,8,8-heptamethyl-4H-
    indeno(4,5-d)-1,3-dioxole
    25 7-isopropyl-8,8-dimethyl-6,10- 62406-73-9 BDEFHIJK
    dioxaspiro[4.5]decane
    28 Octyl 2-furoate 39251-88-2 DEFHJK
    29 Octyl acetate 112-14-1 BDEFHJKL
    30 octanal propylene glycol acetal 74094-61-4 BDEFHJKL
    31 Octanal 124-13-0 ACHIKL
    32 Octanal dimethyl acetal 10022-28-3 ACEFGJKL
    33 Myrcene 123-35-3 ADEFGIKL
    34 Myrcenol 543-39-5 BCEFGIJK
    35 Myrcenyl acetate 1118-39-4 ADEFGJK
    36 Myristaldehyde 124-25-4 DFHJK
    37 Myristicine 607-91-0 CGJK
    38 Myristyl nitrile 629-63-0 DEFHJK
    39 2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a- 103614-86-4 DEFHIJK
    octahydronaphthalen-1-ol
    42 Ocimenol 5986-38-9 BCHIJK
    43 Ocimenol 28977-58-4 BCHIJK
    47 Nopyl acetate 128-51-8 DEFHJK
    48 Nootkatone 4674-50-4 DHJK
    49 Nonyl alcohol 143-08-8 BDEFGIJKL
    50 Nonaldehyde 124-19-6 ADHIKL
    52 12-methyl-14-tetradec-9-enolide 223104-61-8 DFHJK
    57 N-ethyl-p-menthane-3-carboxamide 39711-79-0 DEFGIJK
    61 1-(3-methylbenzofuran-2-yl)ethan-1- 23911-56-0 CEFHIK
    one
    62 2-methoxynaphthalene 93-04-9 BDEFHK
    63 Nerolidol 7212-44-4 DEFHJK
    64 Nerol 106-25-2 BCHIK
    65 1-ethyl-3- 31996-78-8 ACEFHIJKL
    methoxytricyclo[2.2.1.02,6]heptane
    67 Methyl (E)-non-2-enoate 111-79-5 ADEFHJKL
    68 10-isopropyl-2,7-dimethyl-1- 89079-92-5 BDEFHIJK
    oxaspiro[4.5]deca-3,6-diene
    69 2-(2-(4-methylcyclohex-3-en-1- 95962-14-4 DHJK
    yl)propyl)cyclopentan-1-one
    70 Myrtenal 564-94-3 ACFHIJKL
    71 (E)-4-(2,2,3,6- 54992-90-4 BDEFHIJK
    tetramethylcyclohexyl)but-3-en-2-
    one
    74 Myraldyl acetate 53889-39-7 DHJK
    75 Musk tibetine 145-39-1 DHIJ
    76 1,7-dioxacycloheptadecan-8-one 3391-83-1 DGJ
    77 Musk ketone 81-14-1 DHJ
    78 Musk ambrette 83-66-9 DHIJ
    79 3-methylcyclopentadecan-1-one 541-91-3 DEFHJK
    80 (E)-3-methylcyclopentadec-4-en-1- 82356-51-2 DHJK
    one
    82 3-methyl-4-phenylbutan-2-ol 56836-93-2 BCEFHIK
    83 1-(4-isopropylcyclohexyl)ethan-1-ol 63767-86-2 BDEFHIJK
    85 Milk Lactone 72881-27-7 DEFHJK
    91 Methyl octine carbonate 111-80-8 BDEFHKL
    92 Methyl octyl acetaldehyde 19009-56-4 ADFHJKL
    93 6,6-dimethoxy-2,5,5-trimethylhex-2- 67674-46-8 ACHIJKL
    ene
    98 Methyl phenylethyl carbinol 2344-70-9 BCEFHIK
    100 Methyl stearate 112-61-8 DEFHJ
    101 Methyl nonyl acetaldehyde dimethyl 68141-17-3 BDEFHJK
    acetal
    102 Methyl nonyl ketone 112-12-9 BDFHJKL
    103 Methyl nonyl acetaldehyde 110-41-8 BDFHJK
    104 Methyl myristate 124-10-7 DEFHJK
    105 Methyl linoleate 112-63-0 DEFHJ
    106 Methyl lavender ketone 67633-95-8 CFHJK
    108 Methyl isoeugenol 93-16-3 ACEFHK
    109 Methyl hexadecanoate 112-39-0 DEFHJK
    110 Methyl eugenol 93-15-2 ACEFHK
    112 Methyl epijasmonate 1211-29-6 CHJK
    113 Methyl dihydrojasmonate 24851-98-7 DFHJK
    114 Methyl diphenyl ether 3586-14-9 DEFHJK
    117 Methyl cinnamate 103-26-4 BCEFHK
    119 Methyl chavicol 140-67-0 ADEFHK
    120 Methyl beta-naphthyl ketone 93-08-3 CEFHK
    122 Methyl 2-octynoate 111-12-6 ACEFHKL
    123 Methyl alpha-cyclogeranate 28043-10-9 ACHIJKL
    126 Methoxycitronellal 3613-30-7 ACFGIJK
    128 Menthone 1,2-glycerol ketal 67785-70-0 CEFHJ
    (racemic)
    130 Octahydro-1H-4,7-methanoindene-1- 30772-79-3 BCFHIJKL
    carbaldehyde
    134 3-(3-(tert-butyl)phenyl)-2- 62518-65-4 BDHJK
    methylpropanal
    135 (E)-4-(4,8-dimethylnona-3,7-dien-1- 38462-23-6 DEFHJK
    yl)pyridine
    137 (E)-trideca-3,12-dienenitrile 134769-33-8 DEFHJK
    140 2,2-dimethyl-3-(m-tolyl)propan-1-ol 103694-68-4 CEFHIJK
    141 2,4-dimethyl-4,4a,5,9b- 27606-09-3 CEFHJK
    tetrahydroindeno[1,2-d][1,3]dioxine
    142 Maceal 67845-30-1 BDFHJK
    143 4-(4-hydroxy-4- 31906-04-4 CHJ
    methylpentyl)cyclohex-3-ene-1-
    carbaldehyde
    145 l-Limonene 5989-54-8 ADEFGIJKL
    146 (Z)-3-hexen-1-yl-2-cyclopenten-1- 53253-09-1 BDHK
    one
    148 Linalyl octanoate 10024-64-3 DEFHJ
    149 Linalyl isobutyrate 78-35-3 BDHJK
    152 Linalyl benzoate 126-64-7 DFHJ
    153 Linalyl anthranilate 7149-26-0 DFHJ
    155 Linalool oxide (furanoid) 60047-17-8 BCHIJK
    156 linalool oxide 1365-19-1 CGIJK
    158 (2Z,6E)-3,7-dimethylnona-2,6- 61792-11-8 BDEFHJK
    dienenitrile
    159 3-(4-methylcyclohex-3-en-1- 6784-13-0 ACFHIJK
    yl)butanal
    161 (2,5-dimethyl-1,3-dihydroinden-2- 285977-85-7 CEFHJK
    yl)methanol
    162 3-(4-(tert-butyl)phenyl)-2- 80-54-6 BDHJK
    methylpropanal
    167 (E)-1-(1-methoxypropoxy)hex-3-ene 97358-54-8 ACEFGJKL
    168 Leaf acetal 88683-94-7 ACEFGJKL
    170 l-Carveol 2102-58-1 BCHIJK
    174 Lauryl alcohol 112-53-8 DEFGJK
    175 Lauryl acetate 112-66-3 DEFHJK
    176 Lauric acid 143-07-7 DEFHJ
    177 Lactojasmone 7011-83-8 BDEFHIJKL
    178 Lauraldehyde 112-54-9 BDFHJK
    179 3,6-dimethylhexahydrobenzofuran- 92015-65-1 BCEFHIJKL
    2(3H)-one
    182 4-(1-ethoxyvinyl)-3,3,5,5- 36306-87-3 BDFHIJK
    tetramethylcyclohexan-1-one
    183 Khusimol 16223-63-5 CEFHJK
    184 5-(sec-butyl)-2-(2,4- 117933-89-8 DEFHJ
    dimethylcyclohex-3-en-1-yl)-5-
    methyl-1,3-dioxane
    185 (1-methyl-2-((1,2,2- 198404-98-7 DEFHJK
    trimethylbicyclo[3.1.0]hexan-3-
    yl)methyl)cyclopropyl)methanol
    186 2-propylheptanenitrile 208041-98-9 ADEFHIJKL
    187 (E)-6-(pent-3-en-1-yl)tetrahydro-2H- 32764-98-0 BCFHIKL
    pyran-2-one
    189 2-hexylcyclopentan-1-one 13074-65-2 BDFHJKL
    190 2-methyl-4-phenyl-1,3-dioxolane 33941-99-0 BCEFGIK
    192 2,6,9,10-tetramethyl-1- 71078-31-4 BDEFHIJK
    oxaspiro(4.5)deca-3,6-diene
    193 Isopulegol 89-79-2 BCEFHIJKL
    195 Isopropyl palmitate 142-91-6 DEFHJ
    196 Isopropyl myristate 110-27-0 DEFHJK
    197 Isopropyl dodecanoate 10233-13-3 DEFHJK
    199 Isopimpinellin 482-27-9 CFGJ
    206 Iso3-methylcyclopentadecan-1-one 3100-36-5 DEFGJK
    208 Isomenthone 491-07-6 ADEFGIJKL
    209 Isojasmone 95-41-0 BDFHJKL
    210 Isomenthone 36977-92-1 ADEFGIJKL
    211 Isohexenyl cyclohexenyl 37677-14-8 DFHJK
    carboxaldehyde
    212 Isoeugenyl benzyl ether 120-11-6 DFHJ
    215 1-((2S,3S)-2,3,8,8-tetramethyl- 54464-57-2 DHJK
    1,2,3,4,5,6,7,8-octahydronaphthalen-
    2-yl)ethan-1-one
    218 Isocyclocitral 1335-66-6 ACFHIJKL
    221 Isobutyl quinoline 65442-31-1 DEFHJK
    227 Isobornylcyclohexanol 68877-29-2 DEFHJK
    228 Isobornyl propionate 2756-56-1 BDEFHIJK
    229 Isobornyl isobutyrate 85586-67-0 BDEFHIJK
    230 Isobornyl cyclohexanol 66072-32-0 DEFHJK
    231 Isobornyl acetate 125-12-2 ADEFHIJKL
    233 Isobergamate 68683-20-5 DEFHJK
    234 Isoamyl undecylenate 12262-03-2 DEFHJK
    238 Isoamyl laurate 6309-51-9 DEFHJK
    242 Isoambrettolide 28645-51-4 DGJ
    243 Irisnitrile 29127-83-1 ADEFHKL
    244 Indolene 68527-79-7 DEFHJ
    246 Indol/Hydroxycitronellal Schiff base 67801-36-9 DEFHJ
    247 4,4a,5,9b-tetrahydroindeno[1,2- 18096-62-3 BCEFGJK
    d][1,3]dioxine
    249 Hydroxy-citronellol 107-74-4 CEFGIJK
    252 2-cyclododecylpropan-1-ol 118562-73-5 DEFHJK
    253 Hydrocitronitrile 54089-83-7 CEFHJK
    254 Hydrocinnamyl alcohol 122-97-4 BCEFHIK
    256 Hydratropaldehyde dimethyl acetal 90-87-9 ACEFHJK
    259 5-ethyl-4-hydroxy-2-methylfuran- 27538-09-6 CFGIK
    3(2H)-one
    260 2,3-dihydro-3,3-dimethyl-1H-indene- 173445-44-8 DHJK
    5-propanal
    261 3-(3,3-dimethyl-2,3-dihydro-1H- 173445-65-3 DHJK
    inden-5-yl)propanal
    263 Hexyl octanoate 1117-55-1 DEFHJK
    267 Hexyl hexanoate 6378-65-0 DEFHJKL
    269 Hexyl cinnamic aldehyde 101-86-0 DHJ
    271 Hexyl benzoate 6789-88-4 DEFHJK
    274 Hexenyl tiglate 84060-80-0 BDEFHJK
    276 (E)-3,7-dimethylocta-2,6-dien-1-yl 3681-73-0 DEFHJ
    palmitate
    277 Hexadecanolide 109-29-5 DEFGJK
    278 2-butyl-4,4,6-trimethyl-1,3-dioxane 54546-26-8 ADEFHIJKL
    280 Ethyl (1R,2R,3R,4R)-3- 116126-82-0 BDEFHIJK
    isopropylbicyclo[2.2.1]hept-5-ene-2-
    carboxylate
    281 3a,4,5,6,7,7a-hexahydro-1H-4,7- 5413-60-5 CEFGJK
    methanoinden-6-yl acetate
    285 2-(1-(3,3- 141773-73-1 DEFHJ
    dimethylcyclohexyl)ethoxy)-2-
    methylpropyl propionate
    286 Heliotropine diethyl acetal 40527-42-2 CEFGJ
    288 Helional 1205-17-0 CHJK
    289 (E)-oxacyclohexadec-13-en-2-one 111879-80-2 DGJK
    290 Gyrane 24237-00-1 ADEFHIJKL
    292 Guaiol 489-86-1 DEFHJK
    293 1-(2,6,6-trimethylcyclohex-2-en-1- 68611-23-4 DHJK
    yl)pentan-3-one
    294 Ethyl 2-ethyl-6,6-dimethylcyclohex- 57934-97-1 BDEFHIJK
    2-ene-1-carboxylate
    295 Germacrene B 15423-57-1 DEFHJK
    296 Germacrene D 23986-74-5 DEFHJK
    300 Geranyl phenylacetate 102-22-7 DFHJ
    301 Geranyl phenyl acetate 71648-43-6 DFHJ
    303 Geranyl linalool 1113-21-9 DFHJ
    307 Geranyl cyclopentanone 68133-79-9 DHJK
    316 gamma-Undecalactone (racemic) 104-67-6 DEFHJKL
    317 gamma-Terpinyl acetate 10235-63-9 BDHJK
    318 gamma-Terpineol 586-81-2 BCGIJK
    321 gamma-Nonalactone 104-61-0 BCEFHIKL
    322 gamma-Muurolene 30021-74-0 DEFHJKL
    323 gamma-(E)-6-(pent-3-en-1- 63095-33-0 BCEFHKL
    yl)tetrahydro-2H-pyran-2-one
    324 gamma-Ionone 79-76-5 BDEFHIJK
    325 gamma-Himachalene 53111-25-4 BDEFHJKL
    328 gamma-Gurjunene 22567-17-5 DEFHJKL
    329 gamma-Eudesmol 1209-71-8 DFHJK
    330 gamma-Dodecalactone 2305-05-7 DEFHJK
    331 gamma-Damascone 35087-49-1 BDEFHIJK
    332 gamma-Decalactone 706-14-9 BDEFHIJKL
    333 gamma-Cadinene 39029-41-9 DEFHJKL
    334 1-(3,3-dimethylcyclohexyl)pent-4- 56973-87-6 BDEFHJK
    en-1-one
    335 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8- 1222-05-5 DEFHJK
    hexahydrocyclopenta[g]isochromene
    336 Furfuryl octanoate 39252-03-4 DEFHJK
    338 Furfuryl hexanoate 39252-02-3 CEFHJK
    339 Furfuryl heptanoate 39481-28-2 CEFHJK
    342 2-methyldecanenitrile 69300-15-8 BDEFHJKL
    343 8,8-dimethyl-3a,4,5,6,7,7a- 76842-49-4 DEFHJK
    hexahydro-1H-4,7-methanoinden-6-
    yl propionate
    344 Ethyl (3aR,4S,7R,7aR)-octahydro- 80657-64-3 DEFHIJK
    3aH-4,7-methanoindene-3a-
    carboxylate
    347 Diethyl cyclohexane-1,4- 72903-27-6 CEFHJK
    dicarboxylate
    349 (6-isopropyl-9-methyl-1,4- 63187-91-7 CEFHJ
    dioxaspiro[4.5]decan-2-yl)methanol
    350 2-isobutyl-4-methyltetrahydro-2H- 63500-71-0 BCEFHIJK
    pyran-4-ol
    352 Undec-10-enenitrile 53179-04-7 BDEFHJK
    353 (Z)-6-ethylideneoctahydro-2H-5,8- 69486-14-2 CEFGJK
    methanochromen-2-one
    356 3-(2-ethylphenyl)-2,2- 67634-15-5 BDHJK
    dimethylpropanal
    358 (E)-4,8-dimethyldeca-4,9-dienal 71077-31-1 BDFHJK
    359 (E)-4-((3aR,4R,7R,7aR)- 501929-47-1 DEFHJK
    1,3a,4,6,7,7a-hexahydro-5H-4,7-
    methanoinden-5-ylidene)-3-
    methylbutan-2-ol
    360 8,8-dimethyl-3a,4,5,6,7,7a- 171102-41-3 DEFHJK
    hexahydro-1H-4,7-methanoinden-6-
    yl acetate
    361 3-(4-ethylphenyl)-2,2- 134123-93-6 DEFHJK
    dimethylpropanenitrile
    362 2-heptylcyclopentan-1-one 137-03-1 DFHJKL
    363 1-ethoxyethoxy Cyclododecane 389083-83-4 DEFHJK
    364 3-cyclohexene-1-carboxylic acid, 815580-59-7 ACHIJKL
    2,6,6-trimethyl-, methyl ester
    368 Farnesyl acetate 29548-30-9 DEFHJK
    369 Farnesol 4602-84-0 DEFHJK
    370 Oxacyclohexadecan-2-one 106-02-5 DEFGJK
    371 1-cyclopentadec-4-en-1-one 14595-54-1 DEFGJK
    372 1-cyclopentadec-4-en-1-one 35720-57-1 DEFGJK
    373 2-methoxy-4-(4- 128489-04-3 CGJ
    methylenetetrahydro-2H-pyran-2-
    yl)phenol
    374 Eugenyl acetate 93-28-7 CFHJK
    375 Eugenol 97-53-0 CHIK
    377 Ethylmethylphenylglycidate 77-83-8 CFHJK
    378 Ethylene brassylate 105-95-3 DFGJ
    381 Ethyl undecylenate 692-86-4 DEFHJK
    385 Ethyl palmitate 628-97-7 DEFHJ
    386 Ethyl nonanoate 123-29-5 BDEFHJKL
    388 Ethyl myristate 124-06-1 DEFHJK
    390 Ethyl linalool 10339-55-6 BCEFHJK
    391 Ethyl laurate 106-33-2 DEFHJK
    394 Ethyl hexyl ketone 925-78-0 ADFHIKL
    397 Ethyl decanoate 110-38-3 BDEFHJK
    398 Ethyl gamma-Safranate 35044-57-6 ADHIJK
    407 Ethyl 3-phenylglycidate 121-39-1 CGJK
    413 6-ethyl-2,10,10-trimethyl-1- 79893-63-3 BDEFHIJK
    oxaspiro[4.5]deca-3,6-diene
    414 Elemol 639-99-6 DEFHJK
    415 (2-(1-ethoxyethoxy)ethyl)benzene 2556-10-7 BCEFHJK
    416 (E)-3-methyl-5-(2,2,3- 67801-20-1 DHJK
    trimethylcyclopent-3-en-1-yl)pent-4-
    en-2-ol
    417 d-xylose 58-86-6 CGIJ
    418 (E)-4-((3aS,7aS)-octahydro-5H-4,7- 30168-23-1 DFHJK
    methanoinden-5-ylidene)butanal
    421 Dodecanal dimethyl acetal 14620-52-1 DEFHJK
    424 d-Limonene 5989-27-5 ADEFGIJKL
    425 Dipropylene Glycol 25265-71-8 CEFGIK
    426 Dispirone 83863-64-3 BDEFHJK
    428 Diphenyloxide 101-84-8 BDEFHK
    429 Diphenylmethane 101-81-5 DEFGK
    432 Dimethyl benzyl carbinyl butyrate 10094-34-5 DEFHJK
    436 2,6-dimethyloct-7-en-4-one 1879-00-1 ADEFHIJKL
    441 Octahydro-1H-4,7-methanoinden-5- 64001-15-6 DEFHJKL
    yl acetate
    444 Dihydrocarveol acetate 20777-49-5 BDEFHIJK
    445 Dihydrocarveol 619-01-2 BCEFHIJKL
    449 Dihydro Linalool 18479-51-1 BCEFGIJKL
    450 Dihydro Isojasmonate 37172-53-5 DHJK
    453 Dibutyl sulfide 544-40-1 ADEFHIKL
    457 Dibenzyl 103-29-7 DEFGJK
    459 delta-Undecalactone 710-04-3 DEFHJKL
    461 delta-Elemene 20307-84-0 BDEFHJK
    462 delta-Guaiene 3691-11-0 DEFHJKL
    463 delta-Dodecalactone 713-95-1 DEFHJK
    464 delta-Decalactone 705-86-2 BDEFHIJKL
    465 delta-Cadinene 483-76-1 DEFHJKL
    466 delta-damascone 57378-68-4 ADHIJK
    467 delta-Amorphene 189165-79-5 DEFHJKL
    468 delta-3-Carene 13466-78-9 ADEFGIJKL
    470 Decylenic alcohol 13019-22-2 BDEFHJK
    471 Decyl propionate 5454-19-3 DEFHJK
    473 Decanal diethyl acetal 34764-02-8 DEFHJK
    474 Decahydro-beta-naphthol 825-51-4 BCEFGIK
    475 1-cyclohexylethyl (E)-but-2-enoate 68039-69-0 BDFHJK
    478 3-(4-isopropylphenyl)-2- 103-95-7 BDFHJK
    methylpropanal
    479 Cyclotetradecane 295-17-0 DEFGJKL
    480 Cyclopentadecanone 502-72-7 DEFGJK
    482 Cyclohexyl salicylate 25485-88-5 DFGJ
    484 3a,4,5,6,7,7a-hexahydro-1H-4,7- 113889-23-9 DEFHJK
    methanoinden-6-yl butyrate
    485 Cyclic ethylene dodecanedioate 54982-83-1 DFGJ
    486 8,8-dimethyl-1,2,3,4,5,6,7,8- 68991-97-9 DHJK
    octahydronaphthalene-2-
    carbaldehyde
    487 3a,4,5,6,7,7a-hexahydro-1H-4,7- 67634-20-2 DEFHJK
    methanoinden-5-yl isobutyrate
    488 Curzerene 17910-09-7 DHJK
    491 Cumic alcohol 536-60-7 CHIJK
    493 Coumarone 1646-26-0 BCEFHIK
    497 2-(3-phenylpropyl)pyridine 2110-18-1 CEFHJK
    498 Dodecanenitrile 2437-25-4 DEFHJK
    501 (E)-cycloheptadec-9-en-1-one 542-46-1 DEFGJ
    502 Citryl acetate 6819-19-8 DFHJK
    503 Citrus Propanol 15760-18-6 CEFHIJK
    505 Citronitrile 93893-89-1 CEFHJK
    519 Citral propylene glycol acetal 10444-50-5 CEFHJK
    520 Citral dimethyl acetal 7549-37-3 BCEFHJK
    521 Citral diethyl acetal 7492-66-2 BDEFHJK
    524 cis-Ocimene 3338-55-4 ADGIKL
    527 cis-Limonene oxide 13837-75-7 ADEFGIJKL
    529 Cis-iso-ambrettolide 36508-31-3 DGJ
    530 cis-6-nonenol 35854-86-5 BCEFHIKL
    531 cis-carveol 1197-06-4 BCHIJK
    532 cis-4-Decen-1-al 21662-09-9 ADHKL
    534 cis-3-hexenyl-cis-3-hexenoate 61444-38-0 BDEFHJK
    537 cis-3-Hexenyl salicylate 65405-77-8 DEFGJ
    541 Cis-3-hexenyl Benzoate 25152-85-6 DEFHJK
    544 cis-3-Hexenyl 2-methylbutyrate 53398-85-9 ADEFHJKL
    546 cis-3, cis-6-nonadienol 53046-97-2 ACEFHK
    548 Cinnamyl propionate 103-56-0 DEFHJK
    550 Cinnamyl isobutyrate 103-59-3 DEFHJK
    551 Cinnamyl formate 104-65-4 BCEFHK
    552 Cinnamyl cinnamate 122-69-0 DHJ
    553 Cinnamyl acetate 103-54-8 BCEFHK
    555 Cinnamic alcohol 104-54-1 BCEFHIK
    558 Cetyl alcohol 36653-82-4 DEFHJ
    559 (E)-1-(2,6,6-trimethylcyclohex-2-en- 79-78-7 DHJK
    1-yl)hepta-1,6-dien-3-one
    560 2-methyl-4-(2,6,6-trimethylcyclohex- 65405-84-7 DFHJK
    1-en-1-yl)butanal
    561 (3aR,5aR,9aR,9bR)-3a,6,6,9a- 3738-00-9 DEFHJK
    tetramethyldodecahydronaphtho[2,1-
    b]furan
    562 1,6-dioxacycloheptadecan-7-one 6707-60-4 DGJ
    563 1-(6-(tert-butyl)-1,1-dimethyl-2,3- 13171-00-1 DEFHJK
    dihydro-1H-inden-4-yl)ethan-1-one
    565 Cedryl methyl ether 19870-74-7 ADEFHJK
    566 Cedryl formate 39900-38-4 BDEFHJK
    567 Cedryl acetate 77-54-3 DEFHJK
    568 (4Z,8Z)-1,5,9-trimethyl-13- 71735-79-0 DFHJK
    oxabicyclo[10.1.0]trideca-4,8-diene
    569 Cedrol 77-53-2 DEFHJK
    570 5-methyl-1-(2,2,3- 139539-66-5 DEFHJK
    trimethylcyclopent-3-en-1-yl)-6-
    oxabicyclo[3.2.1]octane
    571 5-methyl-1-(2,2,3- 426218-78-2 DFHJ
    trimethylcyclopent-3-en-1-yl)-6-
    oxabicyclo[3.2.1]octane
    572 1,1,2,3,3-pentamethyl-1,2,3,5,6,7- 33704-61-9 BDEFHIJK
    hexahydro-4H-inden-4-one
    573 Caryophyllene alcohol acetate 32214-91-8 DEFHJK
    574 Caryolan-1-ol 472-97-9 DEFHJK
    577 Carvyl acetate 97-42-7 BDHIJK
    578 Caprylnitrile 124-12-9 ACEFGIKL
    580 Caprylic alcohol 111-87-5 ACEFGIKL
    581 Caprylic acid 124-07-2 BCEFHIK
    582 Capric acid 334-48-5 DEFHJK
    584 Capraldehyde 112-31-2 ADHKL
    586 3-(4-methoxyphenyl)-2- 5462-06-6 BCHJK
    methylpropanal
    587 Camphorquinone 10373-78-1 ACEFGIJK
    589 Camphene 79-92-5 ADEFGIJKL
    591 Ethyl 2-methyl-4-oxo-6- 59151-19-8 DHJ
    pentylcyclohex-2-ene-1-carboxylate
    592 Butylated hydroxytoluene 128-37-0 DEFGIJK
    594 Butyl stearate 123-95-5 DEFHJ
    595 Butyl butyryl lactate 7492-70-8 CEFGJK
    599 Butyl 10-undecenoate 109-42-2 DEFHJK
    600 2-methyl-4-(2,2,3- 72089-08-8 DEFHJK
    trimethylcyclopent-3-en-1-yl)butan-
    1-ol
    601 3-(4-(tert-butyl)phenyl)propanal 18127-01-0 BDHJK
    603 Bornyl isobutyrate 24717-86-0 BDEFHIJK
    604 Bornyl acetate 76-49-3 ADEFHIJKL
    606 2-ethoxy-2,6,6-trimethyl-9- 68845-00-1 BDEFHJK
    methylenebicyclo[3.3.1]nonane
    607 (ethoxymethoxy)cyclododecane 58567-11-6 DEFHJK
    608 Bisabolene 495-62-5 DEFHJK
    609 Bigarade oxide 72429-08-4 ADEFHJKL
    610 beta-Vetivone 18444-79-6 DHJK
    611 beta-Terpinyl acetate 10198-23-9 BDHJK
    612 beta-Terpineol 138-87-4 BCGIJK
    613 beta-Sinensal 60066-88-8 DHJK
    614 beta-Sesquiphellandrene 20307-83-9 DEFHJK
    615 beta-Selinene 17066-67-0 BDEFGJK
    616 beta-Santalol 77-42-9 DEFHJK
    618 beta-Pinene 127-91-3 ADEFGIJKL
    620 beta-Naphthyl ethyl ether 93-18-5 BDEFHJK
    621 beta-Patchoulline 514-51-2 BDEFGJKL
    624 beta-Himachalene Oxide 57819-73-5 BDFHJK
    625 beta-Himachalene 1461-03-6 DEFHJKL
    626 beta-Guaiene 88-84-6 DEFHJKL
    627 (2,2-dimethoxyethyl)benzene 101-48-4 DHJK
    628 beta-Farnesene 18794-84-8 DEFHJK
    631 beta-Copaene 18252-44-3 BDEFHJKL
    632 beta-Cedrene 546-28-1 BDEFGJKL
    633 beta-Caryophyllene 87-44-5 DEFHJKL
    635 beta-Bisabolol 15352-77-9 DFHJK
    636 Beta ionone epoxide 23267-57-4 BDEFHIJK
    638 Bergaptene 484-20-8 CGJ
    639 Benzyl-tert-butanol 103-05-9 CEFGJK
    644 Benzyl laurate 140-25-0 DEFHJ
    649 Benzyl dimethyl carbinol 100-86-7 BCEFGIK
    650 Benzyl cinnamate 103-41-3 DHJ
    653 Benzyl benzoate 120-51-4 DHJ
    655 Benzophenone 119-61-9 DEFHK
    658 7-isopentyl-2H- 362467-67-2 DHJ
    benzo[b][1,4]dioxepin-3(4H)-one
    659 2′-isopropyl-1,7,7- 188199-50-0 DEFHJK
    trimethylspiro[bicyclo[2.2.1]heptane-
    2,4′-[1,3]dioxane]
    660 4-(4-methylpent-3-en-1-yl)cyclohex- 21690-43-7 DEFHJK
    3-ene-1-carbonitrile
    661 Aurantiol 89-43-0 DEFHJ
    663 Anisyl phenylacetate 102-17-0 DFHJ
    668 Methyl (E)-octa-4,7-dienoate 189440-77-5 ACEFHKL
    671 Amyl Cinnamate 3487-99-8 DEFHJK
    673 (3aR,5aS,9aS,9bR)-3a,6,6,9a- 6790-58-5 DEFHJK
    tetramethyldodecahydronaphtho[2,1-
    b]furan
    674 (4aR,5R,7aS,9R)-2,2,5,8,8,9a- 211299-54-6 DEFHJK
    hexamethyloctahydro-4H-4a,9-
    methanoazuleno[5,6-d][1,3]dioxole
    675 2,5,5-trimethyl-1,2,3,4,5,6,7,8- 71832-76-3 DEFHJK
    octahydronaphthalen-2-ol
    676 2,5,5-trimethyl-1,2,3,4,5,6,7,8- 41199-19-3 DEFHJK
    octahydronaphthalen-2-ol
    677 1-((2-(tert- 139504-68-0 DEFHJK
    butyl)cyclohexyl)oxy)butan-2-ol
    678 (3S,5aR,7aS,11aS,11bR)-3,8,8,11a- 57345-19-4 DEFHJ
    tetramethyldodecahydro-5H-3,5a-
    epoxynaphtho[2,1-c]oxepine
    679 2,2,6,6,7,8,8-heptamethyldecahydro- 476332-65-7 ADEFHJK
    2H-indeno[4,5-b]furan
    680 2,2,6,6,7,8,8-heptamethyldecahydro- 647828-16-8 ADEFHJK
    2H-indeno[4,5-b]furan
    681 Amber acetate 37172-02-4 BDEFHJK
    682 Alpinofix 811436-82-5 DEFHJ
    683 alpha-Thujone 546-80-5 ADEFGIJKL
    684 alpha-Vetivone 15764-04-2 DHJK
    686 alpha-Terpinyl propionate 80-27-3 BDEFHJK
    691 alpha-Sinensal 17909-77-2 DHJK
    692 alpha-Selinene 473-13-2 BDEFHJK
    693 alpha-Santalene 512-61-8 ADEFHJKL
    694 alpha-Santalol 115-71-9 DEFHJK
    696 alpha-Patchoulene 560-32-7 ADEFHJKL
    697 alpha-neobutenone 56973-85-4 BDHJK
    698 alpha-Muurolene 10208-80-7 DEFHJKL
    700 alpha-methyl ionone 127-42-4 BDHJK
    702 alpha-Limonene 138-86-3 ADEFGIJKL
    704 alpha-Irone 79-69-6 BDHJK
    706 alpha-Humulene 6753-98-6 DEFHJK
    707 alpha-Himachalene 186538-22-7 BDEFHJK
    708 alpha-Gurjunene 489-40-7 BDEFHJKL
    709 alpha-Guaiene 3691-12-1 DEFHJKL
    710 alpha-Farnesene 502-61-4 DEFHJK
    711 alpha-Fenchene 471-84-1 ADEFGIJKL
    712 alpha-Eudesmol 473-16-5 DEFHJK
    713 alpha-Curcumene 4176-17-4 DEFHJK
    714 alpha-Cubebene 17699-14-8 ADEFHJKL
    715 alpha-Cedrene epoxide 13567-39-0 ADEFHJK
    716 alpha-Cadinol 481-34-5 DEFHJK
    717 alpha-Cadinene 24406-05-1 DEFHJKL
    718 alpha-Bisabolol 515-69-5 DFHJK
    719 alpha-bisabolene 17627-44-0 DEFHJK
    720 alpha-Bergamotene 17699-05-7 BDEFHJKL
    721 alpha-Amylcinnamyl alcohol 101-85-9 DEFHJ
    722 alpha-Amylcinnamyl acetate 7493-78-9 DEFHJ
    723 alpha-Amylcinnamaldehyde diethyl 60763-41-9 DEFHJ
    acetal
    724 alpha-Amylcinnamaldehyde 122-40-7 DHJK
    725 alpha-Amorphene 23515-88-0 DEFHJKL
    726 alpha-Agarofuran 5956-12-7 BDEFHJK
    727 1-methyl-4-(4-methyl-3-penten-1- 52475-86-2 DFHJK
    yl)-3-Cyclohexene-1-carboxaldehyde
    730 1-Phenyl-2-pentanol 705-73-7 CEFHK
    731 1-Phenyl-3-methyl-3-pentanol 10415-87-9 CEFHJK
    733 2,3,4-trimethoxy-benzaldehyde 2103-57-3 BCGI
    735 2,4,5-trimethoxy-benzaldehyde 4460-86-0 BCG
    736 2,4,6-trimethoxybenzaldehyde 830-79-5 BCGI
    738 2,4-Nonadienal 6750-03-4 ACHKL
    741 2,6,10-Trimethylundecanal 105-88-4 BDFGJK
    742 alpha,4-Dimethyl benzenepropanal 41496-43-9 ACHJK
    746 Allyl cyclohexyl propionate 2705-87-5 BDEFHJK
    748 Allyl amyl glycolate 67634-00-8 BCEFGJK
    750 Allo-aromadendrene 25246-27-9 BDEFHJKL
    752 Aldehyde C-11 143-14-6 ADHJK
    754 Methyl (E)-2-(((3,5- 94022-83-0 DEFHJ
    dimethylcyclohex-3-en-1-
    yl)methylene)amino)benzoate
    757 2,6,10-trimethylundec-9-enal 141-13-9 BDFHJK
    758 Acetoxymethyl-isolongifolene 59056-62-1 BDEFHJK
    (isomers)
    763 Acetate C9 143-13-5 BDEFHJKL
    764 Acetarolle 744266-61-3 DFHJK
    766 Acetaldehyde phenylethyl propyl 7493-57-4 CEFHJK
    acetal
    767 Acetaldehyde dipropyl acetal 105-82-8 ACEFGIKL
    768 Acetaldehyde benzyl 2-methoxyethyl 7492-39-9 BCEFHJK
    acetal
    769 (Z)-2-(4-methylbenzylidene)heptanal 84697-09-6 DHJ
    770 9-decenal 39770-05-3 ADHKL
    771 8-Hexadecenolide 123-69-3 DGJ
    772 7-Methoxycoumarin 531-59-9 CHK
    774 7-epi-alpha-Selinene 123123-37-5 BDEFHJK
    775 7-eip-alpha-Eudesmol 123123-38-6 DEFHJK
    776 7-Acetyl-1,1,3,4,4,6- 1506-02-1 DEFHJ
    hexamethyltetralin
    778 6-Isopropylquinoline 135-79-5 CEFHJK
    781 6,6-dimethyl-2-norpinene-2- 33885-51-7 BCFHJK
    propionaldehyde
    782 6,10,14-trimethyl-2-Pentadecanone 502-69-2 DEFHJK
    786 5-Isopropenyl-2-methyl-2- 13679-86-2 ACGIJKL
    vinyltetrahydrofuran
    788 5-Cyclohexadecenone 37609-25-9 DEFGJK
    791 4-Terpinenol 562-74-3 BCHIJK
    792 4-Pentenophenone 3240-29-7 BCEFHIK
    800 4-Carvomenthenol 28219-82-1 BCHIJK
    802 4,5,6,7-Tetrahydro-3,6- 494-90-6 BCEFHIJKL
    dimethylbenzofuran
    803 4-(p-Methoxyphenyl)-2-butanone 104-20-1 BCEFHJK
    804 3-Thujopsanone 25966-79-4 BDEFHJK
    805 3-Propylidenephthalide 17369-59-4 CEFHK
    806 3-Nonylacrolein 20407-84-5 BDFHJK
    807 3-Methyl-5-phenyl-1-pentanal 55066-49-4 BDFHJK
    814 3-Hexenyl isovalerate 10032-11-8 ADEFHJKL
    821 3,6-Dimethyl-3-octanyl acetate 60763-42-0 ADEFHIJKL
    824 3,4,5-trimethoxybenzaldehyde 86-81-7 BCGIK
    826 3-(p- 7775-00-0 BDFHJK
    Isopropylphenyl)propionaldehyde
    827 2-Undecenenitrile 22629-48-7 BDEFHJK
    828 2-Undecenal 2463-77-6 ADHJK
    829 2-trans-6-trans-Nonadienal 17587-33-6 ACHKL
    831 2-Phenylethyl butyrate 103-52-6 DEFHJK
    833 2-Phenyl-3-(2-furyl)prop-2-enal 57568-60-2 CHJ
    834 2-Phenoxyethanol 122-99-6 BCEFGIK
    837 2-Nonen-1-al 2463-53-8 ADHKL
    839 2-Nonanol 628-99-9 BDEFGIKL
    840 2-Nonanone 821-55-6 ADFHIKL
    849 2-Isobutyl quinoline 93-19-6 CEFHJK
    850 2-Hexylidene cyclopentanone 17373-89-6 DFHJKL
    852 2-Heptyl tetrahydrofuran 2435-16-7 BDEFHJKL
    856 2-Decenal 3913-71-1 ADHKL
    864 2,6-Nonadienal 26370-28-5 ACHKL
    865 2,6-Nonadien-1-ol 7786-44-9 ACEFHK
    866 2,6-dimethyl-octanal 7779-07-9 ADFGIJKL
    868 1-Decanol 112-30-1 BDEFGJK
    869 1-Hepten-1-ol, 1-acetate 35468-97-4 ACEFHKL
    870 10-Undecen-1-ol 112-43-6 DEFHJK
    871 10-Undecenal 112-45-8 ADHJK
    872 10-epi-gamma-Eudesmol 15051-81-7 DFHJK
    873 1,8-Thiocineol 68391-28-6 ADEFHIJKL
    876 1,3,5-undecatriene 16356-11-9 ADEFHJKL
    877 1,2-Dihydrolinalool 2270-57-7 BCEFGIJKL
    878 1,3,3-trimethyl-2-norbornanyl 13851-11-1 ADEFHIJKL
    acetate
    879 1,1,2,3,3-Pentamethylindan 1203-17-4 ADHIJKL
    881 (Z)-6,10-dimethylundeca-5,9-dien-2- 3239-37-0 DEFHJK
    yl acetate
    884 (Z)-3-Dodecenal 68141-15-1 BCFHJK
    885 (S)-gamma-Undecalactone 74568-05-1 DEFHJKL
    886 (R)-gamma-Undecalactone 74568-06-2 DEFHJKL
    890 (E)-6,10-dimethylundeca-5,9-dien-2- 3239-35-8 DEFHJK
    yl acetate
    892 (2Z)-3-methyl-5-phenyl-2- 53243-59-7 DEFHJK
    Pentenenitrile
    893 (2S,5S,6S)-2,6,10,10-tetramethyl-1- 65620-50-0 DFHIJK
    oxaspiro[4_5]decan-6-ol
    894 (2E)-3-methyl-5-phenyl-2- 53243-60-0 CEFHJK
    pentenenitrile
    897 (+)-Dihydrocarveol 22567-21-1 BCEFHIJKL
    905 Menthone 89-80-5 ADEFGIJKL
    908 (R,E)-2-methyl-4-(2,2,3- 185068-69-3 CHJK
    trimethylcyclopent-3-en-1-yl)but-2-
    en-1-ol
    912 2-(8-isopropyl-6- 68901-32-6 DEFHJK
    methylbicyclo[2.2.2]oct-5-en-2-yl)-
    1,3-dioxolane
    913 gamma-methyl ionone 7388-22-9 BDHIJK
    914 3-(3-isopropylphenyl)butanal 125109-85-5 BDHJK
    916 3-(1-ethoxyethoxy)-3,7- 40910-49-4 BDEFHJK
    dimethylocta-1,6-diene
    919 3a,4,5,6,7,7a-hexahydro-1H-4,7- 17511-60-3 CEFHJK
    methanoinden-6-yl propionate
    920 Bulnesol 22451-73-6 DEFHJK
    922 Benzyl phenylacetate 102-16-9 DHJ
    923 Benzoin 119-53-9 CEFHJ
    924 (E)-1,2,4-trimethoxy-5-(prop-1-en-1- 2883-98-9 BCFGJK
    yl)benzene
    925 alpha,alpha,6,6-tetramethyl 33885-52-8 BDFHJK
    bicyclo[3.1.1]hept-2-ene-propanal
    926 7-epi-sesquithujene 159407-35-9 DEFHJKL
    927 5-Acetyl-1,1,2,3,3,6- 15323-35-0 DEFHJK
    hexamethylindan
    928 3-Methylphenethyl alcohol 1875-89-4 BCEFHIK
    929 3,6-Nonadien-1-ol 76649-25-7 ACEFHK
    930 2-Tridecenal 7774-82-5 BDFHJK
    933 Patchouli alcohol 5986-55-0 DEFHIJK
    937 p-Cresyl isobutyrate 103-93-5 BDHJK
    939 p-Cresyl n-hexanoate 68141-11-7 DEFHJK
    941 5-hexyl-4-methyldihydrofuran- 67663-01-8 BDEFHIJKL
    2(3H)-one
    942 Ethyl (2Z,4E)-deca-2,4-dienoate 3025-30-7 BDEFHJK
    943 Pelargene 68039-40-7 DEFHJK
    945 2-cyclohexylidene-2- 10461-98-0 DFHJK
    phenylacetonitrile
    946 Perillaldehyde 2111-75-3 ACHIJK
    947 Perillyl acetate 15111-96-3 DFHJK
    948 Perillyl alcohol 536-59-4 CHIJK
    950 (2-isopropoxyethyl)benzene 68039-47-4 ACEFHJKL
    951 Ethyl (2Z,4E)-deca-2,4-dienoate 313973-37-4 BDEFHJK
    953 (2-(cyclohexyloxy)ethyl)benzene 80858-47-5 DEFHJK
    954 Phenethyl 2-methylbutyrate 24817-51-4 DEFHJK
    955 Phenethyl alcohol 60-12-8 BCEFGIK
    959 Phenethyl phenylacetate 102-20-5 DHJ
    962 Phenoxanol 55066-48-3 DEFHJK
    965 Phenyl benzoate 93-99-2 DFHJK
    967 Phenyl ethyl benzoate 94-47-3 DHJ
    969 Phenylacetaldehyde ethyleneglycol 101-49-5 BCEFGIK
    acetal
    973 2-(6,6-dimethylbicyclo[3.1.1]hept-2- 30897-75-7 ACFHIJKL
    en-2-yl)acetaldehyde
    974 Pinocarveol 5947-36-4 BCEFGIJKL
    976 Piperonyl acetone 55418-52-5 CEFGJ
    978 3a,4,5,6,7,7a-hexahydro-1H-4,7- 68039-44-1 DEFHJK
    methanoinden-6-yl pivalate
    980 (4aR,8aS)-7-methyloctahydro-1,4- 41724-19-0 CEFGJKL
    methanonaphthalen-6(2H)-one
    982 p-Menth-3-en-1-ol 586-82-3 BCGIJK
    985 (E)-3,3-dimethyl-5-(2,2,3- 107898-54-4 DHJK
    trimethylcyclopent-3-en-1-yl)pent-4-
    en-2-ol
    988 1-methyl-4-(4-methylpent-3-en-1- 52474-60-9 DFHJK
    yl)cyclohex-3-ene-1-carbaldehyde
    993 Propylene glycol 57-55-6 ACEFGIKL
    998 p-Tolyl phenylacetate 101-94-0 DFHJ
    1000 Ethyl 2,4,7-decatrienoate 78417-28-4 BDEFHJK
    1003 2-benzyl-4,4,6-trimethyl-1,3-dioxane 67633-94-7 DEFHJK
    1006 2,4-dimethyl-4- 82461-14-1 BDEFHJK
    phenyltetrahydrofuran
    1007 (2R,4a′R,8a′R)-3,7′-dimethyl- 41816-03-9 DEFHJK
    3′,4′,4a′,5′,8′,8a′-hexahydro-1′H-
    spiro[oxirane-2,2′-
    [1,4]methanonaphthalene]
    1008 (Z)-6-ethylideneoctahydro-2H-5,8- 93939-86-7 BCEFHJKL
    methanochromene
    1009 2-((S)-1-((S)-3,3- 236391-76-7 DFHJ
    dimethylcyclohexyl)ethoxy)-2-
    oxoethyl propionate
    1010 Methyl 2,2-dimethyl-6- 81752-87-6 ADHIJKL
    methylenecyclohexane-1-carboxylate
    1012 2-methyl-5-phenylpentan-1-ol 25634-93-9 DEFHJK
    1016 4-methyl-2-phenyl-3,6-dihydro-2H- 60335-71-9 BCEFGJK
    pyran
    1020 Sabinol 471-16-9 BCEFHIJKL
    1021 Safrole 94-59-7 BCEFHK
    1022 2,2,7,9-tetramethylspiro(5.5)undec- 502847-01-0 DHIJK
    8-en-1-one
    1023 3-methyl-5-(2,2,3- 65113-99-7 DEFHJK
    trimethylcyclopent-3-en-1-yl)pentan-
    2-ol
    1024 (Z)-2-ethyl-4-(2,2,3- 28219-61-6 DEFHJK
    trimethylcyclopent-3-en-1-yl)but-2-
    en-1-ol
    1025 (E)-2-methyl-4-(2,2,3- 28219-60-5 CHJK
    trimethylcyclopent-3-en-1-yl)but-2-
    en-1-ol
    1026 5-methoxyoctahydro-1H-4,7- 86803-90-9 CHJK
    methanoindene-2-carbaldehyde
    1027 5-methoxyoctahydro-1H-4,7- 193425-86-4 CHJK
    methanoindene-2-carbaldehyde
    1028 Sclareol 515-03-7 DEFHJ
    1029 Sclareol oxide 5153-92-4 DEFHJK
    1031 Selina-3,7(11)-diene 6813-21-4 DEFHJKL
    1032 2-(1-(3,3- 477218-42-1 DEFHJ
    dimethylcyclohexyl)ethoxy)-2-
    methylpropyl
    cyclopropanecarboxylate
    1033 3-(4-isobutylphenyl)-2- 6658-48-6 DHJK
    methylpropanal
    1035 Spathulenol 6750-60-3 DEFHJK
    1036 Spirambrene 533925-08-5 BCEFHJK
    1037 Spirodecane 6413-26-9 BCEFGIJKL
    1038 1-(spiro[4.5]dec-7-en-7-yl)pent-4-en- 224031-70-3 DGJK
    1-one
    1042 2-(4-methylthiazol-5-yl)ethan-1-ol 137-00-8 CGIKL
    1043 2-(heptan-3-yl)-1,3-dioxolane 4359-47-1 ACEFHIJKL
    1045 (Z)-dodec-4-enal 21944-98-9 BDFHJK
    1046 tau-Cadinol 5937-11-1 DEFHJK
    1047 tau-Muurolol 19912-62-0 DEFHJK
    1053 Tetrahydrojasmone 13074-63-0 BDFHIJKL
    1057 2,6,10,10-tetramethyl-1- 36431-72-8 BDFHIJKL
    oxaspiro[4.5]dec-6-ene
    1059 Thiomenthone 38462-22-5 BDEFHIJKL
    1060 Thujopsene 470-40-6 BDEFGJKL
    1062 Thymol methyl ether 1076-56-8 ADHIJKL
    1063 1-(2,2,6-trimethylcyclohexyl)hexan- 70788-30-6 DEFHJK
    3-ol
    1064 trans, trans-2,4-Nonadienal 5910-87-2 ACHKL
    1065 trans, trans-Farnesol 106-28-5 DEFHJK
    1066 trans-2, cis-6-Nonadienal 557-48-2 ACHKL
    1067 trans-2-Decenal 3913-81-3 ADHKL
    1070 trans-2-Nonen-1-al 18829-56-6 ADHKL
    1072 trans-3, cis-6-nonadienol 56805-23-3 ACEFHK
    1073 trans-4-Decen-1-al 65405-70-1 ADHKL
    1075 trans-ambrettolide 51155-12-5 DGJ
    1077 trans-beta-ocimene 13877-91-3 ADGIKL
    1078 trans-beta-Ocimene 3779-61-1 ADGIKL
    1082 trans-Geraniol 106-24-1 BCHIK
    1083 trans-Hedione 2570-03-8 DFHJK
    1085 7-(1,1-Dimethylethyl)-2H-1,5- 195251-91-3 CEFHJ
    benzodioxepin-3(4H)-one
    1089 Tricyclone 68433-81-8 DEFHJK
    1090 Tridecyl alcohol 112-70-9 DEFGJK
    1091 Triethyl citrate 77-93-0 CEFGJ
    1093 Methyl 2-((1-hydroxy-3- 144761-91-1 DFHJ
    phenylbutyl)amino)benzoate
    1095 1-((2E,5Z,9Z)-2,6,10- 28371-99-5 DHJK
    trimethylcyclododeca-2,5,9-trien-1-
    yl)ethan-1-one
    1097 Decahydro-2,6,6,7,8,8-hexamethyl- 338735-71-0 BDEFHJK
    2h-indeno(4,5-b)furan
    1099 13-methyl oxacyclopentadec-10-en- 365411-50-3 DEFHJK
    2-one
    1102 Undecanal 112-44-7 BDHJK
    1104 (E)-4-methyldec-3-en-5-ol 81782-77-6 BDEFHIJK
    1105 Valencene 4630-07-3 BDEFHJK
    1107 Valerianol 20489-45-6 DEFHJK
    1111 Vanillin isobutyrate 20665-85-4 CHJ
    1113 Vaniwhite 5533-03-9 CGIK
    1116 (Z)-2-methyl-4-(2,6,6- 68555-62-4 BDFHJK
    trimethylcyclohex-2-en-1-yl)but-2-
    enal
    1117 Methyl 2,4-dihydroxy-3,6- 4707-47-5 CGIJ
    dimethylbenzoate
    1120 1-methoxy-3a,4,5,6,7,7a-hexahydro- 27135-90-6 ACEFHJKL
    1H-4,7-methanoindene
    1121 Methyl (Z)-2-((3-(4-(tert- 91-51-0 DFHJ
    butyl)phenyl)-2-
    methylpropylidene)amino)benzoate
    1125 (Z)-hex-3-en-1-yl isobutyrate 41519-23-7 ADEFHJKL
    1126 Vertacetal 5182-36-5 BCFHJK
    1129 1-((3R,3aR,7R,8aS)-3,6,8,8- 32388-55-9 DHJK
    tetramethyl-2,3,4,7,8,8a-hexahydro-
    1H-3a,7-methanoazulen-5-yl)ethan-
    1-one
    1131 Methyl (Z)-2-(((2,4- 68738-99-8 DEFHJ
    dimethylcyclohex-3-en-1-
    yl)methylene)amino)benzoate
    1135 Vetiverol 89-88-3 CEFHIJK
    1136 Vetivert Acetate 117-98-6 DEFHJK
    1137 Decahydro-3H-spiro[furan-2,5′- 68480-11-5 DEFGJKL
    [4,7]methanoindene]
    1138 (2Z,6E)-nona-2,6-dienenitrile 67019-89-0 ACEFHKL
    1139 (Z)-cyclooct-4-en-1-yl methyl 87731-18-8 BCHJKL
    carbonate
    1140 (1aR,4S,4aS,7R,7aS,7bS)-1,1,4,7- 552-02-3 DEFHJK
    tetramethyldecahydro-1H-
    cyclopropa[e]azulen-4-ol
    1142 3,5,5,6,7,8,8-heptamethyl-5,6,7,8- 127459-79-4 DHJ
    tetrahydronaphthalene-2-carbonitrile
    1143 (1S,2S,3S,5R)-2,6,6- 133636-82-5 DEFHJK
    trimethylspiro[bicyclo[3.1.1]heptane-
    3,1′-cyclohexan]-2′-en-4′-one
    1144 1′,1′,5′,5′-tetramethylhexahydro- 154171-76-3 DEFHJK
    2′H,5′H-spiro[[1,3]dioxolane-2,8′-
    [2,4a]methanonaphthalene]
    1145 1′,1′,5′,5′-tetramethylhexahydro- 154171-77-4 DEFHJK
    2′H,5′H-spiro[[1,3]dioxolane-2,8′-
    [2,4a]methanonaphthalene] K
    1146 4-(4-hydroxy-3- 122-48-5 CEFGJ
    methoxyphenyl)butan-2-one
    1147 (1R,8aR)-4-isopropyl-1,6-dimethyl- 41929-05-9 DEFHJKL
    1,2,3,7,8,8a-hexahydronaphthalene
    1148 4,5-epoxy-4,11,11-trimethyl-8- 1139-30-6 DEFHJK
    methylenebicyclo(7.2.0)undecane
    1149 1,3,4,6,7,8alpha-hexahydro-1,1,5,5- 23787-90-8 DEFHIJK
    tetramethyl-2H-2,4alpha-
    methanophtalen-8(5H)-one
  • TABLE 2
    List of materials with at least one MORV greater than 5 to 10
    Num- CAS Comment
    ber Material Name Number Code
    2 2,4-dimethyl-2-(5,5,8,8-tetramethyl- 131812-67-4 DFHJ
    5,6,7,8-tetrahydronaphthalen-2-yl)-
    1,3-dioxolane
    23 3a,5,6,7,8,8b-hexahydro- 823178-41-2 DEFHJK
    2,2,6,6,7,8,8-heptamethyl-4H-
    indeno(4,5-d)-1,3-dioxole
    141 2,4-dimethyl-4,4a,5,9b- 27606-09-3 CEFHJK
    tetrahydroindeno[1,2-d][1,3]dioxine
    185 (1-methyl-2-((1,2,2- 198404-98-7 DEFHJK
    trimethylbicyclo[3.1.0]hexan-3-
    yl)methyl)cyclopropyl)methanol
    227 Isobornylcyclohexanol 68877-29-2 DEFHJK
    230 Isobornyl cyclohexanol 66072-32-0 DEFHJK
    246 Indol/Hydroxycitronellal Schiff base 67801-36-9 DEFHJ
    248 Hydroxymethyl isolongifolene 59056-64-3 DEFHJK
    343 8,8-dimethyl-3a,4,5,6,7,7a- 76842-49-4 DEFHJK
    hexahydro-1H-4,7-methanoinden-6-
    yl propionate
    359 (E)-4-((3aR,4R,7R,7aR)- 501929-47-1 DEFHJK
    1,3a,4,6,7,7a-hexahydro-5H-4,7-
    methanoinden-5-ylidene)-3-
    methylbutan-2-ol
    565 Cedryl methyl ether 19870-74-7 BDEFHJK
    631 beta-Copaene 18252-44-3 BDEFHJKL
    659 2′-isopropyl-1,7,7- 869292-93-3 BDEFHJK
    trimethylspiro[bicyclo[2.2.1]heptane-
    2,4′-[1,3]dioxane]
    674 (4aR,5R,7aS,9R)-2,2,5,8,8,9a- 211299-54-6 DEFHJK
    hexamethyloctahydro-4H-4a,9-
    methanoazuleno[5,6-d][1,3]dioxole
    678 (3S,5aR,7aS,11aS,11bR)-3,8,8,11a- 57345-19-4 DEFHJ
    tetramethyldodecahydro-5H-3,5a-
    epoxynaphtho[2,1-c]oxepine
    679 2,2,6,6,7,8,8-heptamethyldecahydro- 476332-65-7 DEFHJK
    2H-indeno[4,5-b]furan
    715 alpha-Cedrene epoxide 13567-39-0 BDEFHJK
    758 Acetoxymethyl-isolongifolene 59056-62-1 DEFHJK
    (isomers)
    1028 Sclareol 515-03-7 DEFHJ
    1097 Decahydro-2,6,6,7,8,8-hexamethyl- 338735-71-0 DEFHJK
    2h-indeno(4,5-b)furan
  • TABLE 3
    List of materials with at least one MORV from 0.5 to less than 1
    Number Material Name CAS Number Comment Code
    12 1-ethoxy-4-(tert- 181258-89-9 ADEFHJK
    pentyl)cyclohexane
    19 (3Z)-1-(2-buten-1-yloxy)-3- 888744-18-1 ADEFHJKL
    hexene
    20 4-(2-methoxypropan-2-yl)-1- 14576-08-0 ADHIJKL
    methylcyclohex-1-ene
    24 O-Methyl linalool 60763-44-2 ADHIJKL
    26 o-Methoxycinnamaldehyde 1504-74-1 ACHK
    27 Octanal, 3,7-dimethyl- 25795-46-4 ADGIJKL
    53 3,3-Dimethyl-5(2,2,3- 329925-33-9 CEFHJ
    Trimethyl-3-Cyclopenten-
    1yl)-4-Penten-2-ol
    54 n-Hexyl salicylate 6259-76-3 DEFHJ
    55 n-Hexyl 2-butenoate 19089-92-0 ADEFHJKL
    59 Neryl Formate 2142-94-1 BCEFHJK
    72 Methyl-beta-ionone 127-43-5 DHJK
    73 Myroxide 28977-57-3 ADGIJKL
    81 (E)-3,7-dimethylocta-4,6- 18479-54-4 BCEFGIJK
    dien-3-ol
    84 (Z)-hex-3-en-1-yl 188570-78-7 BCEFHIKL
    cyclopropanecarboxylate
    96 Methyl phenyl carbinyl 120-45-6 BCHJK
    propionate
    97 Methyl phenylacetate 101-41-7 ACEFHIKL
    107 2-methyl-6- 91069-37-3 BCEFGIKL
    oxaspiro[4.5]decan-7-one
    111 Methyl geraniate 2349-14-6 BCHJKL
    115 2-ethoxy-4- 5595-79-9 CFGK
    (methoxymethyl)phenol
    116 Methyl 40203-73-4 ACEFHIKL
    cyclopentylideneacetate
    125 Methoxymelonal 62439-41-2 ACGIJK
    133 ((1s,4s)-4- 13828-37-0 BDEFHIJK
    isopropylcyclohexyl)methanol
    147 Linalyl propionate 144-39-8 BDFHJK
    150 Linalyl formate 115-99-1 ACFHJK
    151 Linalyl butyrate 78-36-4 BDEFHJK
    154 Linalyl acetate 115-95-7 BDHJK
    157 Linalool 78-70-6 BCEFGIJK
    163 (Z)-hex-3-en-1-yl methyl 67633-96-9 ACEFGKL
    carbonate
    166 Lepidine 491-35-0 BCEFHIKL
    169 L-Carvone 6485-40-1 ACGIJKL
    181 Khusinil 75490-39-0 DHJK
    191 Isoraldeine 1335-46-2 BDHIJK
    194 Isopropylvinylcarbinol 4798-45-2 ACGIKL
    198 Isopropyl 2-methylbutyrate 66576-71-4 ACEFGIJKL
    201 Isopentyrate 80118-06-5 ADEFGIJKL
    204 Isononyl acetate 40379-24-6 BDEFHJKL
    205 Isononanol 27458-94-2 BDEFGIKL
    213 Isoeugenyl acetate 93-29-8 CFHJK
    214 Isoeugenol 97-54-1 CEFHIK
    232 Isoborneol 124-76-5 ACEFHIJKL
    237 Isoamyl octanoate 2035-99-6 DEFHJK
    239 Isoamyl isobutyrate 2050-01-3 ACEFGIJKL
    255 Hydrocinnamic acid 501-52-0 CEFHIK
    258 Hydratopic alcohol 1123-85-9 BCEFHIK
    264 Hexyl propanoate 2445-76-3 ADEFHIKL
    270 Hexyl butyrate 2639-63-6 BDEFHJKL
    273 Hexyl 2-methylbutanoate 10032-15-2 BDEFHJKL
    275 Hexyl 2-furoate 39251-86-0 DEFHJK
    282 Heptyl alcohol 111-70-6 ACEFGIKL
    283 Heptyl acetate 112-06-1 ADEFHKL
    284 Heptaldehyde 111-71-7 ACHIKL
    287 Heliotropin 120-57-0 BCGIK
    302 Geranyl nitrile 5146-66-7 BCEFHKL
    306 Geranyl formate 105-86-2 BCEFHJK
    308 Geranyl caprylate 51532-26-4 DEFHJ
    310 Geranyl benzoate 94-48-4 DFHJ
    312 Geranial 141-27-5 ACHIKL
    314 N,2-dimethyl-N- 84434-18-4 BCEFHJK
    phenylbutanamide
    319 gamma-Terpinene 99-85-4 ADEFGIJKL
    346 2-(sec-butyl)cyclohexan-1- 14765-30-1 ADFHIKL
    one
    354 3-(2-ethylphenyl)-2,2- 67634-14-4 BDHJK
    dimethylpropanal
    355 2-(tert-butyl)cyclohexyl ethyl 67801-64-3 BDFHJK
    carbonate
    365 2-(tert-butyl)cyclohexyl ethyl 81925-81-7 ACFHIKL
    carbonate
    366 Fenchyl alcohol 1632-73-1 ACGIJKL
    376 Eucalyptol 470-82-6 ADEFGIJKL
    379 Ethyl vanillin acetate 72207-94-4 CHJ
    387 Ethyl octanoate 106-32-1 BDEFHJKL
    400 Ethyl cinnamate 103-36-6 BCEFHK
    412 Ethyl 2- 2511-00-4 BDFHIJKL
    (cyclohexyl)propionate
    419 d-p-8(9)-Menthen-2-one 5524-05-0 ACGIJKL
    420 4-methyl-2-phenyltetrahydro- 94201-73-7 BDEFHJK
    2H-pyran
    437 Dihydromyrcenol 18479-58-8 ADEFGIJK
    438 Dihydrojasmone 1128-08-1 BCFHIJKL
    439 Dihydroisophorone 873-94-9 ACEFGIJKL
    440 Dihydroeugenol 2785-87-7 CEFHIJK
    442 Dihydrocoumarin 119-84-6 BCGIKL
    443 Dihydrocarvone 7764-50-3 ACGIJKL
    447 Dihydro-alpha-terpinyl 80-25-1 BDEFHIJKL
    acetate
    448 Dihydro-alpha-ionone 31499-72-6 BDHIJK
    454 Dibenzyl ether 103-50-4 DEFHJK
    455 Dibutyl o-phthalate 84-74-2 DEFHJ
    469 2-pentylcyclopentan-1-one 4819-67-4 BDFHIKL
    472 Decyl anthranilate 18189-07-6 DEFHJ
    477 Methyl (1s,4s)-1,4- 23059-38-3 ADEFHIJKL
    dimethylcyclohexane-1-
    carboxylate
    481 Cyclohexylethyl acetate 21722-83-8 BDEFHJKL
    492 Creosol 93-51-6 BCHIK
    495 Cosmene 460-01-5 ADEFGIKL
    496 4-cyclohexyl-2-methylbutan- 83926-73-2 BDEFGIJK
    2-ol
    504 2-benzyl-2-methylbut-3- 97384-48-0 BDHJK
    enenitrile
    509 Citronellyl nitrile 51566-62-2 BCEFGIKL
    510 Citronellyl phenylacetate 139-70-8 DFHJ
    512 Citronellyl formate 105-85-1 BCEFGJKL
    515 Citronellyl benzoate 10482-77-6 DFHJ
    517 Citronellol 106-22-9 BCHIJKL
    518 Citronellal 106-23-0 ACHIJKL
    522 Citral 5392-40-5 ACHIKL
    525 cis-Pinane 6876-13-7 ADEFGIJKL
    526 (Z)-3-methyl-2-(pent-2-en-1- 488-10-8 BCHIJKL
    yl)cyclopent-2-en-1-one
    528 cis-iso-Eugenol 5912-86-7 CEFHIK
    535 cis-3-Hexenyl valerate 35852-46-1 BDEFHJKL
    536 cis-3-Hexenyl tiglate 67883-79-8 BDEFHJK
    538 cis-3-Hexenyl propionate 33467-74-2 ACEFHIKL
    540 cis-3-Hexenyl butyrate 16491-36-4 ADEFHJKL
    542 cis-3-Hexen-1-ol 928-96-1 ACEFHIKL
    547 cis-2-Hexenol 928-94-9 ACEFHIKL
    549 Cinnamyl nitrile 4360-47-8 ACEFGIK
    554 Cinnamic aldehyde 104-55-2 ACHIK
    556 Cinnamyl nitrile 1885-38-7 ACEFGIK
    557 Chloroxylenol 88-04-0 BCHIJK
    575 Carvacrol 499-75-2 DHIJK
    576 Carvone 99-49-0 ACGIJKL
    579 Carbitol 111-90-0 BCEFGIK
    583 Caproyl alcohol 111-27-3 ACEFGIKL
    585 2-(2,2,3-trimethylcyclopent-3- 15373-31-6 ACGIJKL
    en-1-yl)acetonitrile
    588 Camphor 76-22-2 ACEFGIJKL
    602 (E)-2-methyl-4-(2,6,6- 3155-71-3 DHJK
    trimethylcyclohex-1-en-1-
    yl)but-2-enal
    605 Borneol 507-70-0 ACEFHIJKL
    617 beta-Pinene epoxide 6931-54-0 ACEFGIJKL
    619 beta-Phellandrene 555-10-2 ADEFGIJKL
    640 Benzylacetone 2550-26-7 ACEFGIK
    641 Benzyl salicylate 118-58-1 DFGJ
    645 Benzyl isovalerate 103-38-8 BDEFHJK
    647 Benzyl isobutyrate 103-28-6 BCHJK
    651 Benzyl butyrate 103-37-7 BCEFHJK
    652 Benzyl alcohol 100-51-6 ACEFGIKL
    662 1-(3,3- 25225-08-5 ADEFHIJKL
    dimethylcyclohexyl)ethyl
    formate
    664 Anisyl acetate 104-21-2 BCEFGK
    665 Anisyl formate 122-91-8 BCEFGK
    667 Anethole 104-46-1 ACEFHK
    672 Amyl benzoate 2049-96-9 DEFHJK
    687 alpha-Terpinyl acetate 80-26-2 BDHJK
    699 alpha-methyl- 10528-67-3 BDEFHIK
    cyclohexanepropanol
    701 alpha-methyl cinnamaldehyde 101-39-3 ACHIK
    703 alpha-Isomethylionone 127-51-5 BDHIJK
    740 2,5-Dimethyl-4-methoxy- 4077-47-8 ACEFGIJKL
    3(2H)-furanone
    743 Allyl phenoxyacetate 7493-74-5 BCGK
    744 Allyl Phenethyl ether 14289-65-7 ACEFHK
    745 Allyl heptanoate 142-19-8 ADEFHJKL
    755 N-ethyl-N-(m- 179911-08-1 CEFHJK
    tolyl)propionamide
    760 3-hydroxybutan-2-one 513-86-0 ACEFGIKL
    761 Acetoanisole 100-06-1 BCEFHIK
    777 6-Methylquinoline 91-62-3 BCEFHIKL
    779 6,8-Diethyl-2-nonanol 70214-77-6 BDEFGIJKL
    784 5-Methyl-3-heptanone 541-85-5 ACFGIKL
    789 4-Vinylphenol 2628-17-3 BCHIK
    796 4-hydroxy-3-methoxy- 458-36-6 CH
    cinnamaldehyde
    797 4-Ethylguaiacol 2785-89-9 CEFHIK
    799 4-Damascol 4927-36-0 BDFHJK
    808 3-methyl-4-phenylpyrazole 13788-84-6 CEFHK
    810 3-Methyl-1,2- 765-70-8 ACEFGIKL
    cyclopentanedione
    811 3-Methoxy-5-methylphenol 3209-13-0 BCHIK
    812 3-Methoxy-3-Methyl Butanol 56539-66-3 ACGIKL
    817 3-Hexenol 544-12-7 ACEFHIKL
    819 3,7-dimethyl-2-methylene-6- 22418-66-2 ADFHIJK
    octenal
    820 3,7-dimethyl-1-octanol 106-21-8 BDEFGIJKL
    832 2-Phenylethyl acetate 103-45-7 BCEFHK
    835 2-Phenethyl propionate 122-70-3 BCEFHJK
    836 2-Pentylcyclopentan-1-ol 84560-00-9 DEFHIKL
    838 2-nonanone propylene glycol 165191-91-3 BDEFHJK
    acetal
    845 2-Methoxy-3-(1- 24168-70-5 BCEFGIK
    methylpropyl)pyrazine
    846 2-isopropyl-N,2,3- 51115-67-4 ACEFGIJK
    trimethylbutyramide
    847 2-Isopropyl-5-methyl-2- 35158-25-9 ADFGIJKL
    hexenal
    848 2-Isopropyl-4-methylthiazole 15679-13-7 ACHIJKL
    851 2-Hexen-1-ol 2305-21-7 ACEFHIKL
    858 2-Butoxyethanol 111-76-2 ACEFGIKL
    875 1,4-Cineole 470-67-7 ADGIJKL
    880 1-(2,6,6-Trimethyl-2- 43052-87-5 BDHIJK
    cyclohexen-1-yl)-2-buten-1-
    one
    882 (Z)-3-hepten-1-yl acetate 1576-78-9 ACEFHKL
    883 (S)—(1R,5R)-4,6,6- 1196-01-6 ACEFGIJKL
    trimethylbicyclo[3.1.1]hept-3-
    en-2-one
    888 (R)-(−)-Linalool 126-91-0 BCEFGIJK
    889 (l)-Citronellal 5949-05-3 ACHIJKL
    891 (d)-Citronellal 2385-77-5 ACHIJKL
    899 (+)-Citronellol 1117-61-9 BCHIJKL
    900 (−)-Citronellol 7540-51-4 BCHIJKL
    901 (+)-alpha-Pinene 7785-70-8 ADEFGIJKL
    902 (+)-Carvone 2244-16-8 ACGIJKL
    903 (−)-alpha-Pinene 7785-26-4 ADEFGIJKL
    904 Methyl 2-methylbutyrate 868-57-5 ACEFGIKL
    909 Hexyl tiglate 16930-96-4 BDEFHJKL
    918 Allyl 2- 68901-15-5 CHJK
    (cyclohexyloxy)acetate
    921 1,5- 75147-23-8 CFHIJK
    dimethylbicyclo[3.2.1]octan-
    8-one oxime
    931 alpha-acetoxystyrene 2206-94-2 ACEFHIK
    940 p-Cymene 99-87-6 ADGIJKL
    956 Phenethyl formate 104-62-1 ACEFHK
    958 Phenethyl isobutyrate 103-48-0 DHJK
    960 Phenethyl tiglate 55719-85-2 DHJK
    971 Phenylethyl methacrylate 3683-12-3 DHJK
    977 p- 4395-92-0 BDFHK
    Isopropylphenylacetaldehyde
    981 1,2-dimethyl-3-(prop-1-en-2- 72402-00-7 BCEFGIJKL
    yl)cyclopentan-1-ol
    983 p-Methoxyphenylacetone 122-84-9 BCEFHK
    986 (2Z,5Z)-5,6,7-trimethylocta- 358331-95-0 ADHIJKL
    2,5-dien-4-one
    987 p-Propyl anisole 104-45-0 ADEFHKL
    994 p-t-butyl phenyl acetaldehyde 109347-45-7 BDHJK
    995 p-tert-Amyl cyclohexanol 5349-51-9 BDEFHIJK
    1001 Racemic alpha-Pinene 80-56-8 ADEFGIJKL
    1002 4-(4-hydroxyphenyl)butan-2- 5471-51-2 CEFGIK
    one
    1004 Rhodinol 141-25-3 BCHIJKL
    1005 Ethyl (2,3,6- 93981-50-1 BDEFHJKL
    trimethylcyclohexyl)carbonate
    1011 1-(3,3- 25225-10-9 ADHIJKL
    dimethylcyclohexyl)ethyl
    acetate
    1017 S)-(+)-Linalool 126-90-9 BCEFGIJK
    1018 Sabinene 3387-41-5 ADEFGIJKL
    1019 Sabinene hydrate 546-79-2 ADEFGIJKL
    1030 Propyl (S)-2-(tert- 319002-92-1 BDEFHJK
    pentyloxy)propanoate
    1039 Spirolide 699-61-6 BCGIKL
    1040 (Z)-5-methylheptan-3-one 22457-23-4 BCEFGIJKL
    oxime
    1041 1-phenylethyl acetate 93-92-5 ACEFHIK
    1051 Tetrahydrogeranial 5988-91-0 ADGIJKL
    1052 Tetrahydroionol 4361-23-3 BDEFHIJK
    1054 Tetrahydrolinalool 78-69-3 BDEFGIJKL
    1055 Tetrahydrolinalyl acetate 20780-48-7 ADEFHJKL
    1058 Ethyl (1R,6S)-2,2,6- 22471-55-2 ADEFHIJKL
    trimethylcyclohexane-1-
    carboxylate
    1061 Thymol 89-83-8 BDHIJK
    1069 trans-2-Hexenol 928-95-0 ACEFHIKL
    1071 trans-2-tert- 5448-22-6 ACGIJKL
    Butylcyclohexanol
    1074 trans-alpha-Damascone 24720-09-0 BDHIJK
    1076 trans-Anethole 4180-23-8 ACEFHK
    1079 trans-Cinnamic acid 140-10-3 CEFHK
    1081 trans-Dihydrocarvone 5948-04-9 ACGIJKL
    1084 trans-Isoeugenol 5932-68-3 CEFHIK
    1088 Trichloromethyl phenyl 90-17-5 BDEFGJ
    carbinyl acetate
    1098 2-mercapto-2-methylpentan- 258823-39-1 ACEFHIJKL
    1-ol
    1110 Vanillin acetate 881-68-5 CH
    1112 Vanitrope 94-86-0 CEFHK
    1115 2,2,5-trimethyl-5- 65443-14-3 BDFGIJKL
    pentylcyclopentan-1-one
    1118 Veratraldehyde 120-14-9 BCGIK
    1119 (1R,5R)-4,6,6- 18309-32-5 ACEFGIJKL
    trimethylbicyclo[3.1.1]hept-3-
    en-2-one
    1122 Verdol 13491-79-7 ACGIJKL
    1127 4-(tert-butyl)cyclohexyl 10411-92-4 BDEFHJK
    acetate
    1128 4-(tert-butyl)cyclohexyl 32210-23-4 BDEFHJK
    acetate
    1133 Vethymine 7193-87-5 CEFGK
    1134 4-methyl-4-phenylpentan-2-yl 68083-58-9 BDFHJK
    acetate
    1141 (Z)-1-((2- 292605-05-1 ADEFHKL
    methylallyl)oxy)hex-3-ene
  • TABLE 4
    List of materials with ALL MORVs from 1 to 5
    Num- CAS Comment
    ber Material Name Number Code
    7 3-methoxy-7,7-dimethyl-10- 216970-21-7 BDEFHJK
    methylenebicyclo[4.3.1]decane
    14 Oxyoctaline formate 65405-72-3 DFHJK
    39 2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a- 103614-86-4 DEFHIJK
    octahydronaphthalen-1-ol
    48 Nootkatone 4674-50-4 DHJK
    183 Khusimol 16223-63-5 CEFHJK
    199 Isopimpinellin 482-27-9 CFGJ
    206 Iso3-methylcyclopentadecan-1-one 3100-36-5 DEFGJK
    212 Isoeugenyl benzyl ether 120-11-6 DFHJ
    215 1-((2S,3S)-2,3,8,8-tetramethyl- 54464-57-2 DHJK
    1,2,3,4,5,6,7,8-octahydronaphthalen-
    2-yl)ethan-1-one
    229 Isobornyl isobutyrate 85586-67-0 BDEFHIJK
    260 2,3-dihydro-3,3-dimethyl-1H-indene- 173445-44-8 DHJK
    5-propanal
    261 3-(3,3-dimethyl-2,3-dihydro-1H- 173445-65-3 DHJK
    inden-5-yl)propanal
    281 3a,4,5,6,7,7a-hexahydro-1H-4,7- 5413-60-5 CEFGJK
    methanoinden-6-yl acetate
    329 gamma-Eudesmol 1209-71-8 DFHJK
    335 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8- 1222-05-5 DEFHJK
    hexahydrocyclopenta[g]isochromene
    353 (Z)-6-ethylideneoctahydro-2H-5,8- 69486-14-2 CEFGJK
    methanochromen-2-one
    360 8,8-dimethyl-3a,4,5,6,7,7a- 171102-41-3 DEFHJK
    hexahydro-1H-4,7-methanoinden-6-
    yl acetate
    441 Octahydro-1H-4,7-methanoinden-5- 64001-15-6 DEFHJKL
    yl acetate
    484 3a,4,5,6,7,7a-hexahydro-1H-4,7- 113889-23-9 DEFHJK
    methanoinden-6-yl butyrate
    487 3a,4,5,6,7,7a-hexahydro-1H-4,7- 67634-20-2 DEFHJK
    methanoinden-5-yl isobutyrate
    488 Curzerene 17910-09-7 DHJK
    501 (E)-cycloheptadec-9-en-1-one 542-46-1 DEFGJ
    566 Cedryl formate 39900-38-4 BDEFHJK
    567 Cedryl acetate 77-54-3 DEFHJK
    569 Cedrol 77-53-2 DEFHJK
    570 5-methyl-1-(2,2,3- 139539-66-5 DEFHJK
    trimethylcyclopent-3-en-1-yl)-6-
    oxabicyclo[3.2.1]octane
    573 Caryophyllene alcohol acetate 32214-91-8 DEFHJK
    574 Caryolan-1-ol 472-97-9 DEFHJK
    603 Bornyl isobutyrate 24717-86-0 BDEFHIJK
    616 beta-Santalol 77-42-9 DEFHJK
    621 beta-Patchoulline 514-51-2 BDEFGJKL
    624 beta-Himachalene Oxide 57819-73-5 BDFHJK
    627 (2,2-dimethoxyethyl)benzene 101-48-4 DHJK
    632 beta-Cedrene 546-28-1 BDEFGJKL
    663 Anisyl phenylacetate 102-17-0 DFHJ
    680 2,2,6,6,7,8,8-heptamethyldecahydro- 647828-16-8 ADEFHJK
    2H-indeno[4,5-b]furan
    684 alpha-Vetivone 15764-04-2 DHJK
    694 alpha-Santalol 115-71-9 DEFHJK
    696 alpha-Patchoulene 560-32-7 ADEFHJKL
    708 alpha-Gurjunene 489-40-7 BDEFHJKL
    712 alpha-Eudesmol 473-16-5 DEFHJK
    714 alpha-Cubebene 17699-14-8 ADEFHJKL
    726 alpha-Agarofuran 5956-12-7 BDEFHJK
    750 Allo-aromadendrene 25246-27-9 BDEFHJKL
    764 Acetarolle 744266-61-3 DFHJK
    775 7-eip-alpha-Eudesmol 123123-38-6 DEFHJK
    776 7-Acetyl-1,1,3,4,4,6- 1506-02-1 DEFHJ
    hexamethyltetralin
    788 5-Cyclohexadecenone 37609-25-9 DEFGJK
    804 3-Thujopsanone 25966-79-4 BDEFHJK
    872 10-epi-gamma-Eudesmol 15051-81-7 DFHJK
    919 3a,4,5,6,7,7a-hexahydro-1H-4,7- 17511-60-3 CEFHJK
    methanoinden-6-yl propionate
    927 5-Acetyl-1,1,2,3,3,6- 15323-35-0 DEFHJK
    hexamethylindan
    933 Patchouli alcohol 5986-55-0 DEFHIJK
    978 3a,4,5,6,7,7a-hexahydro-1H-4,7- 68039-44-1 DEFHJK
    methanoinden-6-yl pivalate
    1007 (2R,4a′R,8a′R)-3,7′-dimethyl- 41816-03-9 DEFHJK
    3′,4′,4a′,5′,8′,8a′-hexahydro-1′H-
    spiro[oxirane-2,2′-
    [1,4]methanonaphthalene]
    1022 2,2,7,9-tetramethylspiro(5.5)undec- 502847-01-0 DHIJK
    8-en-1-one
    1024 (Z)-2-ethyl-4-(2,2,3- 28219-61-6 DEFHJK
    trimethylcyclopent-3-en-1-yl)but-2-
    en-1-ol
    1027 5-methoxyoctahydro-1H-4,7- 193425-86-4 CHJK
    methanoindene-2-carbaldehyde
    1029 Sclareol oxide 5153-92-4 DEFHJK
    1035 Spathulenol 6750-60-3 DEFHJK
    1038 1-(spiro[4.5]dec-7-en-7-yl)pent-4-en- 224031-70-3 DGJK
    1-one
    1060 Thujopsene 470-40-6 BDEFGJKL
    1089 Tricyclone 68433-81-8 DEFHJK
    1107 Valerianol 20489-45-6 DEFHJK
    1129 1-((3R,3aR,7R,8aS)-3,6,8,8- 32388-55-9 DHJK
    tetramethyl-2,3,4,7,8,8a-hexahydro-
    1H-3a,7-methanoazulen-5-yl)ethan-
    1-one
    1131 Methyl (Z)-2-(((2,4- 68738-99-8 DEFHJ
    dimethylcyclohex-3-en-1-
    yl)methylene)amino)benzoate
    1136 Vetivert Acetate 117-98-6 DEFHJK
    1137 Decahydro-3H-spiro[furan-2,5′- 68480-11-5 DEFGJKL
    [4,7]methanoindene]
    1140 (1aR,4S,4aS,7R,7aS,7bS)-1,1,4,7- 552-02-3 DEFHJK
    tetramethyldecahydro-1H-
    cyclopropa[e]azulen-4-ol
    1142 3,5,5,6,7,8,8-heptamethyl-5,6,7,8- 127459-79-4 DHJ
    tetrahydronaphthalene-2-carbonitrile
    1143 (1S,2S,3S,5R)-2,6,6- 133636-82-5 DEFHJK
    trimethylspiro[bicyclo[3.1.1]heptane-
    3,1′-cyclohexan]-2′-en-4′-one
    1144 1′,1′,5′,5′-tetramethylhexahydro- 154171-76-3 DEFHJK
    2′H,5′H-spiro[[1,3]dioxolane-2,8′-
    [2,4a]methanonaphthalene]
    1145 1′,1′,5′,5′-tetramethylhexahydro- 154171-77-4 DEFHJK
    2′H,5′H-spiro[[1,3]dioxolane-2,8′-
    [2,4a]methanonaphthalene] K
    1148 4,5-epoxy-4,11,11-trimethyl-8- 1139-30-6 DEFHJK
    methylenebicyclo(7.2.0)undecane
    1149 1,3,4,6,7,8alpha-hexahydro-1,1,5,5- 23787-90-8 DEFHIJK
    tetramethyl-2H-2,4alpha-
    methanophtalen-8(5H)-one
  • TABLE 5
    List of materials with ALL MORVs greater than 5 to 10
    Number Material Name CAS Number Comment Code
    248 Hydroxymethyl 59056-64-3 BDEFHJK
    isolongifolene
  • TABLE 6
    List of materials with ALL MORVs from 0.5 to less than 1
    Number Material Name CAS Number Comment Code
    472 Decyl anthranilate 18189-07-6 DEFHJ
    526 (Z)-3-methyl-2-(pent- 488-10-8 BCHIJKL
    2-en-1-yl)cyclopent-
    2-en-1-one

    The materials in Tables 1-6 can be supplied by one or more of the following:
    • Firmenich Inc. of Plainsboro N.J. USA; International Flavor and Fragrance Inc. New York, N.Y. USA; Takasago Corp. Teterboro, N.J. USA; Symrise Inc. Teterboro, N.J. USA; Sigma-Aldrich/SAFC Inc. Carlsbad, Calif. USA; and Bedoukian Research Inc. Danbury, Conn. USA.
      Actual MORV values for each material listed in Tables 1-6 above are as follows:
  • MORV MORV Value MORV
    Material value for for MORV Value value for
    No. Equation a.) Equation b.) for Equation c.) Equation d.)
    1 0.548223914 0.876283261 1.22018588 −0.41901144
    2 1.520311929 3.493450446 2.70657265 5.11342862
    3 2.267801995 −0.81712657 0.43218875 1.595983683
    4 −0.591063369 −0.48283571 0.16199804 1.210497701
    7 1.437444636 2.131822996 3.81633465 1.318339345
    9 2.151445882 −0.46189495 0.56090469 1.206360803
    10 2.5733592 −0.58780849 1.39751471 1.258361951
    11 3.052627325 1.008519135 −0.30475953 0.076323462
    12 0.683776599 −0.01157903 0.82853231 0.326169402
    13 1.549643217 1.809183231 0.70864531 2.22799611
    14 2.82111224 2.339505033 1.240818 2.502429355
    16 −0.31551128 −0.06816599 −0.04371934 2.76742389
    17 −1.334904153 −0.5773313 1.75644798 1.898455724
    18 −1.34154226 −2.63596666 0.06885109 1.001431671
    19 0.15532384 0.09866097 0.64214585 −0.33330779
    20 0.640261783 0.693213268 0.54637273 −0.97556029
    21 0.936895364 −0.01521118 1.1697513 −0.63510809
    22 1.158981042 1.115900089 −0.25859776 1.318200884
    23 3.702361074 1.399942641 5.23954766 7.089933671
    24 0.773874141 0.146848137 −1.05705847 −0.36193173
    25 −1.016103969 −1.18967936 0.78064625 2.944710012
    25 −1.016103969 −1.18967936 0.78064625 2.944710012
    26 0.615085491 −0.00096877 −0.35697252 −0.18121401
    27 0.70261974 −0.22197386 0.19710806 −2.37196477
    28 1.366472597 −0.42546942 −0.59394241 −0.01417395
    29 1.096043453 −1.02972898 −1.42167356 −0.63817943
    30 1.143415203 −0.85945441 −0.41416913 2.499807942
    31 1.138642907 −0.19595476 −0.54547769 −0.98828898
    32 1.914414495 −0.64487788 0.63212987 1.166699371
    33 0.314847366 1.848003955 −1.3905032 −0.62848261
    34 −0.113542761 0.981530917 0.32824239 1.126524277
    35 0.472382903 1.494882467 −0.07201236 −0.64589543
    36 3.158513795 1.084094934 −0.00328981 −0.17786385
    37 −1.055631982 2.240172964 0.92596118 2.105391988
    38 3.158513795 0.592820874 −0.49326241 0.212867212
    39 1.083800659 2.069727985 2.48170879 3.205630609
    42 −0.103134861 0.267726008 −0.65350189 1.125952363
    43 0.323961628 1.469295081 −0.52991193 0.797908251
    47 1.703678841 1.348737095 2.00634162 −0.16505407
    48 2.370955056 2.783472865 2.68240273 1.221864405
    49 1.670680003 −0.41866107 −0.9173849 1.181929544
    50 1.670680003 0.076369374 −0.49915943 −0.85392575
    52 0.464485039 0.057512869 1.31230219 −0.11170276
    53 0.626671823 −0.46954947 −0.33383736 0.277079201
    54 0.666149043 0.009549925 −0.36226343 0.197224432
    55 0.723473579 −1.50916383 −0.3848989 −0.71458778
    57 0.381273227 1.192994109 1.65593321 −1.65739236
    59 0.561360663 −0.17793966 −1.63250554 −0.7564969
    61 0.146473611 −0.01535544 −0.16339658 1.738656146
    62 1.20162032 −0.3576095 −0.10695443 1.322155191
    63 1.084291915 2.258720158 −1.01245416 1.688283974
    64 0.744770665 0.155243763 −1.8029919 1.023503542
    65 0.972835178 2.797151284 1.53453579 0.857051645
    67 2.069410561 0.021831924 0.37855159 −0.67235457
    68 0.527636614 0.590831983 1.02843762 2.208655795
    69 2.133965691 2.088998449 2.05751412 −0.9433713
    70 0.327378959 0.996844599 1.23648533 −1.25138371
    71 1.40093669 0.778222691 0.70401172 −0.24075444
    72 0.617697349 −0.29503359 0.52404847 0.816184656
    73 0.617792473 0.888976061 −0.45289639 0.615659244
    74 1.437359024 1.548292147 0.10314807 −0.48982286
    75 −1.970885622 3.398008325 4.08025266 −0.89948156
    76 −1.32746934 −2.65365233 0.10272816 1.001614125
    77 −2.541686116 3.295534192 3.75284227 0.404837808
    78 −2.110794 2.109874746 3.13350902 −0.3880285
    79 1.641162056 −0.28533994 1.53676145 0.652696023
    80 1.594400214 0.283682865 2.23140233 1.111682021
    81 0.176566806 −2.0786518 −2.13986952 0.981126964
    82 0.980373758 −0.28813159 0.19404501 1.252564677
    83 0.941833098 0.317310013 1.17606727 0.72992237
    84 0.774237336 −0.27140727 0.72461427 −1.56415746
    85 2.092976965 0.810644229 0.82999192 −0.62861806
    91 2.061595915 −0.79930338 −0.18285395 −0.66898499
    92 2.068748434 −0.24299896 0.07214682 −1.11758276
    93 −0.08984279 −1.06025959 −0.05068694 1.560050105
    96 0.927758203 −0.44129515 0.89190422 0.744284978
    97 0.658667572 −0.68771072 0.46051026 −0.53120883
    98 0.853222693 −0.2037738 −0.21414441 1.119784962
    100 1.654535066 0.995056228 2.35139085 0.543654824
    101 2.173663649 −0.11491477 1.48285148 1.698527571
    102 2.066679492 −0.16785146 −0.84780149 0.12159477
    103 2.335152618 −0.02866585 0.16993375 −0.98254522
    104 2.760588276 0.459513599 1.35310241 0.000336976
    105 1.654535066 3.654489674 3.13033965 0.544225478
    106 1.750588169 −0.55853348 0.50257773 1.630011313
    107 0.896789863 0.73615897 0.53011623 −0.54697747
    108 0.532375207 0.826537134 1.21040312 0.690230716
    109 2.407655187 0.742651426 1.80322099 0.271832856
    110 0.54830833 2.916795026 1.40126098 0.690230716
    111 0.939597126 −0.3750368 −1.23479972 −0.89366351
    112 1.398518854 1.265740274 4.19618377 −0.12762692
    113 1.415726941 0.086297006 3.43559555 −0.12964168
    115 −1.557729423 −0.44113526 0.86330536 0.590708892
    116 0.193562268 −1.58091165 0.83247813 −0.70978039
    117 1.353510875 −0.59062398 −0.31776345 −0.3050158
    119 0.830052725 2.28725579 0.38409695 0.219336109
    120 1.261997955 −0.22622961 −1.04772194 2.028504137
    122 1.505653628 −1.14748206 −0.19760084 −0.81373045
    123 −0.658721962 −0.21299878 1.01439841 −0.76731016
    125 0.749676998 −1.0761601 0.99563924 −1.15409002
    126 0.931054384 −0.35067079 1.06050832 −1.62171794
    128 −1.344832644 −0.09451199 1.19145467 1.621274257
    130 1.153249538 1.605070708 2.38047907 −0.93842293
    133 0.840066046 0.2323025 0.19054023 −0.26588341
    134 0.522267541 0.824106618 1.83479545 0.364403434
    135 2.142817887 2.142411243 −0.93830995 0.696522652
    137 3.052627325 3.606270166 0.50445208 0.076323462
    140 −0.153437637 0.246303216 0.76565758 1.800968868
    141 2.067620311 1.424830396 2.33536931 7.644025075
    142 0.98353103 1.950251373 2.50851828 −0.24499521
    143 1.736969725 0.991537809 2.5691601 1.227191656
    145 −0.211768579 1.46336231 −0.93580247 −1.48749449
    146 1.912710035 0.926306508 1.81253333 0.494121361
    147 0.675736703 0.99202385 −0.66034472 −0.66302669
    148 0.757176542 1.83006252 0.16210659 0.243674851
    149 0.438772371 1.091438092 −0.1560319 −0.61711642
    150 0.84399938 0.675302022 −1.69771411 −0.73841711
    151 0.633570539 0.988413715 −0.54991825 −0.43550324
    152 0.911582356 1.974700218 −0.92267786 0.628660087
    153 0.319053885 2.531735341 −0.39139184 0.734629224
    154 0.714814512 0.690769753 −2.06588692 −0.73356628
    155 −0.161798388 0.032135767 −0.13802086 1.734928461
    156 −0.571799976 −1.32834264 −1.65346017 1.856689553
    157 0.131224024 0.21510779 −1.70996346 0.964902175
    158 1.201616145 −0.21158932 −0.8501176 −0.33330779
    159 0.811289908 1.606645397 0.25352447 −1.83775117
    159 0.811289908 1.606645397 0.25352447 −1.83775117
    161 0.475184006 1.99305646 1.90910177 3.288337059
    162 0.833030517 0.487189028 1.76798642 0.104378164
    163 0.58993703 −0.46431772 0.74883588 −0.81090824
    166 −0.121286831 −0.84664528 −0.32625341 0.778055656
    167 0.846400186 −0.25922232 0.69248774 1.183696217
    168 −0.310930833 −0.81048493 0.08527131 1.61831109
    169 −0.2346025 0.890438419 −0.13206526 −0.83961838
    170 −0.169223695 1.172917966 −0.11306441 0.099121666
    174 2.863652137 0.236674094 −0.69038707 1.610215283
    175 1.789769228 −0.31740428 −0.89529921 −0.09686469
    176 2.625947334 0.083548191 0.30634559 −0.35925728
    177 1.674319352 −0.22179044 0.42093738 −0.23683577
    178 2.863652137 0.727069168 −0.26724686 −0.44888613
    179 0.070511885 0.365852864 1.35327505 −0.03748038
    181 0.976254543 0.691638796 0.51371978 −0.02503945
    182 −1.842503751 −0.12688474 2.56277877 0.111744488
    183 3.195758563 3.886545621 4.29482769 3.829845293
    184 0.333889534 −0.67236766 2.21605977 4.254612125
    185 5.61162203 1.40458529 2.86231343 1.035135749
    186 1.068190511 −0.65969343 −0.63104765 −1.36962992
    187 1.396358739 0.249705611 0.81449499 −0.15353102
    189 1.544466636 −0.33742685 0.8096674 −0.44483677
    190 −0.210918777 −1.04086063 0.02614862 3.362615492
    191 0.715897301 0.666316436 −0.41719538 0.400723176
    192 0.65612864 1.231196814 0.75462061 1.514581532
    193 −0.394884432 1.129269425 −0.3157071 −0.61478944
    194 −2.111794245 −0.71010521 0.53077207 0.59302222
    195 1.18880856 0.704463775 1.99312777 1.419709023
    196 1.885714606 0.436434665 1.44657532 1.145809063
    197 2.174580668 0.133070149 0.99814905 0.871658496
    198 −0.533922573 −2.16213117 0.5812107 −0.92280453
    199 1.493919434 1.45125612 1.95141371 4.403441058
    201 −0.005520296 −0.83362523 0.65480762 −0.38894276
    204 0.732981164 −0.97494758 −0.91192246 −1.00034323
    205 0.991838899 −0.60053505 −0.49983634 0.674468753
    206 2.147983695 1.291351958 1.64553247 1.626455601
    208 −0.386224123 −0.24799559 1.19406353 −1.61243489
    209 1.447075297 0.122626462 1.08021156 0.473154634
    210 −0.386224123 −0.24799559 1.19406353 −1.61243489
    211 2.186118467 1.873949371 0.64852028 −0.59205851
    212 1.367811201 1.689658923 1.8017376 2.525531645
    213 0.925016223 0.875610609 0.31462609 0.847028648
    214 −0.239873321 1.808823425 −0.36105512 −0.07650286
    215 2.264275088 1.360001278 3.25759951 2.147928282
    218 −0.509585598 −0.93428643 1.63030386 −0.79436377
    221 1.876297063 0.026873469 0.45442758 1.538486988
    227 5.317676982 2.824566654 1.73360625 3.103310061
    228 3.323728685 1.554268023 1.8883835 0.957527434
    229 3.218950175 1.464118271 2.47512497 1.214429025
    230 5.242356467 3.482206715 3.50441556 1.614847073
    230 5.242356467 3.482206715 3.50441556 1.614847073
    231 2.710087358 1.517756148 0.35088855 0.603171932
    231 2.710087358 1.517756148 0.35088855 0.603171932
    232 0.703604481 0.42129186 0.39567696 0.41729786
    233 1.312921486 0.816597603 2.17066283 0.472801294
    234 0.874145958 0.741410502 1.71105733 −0.47289415
    237 0.778921491 −1.02119303 0.4612164 −0.8881184
    238 0.681403734 −0.342052 1.27750286 −0.3383341
    239 −0.870637933 −2.58292907 0.79173772 −1.27888846
    242 0.910211214 0.374558101 1.01712685 1.001043471
    243 1.670680003 0.104780951 −0.6545574 −0.46985154
    244 1.140332181 0.116513028 1.61110902 3.713305291
    246 −0.634992987 0.548746912 4.62542427 7.660969857
    247 −1.739729444 −0.91508372 1.18693162 3.108631198
    248 5.81821686 6.320330665 6.14379552 5.214046447
    249 0.348188924 −0.95333461 −0.08432225 1.866717393
    252 2.456287983 −0.02516176 0.76814124 1.756087132
    253 1.76915226 0.226389981 −0.18115009 −0.62385199
    254 0.658956861 −0.39322197 −0.67153044 1.416053304
    255 0.892122738 −0.46985097 0.42813903 −0.46752753
    256 0.625043963 −0.65111806 1.4319541 2.110656697
    258 −0.187789327 −0.85870492 −0.21766971 0.931521178
    259 −1.261365139 −2.33099427 1.33595129 0.43644676
    260 2.4020693 2.669351733 2.36395771 1.910609499
    261 1.978618006 2.732613301 2.19594212 1.683156477
    263 1.350274014 −0.59210334 0.14780643 −0.13113746
    264 0.526085484 −1.54983116 −0.17497208 −0.8204696
    267 1.175997006 −1.03507906 −0.11004734 −0.50564806
    269 2.367197222 0.457286256 0.02211231 0.497925297
    270 0.711734628 −1.45058685 −0.17018094 −0.71795736
    271 1.073564668 −0.47951936 −0.80269361 0.136837431
    273 0.663835001 −1.5674675 0.28509522 −1.12959038
    274 1.628173498 −0.58892922 −0.3892777 −0.66728139
    275 0.935336765 −0.9522644 −0.87000279 −0.29365972
    276 −5.989155804 1.722071272 3.31094703 1.273171428
    277 0.904631703 −1.02628534 0.49274649 1.000655271
    278 0.293923493 −0.82335619 0.13147975 2.730914048
    280 −0.284822555 0.322094188 3.2184015 0.383213731
    281 2.201373139 2.228820089 2.03455575 1.720697243
    282 0.505189899 −1.01844885 −0.98499144 0.912195522
    283 0.775002479 −1.29876341 −1.52162214 −0.77292581
    284 0.505189899 −0.57830662 −0.55673047 −1.09870665
    285 −0.987611415 0.908212704 2.59089199 1.311154128
    286 −2.635687733 −1.53554173 0.68132558 4.350511118
    287 −1.890800496 −0.9175912 −0.84177071 0.615422874
    288 −0.417807714 −0.27643667 1.06515025 0.958812195
    289 1.078763544 0.263281029 1.00763749 0.866949263
    290 0.733561298 −0.47493387 0.17088582 1.536463653
    292 1.2252731 0.720498276 4.33362953 2.202084022
    293 0.947860369 0.93449449 1.85056304 0.355024738
    294 −1.051634009 0.136579632 2.17918871 −0.01949057
    295 1.039790111 0.81471915 −0.94326824 0.887662055
    296 1.009509413 1.364418947 1.42805339 0.429992055
    300 0.246930208 1.113809101 0.25540773 0.528760053
    301 0.246930208 1.113809101 0.25540773 0.528760053
    302 0.697198045 −0.41500676 −2.35076003 −0.60639529
    303 0.10667178 3.580489288 0.25893587 2.329367856
    306 0.561360663 −0.17793966 −1.63250554 −0.7564969
    307 1.583243229 1.398558046 0.152423 −0.13988304
    308 −0.067380931 0.74278658 0.29217479 0.180866298
    310 0.238202662 0.926241567 −0.66649303 0.508184193
    312 0.714965519 −0.45511207 −2.34849436 −0.9953911
    314 0.736369931 −0.52068396 0.53882253 −0.7059813
    316 2.314558863 −0.25458611 0.22080129 −0.04142716
    317 1.095005005 0.057439852 −1.20728654 0.035895107
    318 −0.111714595 −0.61079351 −1.16010053 1.102488007
    319 −0.264829849 0.540388888 0.10729709 −0.57215449
    321 1.243861203 −0.75229123 0.05515858 −0.34659253
    322 0.956379568 2.838565742 2.7997689 0.805938034
    323 1.884902746 0.813499245 0.86344403 −0.1241887
    324 0.189037208 1.105600415 0.48460989 0.285938173
    325 0.791400443 2.454239197 1.54315324 1.416449646
    328 1.22836182 2.190068443 2.48751772 0.126982574
    329 1.800767509 1.372656013 2.09551175 2.849728342
    330 2.688999059 0.017422444 0.34929031 0.108155361
    331 −0.223648429 0.873635097 1.78683863 0.126324441
    332 1.884902746 −0.46695445 0.1761545 −0.11026722
    333 0.956379568 2.838565742 2.7997689 0.805938034
    334 0.569368001 2.811464091 1.88866785 −0.16122533
    335 1.931053264 2.306571877 4.45651797 4.474221307
    336 1.355107839 −0.49142588 0.83879083 0.18350392
    338 1.025467157 −0.99345477 0.57780149 −0.19101275
    339 1.216559787 −0.68632827 0.71921804 0.140021721
    342 2.073599715 −0.19777074 −0.44964804 −0.71885866
    343 3.375840967 3.294907583 5.0378352 4.14804591
    344 0.926453735 1.336260845 2.20088072 0.226359561
    346 −0.133453942 −0.27276578 0.95852923 −0.88404805
    347 −0.414858428 −0.94736055 1.9452074 −1.32753709
    349 0.011110326 0.415952358 1.08076289 2.638925816
    350 −1.366284701 −1.3912958 −0.0683659 1.205395618
    352 2.592229701 2.014162407 −0.56599991 −0.19676404
    353 2.347680291 1.432589328 3.81650185 2.28664738
    354 −0.094599823 0.704257624 0.8494127 −0.05632553
    355 −0.534528735 −0.26820008 0.69328667 0.63557685
    356 0.71431796 0.568464069 1.14931631 0.32594963
    358 1.637857828 1.932629993 0.68535871 −1.06298922
    359 3.169264285 2.326146291 5.44251947 3.621423972
    360 2.824830639 3.29829616 3.43870859 3.771256974
    361 0.772183137 0.62924397 1.14549597 0.743423792
    362 2.158106604 −0.08901432 0.85035629 −0.37323677
    363 1.485114303 −0.85819594 0.70929196 4.132013298
    364 −0.661168364 −0.30270875 2.49237859 −0.7675819
    365 −0.518303431 −2.08665423 0.5658944 −1.10451499
    366 −0.501301831 0.561788544 0.14113617 0.610082057
    368 −0.106125097 1.092782715 −0.89571841 −0.08594454
    369 1.43532227 1.656262941 −1.09448841 1.674272267
    370 1.064083705 −1.08482967 0.35640283 0.866246621
    371 1.933819902 0.975863726 1.62799441 1.492919426
    372 1.933819902 0.975863726 1.62799441 1.492919426
    373 0.274120553 2.246646022 2.93946992 2.617412085
    374 0.940949346 2.935858163 0.52084392 0.847114052
    375 0.177236108 2.745061961 0.76268843 0.373809692
    376 −0.999571921 0.579320229 −0.06019938 −0.94280945
    377 0.521811983 −0.8476641 0.7732327 1.729406547
    378 −0.532701772 −2.17823188 1.26760147 0.815211357
    379 −0.684994963 0.018353057 −0.8170018 0.582030709
    381 1.592237677 1.373054134 0.60184939 −0.30300485
    385 0.967501839 0.136172137 1.3645564 0.374341215
    385 0.967501839 0.136172137 1.3645564 0.374341215
    386 1.247138794 −0.97883463 0.03688288 −0.57321578
    387 0.785485559 −1.23629818 −0.07759084 −0.71795736
    388 1.503632155 −0.13455265 0.86630165 0.102845335
    388 1.503632155 −0.13455265 0.86630165 0.102845335
    390 0.811363694 0.872605919 −0.17445198 1.358866557
    391 1.653006495 −0.44095837 0.46475017 −0.16817306
    394 1.043989895 −0.82625074 0.40893134 −0.10417542
    397 1.430046723 −0.79407262 0.15684862 −0.4384694
    398 −1.401723491 0.271079592 1.35530191 −0.63550333
    400 0.762211626 −1.06778628 −0.93642574 −0.13193338
    407 0.591198428 −0.8943503 1.41392426 2.694863328
    412 −0.067309295 −0.21963004 0.57788677 −1.22740398
    413 0.630456164 1.538096427 2.10994563 2.45668637
    414 0.460631327 3.678501689 1.18326431 1.28320952
    415 0.060485009 −1.37776759 −0.22689728 2.328813337
    416 1.864088631 0.2451067 1.63260125 1.855346924
    417 −0.747017264 −2.60335412 0.85092701 3.525229717
    418 3.678359573 3.437930194 4.42449746 0.716864637
    419 −0.131519393 0.731836014 0.81604919 −1.29993979
    420 0.11276779 −0.13029453 0.19422843 0.853490939
    421 2.819997124 0.193567405 1.15903162 1.748390255
    424 −0.211768579 1.46336231 −0.93580247 −1.48749449
    425 −1.467980751 −2.41196874 −0.34454968 2.161517022
    426 2.176374648 2.131594325 1.99252316 0.002774099
    428 2.10568799 0.336366154 −1.41176883 0.827982605
    429 2.179080731 0.811454228 −0.58304782 0.827982605
    432 0.814675557 −0.13076033 1.07380397 −0.01560954
    436 0.003614069 −0.4704298 1.6004974 −1.27605297
    437 −0.070955783 −0.17246926 0.32599434 0.682083059
    438 0.71141055 −0.62729405 0.6220964 0.498836975
    439 −2.152188932 −1.81662702 0.66042162 −1.57001886
    440 0.194444196 0.880854446 0.80016905 0.373809692
    441 2.349282571 1.734747324 1.71148239 1.274963632
    442 0.243841724 0.036287037 0.51243015 0.361825534
    443 −0.131519393 0.731836014 0.81604919 −1.29993979
    444 0.607958335 1.910541857 −0.42710132 −0.46909656
    445 −0.047486491 1.045012945 −0.25220201 −0.31982826
    447 0.611981677 0.559261438 −0.31210071 −2.20421695
    448 0.45491409 0.804084437 0.03088748 −0.17549737
    449 0.323968221 −1.00428076 −1.65151616 1.031096548
    450 1.433196296 −0.12277841 3.46809784 −0.14760118
    453 1.138642907 0.238344138 −0.56453732 −0.60639529
    454 0.689556954 −0.32116049 0.17614165 0.99165159
    455 −0.978653338 −0.96381951 0.37950282 0.793341469
    457 2.740852074 1.146976436 0.01429902 0.909817098
    459 2.034203389 −0.06483391 0.25864307 0.096715771
    461 0.405441454 3.029508918 1.66201629 0.621375526
    462 1.348588872 2.252065606 1.98535615 0.126982574
    463 2.402548765 0.141297665 0.32401564 0.165555831
    464 1.396358739 −0.35292634 0.11760582 −0.13960954
    465 0.940569103 1.267891616 1.68420132 1.263608034
    466 −0.191220659 0.067062979 2.24237992 0.125280183
    467 0.940569103 1.267891616 1.68420132 1.263608034
    468 0.123370943 1.164309475 0.17099727 −0.95446701
    469 0.925252053 −0.57178441 0.69807561 −0.59133195
    470 2.237616041 1.810156128 −0.58140154 1.320304914
    471 1.714516544 −0.62135116 0.23636624 −0.2706853
    472 0.605628283 0.938001104 0.50028363 0.743911872
    473 0.093847515 −1.1973016 −0.26960381 1.829684619
    474 0.696773849 1.065592689 0.37607733 −0.19214193
    475 1.405352842 0.379589036 0.27781476 0.041425889
    477 0.237582954 0.629327199 0.45159895 −1.59912382
    478 1.360648836 0.598053217 2.00883441 −0.0827715
    479 2.214928637 −0.24358938 −0.3486103 0.9190125
    480 1.933819902 −0.3826187 0.97439148 1.491603428
    480 1.933819902 −0.3826187 0.97439148 1.491603428
    481 0.612364301 −0.26364231 −1.3201026 −1.62884377
    482 1.604448424 1.286308964 −0.34289284 0.887781648
    482 1.604448424 1.286308964 −0.34289284 0.887781648
    484 3.269313083 2.336715633 3.65534824 2.158890088
    486 1.530484593 1.052491466 3.11297562 0.430146348
    487 2.889323404 2.226094104 4.12877599 2.184426542
    488 1.062548487 4.75312035 2.78435853 2.01925207
    491 0.397432667 −0.20071274 0.842202 1.944142408
    493 0.270731661 −0.7406408 −1.17192239 1.401933582
    495 0.298981649 0.854414067 −2.2714622 −0.62848261
    496 0.565278409 0.659352661 −0.00159534 0.384991859
    497 2.972647554 1.210988046 0.08629653 0.991649406
    498 2.863652137 0.229707592 −0.75515466 −0.06022029
    502 0.478208715 1.827989577 0.67676345 −0.88328385
    503 0.845706083 1.117392544 −0.21773539 0.272770415
    504 0.837488879 0.874463134 −0.08311625 0.149327397
    505 1.749446006 0.076054765 −0.59137073 0.291488011
    509 0.716903285 −0.22917288 −1.93027881 −1.52173529
    510 0.241638743 0.769444787 −0.07283731 −0.38771737
    512 0.556069536 −0.47514685 −1.88388474 −1.67297277
    515 0.23291131 0.598998195 −0.99553291 −0.40829542
    517 0.784181146 −0.20530019 −1.89414748 0.152726109
    518 0.742030255 0.281479436 −1.4156326 −1.91369695
    519 0.367442761 −0.50911405 −0.77651804 3.081125259
    520 1.28335174 −0.16976166 0.19676128 1.493753388
    521 −1.105672292 −1.29204085 −0.95149628 1.817322011
    522 0.714965519 −0.45511207 −2.34849436 −0.9953911
    524 0.325255266 1.131242708 −2.79377204 −0.62848261
    525 −0.210625832 0.979060885 0.37926876 −2.08002977
    526 0.698504484 0.548193178 0.92265651 0.500152973
    527 0.420012766 1.731459464 −0.23341719 0.139565409
    528 0.161304111 0.66712144 0.58401752 0.373809692
    529 0.911890585 0.353572744 1.04706167 1.001090055
    530 1.670680003 0.86138741 −0.27652639 1.174059185
    531 −0.169223695 1.172917966 −0.11306441 0.099121666
    532 2.237616041 1.438074134 0.31117554 −0.71786492
    534 1.205873658 1.32208026 1.21816392 −0.5027271
    535 0.999469738 0.056406435 0.72382479 −0.61170287
    536 0.63876931 −0.39111525 0.08747854 −0.66833729
    537 0.689953348 1.206425159 0.58870271 0.198159994
    538 0.54988634 −0.32842011 0.69258273 −0.81953404
    540 0.735538933 −0.20826876 0.6955468 −0.7170218
    541 1.097368973 0.740159871 0.12012053 0.137772993
    542 −0.24632881 −0.09354384 −0.13580399 0.599029186
    544 0.687639306 −0.30861817 1.14537443 −1.12865481
    546 1.670680003 1.94609957 0.19633838 1.14825764
    547 −0.24632881 −0.23975349 −0.01449288 0.574861147
    548 1.349418105 −0.29885837 0.42849141 0.008671721
    549 0.623933699 −0.62776258 −1.2835205 −0.23131507
    550 1.091300413 −0.33969057 0.91994098 0.043900994
    550 1.091300413 −0.33969057 0.91994098 0.043900994
    551 1.172668936 −0.39476924 −0.61394794 −0.16425167
    552 1.434150355 1.041294025 0.32000606 1.24279868
    553 1.040907688 −0.38050079 −0.95306497 −0.03036668
    554 0.623933699 −0.65991007 −1.27562979 −0.61529805
    555 0.623933699 −0.09654208 −0.6432411 1.36608372
    556 0.623933699 −0.62776258 −1.2835205 −0.23131507
    557 −1.043779684 0.358151507 0.96578333 −0.7498558
    558 3.113548387 0.901949497 −0.07402944 2.171129217
    559 1.433732801 2.854621121 1.81079379 0.893806123
    560 0.793851811 0.195900744 1.13222828 −0.38432626
    561 1.874725149 0.921395625 3.05642524 2.616508159
    562 −1.30410643 −2.63450231 0.12574616 1.001870337
    563 −0.153585698 2.733591064 2.12854196 3.424603045
    565 3.655479783 3.751479035 5.51820797 3.282822615
    566 4.034374094 3.755759834 4.82506006 3.190861648
    567 4.203811008 3.627632534 4.68751919 3.372829008
    568 1.643514525 0.827299302 0.70706274 2.545428997
    569 2.692371513 3.589810155 4.40390088 4.506937878
    570 1.707556133 2.400065573 1.78745169 2.655458557
    571 1.862893827 2.803280605 0.98209954 3.188564781
    572 1.203581368 0.798608763 2.67898788 1.659633314
    573 2.459623568 2.656773866 3.54771795 2.085649266
    574 2.878405284 1.770500246 4.00464111 4.859737959
    575 −0.395731956 0.325594009 0.98982713 −0.25791379
    576 −0.2346025 0.890438549 −0.13206526 −0.83961838
    577 0.484934913 2.001798597 −0.11430063 −0.05230593
    578 1.138642907 −0.72228381 −1.0321 −0.60639529
    579 −2.722013313 −3.79238321 −1.13572295 0.953543134
    580 1.138642907 −0.66601616 −0.95089973 1.036450105
    581 1.105119249 −0.82090309 −0.06184517 −0.90904158
    582 2.092976965 −0.31228784 0.08755137 −0.62955362
    583 −0.24632881 −1.33540368 −0.96483147 0.624830731
    584 2.237616041 0.30800753 −0.44296441 −0.71918014
    585 0.634021669 −0.28724544 −0.74527157 −1.361765
    586 1.313957377 0.449601 1.50810166 −0.30998322
    587 0.304876136 −0.43283205 1.23096012 0.398961811
    588 0.449793066 0.007950225 0.8004147 −0.63434071
    589 −0.681766404 1.08547116 0.54331319 −2.16710754
    591 −0.34676031 −0.77573166 1.85884084 0.312272735
    592 −1.573190219 2.29028194 1.86285367 0.687279186
    594 −1.45374647 0.452156392 2.48970747 0.858468114
    595 0.058003677 −1.91126878 1.52586392 −0.07528071
    599 1.485777974 1.54384772 0.79002365 −0.09069773
    600 1.914093549 0.841364523 0.15173954 0.255445859
    601 1.203870517 1.17864533 1.22686262 0.453935114
    602 0.771984982 0.66859171 −0.37427136 0.07599515
    603 3.218950175 1.464118271 2.47512497 1.214429025
    604 2.710087358 1.517756148 0.35088855 0.603171932
    605 0.703615734 0.42129186 0.39567696 0.41729786
    606 0.055463315 1.972687323 3.42898264 1.395457482
    607 −0.146397553 −2.05649732 0.17598641 1.900931587
    608 1.473771668 2.08260463 −1.09319437 0.44289209
    609 −0.466215117 0.845009196 1.89800228 0.840292062
    610 2.14236439 1.079695535 0.29060257 1.329215628
    611 1.078583502 1.707732184 −0.73721672 −0.87923138
    612 −0.128136098 1.038320983 −0.63703066 0.184527669
    613 1.599427115 3.615521066 0.43343413 −0.1515479
    614 1.489603514 2.706865637 −0.06242639 −0.47244791
    615 1.960664614 4.490550162 2.26962278 0.346542121
    616 2.689328335 3.692579375 2.01499213 1.348800283
    617 −0.845027889 0.504788036 0.4957383 −0.65628324
    618 −0.461016335 1.612995126 1.09551709 −1.62235977
    619 −0.222804396 0.361727974 0.62743416 −1.02982449
    620 0.745610019 −0.76737462 −0.67364137 1.696394301
    621 3.671429366 1.708460032 4.57083156 1.955988764
    624 2.139270802 2.093130621 2.5533383 3.30383102
    625 0.665423108 1.356936283 1.5515704 1.874119646
    626 1.292942787 0.621140137 2.28513785 1.042322574
    627 1.14724223 −0.51104438 1.01088446 1.51232276
    628 1.44418619 3.825155203 −0.84341678 −0.02251455
    631 2.622138509 5.106659136 4.48303003 2.115425367
    632 2.450328692 4.670297017 4.54579766 2.15781135
    633 1.560465308 2.636096631 2.45546606 0.920962489
    635 1.510161132 2.388971583 −0.63579931 1.939575919
    636 1.433842763 0.529693203 −0.23195491 1.22356734
    638 1.921725015 0.758255259 0.81570609 3.615611357
    639 0.422001837 −0.14885323 −0.00660617 1.726576493
    640 0.865825265 −0.28827025 −0.54129473 0.283616979
    641 0.813978315 0.509726232 0.37457254 0.842075065
    644 0.85173251 0.664325682 1.88299246 0.951603698
    645 0.417907652 −1.00347186 0.9667556 −0.47157656
    647 0.221569324 −1.2239438 0.91464498 −0.19166679
    649 −0.560315649 −0.67419393 −0.02482011 1.492767049
    650 1.640396187 0.328871961 0.04729888 0.912259803
    651 0.672555558 −0.9987845 0.48545476 −0.13530683
    652 −0.995969271 −1.38653208 −0.49268035 0.944524468
    653 1.203949791 0.0153333 −0.10401424 0.73323846
    655 1.334772083 0.418728831 −0.92221842 1.317365259
    658 0.414934548 0.314990682 2.78051829 2.656854539
    659 3.996948911 1.915319951 3.03990612 5.764113617
    660 2.175041013 1.882945358 0.07779745 −0.18323732
    661 −0.316755016 1.64607349 2.76327471 2.024910676
    662 0.258228842 0.844792644 0.1924797 0.098776211
    663 1.521826905 1.097809988 2.13583044 1.30609234
    664 0.708920214 −0.27795513 0.15395433 0.014791904
    665 0.630772742 −0.34278374 0.49097281 −0.0565644
    667 0.812238101 0.195908668 0.21564664 0.219336109
    668 1.529097453 2.246515706 1.4678099 −0.81836944
    671 1.453855457 −0.51177209 −0.78608937 0.361715513
    672 0.771613806 −0.81209599 −0.85297613 0.084880782
    673 1.874725149 0.921395625 3.05642524 2.616508159
    674 5.912391366 3.468705262 6.81994671 7.217631788
    675 0.525794155 0.473286101 2.51749677 2.935001452
    676 0.623704257 1.523736626 2.50208859 2.474137331
    677 −0.548848405 0.058004962 1.07849806 2.361730638
    678 4.818555677 1.506257638 4.96635528 5.508133385
    679 4.332202737 2.699343437 5.65576391 5.021298111
    680 4.042984412 4.75506829 4.65903898 4.913020939
    681 0.5959536 2.091803965 −0.14697928 −0.71889234
    683 0.87899671 0.043210589 1.37554648 −0.60198897
    684 2.349844428 1.181400632 2.15359469 2.136987013
    686 1.024635336 1.040500794 0.9820242 −1.16405004
    687 0.551495677 0.66297128 −0.45433071 −1.28827912
    691 1.609835015 2.898881191 −0.99203246 −0.15162554
    692 2.002379485 3.95875961 1.1705779 0.346542121
    693 4.264631423 4.375626605 0.93418004 0.114988571
    693 4.264631423 4.375626605 0.93418004 0.114988571
    694 4.858313721 4.772826468 3.58732214 2.558402204
    696 2.99409154 3.843066736 2.50597637 1.205022789
    697 0.407534444 2.829113684 2.16548165 0.756766079
    698 0.983060431 2.328872529 1.67788951 0.805938034
    699 0.996500165 0.60129571 −0.27496491 −0.22179967
    700 0.698400489 0.514637899 1.14265307 0.816064314
    701 0.592372435 −0.67812322 −1.75051912 −0.51109618
    702 −0.211768579 1.46336231 −0.93580247 −1.48749449
    703 0.372029303 0.866016277 −0.91679974 0.347054507
    704 1.187861135 0.858978871 0.1265005 0.217668671
    706 0.193569186 1.623921627 0.08867618 0.808617424
    707 0.819562098 3.57840156 3.38080377 1.26599216
    708 2.391828225 1.877690145 3.85935427 1.647356195
    709 1.280902077 2.17019575 3.40315777 0.126982574
    710 1.454593977 3.128186882 −2.26368122 −0.02251455
    711 −0.783387499 1.465620573 1.22912535 −1.41213701
    712 1.936489942 2.528373237 2.13424487 2.393940425
    713 1.303999908 2.146563611 −0.26420591 −0.01477791
    714 2.3584433 3.778880151 3.4396901 1.593719007
    715 4.023918591 3.403899942 5.07447567 4.880181625
    716 0.981194248 1.73892162 2.21166953 2.738129365
    717 0.983060431 2.328872529 1.67788951 0.805938034
    718 1.241840746 3.430871861 0.55000978 1.073616332
    719 1.483275952 3.037398628 −1.55547275 −0.47244791
    720 2.372311412 3.403234423 −0.21191089 −0.08519829
    721 2.128185431 0.274654772 0.47626043 2.465333527
    722 0.616377169 −0.58753328 0.48821573 1.063402884
    723 −1.273274319 −1.12897478 1.71118519 4.067480158
    724 2.103515193 0.165377929 −0.18223896 0.288303217
    725 0.983060431 2.328872529 1.67788951 0.805938034
    726 2.887615733 3.282342953 1.95034945 2.462290186
    727 2.241052707 2.13951389 0.36814978 0.371689426
    730 1.121105724 −0.20397307 −0.15741334 0.897609916
    731 1.437838545 −0.09620743 0.02756967 1.949139525
    733 −0.46922259 1.067777032 1.61226345 0.185415155
    735 −0.081273581 1.192925027 1.67970188 0.33874614
    736 −0.13000788 1.099012031 1.64139691 0.248287146
    738 1.670680003 −0.20756775 −0.73755051 −0.84924056
    740 −1.532691904 −2.55214711 0.57438104 0.555698696
    741 1.407504561 0.048284736 1.01405149 −2.2579901
    742 0.644803847 0.644647752 1.35192052 −0.62780087
    743 0.174679072 0.169515693 0.62350977 −0.08144308
    744 0.02068385 0.648730454 −0.04946215 0.214634634
    745 0.741424752 0.523647641 0.52863925 −0.65426285
    746 1.285306965 1.929408375 0.85560877 −1.4619958
    748 −1.513804897 −1.10823383 1.09397284 −0.88975989
    750 2.554017714 3.544542579 4.42317523 1.647356195
    752 2.592229701 1.158945916 0.24149847 −0.58379051
    754 1.649506181 1.31981993 2.36997533 0.406081966
    755 −0.028552173 0.253838465 0.95694896 −0.16565786
    757 1.446915042 0.673406021 −0.6641103 −1.80002119
    758 5.933043009 5.716461604 6.67410554 4.433272782
    760 −3.195604514 −2.60998376 −0.11222221 0.792186468
    761 0.286783044 −0.52414055 −0.57593161 0.628896611
    763 1.405567948 −0.84372738 −1.32379279 −0.50314577
    766 0.279442569 −1.00722191 −0.18524031 2.487147765
    767 −1.32777782 −2.36136561 −0.79602501 1.247063893
    768 −0.692560954 −1.92177717 0.46687554 2.400762497
    769 1.889999468 1.112266205 0.82815523 0.525271623
    770 2.237616041 2.282141767 −0.149966 −0.71866539
    771 0.909356011 0.368597887 1.03689838 1.001198751
    772 1.328601831 0.715296776 0.20358825 1.147403521
    774 2.002379485 3.95875961 1.1705779 0.346542121
    775 1.936489942 2.528373237 2.13424487 2.393940425
    776 1.495019673 4.35984375 2.59969954 2.95313487
    777 0.206892499 −0.57813502 −0.32983 0.781221286
    778 1.340232187 −0.11034804 0.35759778 1.690582999
    779 0.595257521 −0.85639987 0.19436224 −0.73333902
    781 2.187955186 2.571774369 2.74817529 −0.52827851
    782 0.893855657 0.63313304 1.19104388 −1.61620514
    784 −0.275919571 −1.64491584 0.60429762 −1.5580623
    786 −0.043537347 1.337721065 −0.56551398 −0.02167052
    788 2.147983695 1.250042565 1.72576392 1.626956379
    789 −0.624451013 0.76248127 −0.79219481 −0.73513092
    791 0.227060873 −0.04783658 −0.16862915 1.166609659
    792 0.90746622 1.643598677 0.26467094 0.396081003
    796 0.811374104 0.766579899 0.10161642 0.135186519
    797 −0.185638022 0.53853264 0.65441562 −0.25681926
    799 0.657769581 0.095543194 0.89522656 0.558428618
    800 0.227060873 −0.04783658 −0.16862915 1.166609659
    802 −0.660595577 1.597474466 1.49106895 −0.20429128
    803 1.706162052 0.623892414 0.59662073 0.7745661
    804 3.478490379 2.348697011 3.96279011 2.456963386
    805 0.377241729 0.83329773 0.1712741 1.057125999
    806 2.863652137 0.771287371 −0.4183972 −0.44551461
    807 1.794279084 0.711717977 0.35187068 −1.0208486
    808 0.408210632 0.633556897 −0.37022584 0.717270748
    810 −2.506277966 −2.61703099 0.87880054 −0.72832121
    811 −0.789075789 −0.15346024 0.64720487 −0.48507671
    812 −1.395132583 −2.59063834 0.14973761 0.623759794
    814 0.414608216 −0.23108581 1.15081653 −1.10351559
    817 −0.24632881 −0.09354384 −0.13580399 0.599029186
    819 0.805916178 0.96701754 −0.8811308 −1.23858491
    820 0.744770665 −0.73855596 −0.2249849 −0.2981968
    821 1.099377934 −0.55297074 −0.58846144 −1.64325365
    824 −0.183625049 1.183962609 1.63494269 0.25504959
    826 1.678825829 1.234136613 1.45948258 0.224375571
    827 2.592229701 0.621958527 −0.52522117 −0.19676404
    828 2.592229701 0.57915141 −0.51767373 −0.58077497
    829 1.670680003 1.284791367 0.14864516 −0.84985664
    831 1.116827432 −0.75462162 0.39137278 −0.04171761
    832 0.516805788 −0.98195801 −1.03806082 −0.25383454
    833 1.490368312 0.080687244 −0.97130296 0.833722265
    834 −0.369014518 −1.35841128 −1.27372214 1.351157886
    835 0.914072736 −0.8695664 0.36889122 −0.08606658
    836 0.998848923 −0.42464651 −0.23731009 0.395895785
    837 1.670680003 0.070165381 −0.64700996 −0.85055617
    838 0.810918992 −0.75696962 −0.21854084 0.836677293
    839 1.066219316 −0.66764691 −0.49983634 0.669914
    840 1.078821776 −0.72511699 −1.00012288 −0.15789319
    845 −0.163950017 −0.21616766 0.65276069 −0.52575739
    846 0.665621985 −3.16625248 0.34329102 −1.44312939
    847 −0.233400992 −1.15488444 0.83051343 −1.85751897
    848 −0.631135606 0.037691556 0.57903451 −0.9926
    849 1.707541313 0.010345383 0.48581606 1.513341091
    850 1.447075297 0.022864201 0.99130501 0.473154634
    851 −0.24632881 −0.23975349 −0.01449288 0.574861147
    852 1.176028423 −0.85747031 −0.72464089 0.30542841
    856 2.237616041 0.345329597 −0.60597063 −0.71581056
    858 −1.47960224 −2.5770536 −1.03619781 0.847300104
    864 1.670680003 1.284791101 0.14864516 −0.84985664
    865 1.670680003 1.916382859 0.6998144 1.124089601
    866 1.024819853 −0.7521596 0.35073152 −2.14193241
    868 2.237616041 −0.17986241 −0.86317199 1.325805381
    869 1.747776963 −0.25802105 −1.11614995 −0.77093434
    870 2.592229701 2.030913569 −0.50618719 1.463926567
    871 2.592229701 2.510587108 −0.07540594 −0.58371481
    872 1.800767509 1.372656013 2.09551175 2.849728342
    873 1.849432484 4.556065495 −0.39732139 −0.67726477
    875 0.201768224 0.618509503 −0.39732139 −0.67726477
    876 2.237616041 1.553468488 −0.72864242 −0.33330779
    877 0.323968221 −1.00428076 −1.65151616 1.031096548
    878 0.783570663 2.023288951 −0.03975252 0.474038265
    879 1.187592149 1.464239711 0.67009263 1.103774764
    880 −0.192632911 0.142411101 0.79310676 0.125548041
    881 1.071875228 0.911734331 −1.50008456 0.185176261
    882 0.798806784 −0.1516478 −0.64900063 −0.77199025
    883 −0.671908804 −0.65984824 0.5238174 −0.85314111
    884 2.863652137 1.896850773 0.06443558 −0.44689505
    885 2.314558863 −0.25458637 0.22080129 −0.04142716
    886 2.314558863 −0.25458637 0.22080129 −0.04142716
    888 0.131224024 0.21510779 −1.70996346 0.964902175
    889 0.742030255 0.281479436 −1.4156326 −1.91369695
    890 1.071875228 0.911734331 −1.50008456 0.185176261
    891 0.742030255 0.281479436 −1.4156326 −1.91369695
    892 1.749446006 0.076054765 −0.59137073 0.291488011
    893 0.869958847 0.843158237 0.61532515 3.158279932
    894 1.749446006 0.076054765 −0.59137073 0.291488011
    897 −0.047486491 1.045012945 −0.25220201 −0.31982826
    899 0.784181146 −0.20530019 −1.89414748 0.152726109
    900 0.784181146 −0.20530019 −1.89414748 0.152726109
    901 −0.440378333 0.918089245 0.03050609 −1.62235977
    902 −0.2346025 0.890438419 −0.13206526 −0.83961838
    903 −0.440378333 0.918089245 0.03050609 −1.62235977
    904 −1.320466583 −2.49763118 0.9787365 −1.85867969
    905 −0.386224123 −0.24799559 1.19406353 −1.61243489
    908 1.878331515 1.287303121 0.11530502 1.132065786
    909 0.614968453 −1.61827184 −0.80789799 −0.66927285
    912 0.530707518 0.774109528 3.0396125 4.394775258
    913 0.337020095 1.531840025 0.10544973 0.347450471
    914 0.774589061 1.224705331 1.87994281 −0.11684579
    916 −0.363201351 0.35600238 −1.20673542 2.056973054
    918 0.153047955 0.702054562 0.76757802 0.096096862
    919 2.891894151 2.295157633 3.54101626 1.984030826
    920 1.292959895 0.808281618 2.92956952 2.204248324
    921 −0.465333775 0.862817284 0.1439546 0.64701735
    922 1.54265003 0.291977233 0.79089158 0.801314068
    923 1.340862559 0.503169303 0.53213093 3.164832031
    924 0.158497146 1.507280765 2.25315926 1.173977914
    925 1.23162703 1.671882685 3.1838372 −0.22917041
    926 2.608734063 3.080604939 −0.69726361 −0.36219702
    927 1.879182741 3.409153142 2.48473663 3.409954437
    928 −0.093106169 0.019939108 0.15932154 1.229749745
    929 1.670680003 1.94609957 0.19633838 1.14825764
    930 3.052627325 0.956834107 −0.29721209 −0.31007607
    931 0.367631287 0.501274945 −1.31074554 −0.39331005
    933 3.702965303 3.03402795 4.33630831 4.238503729
    937 0.570011387 0.097928934 1.03350455 −0.13392581
    939 1.801474588 0.770314085 0.70188154 0.22333959
    940 −0.412950838 −0.1781887 0.50649275 −0.57215449
    941 1.691004766 −0.42331992 0.66279648 0.0318465
    942 1.451782586 −0.565439 −0.32447381 −0.43378383
    943 1.188491672 0.120632811 0.20106994 3.078484746
    945 1.214814941 0.806987609 0.47605587 1.372949466
    946 0.561732094 1.21448402 0.35542793 −1.03704442
    947 0.956565856 1.505997176 0.88115653 −0.60583691
    948 0.592575441 1.383482681 0.93567635 1.058669028
    950 0.343657562 −0.85471906 −0.21125904 1.184648122
    951 1.236659334 3.828926809 1.57729777 −0.31942874
    953 1.836389049 0.755753735 −0.36014522 1.262853393
    953 1.836389049 0.755753735 −0.36014522 1.262853393
    954 1.001653875 −0.85635082 0.89224781 −0.39245818
    955 −0.122918652 −0.846489 −0.63367729 1.182912962
    956 0.589766639 −0.9783487 −0.67638264 −0.38772225
    958 0.715082397 −0.90020686 0.86817768 0.030652004
    959 1.609198886 0.500797943 0.795571 0.908389449
    960 0.952787327 −0.90555475 −0.17381408 0.06786323
    962 1.836429446 0.208275147 −0.14300625 1.067462181
    965 1.9158432 0.35211823 −1.02174589 0.625657932
    967 1.383869627 0.274520494 −0.11659267 0.840327437
    969 −0.445579934 −1.68867059 −0.5241276 2.233793943
    971 0.736419048 0.409875189 −0.63140848 0.034514594
    973 1.073465817 2.18418874 2.01361447 −0.93754437
    974 0.130904221 1.882440008 1.85101055 0.112524893
    976 −0.236681385 −0.09745533 0.1779313 2.08923366
    977 0.904402612 0.936956925 0.87731788 0.102346515
    978 2.201759817 2.123549573 3.7881607 2.358768953
    980 1.784266982 1.845281076 3.42873622 −0.31098233
    981 −0.225023329 0.087962898 −0.29053012 0.514272787
    982 −0.231175318 −0.0159671 1.27391892 1.090487158
    983 0.889215441 0.24321159 0.06877629 0.816247177
    985 1.864634345 0.133647536 1.29803755 1.951226654
    986 0.511450274 −2.33512445 −0.56246315 −0.42184152
    987 0.847260813 0.368638185 0.4114346 0.219336109
    988 1.596170102 1.592158381 0.30052357 0.283467897
    993 −3.549941097 −2.6847861 −0.17502622 1.41034664
    994 0.445802042 0.899738574 0.61059602 0.323194673
    995 0.949498724 0.357111159 0.28371155 −0.14156488
    998 2.197271885 1.578871826 0.90563334 1.056619658
    998 2.197271885 1.578871826 0.90563334 1.056619658
    1000 1.456120673 0.626173572 0.07683183 −0.43324035
    1001 −0.440378333 0.918089245 0.03050609 −1.62235977
    1002 0.819929066 0.459101825 −0.09227583 0.324342063
    1003 1.64412453 −0.09343399 0.70197344 3.710273595
    1004 0.796928207 0.459954079 −0.88538616 0.152000937
    1005 0.044923203 −0.19994963 0.60082875 0.258347835
    1006 −0.320452673 −0.33232662 −0.52315783 1.406273663
    1007 4.040291133 3.474551355 3.57146797 3.565985043
    1008 0.764519082 0.917635102 2.88258762 2.319622474
    1009 −0.071112206 0.539362906 2.98048732 0.580423329
    1010 −0.689737481 0.547928768 1.98805626 −0.76653376
    1011 0.343668917 0.931501008 −0.05483722 0.395369857
    1012 1.926713131 0.124849138 −0.09654906 1.126499382
    1016 0.124247716 0.193102712 0.39003599 1.737670628
    1017 0.131224136 0.21510779 −1.70996346 0.964902175
    1018 0.499624069 0.962843507 0.77617619 −1.15296947
    1019 0.813491983 0.322635656 0.02800396 0.599500927
    1020 0.715468114 1.015469049 1.45994989 0.352548581
    1021 −1.176339404 1.539767848 −0.14427147 1.389902738
    1022 1.364966718 1.690570939 2.05914194 2.364375484
    1023 2.154641091 0.800066339 0.85365652 0.965810338
    1024 2.302280068 1.252164308 1.73414439 1.549538352
    1025 1.878331515 1.287303121 0.11530502 1.132065786
    1026 2.97722987 2.096441965 3.87172868 0.550274831
    1027 2.474381478 1.950326182 3.81861867 1.366897355
    1028 1.778414353 3.114931059 4.47690731 6.054314034
    1029 3.672910795 2.760483725 3.26915034 3.042677588
    1030 −0.604959715 −2.13584086 0.8687855 0.024144016
    1031 2.012732245 2.293857161 0.54405555 1.261882121
    1032 −1.086688867 0.953083194 2.92177054 0.876865185
    1033 1.617520676 1.008017006 2.21183536 −0.1288484
    1035 2.506372295 3.419954592 4.58206882 4.134341651
    1036 −0.675805062 −0.15357004 0.94597719 3.966016669
    1037 −0.275092569 −0.67687665 −0.52763797 1.489972106
    1038 2.753559643 3.81185814 2.71344734 2.243351472
    1039 0.65087433 0.026885305 −0.0153558 0.011870127
    1040 0.141526548 −1.65455278 0.50170705 −1.90794
    1041 0.458680435 −0.69730218 −0.48806249 0.586073092
    1042 −0.513264812 −0.22001961 0.36339519 1.03208599
    1043 −1.497887014 −1.76116109 −0.76634926 1.137002742
    1045 2.863652137 1.96790869 0.43661485 −0.44756897
    1046 0.981194248 1.73892162 2.21166953 2.738129365
    1047 0.981194248 1.73892162 2.21166953 2.738129365
    1051 0.70261974 −0.22197386 0.19710806 −2.37196477
    1052 0.662126832 0.741436531 0.61672724 0.289359903
    1053 0.87463644 −0.19717783 1.2664131 −0.4187507
    1054 0.284558077 −1.46754925 −0.03124571 0.587227244
    1055 0.885837831 −0.91907796 −0.45817355 −1.1936897
    1057 0.790964847 1.387925398 −0.18370692 1.302393792
    1058 −1.052897931 −0.85226912 0.90324527 −1.09684959
    1059 −0.871565421 −0.17856476 1.51267137 −1.52734367
    1060 3.311161199 3.074783921 2.10199297 1.822541682
    1061 −0.655128061 0.497032417 0.92381279 −0.56348341
    1062 −0.443129049 0.96200606 1.51641349 −0.22974864
    1063 1.385675542 0.738759296 1.1677069 0.501211562
    1064 1.670680003 −0.20756775 −0.73755051 −0.84924056
    1065 1.43532227 1.656262941 −1.09448841 1.674272267
    1066 1.670680003 1.284791101 0.14864516 −0.84985664
    1067 2.237616041 0.345329863 −0.60597063 −0.71581056
    1069 −0.24632881 −0.23975349 −0.01449288 0.574861147
    1070 1.670680003 0.070165381 −0.64700996 −0.85055617
    1071 −1.02687397 −0.36244273 0.13010074 0.535909448
    1072 1.670680003 1.94609957 0.19633838 1.14825764
    1073 2.237616041 1.438074134 0.31117554 −0.71786492
    1074 −0.192632911 0.142411101 0.79310676 0.125548041
    1075 0.909356011 0.368597887 1.03689838 1.001198751
    1076 0.812238101 0.195908668 0.21564664 0.219336109
    1077 0.325255266 1.131242708 −2.79377204 −0.62848261
    1078 0.325255266 1.131242708 −2.79377204 −0.62848261
    1079 0.85330799 −0.6855194 −0.90046979 −0.46415796
    1081 −0.131519393 0.731836014 0.81604919 −1.29993979
    1082 0.744770665 0.155243763 −1.8029919 1.023503542
    1083 1.415726941 0.086297223 3.43559555 −0.12964168
    1084 0.161304111 0.66712144 0.58401752 0.373809692
    1085 −0.72863532 −0.2873027 2.21251376 3.003873022
    1088 −1.1773616 −0.23258175 0.40529195 0.994988969
    1089 2.769817302 1.661618789 3.97585272 1.059236597
    1090 3.052627325 0.420821685 −0.57080756 1.751222205
    1091 −3.379896722 −3.71174986 2.53586709 0.644702886
    1093 0.72304265 1.667011476 2.53982093 2.7903213
    1095 0.744219765 1.372184572 0.15852396 1.126053442
    1097 4.407270402 2.670641491 5.02636153 5.361271976
    1098 −1.85804837 −2.59071226 −0.46522239 0.655734646
    1099 0.745797788 −0.20547378 4.27836342 4.646390386
    1102 2.068748434 −0.24299896 0.07214682 −1.11758276
    1104 1.018876287 0.025163067 −0.1106021 0.838914654
    1105 2.387326861 3.865456674 2.2251199 0.728667998
    1107 2.352582059 2.595496601 3.20492728 2.844590737
    1110 0.302703712 0.599942142 −0.25637571 −0.03195517
    1111 0.750930333 0.656784751 1.68326413 0.329846578
    1112 −0.205527848 0.287622624 −0.00340777 0.59203719
    1115 0.999825037 0.662221152 0.43571192 0.342558518
    1116 0.873381263 1.544324176 0.13703728 −0.38172701
    1117 −0.682983903 1.798204302 2.42110319 −0.39173951
    1118 0.069769623 0.496895599 0.67857133 −0.14954441
    1119 −0.671908804 −0.65984824 0.5238174 −0.85314111
    1120 0.953790113 1.106552668 3.00006904 1.585038764
    1121 −1.184630973 2.476138312 4.80971952 2.450646806
    1122 −1.02687397 −0.36244273 0.13010074 0.535909448
    1125 0.387315524 −0.36101406 1.14153708 −0.75303953
    1126 1.021783831 −0.0070257 −0.14327539 3.954381426
    1127 0.990592079 0.305612583 0.14155512 −0.29526854
    1128 0.990592079 0.305612583 0.14155512 −0.29526854
    1129 3.18966648 3.284362987 4.49398568 3.950809104
    1131 1.650621055 1.545704806 2.37535081 1.259373143
    1133 −1.519747805 −0.60804324 0.02746106 0.590708892
    1134 0.815942067 −0.16126019 −0.54117238 0.613093526
    1135 0.626973385 1.998305877 2.61706075 1.570404253
    1136 2.812199484 1.353198146 2.05618426 1.869204406
    1137 2.208307057 1.387136198 3.21521374 2.069795393
    1138 1.670680003 1.316442078 0.14822999 −0.46985154
    1139 1.408517438 0.890457374 1.24524408 0.685687797
    1140 2.765860952 2.525539595 4.12464228 3.833744077
    1141 −0.484394663 0.677713073 −0.22783646 −0.37267608
    1142 2.54335679 4.298105601 3.36234238 2.684404542
    1143 4.204367611 3.062126931 3.4234313 2.072899554
    1144 2.479165229 3.226545885 4.65897152 4.952127235
    1145 2.479158921 3.226545885 4.65897152 4.952127235
    1146 0.774334025 1.075800774 1.06893156 1.011113116
    1147 0.844648531 1.21935371 2.59138595 0.805938034
    1148 2.906236436 1.550674121 3.56959167 2.832126896
    1149 2.837627443 3.707154326 4.53384262 2.625871865

    Antiperspirant and/or Deodorant Compositions and Methods of Use
  • An antiperspirant and/or deodorant composition comprising, based on total composition weight,
      • a) a sum total of from about 0.0001% to about 2%, preferably from about 0.0001% to about 0.75%, more preferably from about 0.001% to about 0.5%, most preferably from about 0.007% to about 0.25% of 1 or more malodor reduction materials, preferably 1 to about 75 malodor reduction materials, more preferably 1 to about 50 malodor reduction materials, more preferably 1 to about 35 malodor reduction materials, most preferably 1 to about 20 malodor reduction materials, each of said malodor reduction materials having a MORV of at least 0.5, preferably from 0.5 to 10, more preferably from 1 to 10, most preferably from 1 to 5, and preferably each of said malodor reduction materials having a Universal MORV, or said sum total of malodor reduction materials having a Blocker Index of less than 3, more preferable less than about 2.5 even more preferably less than about 2 and still more preferably less than about 1 and most preferably 0 and/or a Blocker Index average of 3 to about 0.001; and
      • b) from about 0% to about 12%, preferably from about 0% to about 8%, more preferably from about 0.1% to about 4%, of one or more perfume raw materials having a MORV of less than 0.5, preferably less than 0, more preferably less than −2, most preferably less than −5;
      • c) from about 0.1% to about 99%, preferably from about 1% to about 80%, more preferably from about 5% to about 55%, most preferably from about 10% to about 50% of a solvent, preferably said solvent is selected from cyclopentasiloxane, ethanol, water, propylene glycol, dipropylene glycol, and mixtures thereof;
      • d) from about 0% to about 30%, preferably from about 0% to about 20%, more preferably from about 0.1% to about 4%, most preferably from about 0.1% to about 4% of a material selected from the group consisting of a structurant, a residue masker, an antimicrobial, and mixtures thereof
        is disclosed. The aforementioned solvent levels help disperse perfume and MORV materials into the APDO base to give even coverage when used
  • In one aspect of said antiperspirant and/or deodorant composition, said sum total of malodor reduction materials has a Blocker Index of less than 3, more preferable less than about 2.5 even more preferably less than about 2 and still more preferably less than about 1 and most preferably 0 and/or a Blocker Index average of 3 to about 0.001.
  • In one aspect of said antiperspirant and/or deodorant composition, each of said malodor reduction materials has a MORV of at least 0.5, preferably from 0.5 to 10, more preferably from 1 to 10, most preferably from 1 to 5, and preferably each of said malodor reduction materials has a Universal MORV.
  • In one aspect of said antiperspirant and/or deodorant composition, said sum total of malodor reduction materials has a Fragrance Fidelity Index average of 3 to about 0.001 Fragrance Fidelity Index, preferably each malodor reduction material in said sum total of malodor reduction materials has a Fragrance Fidelity Index of less than 3, preferably less than 2, more preferably less than 1 and most preferably each malodor reduction material in said sum total of malodor reduction materials has a Fragrance Fidelity Index of 0.
  • In one aspect of said antiperspirant and/or deodorant composition, said sum total of malodor reduction materials has an average boiling point, based on the weight percent of each malodor reduction material in said sum total of malodor reduction materials, of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.; preferably 25%, more preferably 50%, more preferably 75%, most preferably each of said malodor reduction materials in said sum total of malodor reduction materials has a of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.
  • In one aspect of antiperspirant and/or deodorant composition, said composition comprises a malodor reduction material is selected from the group consisting of Table 1 materials and mixtures thereof; preferably said material is selected from the group consisting of Table 1 materials 1, 2, 3, 4, 7, 9, 10, 11, 13, 14, 16, 17, 18, 21, 22, 23, 25, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 42, 43, 47, 48, 49, 50, 52, 57, 61, 62, 63, 64, 65, 67, 68, 69, 70, 71, 74, 75, 76, 77, 78, 79, 80, 82, 83, 85, 91, 92, 93, 98, 100, 101, 102, 103, 104, 105, 106, 108, 109, 110, 112, 113, 114, 117, 119, 120, 122, 123, 126, 128, 130, 134, 135, 137, 140, 141, 142, 143, 145, 146, 148, 149, 152, 153, 155, 156, 158, 159, 161, 162, 167, 168, 170, 174, 175, 176, 177, 178, 179, 182, 183, 184, 185, 186, 187, 189, 190, 192, 193, 195, 196, 197, 199, 206, 208, 209, 210, 211, 212, 215, 218, 221, 227, 228, 229, 230, 231, 233, 234, 238, 242, 243, 244, 246, 247, 249, 252, 253, 254, 256, 259, 260, 261, 263, 267, 269, 271, 274, 276, 277, 278, 280, 281, 285, 286, 288, 289, 290, 292, 293, 294, 295, 296, 300, 301, 303, 307, 316, 317, 318, 321, 322, 323, 324, 325, 328, 329, 330, 331, 332, 333, 334, 335, 336, 338, 339, 342, 343, 344, 347, 349, 350, 352, 353, 356, 358, 359, 360, 361, 362, 363, 364, 368, 369, 370, 371, 372, 373, 374, 375, 377, 378, 381, 385, 386, 388, 390, 391, 394, 397, 398, 407, 413, 414, 415, 416, 417, 418, 421, 424, 425, 426, 428, 429, 432, 436, 441, 444, 445, 449, 450, 453, 457, 459, 461, 462, 463, 464, 465, 466, 467, 468, 470, 471, 473, 474, 475, 478, 479, 480, 482, 484, 485, 486, 487, 488, 491, 493, 497, 498, 501, 502, 503, 505, 519, 520, 521, 524, 527, 529, 530, 531, 532, 534, 537, 541, 544, 546, 548, 550, 551, 552, 553, 555, 558, 559, 560, 561, 562, 563, 565, 566, 567, 568, 569, 570, 571, 572, 573, 574, 577, 578, 580, 581, 582, 584, 586, 587, 589, 591, 592, 594, 595, 599, 600, 601, 603, 604, 606, 607, 608, 609, 610, 611, 612, 613, 614, 615, 616, 618, 620, 621, 624, 625, 626, 627, 628, 631, 632, 633, 635, 636, 638, 639, 644, 649, 650, 653, 655, 658, 659, 660, 661, 663, 668, 671, 673, 674, 675, 676, 677, 678, 679, 680, 681, 682, 683, 684, 686, 691, 692, 693, 694, 696, 697, 698, 700, 702, 704, 706, 707, 708, 709, 710, 711, 712, 713, 714, 715, 716, 717, 718, 719, 720, 721, 722, 723, 724, 725, 726, 727, 730, 731, 733, 735, 736, 738, 741, 742, 746, 748, 750, 752, 754, 757, 758, 763, 764, 766, 767, 768, 769, 770, 771, 772, 774, 775, 776, 778, 781, 782, 786, 788, 791, 792, 800, 802, 803, 804, 805, 806, 807, 814, 821, 824, 826, 827, 828, 829, 831, 833, 834, 837, 839, 840, 849, 850, 852, 856, 864, 865, 866, 868, 869, 870, 871, 872, 873, 876, 877, 878, 879, 881, 884, 885, 886, 890, 892, 893, 894, 897, 905, 908, 912, 913, 914, 916, 919, 920, 922, 923, 924, 925, 926, 927, 928, 929, 930, 933, 937, 939, 941, 942, 943, 945, 946, 947, 948, 950, 951, 953, 954, 955, 959, 962, 965, 967, 969, 973, 974, 976, 978, 980, 982, 985, 988, 993, 998, 1000, 1003, 1006, 1007, 1008, 1009, 1010, 1012, 1016, 1020, 1021, 1022, 1023, 1024, 1025, 1026, 1027, 1028, 1029, 1031, 1032, 1033, 1035, 1036, 1037, 1038, 1042, 1043, 1045, 1046, 1047, 1053, 1057, 1059, 1060, 1062, 1063, 1064, 1065, 1066, 1067, 1070, 1072, 1073, 1075, 1077, 1078, 1082, 1083, 1085, 1089, 1090, 1091, 1093, 1095, 1097, 1099, 1102, 1104, 1105, 1107, 1111, 1113, 1116, 1117, 1120, 1121, 1125, 1126, 1129, 1131, 1135, 1136, 1137, 1138, 1139, 1140, 1142, 1143, 1144, 1145, 1146, 1147, 1148, 1149, Table 2 materials 2, 23, 141, 185, 227, 230, 246, 248, 343, 359, 565, 631, 659, 674, 678, 679, 715, 758, 1028, 1097, Table 3 materials 12, 19, 20, 24, 26, 27, 53, 54, 55, 59, 72, 73, 81, 84, 96, 97, 107, 111, 115, 116, 125, 133, 147, 150, 151, 154, 157, 163, 166, 169, 181, 191, 194, 198, 201, 204, 205, 213, 214, 232, 237, 239, 255, 258, 264, 270, 273, 275, 282, 283, 284, 287, 302, 306, 308, 310, 312, 314, 319, 346, 354, 355, 365, 366, 376, 379, 387, 400, 412, 419, 420, 437, 438, 439, 440, 442, 443, 447, 448, 454, 455, 469, 472, 477, 481, 492, 495, 496, 504, 509, 510, 512, 515, 517, 518, 522, 525, 526, 528, 535, 536, 538, 540, 542, 547, 549, 554, 556, 557, 575, 576, 579, 583, 585, 588, 602, 605, 617, 619, 640, 641, 645, 647, 651, 652, 662, 664, 665, 667, 672, 687, 699, 701, 703, 740, 743, 744, 745, 755, 760, 761, 777, 779, 784, 789, 796, 797, 799, 808, 810, 811, 812, 817, 819, 820, 832, 835, 836, 838, 845, 846, 847, 848, 851, 858, 875, 880, 882, 883, 888, 889, 891, 899, 900, 901, 902, 903, 904, 909, 918, 921, 931, 940, 956, 958, 960, 971, 977, 981, 983, 986, 987, 994, 995, 1001, 1002, 1004, 1005, 1011, 1017, 1018, 1019, 1030, 1039, 1040, 1041, 1051, 1052, 1054, 1055, 1058, 1061, 1069, 1071, 1074, 1076, 1079, 1081, 1084, 1088, 1098, 1110, 1112, 1115, 1118, 1119, 1122, 1127, 1128, 1133, 1134, 1141 and mixtures thereof; more preferably said material is selected from the group consisting of Table 1 materials 1, 2, 3, 4, 7, 9, 10, 11, 13, 14, 16, 17, 18, 21, 22, 23, 25, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 42, 43, 47, 48, 49, 50, 52, 57, 61, 62, 63, 64, 65, 67, 68, 69, 70, 71, 74, 75, 76, 77, 78, 79, 80, 82, 83, 85, 91, 92, 93, 98, 100, 101, 102, 103, 104, 105, 106, 108, 109, 110, 112, 113, 114, 117, 119, 120, 122, 123, 126, 128, 130, 134, 135, 137, 140, 141, 142, 143, 145, 146, 148, 149, 152, 153, 155, 156, 158, 159, 161, 162, 167, 168, 170, 174, 175, 176, 177, 178, 179, 182, 183, 184, 185, 186, 187, 189, 190, 192, 193, 195, 196, 197, 199, 206, 208, 209, 210, 211, 212, 215, 218, 221, 227, 228, 229, 230, 231, 233, 234, 238, 242, 243, 244, 246, 247, 249, 252, 253, 254, 256, 259, 260, 261, 263, 267, 269, 271, 274, 276, 277, 278, 280, 281, 285, 286, 288, 289, 290, 292, 293, 294, 295, 296, 300, 301, 303, 307, 316, 317, 318, 321, 322, 323, 324, 325, 328, 329, 330, 331, 332, 333, 334, 335, 336, 338, 339, 342, 343, 344, 347, 349, 350, 352, 353, 356, 358, 359, 360, 361, 362, 363, 364, 368, 369, 370, 371, 372, 373, 374, 375, 377, 378, 381, 385, 386, 388, 390, 391, 394, 397, 398, 407, 413, 414, 415, 416, 417, 418, 421, 424, 425, 426, 428, 429, 432, 436, 441, 444, 445, 449, 450, 453, 457, 459, 461, 462, 463, 464, 465, 466, 467, 468, 470, 471, 473, 474, 475, 478, 479, 480, 482, 484, 485, 486, 487, 488, 491, 493, 497, 498, 501, 502, 503, 505, 519, 520, 521, 524, 527, 529, 530, 531, 532, 534, 537, 541, 544, 546, 548, 550, 551, 552, 553, 555, 558, 559, 560, 561, 562, 563, 565, 566, 567, 568, 569, 570, 571, 572, 573, 574, 577, 578, 580, 581, 582, 584, 586, 587, 589, 591, 592, 594, 595, 599, 600, 601, 603, 604, 606, 607, 608, 609, 610, 611, 612, 613, 614, 615, 616, 618, 620, 621, 624, 625, 626, 627, 628, 631, 632, 633, 635, 636, 638, 639, 644, 649, 650, 653, 655, 658, 659, 660, 661, 663, 668, 671, 673, 674, 675, 676, 677, 678, 679, 680, 681, 682, 683, 684, 686, 691, 692, 693, 694, 696, 697, 698, 700, 702, 704, 706, 707, 708, 709, 710, 711, 712, 713, 714, 715, 716, 717, 718, 719, 720, 721, 722, 723, 724, 725, 726, 727, 730, 731, 733, 735, 736, 738, 741, 742, 746, 748, 750, 752, 754, 757, 758, 763, 764, 766, 767, 768, 769, 770, 771, 772, 774, 775, 776, 778, 781, 782, 786, 788, 791, 792, 800, 802, 803, 804, 805, 806, 807, 814, 821, 824, 826, 827, 828, 829, 831, 833, 834, 837, 839, 840, 849, 850, 852, 856, 864, 865, 866, 868, 869, 870, 871, 872, 873, 876, 877, 878, 879, 881, 884, 885, 886, 890, 892, 893, 894, 897, 905, 908, 912, 913, 914, 916, 919, 920, 922, 923, 924, 925, 926, 927, 928, 929, 930, 933, 937, 939, 941, 942, 943, 945, 946, 947, 948, 950, 951, 953, 954, 955, 959, 962, 965, 967, 969, 973, 974, 976, 978, 980, 982, 985, 988, 993, 998, 1000, 1003, 1006, 1007, 1008, 1009, 1010, 1012, 1016, 1020, 1021, 1022, 1023, 1024, 1025, 1026, 1027, 1028, 1029, 1031, 1032, 1033, 1035, 1036, 1037, 1038, 1042, 1043, 1045, 1046, 1047, 1053, 1057, 1059, 1060, 1062, 1063, 1064, 1065, 1066, 1067, 1070, 1072, 1073, 1075, 1077, 1078, 1082, 1083, 1085, 1089, 1090, 1091, 1093, 1095, 1097, 1099, 1102, 1104, 1105, 1107, 1111, 1113, 1116, 1117, 1120, 1121, 1125, 1126, 1129, 1131, 1135, 1136, 1137, 1138, 1139, 1140, 1142, 1143, 1144, 1145, 1146, 1147, 1148, 1149, Table 2 materials 2, 23, 141, 185, 227, 230, 246, 248, 343, 359, 565, 631, 659, 674, 678, 679, 715, 758, 1028, 1097 and mixtures thereof, more preferably said material is selected from the group consisting of Table 4 materials 7, 14, 39, 48, 183, 199, 206, 212, 215, 229, 260, 261, 281, 329, 335, 353, 360, 441, 484, 487, 488, 501, 566, 567, 569, 570, 573, 574, 603, 616, 621, 624, 627, 632, 663, 680, 684, 694, 696, 708, 712, 714, 726, 750, 764, 775, 776, 788, 804, 872, 919, 927, 933, 978, 1007, 1022, 1024, 1027, 1029, 1035, 1038, 1060, 1089, 1107, 1129, 1131, 1136, 1137, 1140, 1142, 1143, 1144, 1145, 1148, 1149, Table 5 materials 248, more preferably said material is selected from the group consisting of Table 4 and 5 materials 261, 680, 788, 1129, 1148, 1149 and mixtures thereof.
  • In one aspect of said antiperspirant and/or deodorant composition, said sum total of malodor reduction materials has an average boiling point, based on the weight percent of each malodor reduction material in said sum total of malodor reduction materials, of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.; preferably 25%, more preferably 50%, more preferably 75%, most preferably each of said malodor reduction materials in said sum total of malodor reduction materials has a of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.
  • In one aspect of said antiperspirant and/or deodorant composition, said composition comprises one or more perfume raw materials.
  • In one aspect of said antiperspirant and/or deodorant composition, said combination of said sum total of malodor reduction materials and said one or more perfume raw materials combined has an average boiling point, based on the weight percent of each malodor reduction material in said sum total of malodor reduction materials, of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.; preferably 25%, more preferably 50%, more preferably 75%, most preferably each of said malodor reduction materials in said sum total of malodor reduction materials and each of said one or more perfume raw materials has a boiling point of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.
  • In one aspect of said antiperspirant and/or deodorant composition, the ratio of said one or more perfume raw materials to said sum total of malodor reduction material is from about 500:1 to about 1:1, preferably from about 50:1 to about 1:1, more preferably from about 20:1 to about 1:1, most preferably from about 2:1 to about 1:1.
  • In one aspect of said antiperspirant and/or deodorant composition, less than 10%, preferably less than 5%, more preferably less than 1% of said malodor reduction materials and said one or more perfume raw materials, based on total combined weight of malodor reduction materials and said one or more perfume raw materials comprise an ionone moiety.
  • In one aspect of said antiperspirant and/or deodorant composition, said malodor reduction materials are not selected from the group consisting of Table 1-3 materials 302; 288; 50; 157; 1017; 888; 64; 1054; 832; 375; 390; 745; 504; 505; 140; 1012; 498; 362; 103; 356; 1074; 908; 1127; 475; 918; 687; 611; 317; 9; 141; 550; 602; 913; 1005; 521; 10; 215; 370; 335; 378; 1121; 360; 565; 1136; 1129; 655; 369; 1065; 914; 757; 601; 478; 889; 891; 358; 973; 162; 554; 522; 312; 125; 26; 418; 92; 586; 1026; 218; 31; 828; 871; 829; 1066; 287; 269; 769; 701; 1118; 70; 946; 142; 109; 108 or mixtures thereof.
  • In one aspect of said antiperspirant and/or deodorant composition, said said antiperspirant and/or deodorant composition is a antiperspirant composition that comprises a total of, based on total antiperspirant composition weight, from about 0.1% to about 7% of one or more of said malodor reduction materials and, optionally, from about 1% to about 25% of an aluminum salt antiperspirant active.
  • In one aspect of said antiperspirant and/or deodorant composition, said composition is an anhydrous antiperspirant composition, said anhydrous antiperspirant composition comprising a total of, based on total anhydrous antiperspirant composition weight, from about 0.1% to about 7% of one or more of said malodor reduction materials and from about 1% to about 25% of an antiperspirant actives selected from the group consisting of astringent metallic salts, preferably inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof, more preferably aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof.
  • In one aspect of said antiperspirant and/or deodorant composition, said composition comprises an adjunct ingredient selected from the group consisting of clay mineral powders, pearl pigments, organic powders, emulsifiers, distributing agents, pharmaceutical active, topical active, preservatives, surfactants and mixtures thereof.
  • A method of controlling malodors comprising: contacting a situs comprising a malodor and/or a situs that may become malodorous with an antiperspirant or deodorant composition selected from the group consisting of the antiperspirant and/or deodorant composition disclosed herein, is disclosed.
  • In one aspect of said method, said situs is an underarm and said contacting step comprises contacting said underarm with a sufficient amount of Applicants' antiperspirant and/or deodorant composition containing said sum of malodor reduction materials to provide said underarm with a level of malodor reduction materials of at least 0.0001 mg of malodor reduction material per underarm, preferably from about 0.0001 mg of malodor reduction material per underarm to about 10 mg of malodor reduction material per underarm, more preferably from about 0.001 mg of malodor reduction material per underarm about 5 mg of malodor reduction material per underarm, most preferably from about 0.01 of malodor reduction material per underarm to about 0.2 mg of malodor reduction material per underarm.
  • Antiperspirant Compositions
  • Antiperspirant compositions can be formulated in many forms. For example an antiperspirant composition can be, without limitation, a roll on product, a body spray, a stick including soft solid sticks and invisible solids, or an aerosol. Each of the antiperspirant compositions described below can include perfume materials as described herein.
  • A. Roll-On and Clear Gel
  • A roll-on antiperspirant composition can comprise, for example, water, emollient, solubilizer, deodorant actives, antioxidants, preservatives, or combinations thereof. A clear gel antiperspirant composition can comprise, for example, water, emollient, solubilizer, deodorant actives, antioxidants, preservatives, ethanol, or combinations thereof.
  • Water
  • The roll-on composition can include water. Water can be present in an amount of about 1% to about 99.5%, about 25% to about 99.5%, about 50% to about 99.5%, about 75% to about 99.5% about 80% to about 99.5%, from about 15% to about 45%, or any combination of the end points and points encompassed within the ranges, by weight of the deodorant composition.
  • Emollients
  • Roll-on compositions can comprise an emollient system including at least one emollient, but it could also be a combination of emollients. Suitable emollients are often liquid under ambient conditions. Depending on the type of product form desired, concentrations of the emollient(s) in the deodorant compositions can range from about 1% to about 95%, from about 5% to about 95%, from about 15% to about 75%, from about 1% to about 10%, from about 15% to about 45%, or from about 1% to about 30%, by weight of the deodorant composition.
  • Emollients suitable for use in the roll-on compositions include, but are not limited to, propylene glycol, polypropylene glycol (like dipropylene glycol, tripropylene glycol, etc.), diethylene glycol, triethylene glycol, PEG-4, PEG-8, 1,2 pentanediol, 1,2 hexanediol, hexylene glycol, glycerin, C2 to C20 monohydric alcohols, C2 to C40 dihydric or polyhydric alcohols, alkyl ethers of polyhydric and monohydric alcohols, volatile silicone emollients such as cyclopentasiloxane, nonvolatile silicone emollients such as dimethicone, mineral oils, polydecenes, petrolatum, and combinations thereof. One example of a suitable emollient comprises PPG-15 stearyl ether. Other examples of suitable emollients include dipropylene glycol and propylene glycol.
  • Deodorant Actives
  • Suitable deodorant actives can include any topical material that is known or otherwise effective in preventing or eliminating malodor associated with perspiration. Suitable deodorant actives may be selected from the group consisting of antimicrobial agents (e.g., bacteriocides, fungicides), malodor-absorbing material, and combinations thereof. For example, antimicrobial agents may comprise cetyl-trimethylammonium bromide, cetyl pyridinium chloride, benzethonium chloride, diisobutyl phenoxy ethoxy ethyl dimethyl benzyl ammonium chloride, sodium N-lauryl sarcosine, sodium N-palmethyl sarcosine, lauroyl sarcosine, N-myristoyl glycine, potassium N-lauryl sarcosine, trimethyl ammonium chloride, sodium aluminum chlorohydroxy lactate, triethyl citrate, tricetylmethyl ammonium chloride, 2,4,4′-trichloro-2′-hydroxy diphenyl ether (triclosan), 3,4,4′-trichlorocarbanilide (triclocarban), diaminoalkyl amides such as L-lysine hexadecyl amide, heavy metal salts of citrate, salicylate, and piroctose, especially zinc salts, and acids thereof, heavy metal salts of pyrithione, especially zinc pyrithione, zinc phenolsulfate, farnesol, and combinations thereof. The concentration of the optional deodorant active may range from about 0.001%, from about 0.01%, of from about 0.1%, by weight of the composition to about 20%, to about 10%, to about 5%, or to about 1%, by weight of the composition.
  • Odor Entrappers
  • The composition can include an odor entrapper. Suitable odor entrappers for use herein include, for example, solubilized, water-soluble, uncomplexed cyclodextrin. As used herein, the term “cyclodextrin” includes any of the known cyclodextrins such as unsubstituted cyclodextrins containing from six to twelve glucose units, especially, alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and/or their derivatives and/or mixtures thereof. The alpha-cyclodextrin consists of six glucose units, the beta-cyclodextrin consists of seven glucose units, and the gamma-cyclodextrin consists of eight glucose units arranged in a donut-shaped ring. The specific coupling and conformation of the glucose units give the cyclodextrins a rigid, conical molecular structure with a hollow interior of a specific volume. The “lining” of the internal cavity is formed by hydrogen atoms and glycosidic bridging oxygen atoms, therefore this surface is fairly hydrophobic. The unique shape and physical-chemical property of the cavity enable the cyclodextrin molecules to absorb (form inclusion complexes with) organic molecules or parts of organic molecules which can fit into the cavity. Many perfume molecules can fit into the cavity. Cyclodextrin molecules are described in U.S. Pat. No. 5,714,137, and U.S. Pat. No. 5,942,217. Suitable levels of cyclodextrin are from about 0.1% to about 5%, alternatively from about 0.2% to about 4%, alternatively from about 0.3% to about 3%, alternatively from about 0.4% to about 2%, by weight of the composition.
  • Buffering Agent
  • The composition can include a buffering agent which may be alkaline, acidic or neutral. The buffer can be used in the composition for maintaining the desired pH. The composition may have a pH from about 3 to about 10, from about 4 to about 9, from about 5 to about 8, from about 6 to about 7, or it may have a pH of about 6.5. One unique feature of the polyvinyl amine malodor control polymers is its ability to maintain active nitrogen sites at high pH levels which can help enhance the antibacterial effect which comes, at least in part, from the nitrogen sites.
  • Suitable buffering agents include, for example, hydrochloric acid, sodium hydroxide, potassium hydroxide, and combinations thereof.
  • The compositions can contain at least about 0%, alternatively at least about 0.001%, alternatively at least about 0.01%, by weight of the composition, of a buffering agent. The composition may also contain no more than about 1%, alternatively no more than about 0.75%, alternatively no more than about 0.5%, by weight of the composition, of a buffering agent.
  • Solubilizer
  • The composition can contain a solubilizer. A suitable solubilizer can be, for example, a surfactant, such as a no-foaming or low-foaming surfactant. Suitable surfactants are nonionic surfactants, cationic surfactants, amphoteric surfactants, zwitterionic surfactants, and mixtures thereof.
  • Suitable solubilizers include, for example, hydrogenated castor oil, polyoxyethylene 2 stearyl ether, polyoxyethylene 20 stearyl ether, and combinations thereof. One suitable hydrogenated castor oil that may be used in the present composition is polyoxyethylene hydrogenated castor oil.
  • When the solubilizing agent is present, it is typically present at a level of from about 0.01% to about 5%, alternatively from about 0.01% to about 3%, alternatively from about 0.05% to about 1%, alternatively from about 0.01% to about 0.05%, by weight of the composition.
  • Preservatives
  • The composition can include a preservative. The preservative is included in an amount sufficient to prevent spoilage or prevent growth of inadvertently added microorganisms for a specific period of time, but not sufficient enough to contribute to the odor neutralizing performance of the composition. In other words, the preservative is not being used as the antimicrobial compound to kill microorganisms on the surface onto which the composition is deposited in order to eliminate odors produced by microorganisms. Instead, it is being used to prevent spoilage of the composition in order to increase shelf-life.
  • The preservative can be any organic preservative material which will not cause damage to fabric appearance, e.g., discoloration, coloration, bleaching. Suitable water-soluble preservatives include organic sulfur compounds, halogenated compounds, cyclic organic nitrogen compounds, low molecular weight aldehydes, parabens, propane diol materials, isothiazolinones, quaternary compounds, benzoates, low molecular weight alcohols, dehydroacetic acid, phenyl and phenoxy compounds, or mixtures thereof.
  • Non-limiting examples of commercially available water-soluble preservatives include a mixture of about 77% 5-chloro-2-methyl-4-isothiazolin-3-one and about 23% 2-methyl-4-isothiazolin-3-one, a broad spectrum preservative available as a 1.5% aqueous solution under the trade name Kathon® CG by Rohm and Haas Co.; 5-bromo-5-nitro-1,3-dioxane, available under the tradename Bronidox L® from Henkel; 2-bromo-2-nitropropane-1,3-diol, available under the trade name Bronopol® from Inolex; 1,1′-hexamethylene bis(5-(p-chlorophenyl)biguanide), commonly known as chlorhexidine, and its salts, e.g., with acetic and digluconic acids; a 95:5 mixture of 1,3-bis(hydroxymethyl)-5,5-dimethyl-2,4-imidazolidinedione and 3-butyl-2-iodopropynyl carbamate, available under the trade name Glydant Plus® from Lonza; N-[1,3-bis(hydroxymethyl)2,5-dioxo-4-imidazolidinyl]-N,N′-bis(hydroxy-methyl)urea, commonly known as diazolidinyl urea, available under the trade name Germall® II from Sutton Laboratories, Inc.; N,N″-methylenebis{N′-[1-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]urea}, commonly known as imidazolidinyl urea, available, e.g., under the trade name Abiol® from 3V-Sigma, Unicide U-13® from Induchem, Germall 115® from Sutton Laboratories, Inc.; polymethoxy bicyclic oxazolidine, available under the trade name Nuosept® C from Hüls America; formaldehyde; glutaraldehyde; polyaminopropyl biguanide, available under the trade name Cosmocil CQ® from ICI Americas, Inc., or under the trade name Mikrokill® from Brooks, Inc; dehydroacetic acid; and benzsiothiazolinone available under the trade name Koralone™ B-119 from Rohm and Hass Corporation.
  • Suitable levels of preservative can range from about 0.0001% to about 0.5%, alternatively from about 0.0002% to about 0.2%, alternatively from about 0.0003% to about 0.1%, by weight of the composition.
  • B. Body Spray
  • A body spray can contain, for example, a carrier, perfume, a deodorant active, odor entrappers, propellant, or combinations thereof. The body spray compositions can be applied as a liquid.
  • Carrier
  • A carrier suitable for use in a body spray can include, water, alcohol, or combinations thereof. The carrier may be present in an amount of about 1% to about 99.5%, about 25% to about 99.5%, about 50% to about 99.5%, about 75% to about 99.5% about 80% to about 99.5%, from about 15% to about 45%, or any combination of the end points and points encompassed within the ranges, by weight of the composition. A suitable example of an alcohol can include ethanol.
  • Propellant
  • The compositions described herein can include a propellant. Some examples of propellants include compressed air, nitrogen, inert gases, carbon dioxide, and mixtures thereof. Propellants may also include gaseous hydrocarbons like propane, n-butane, isobutene, cyclopropane, and mixtures thereof. Halogenated hydrocarbons like 1,1-difluoroethane may also be used as propellants. Some non-limiting examples of propellants include 1,1,1,2,2-pentafluoroethane, 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, trans-1,3,3,3-tetrafluoroprop-1-ene, dimethyl ether, dichlorodifluoromethane (propellant 12), 1,1-dichloro-1,1,2,2-tetrafluoroethane (propellant 114), 1-chloro-1,1-difluoro-2,2-trifluoroethane (propellant 115), 1-chloro-1,1-difluoroethylene (propellant 142B), 1,1-difluoroethane (propellant 152A), monochlorodifluoromethane, and mixtures thereof. Some other propellants suitable for use include, but are not limited to, A-46 (a mixture of isobutane, butane and propane), A-31 (isobutane), A-17 (n-butane), A-108 (propane), AP70 (a mixture of propane, isobutane and n-butane), AP40 (a mixture of propane, isobutene and n-butane), AP30 (a mixture of propane, isobutane and n-butane), and 152A (1,1 diflouroethane). The propellant may have a concentration from about 15%, 25%, 30%, 32%, 34%, 35%, 36%, 38%, 40%, or 42% to about 70%, 65%, 60%, 54%, 52%, 50%, 48%, 46%, 44%, or 42%, or any combination thereof, by weight of the total fill of materials stored within the container.
  • C. Invisible Solid
  • Invisible solid antiperspirant compositions as described herein can contain a primary structurant, an antiperspirant active, a perfume, and additional chassis ingredient(s). The antiperspirant composition can further comprise other optional ingredient(s). The compositions can be in the form of a solid stick. The compositions can have a product hardness of about 600 gram force or more. The compositions may be free of dipropylene glycol, added water, castor wax, or any combination thereof. The antiperspirant composition may be anhydrous. The antiperspirant composition may be free of added water.
  • Hardness
  • The invisible solid can have a product hardness of least about 600 gram·force, more specifically from about 600 gram·force to about 5,000 gram·force, still more specifically from about 750 gram·force to about 2,000 gram·force, and yet more specifically from about 800 gram·force to about 1,400 gram·force.
  • The term “product hardness” or “hardness” as used herein is a reflection of how much force is required to move a penetration cone a specified distance and at a controlled rate into an antiperspirant composition under the test conditions described herein below. Higher values represent harder product, and lower values represent softer product. These values are measured at 27° C., 15% relative humidity, using a TA-XT2 Texture Analyzer, available from Texture Technology Corp., Scarsdale, N.Y., U.S.A. The product hardness value as used herein represents the peak force required to move a standard 45-degree angle penetration cone through the composition for a distance of 10 mm at a speed of 2 mm/second. The standard cone is available from Texture Technology Corp., as part number TA-15, and has a total cone length of about 24.7 mm, angled cone length of about 18.3 mm, and a maximum diameter of the angled surface of the cone of about 15.5 mm. The cone is a smooth, stainless steel construction and weighs about 17.8 grams.
  • Primary Structurants
  • The invisible solid can comprise a suitable concentration of a primary structurant to help provide the antiperspirant with the desired viscosity, rheology, texture and/or product hardness, or to otherwise help suspend any dispersed solids or liquids within the composition.
  • The term “solid structurant” as used herein means any material known or otherwise effective in providing suspending, gelling, viscosifying, solidifying, and/or thickening properties to the composition or which otherwise provide structure to the final product form. These solid structurants include gelling agents, and polymeric or non-polymeric or inorganic thickening or viscosifying agents. Such materials will typically be solids under ambient conditions and include organic solids, crystalline or other gellants, inorganic particulates such as clays or silicas, or combinations thereof.
  • The concentration and type of solid structurant selected for use in the antiperspirant compositions will vary depending upon the desired product hardness, rheology, and/or other related product characteristics. For most structurants suitable for use herein, the total structurant concentration ranges from about 5% to about 35%, more typically from about 10% to about 30%, or from about 7% to about 20%, by weight of the composition.
  • Non-limiting examples of suitable primary structurants include stearyl alcohol and other fatty alcohols; hydrogenated castor wax (e.g., Castorwax MP80, Castor Wax, etc.); hydrocarbon waxes include paraffin wax, beeswax, carnauba, candelilla, spermaceti wax, ozokerite, ceresin, baysberry, synthetic waxes such as Fischer-Tropsch waxes, and microcrystalline wax; polyethylenes with molecular weight of 200 to 1000 daltons; solid triglycerides; behenyl alcohol, or combinations thereof.
  • Other non-limiting examples of primary structurants suitable for use herein are described in U.S. Pat. No. 5,976,514 and U.S. Pat. No. 5,891,424,the descriptions of which are incorporated herein by reference.
  • Antiperspirant Active
  • The antiperspirant stick compositions can comprise a particulate antiperspirant active suitable for application to human skin. The concentration of antiperspirant active in the composition should be sufficient to provide the desired perspiration wetness and odor control from the antiperspirant stick formulation selected.
  • The antiperspirant stick compositions can comprise an antiperspirant active at concentrations of from about 0.5% to about 60%, and more specifically from about 5% to about 35%, by weight of the composition. These weight percentages are calculated on an anhydrous metal salt basis exclusive of water and any complexing agents such as, for example, glycine, and glycine salts. The antiperspirant active as formulated in the composition can be in the form of dispersed particulate solids having an average particle size or equivalent diameter of less than about 100 microns, more specifically less than about 20 microns, and even more specifically less than about 10 microns.
  • The antiperspirant active for use in the anhydrous antiperspirant compositions of the present invention can include any compound, composition or other material having antiperspirant activity. More specifically, the antiperspirant actives may include astringent metallic salts, especially inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof. Even more specifically, the antiperspirant actives may include aluminum-containing and/or zirconium-containing salts or materials, such as, for example, aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof.
  • Aluminum salts for use in the anhydrous antiperspirant stick compositions include those that conform to the formula:

  • Al2(OH)aClb.xH2O,
    • wherein a is from about 2 to about 5;
    • the sum of a and b is about 6;
    • x is from about 1 to about 6; and
    • a, b, and x may have non-integer values.
  • More specifically, aluminum chlorohydroxides referred to as “5/6 basic chlorohydroxide” can be used, wherein a=5, and “2/3 basic chlorohydroxide”, wherein a=4.
  • Processes for preparing aluminum salts are disclosed in U.S. Pat. No. 3,887,692; U.S. Pat. No. 3,904,741; U.S. Pat. No. 4,359,456; and British Patent Specification 2,048,229, the disclosures of which are incorporated herein by reference for the purpose of describing processes for preparing aluminum salts.
  • Mixtures of aluminum salts are described in British Patent Specification 1,347,950, which description is also incorporated herein by reference.
  • Zirconium salts for use in the anhydrous antiperspirant stick compositions include those which conform to the formula:

  • ZrO(OH)2-aCla.xH2O,
    • wherein a is from about 1.5 to about 1.87;
    • x is from about 1 to about 7; and
    • a and x may both have non-integer values.
  • These zirconium salts are described in Belgian Patent 825,146, Schmitz, issued Aug. 4, 1975, which description is incorporated herein by reference. Zirconium salts that additionally contain aluminum and glycine, commonly known as “ZAG complexes,” are believed to be especially beneficial. These ZAG complexes contain aluminum chlorohydroxide and zirconyl hydroxy chloride conforming to the above-described formulas. Such ZAG complexes are described in U.S. Pat. No. 3,792,068; Great Britain Patent Application 2,144,992; and U.S. Pat. No. 4,120,948, disclosures of which are incorporated herein by reference for the limited purpose of describing ZAG complexes.
  • Also suitable for use herein are enhanced efficacy aluminum-zirconium chlorohydrex-amino acid which typically has the empirical formula AlnZr(OH)[3n+4-m(n+1)](Cl)[m(n+1)]-AAq where n is 2.0 to 10.0, preferably 3.0 to 8.0; m is about 0.48 to about 1.11 (which corresponds to M:Cl approximately equal to 2.1-0.9), preferably about 0.56 to about 0.83 (which corresponds to M:Cl approximately equal to 1.8-1.2); q is about 0.8 to about 4.0, preferably about 1.0 to 2.0; and AA is an amino acid such as glycine, alanine, valine, serine, leucine, isoleucine, β-alanine, cysteine, β-amino-n-butyric acid, or y-amino-n-butyric acid, preferably glycine. These salts also generally have some water of hydration associated with them, typically on the order of 1 to 5 moles per mole of salt (typically, about 1% to about 16%, more typically about 4% to about 13% by weight). These salts are generally referred to as aluminum-zirconium trichlorohydrex or tetrachlorohydrex when the Al:Zr ratio is between 2 and 6 and as aluminum-zirconium pentachlorohydrex or octachlorohydrex when the Al:Zr ratio is between 6 and 10. The term “aluminum-zirconium chlorohydrex” is intended to embrace all of these forms. The preferred aluminum-zirconium salt is aluminum-zirconium chlorohydrex-glycine. Additional examples of suitable high efficacy antiperspirant actives can include Aluminum Zirconium Pentachlorohydrex Glycine, Aluminum Zirconium Octachlorohydrex Glycine, or a combination thereof. These high efficacy actives are more fully described in U.S. App. Pub. No. 2007/0003499 by Shen et al. filed Jun. 30, 2005.
  • Additional Chassis Ingredients Additional Structurant
  • The antiperspirant composition can further comprise an additional structurant. The additional structurant may be present in an amount from 1% to about 10%, by weight of the composition. The additional structurant(s) will likely be present at an amount less than the primary structurant.
  • Non-limiting examples of suitable additional structurants include stearyl alcohol and other fatty alcohols; hydrogenated castor wax (e.g., Castorwax MP80, Castor Wax, etc.); hydrocarbon waxes include paraffin wax, beeswax, carnauba, candelilla, spermaceti wax, ozokerite, ceresin, baysberry, synthetic waxes such as Fisher-Tropsch waxes, and microcrystalline wax; polyethylenes with molecular weight of 200 to 1000 daltons; and solid triglycerides; behenyl alcohol, or combinations thereof.
  • Other non-limiting examples of additional structurants suitable for use herein are described in U.S. Pat. No. 5,976,514 and U.S. Pat. No. 5,891,424.
  • Solvent
  • The antiperspirant composition can comprise a solvent at concentrations ranging from about 20% to about 80%, and more specifically from about 30% to about 70%, by weight of the composition. The solvent can be a volatile silicone which may be cyclic or linear.
  • “Volatile silicone” as used herein refers to those silicone materials that have measurable vapor pressure under ambient conditions. Non-limiting examples of suitable volatile silicones are described in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976), which descriptions are incorporated herein by reference.
  • The volatile silicone can be a cyclic silicone having from 3 to 7, and more specifically from 5 to 6, silicon atoms, and still more specifically 5, like cyclopentasiloxane. These cyclic silicone materials will generally have viscosities of less than about 10 centistokes at 25° C. Linear volatile silicone materials suitable for use in the antiperspirant compositions include those represented by the formula:
  • Figure US20160089317A1-20160331-C00001
  • wherein n is from 1 to 7, and more specifically from 2 to 3. These linear silicone materials will generally have viscosities of less than about 5 centistokes at 25° C.
  • Specific examples of volatile silicone solvents suitable for use in the antiperspirant compositions include, but are not limited to, Cyclomethicone D-5; GE 7207 and GE 7158 (commercially available from General Electric Co.); Dow Corning 344; Dow Corning 345; Dow Corning 200; and DC1184 (commercially available from Dow Corning Corp.); and SWS-03314 (commercially available from SWS Silicones).
  • Non-Volatile Organic Fluids
  • Non-volatile organic fluids may be present, for example, in an amount of about 15% or less, by weight of the composition.
  • Non-limiting examples of nonvolatile organic fluids include mineral oil, PPG-14 butyl ether, isopropyl myristate, petrolatum, butyl stearate, cetyl octanoate, butyl myristate, myristyl myristate, C12-15 alkylbenzoate (e.g., Finsolv™), octyldodecanol, isostearyl isostearate, octododecyl benzoate, isostearyl lactate, isostearyl palmitate, and isobutyl stearate.
  • Adjunct Ingredients
  • The anhydrous antiperspirant compositions can further comprise any optional material that is known for use in antiperspirant and deodorant compositions or other personal care products, or which is otherwise suitable for topical application to human skin.
  • One example of optional materials are clay mineral powders such as talc, mica, sericite, silica, magnesium silicate, synthetic fluorphlogopite, calcium silicate, aluminum silicate, bentonite and montomorillonite; pearl pigments such as alumina, barium sulfate, calcium secondary phosphate, calcium carbonate, titanium oxide, finely divided titanium oxide, zirconium oxide, zinc oxide, hydroxy apatite, iron oxide, iron titrate, ultramarine blue, Prussian blue, chromium oxide, chromium hydroxide, cobalt oxide, cobalt titanate, titanium oxide coated mica; organic powders such as polyester, polyethylene, polystyrene, methyl methacrylate resin, cellulose, 12-nylon, 6-nylon, styrene-acrylic acid copolymers, poly propylene, vinyl chloride polymer, tetrafluoroethylene polymer, boron nitride, fish scale guanine, laked tar color dyes, laked natural color dyes; and combinations thereof.
  • Talc, if used at higher levels can produce a significant amount of white residue which has been found to be a consumer negative for product acceptance. Therefore it is best to limit the composition to less than 10%, less than about 8%, less than about 6%, or less than about 3%, by weight of the composition.
  • Nonlimiting examples of other optional materials include emulsifiers, distributing agents, antimicrobials, pharmaceutical or other topical active, preservatives, surfactants, and so forth. Examples of such optional materials are described in U.S. Pat. No. 4,049,792; U.S. Pat. No. 5,019,375; and U.S. Pat. No. 5,429,816; which descriptions are incorporated herein by reference.
  • D. Soft Solid
  • Soft solid composition can comprise volatile silicone, antiperspirant active, gellant, residue masking material, or combinations thereof. In addition, soft solids generally have a hardness value after dispensing of about 500 gram force or less.
  • Volatile Silicone Solvent
  • The soft solid can comprises a volatile silicone solvent at concentrations ranging from about 20% to about 80%, preferably from about 30% to about 70%, more preferably from about 45% to about 70%, by weight of the composition. The volatile silicone of the solvent may be cyclic or linear.
  • “Volatile silicone” as used herein refers to those silicone materials which have measurable vapor pressure under ambient conditions. Nonlimiting examples of suitable volatile silicones are described in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976), which descriptions are incorporated herein by reference. Preferred volatile silicone materials are those having from about 3 to about 7, preferably from about 4 to about 5, silicon atoms.
  • Cyclic volatile silicones are preferred for use in the antiperspirant compositions herein, and include those represented by the formula:
  • Figure US20160089317A1-20160331-C00002
  • wherein n is from about 3 to about 7, preferably from about 4 to about 5, most preferably 5. These cyclic silicone materials will generally have viscosities of less than about 10 centistokes at 25° C.
  • Linear volatile silicone materials suitable for use in the antiperspirant compositions include those represented by the formula:
  • Figure US20160089317A1-20160331-C00003
  • wherein n is from about 1 to about 7, preferably from about 2 to about 3. These linear silicone materials will generally have viscosities of less than about 5 centistokes at 25° C.
  • Specific examples of volatile silicone solvents suitable for use in the antiperspirant compositions include, but are not limited to, Cyclomethicone D-5 (commercially available from G. E. Silicones), Dow Corning 344, Dow Corning 345 and Dow Corning 200 (commercially available from Dow Corning Corp.), GE 7207 and 7158 (commercially available from General Electric Co.) and SWS-03314 (commercially available from SWS Silicones Corp.).
  • Gellant Material
  • The soft solid can include a gellant material comprising fatty alcohols having from about 20 to about 60 carbon atoms, or combinations thereof, at concentrations ranging from about 0.1% to about 8% by weight of the composition. The gellant material, when combined with the volatile silicone solvent described hereinbefore, provides the composition with a physically stable structure within which the particulate antiperspirant materials are dispersed, and maintained as such over an extended period of time.
  • Specifically, the gellant material can comprise saturated or unsaturated, substituted or unsubstituted, fatty alcohols or mixtures of fatty alcohols having from about 20 to about 60 carbons atoms, preferably from about 20 to about 40 carbon atoms. Preferred are combinations of the fatty alcohols. The fatty alcohol gellants are preferably saturated, unsubstituted monohydric alcohols or combinations thereof, which have a melting point of at less than about 110° C., more preferably from about 60° to about 110° C., even more preferably between about 100° C. and 110° C.
  • It has been found that this fatty alcohol-based gellant material, when combined with volatile silicone solvents provides a stable structure for maintaining a dispersion of particulate antiperspirant material in a topical formulation without the necessity of using conventional particulate thickening agents. This gellant material is especially useful in maintaining the physical stability of particulate dispersions containing higher concentrations of volatile silicone solvents.
  • It was also found that penetration force values for the antiperspirant compositions can be controlled by adjusting total fatty alcohol concentrations. In controlling penetration force values in this manner, there is no longer a need to use organic solvents or thickening agents to control penetration force values, which solvents or thickening agents often add cost to the formulation, introduce additional compatibility issues, and often contribute undesirable cosmetics such as prolonged stickiness, difficulty in ease of spreading, increased dry-down times and reduced dry feel after application.
  • Specific concentrations of the gellant materials can be selected according to the desired penetration force value. For roll-on formulations having a penetration force value of from about 20 gram·force to about 100 gram·force, gellant material concentrations preferably range from about 0.1% to about 3% , preferably from about 1.5% to about 3%, by weight of the antiperspirant composition. For other cream formulations, including those formulations suitable for use in cream applicator devices, which have a penetration force value of from about 100 gram·force to about 500 gram·force, gellant material concentrations preferably range from about 3% to about 8%, preferably from about 3% to about 6%, by weight of the antiperspirant composition.
  • Specific examples of fatty alcohol gellants for use in the antiperspirant compositions that are commercially available include, but are not limited to, Unilin® 425, Unilin® 350, Unilin® 550 and Unilin® 700 (supplied by Petrolite)
  • Residue Masking Material
  • The soft solid compositions can further comprise a nonvolatile emollient as a residue masking material Such materials and their use in antiperspirant products are well known in the antiperspirant art, and any such material may be incorporated into the composition of the present invention, provided that such optional material is compatible with the essential elements of the composition, or does not unduly impair product performance or cosmetics.
  • Concentrations of the optional residue masking material can range from about 0.1% to about 40%, preferably from about 1% to about 10%, by weight of the antiperspirant composition. These optional materials can be liquid at ambient temperatures, and can be nonvolatile. The term “nonvolatile” as used in this context refers to materials which have a boiling point under atmospheric pressure of at least about 200° C. Nonlimiting examples of suitable residue masking materials for use in the antiperspirant products include butyl stearate, diisopropyl adipate, petrolatum, nonvolatile silicones, octyldodecanol, phenyl trimethicone, isopropyl myristate, C12-15 ethanol benzoates and PPG-14 Butyl Ether. Residue masking materials are described, for example, in U.S. Pat. No. 4,985,238, which description is incorporated herein by reference.
  • Other Materials
  • The soft solid compositions can further comprise one, or more, other materials which modify the physical characteristics of the compositions or serve as additional “active” components when deposited on the skin. Many such materials are known in the antiperspirant art and can be used in the antiperspirant compositions herein, provided that such optional materials are compatible with the essential materials described herein, or do not otherwise unduly impair product performance.
  • Non limiting examples of materials can include active components such as bacteriostats and fungiostats, and “non-active” components such as colorants, perfumes, cosmetic powders, emulsifiers, chelants, distributing agents, preservatives, and wash-off aids. Examples of such optional materials are described in U.S. Pat. No. 4,049,792; Canadian Patent 1,164,347; U.S. Pat. No. 5,019,375; and U.S. Pat. No. 5,429,816; which descriptions are incorporated herein by reference.
  • E. Aerosol
  • An aerosol composition can comprise a concentrate, a propellant, or a combination thereof. Alcohol is a predominant component of the concentrates provided herein. Useful alcohols include C1-C3 alcohols, with the preferred alcohol being ethanol. In certain examples, the alcohol is employed at a concentration level of from at least about 40%, 50% or 55% to about 80%, by weight of the concentrate.
  • An antiperspirant active is dissolved in the alcohol, at a level of from about 1% to about 15%, by weight of the concentrate. Various antiperspirant actives can be employed, including, for example, aluminum chloride, aluminum chlorohydrate, aluminum chlorohydrex, aluminum chlorohydrex PG, aluminum chlorohydrex PEG, aluminum dichlorohydrate, aluminum dichlorohydrex PG, aluminum dichlorohydrex PEG, aluminum sesquichlorohydrate, aluminum sesquichlorohydrex PG, aluminum sesquichlorohydrex PEG, aluminum sulfate, aluminum zirconium octachlorohydrate, aluminum zirconium octachlorohydrex GLY, aluminum zirconium pentachlorohydrate, aluminum zirconium pentachlorohydrex GLY, aluminum zirconium tetrachlorohydrate, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate GLY, and aluminum zirconium trichlorohydrate GLY. In one example, aluminum chlorohydrex PG is the chosen antiperspirant active.
  • The antiperspirant concentrates can also include an oil or a mixture of two or more oils. Useful oils include, for example, volatile silicone oils and non-volatile organic oils. “Volatile silicone”, as used herein, refers to those silicone materials that have measurable vapor pressure under ambient conditions. Non-limiting examples of suitable volatile silicones are described in Todd et al., “Volatile Silicone Fluids for Cosmetics”, Cosmetics and Toiletries, 91:27-32 (1976). The volatile silicone can be a cyclic silicone having from at least about 3 silicone atoms or from at least about 5 silicone atoms but no more than about 7 silicone atoms or no more than about 6 silicone atoms. For example, volatile silicones can be used which conform to the formula:
  • Figure US20160089317A1-20160331-C00004
  • wherein n is from about 3 or from about 5 but no more than about 7 or no more than about 6. These volatile cyclic silicones generally have a viscosity of less than about 10 centistokes at 25° C. Suitable volatile silicones for use herein include, but are not limited to, Cyclomethicone D5 (commercially available from G. E. Silicones); Dow Corning 344, and Dow Corning 345 (commercially available from Dow Corning Corp.); and GE 7207, GE 7158 and Silicone Fluids SF-1202 and SF-1173 (available from General Electric Co.). SWS-03314, SWS-03400, F-222, F-223, F-250, F-251 (available from SWS Silicones Corp.); Volatile Silicones 7158, 7207, 7349 (available from Union Carbide); MASIL SF-V (available from Mazer) and combinations thereof. Suitable volatile silicone oils can also include linear silicone oils such as, for example, DC200 (1 cSt), DC200 (0.65 cSt), and DC2-1184, all of which are available from Dow Corning Corp. In certain examples, the volatile silicone oil can have a viscosity of less than 10 centistokes at 25° C.
  • Non-volatile organic, emollient oils can also be employed. A representative, non-limiting list of emollient oils includes CETIOL CC (dicaprylyl carbonate), CETIOL OE (dicaprylyl ether), CETIOL S (diethylhexylcyclohexane), and CETIOL B (dibutyl adipate), all of which are available from Cognis, and LEXFEEL 7 (neopentyl glycol diheptanoate) from Inolex. In certain examples, the organic emollient oils have a viscosity of less than 50 centistokes at 25° C. The term “organic emollient oil” as used herein means silicon-free emollient oils that are liquid at 25° C., and that are safe and light to skin and can be miscible with volatile silicone oils (as described above) and the antiperspirant active-alcohol solution in the concentration ranges described below.
  • The oil or mixture of oils is generally included in the concentrate formulas at a level of from about 5% to about 45%, by weight of the concentrate. This viscosity ranges noted above in connection with the different classes of oil can facilitate desired spray rates and patterns, and can help minimize nozzle clogging. To provide desired skin feel, minimal nozzle clogging, and good concentrate stability, the ratio of alcohol to volatile silicone oil is preferably greater than 1.0, 1.35, or 1.5. And in examples having both a volatile silicone oil and an organic emollient oil, the ratio of alcohol to total oil is preferably greater than or equal to about 0.90. The oils in certain examples are miscible with the alcohol and antiperspirant active solution. Although various levels of miscibility are acceptable, the oils are preferably miscible enough with the alcohol and antiperspirant active solution to yield a concentrate having a clear appearance.
  • The antiperspirant compositions can also include residue-masking agents and propellants as discussed above.
  • Test Methods
  • Malodor reduction materials may be separated from mixtures, including but not limited to finished products such as consumer products and identified, by analytical methods that include GC-MS and/or NMR.
  • Test Method for Determining Saturation Vapour Pressure (VP)
  • The saturation Vapour Pressure (VP) values are computed for each PRM in the perfume mixture being tested. The VP of an individual PRM is calculated using the VP Computational Model, version 14.02 (Linux) available from Advanced Chemistry Development Inc. (ACD/Labs) (Toronto, Canada) to provide the VP value at 25° C. expressed in units of torr. The ACD/Labs' Vapor Pressure model is part of the ACD/Labs model suite.
  • Test Method for Determining the Logarithm of the Octanol/Water Partition Coefficient (log P)
  • The value of the log of the Octanol/Water Partition Coefficient (log P) is computed for each PRM in the perfume mixture being tested. The log P of an individual PRM is calculated using the Consensus log P Computational Model, version 14.02 (Linux) available from Advanced Chemistry Development Inc. (ACD/Labs) (Toronto, Canada) to provide the unitless log P value. The ACD/Labs' Consensus log P Computational Model is part of the ACD/Labs model suite.
  • Test Method for the Generation of Molecular Descriptors
  • In order to conduct the calculations involved in the computed-value test methods described herein, the starting information required includes the identity, weight percent, and molar percent of each PRM in the perfume being tested, as a proportion of that perfume, wherein all PRMs in the perfume composition are included in the calculations. Additionally for each of those PRMs, the molecular structure, and the values of various computationally-derived molecular descriptors are also required, as determined in accordance with the Test Method for the Generation of Molecular Descriptors described herein.
  • For each PRM in a perfume mixture or composition, its molecular structure is used to compute various molecular descriptors. The molecular structure is determined by the graphic molecular structure representations provided by the Chemical Abstract Service (“CAS”), a division of the American Chemical Society, Columbus, Ohio, U.S.A. These molecular structures may be obtained from the CAS Chemical Registry System database by looking up the index name or CAS number of each PRM. For PRMs, which at the time of their testing are not yet listed in the CAS Chemical Registry System database, other databases or information sources may be used to determine their structures. For a PRM which has potentially more than one isomer present, the molecular descriptor computations are conducted using the molecular structure of only one of the isomers, which is selected to represent that PRM. The selection of isomer is determined by the relative amount of extension in the molecular structures of the isomers. Of all the isomers of a given PRM, it is the isomer whose molecular structure that is the most prevalent which is the one that is selected to represent that PRM. The structures for other potential isomers of that PRM are excluded from the computations. The molecular structure of the isomer that is the most prevalent is paired with the concentration of that PRM, where the concentration reflects the presence of all the isomers of that PRM that are present.
  • A molecule editor or molecular sketching software program, such as ChemDraw (CambridgeSoft/PerkinElmer Inc., Waltham, Mass., U.S.A.), is used to duplicate the 2-dimensional molecular structure representing each PRM. Molecular structures should be represented as neutral species (quaternary nitrogen atoms are allowed) with no disconnected fragments (e.g., single structures with no counter ions). The winMolconn program described below can convert any deprotonated functional groups to the neutral form by adding the appropriate number of hydrogen atoms and will discard the counter ion.
  • For each PRM, the molecular sketching software is used to generate a file which describes the molecular structure of the PRM. The file(s) describing the molecular structures of the PRMs is subsequently submitted to the computer software program winMolconn, version 1.0.1.3 (Hall Associates Consulting, Quincy, Mass., U.S.A., www.molconn.com), in order to derive various molecular descriptors for each PRM. As such, it is the winMolconn software program which dictates the structure notations and file formats that are acceptable options. These options include either a MACCS SDF formatted file (i.e., a Structure-Data File); or a Simplified Molecular Input Line Entry Specification (i.e., a SMILES string structure line notation) which is commonly used within a simple text file, often with a “.smi” or “.txt” file name extension. The SDF file represents each molecular structure in the format of a multi-line record, while the syntax for a SMILES structure is a single line of text with no white space. A structure name or identifier can be added to the SMILES string by including it on the same line following the SMILES string and separated by a space, e.g.: C1=CC═CC═C1 benzene.
  • The winMolconn software program is used to generate numerous molecular descriptors for each PRM, which are then output in a table format. Specific molecular descriptors derived by winMolconn are subsequently used as inputs (i.e., as variable terms in mathematical equations) for a variety of computer model test methods in order to calculate values such as: saturation Vapour Pressure (VP); Boiling Point (BP); logarithm of the Octanol/Water Partition Coefficient (log P); Odour Detection Threshold (ODT); Malodour Reduction Value (MORV); and/or Universal Malodour Reduction Value (Universal MORV) for each PRM. The molecular descriptor labels used in the models' test method computations are the same labels reported by the winMolconn program, and their descriptions and definitions can be found listed in the winMolconn documentation. The following is a generic description of how to execute the winMolconn software program and generate the required molecular structure descriptors for each PRM in a composition.
  • Computing Molecular Structure Descriptors using winMolconn:
      • 1) Assemble the molecular structure for one or more perfume ingredients in the form of a MACCS Structure-Data File, also called an SDF file, or as a SMILES file.
      • 2) Using version 1.0.1.3 of the winMolconn program, running on an appropriate computer, compute the full complement of molecular descriptors that are available from the program, using the SDF or SMILES file described above as input.
        • a. The output of winMolconn is in the form of an ASCII text file, typically space delimited, containing the structure identifiers in the first column and respective molecular descriptors in the remaining columns for each structure in the input file.
      • 3) Parse the text file into columns using a spreadsheet software program or some other appropriate technique. The molecular descriptor labels are found on the first row of the resulting table.
      • 4) Find and extract the descriptor columns, identified by the molecular descriptor label, corresponding to the inputs required for each model.
        • a. Note that the winMolconn molecular descriptor labels are case-sensitive.
    MORV and Universal MORV Calculation
    • 1.) Input Molecular Descriptor values as determined via the method above into the following four equations:

  • MORV=−8.5096+2.8597×(dxp9)+1.1253×(knotpv)−0.34484×(e1C2O2)−0.00046231×(idw)+3.3509×(idcbar)+0.11158×(n2pag22)   a)

  • MORV=−5.2917+2.1741×(dxvp5)−2.6595×(dxvp8)+0.45297×(c1C2C2d)−0.6202×(c1C2O2)+1.3542×(CdCH2)+0.68105×(CaasC)+1.7129×(idcbar)   b)

  • MORV=−0.0035+0.8028×(SHCsatu)+2.1673×(xvp7)−1.3507×(c1C1C3d)+0.61496×(c1C1O2)+0.00403×(idc)−0.23286×(nd2).   c)

  • MORV=−0.9926−0.03882×(SdO)+0.1869×(Ssp3OH)+2.1847×(xp7)+0.34344×(e1C302)−0.45767×(c1C2C3)+0.7684×(CKetone)   d)
    • Equation a) relates a material's effectiveness in reducing the malodor trans-3-methyl-2-hexenoic acid (carboxylic acid based malodors)
    • Equation b) relates a material's effectiveness in reducing the malodor trimethylamine (amine based malodors)
    • Equation c) relates a material's effectiveness in reducing the malodor 3-mercapto-3-methylhexan-1-ol (thiol based malodors)
    • Equation d) relates a material's effectiveness in reducing the malodor skatole (indole based malodors)
    • 2.) For purpose of the present application, a material's MORV is the highest MORV value from equations 1.)a) through 1.)d).
    • 3.) If all MORVvalues from equations 1.)a) through 1.)d) above are greater than 0.5, the subject material has a Universal MORV.
    Method for Assigning Fragrance Fidelity Index (FFI) and the Blocker Index (BI) for a Malodor Reduction Compound
  • Blocker materials suitable for use in consumer products of the present invention are chosen for their ability to decrease malodor, while not interfering with perception of a fragrance. Material selection is done by assigning two indices to a test sample material from two reference scales in order to rank odor strengths. The two reference scales are the Fragrance Fidelity Index (FFI) scale and the Blocker Index (BI) scale. The FFI ranks the ability of the test sample material to impart a perceivable odor which could cause interference when combined with another fragrance and the BI ranks the ability of the test sample material to reduce malodor perception. The two methods for assigning the indices to a test sample on the FFI and the BI reference scales are given below.
  • Method for Assigning the FFI to Test samples
  • The first step in the method for assigning an FFI on the FFI reference scale is to create the FFI reference swatches. The swatches for the scale are created by treating clean fabrics swatches with a known amount of a known concentration of an ethyl vanillin solution. Fabric swatches for this test are white knit polycotton (4 inch×4 inch) swatches from EMC ordered as PC 50/50. The supplier is instructed to strip the swatches first, stripping involves washing twice with a fragrance-free detergent and rinsing three times.
  • Making the FFI Reference Swatches
  • Make three solutions of ethyl vanillin using a 50%/50% EtOH/water as the diluent at the following concentrations: 25 ppm, 120 ppm and 1000 ppm. Pipette 13 μL of each of the three solutions into the middle of a clean swatch resulting in about a 1 cm diameter of the solution in the middle of the swatch. This will create a sensory scale of three swatches with three different odor levels based on the concentration of the solution pipetted onto the swatch. After drying for 30 minutes in a vented hood, the swatches are wrapped in aluminum foil to prevent odor contamination to the treated swatch. A clean untreated swatch is also included as the lowest anchor point of reference for odor strength on the FFI scale. The FFI reference scale swatches should be used within 0.5 to 12 hours and discarded after 12 hours. The swatches are used as scale anchor points when graders evaluate a test sample(s) and are assigned a Fragrance Fidelity Index (FFI) as show in Table 7.
  • At least four perfumers/expert graders are used to rank the ethyl vanillin swatches in the FFI scale. The perfumer/expert grader needs to demonstrate adequate discrimination on the scale. The perfumer/expert panel is asked to rank order swatches according to a scale between 0 and 3. The panel must demonstrate statistical differences between the swatches as seen in Table 7.
  • TABLE 7
    Results FFI of reference swatches
    from six perfumers/expert graders.
    Expert Grader Std
    FFI Swatch 1 2 3 4 5 6 Ave Dev.
    0 Control: stripped 0 0 0.5 0 0 0 0.08 0.2
    swatch NIL
    ethyl vanillin
    1 Stripped swatch with 0.5 0.5 0.5 1.5 0.5 1.0 0.75 0.4
    13 μL 25 ppm
    ethyl vanillin
    2 Stripped swatch with 2.0 1.5 1.5 2.0 2.0 2.0 1.8 0.2
    13 μL 120 ppm
    ethyl vanillin
    3 Stripped swatch with 3.0 2.0 3.0 3.0 3.0 3.0 2.8 0.4
    13 μL 1000 ppm
    ethyl vanillin
  • The expert graders must demonstrate a full range of 2.5 over the 4 swatches to be acceptably discriminating. Grader 2 in table 1 has a range of only 2 and is eliminated from the panel. The panel of expert graders must also demonstrated the ability to statistically discriminate between swatches in the scale.
  • TABLE 8
    This table demonstrates acceptable expert graders
    with an acceptable range and the panel meets the
    requirement for discriminating statistics.
    Expert Grader Std
    FFI Swatch 1 3 4 5 6 Ave Dev.
    0 Control: stripped 0 0.5 0 0 0 0.08 0.2
    swatch NIL
    ethyl vanillin
    1 Stripped swatch with 0.5 0.5 1.5 0.5 1.0 0.80 0.4
    13 μL 25 ppm
    ethyl vanillin
    2 Stripped swatch with 2.0 1.5 2.0 2.0 2.0 1.9 0.2
    13 μL 120 ppm
    ethyl vanillin
    3 Stripped swatch with 3.0 3.0 3.0 3.0 3.0 3.0 0.0
    13 μL 1000 ppm
    ethyl vanillin
  • The reference swatches represent the 0, 1, 2, and 3 FFIs on the FFI reference scale, Table 9. The expert grader should familiarize them self with the strength of the odor on the FFI reference swatches by sniffing each one starting at 0 (the lowest odor strength) and ending at 3 (the highest odor strength). This should be done prior to evaluating the test sample material treated swatch.
  • TABLE 9
    Swatch treatments comprising the Fragrance Fidelity
    Index (FFI) reference scale
    Swatch treatment Conc. of ethyl vanillin FFI
    Clean fabric swatch w/ 13 μL ethyl 1000 ppm ethyl vanillin 3
    vanillin
    Clean fabric swatch w/ 13 μL ethyl  120 ppm ethyl vanillin 2
    vanillin
    Clean fabric swatch w/ 13 μL ethyl  25 ppm ethyl vanillin 1
    vanillin
    Clean fabric swatch NIL ethyl vanillin NIL ethyl vanillin 0

    Making Swatches Treated with the Test Material
  • A clean swatch is treated with 13 μL of a known concentration of a test sample material resulting in an about 1 cm of the solution on the clean swatch. Just like the reference swatches, the test sample material swatch is dried in a vented hood for 30 minutes and then wrapped in aluminum foil to prevent contamination. The test material swatches and the FFI reference swatches should be made within 2 hrs. of each other. The test material swatch must be used within 0.5 to 12 hours and discarded after 12 hours.
  • Assigning the FFI to the Test Material
  • At least two perfumers/expert graders are used to assign an FFI grade to a test sample. The perfumer/expert grader smells the test sample swatch by holding that swatch 1 inch from their nose with their nose centered over the area where the test sample was pipetted on to the fabric and then assigns the test sample an FFI grade using the FFI reference scale anchor swatches as references. The test sample swatch is assigned an FFI grade at or between numbers on the FFI scale shown in Table 9. In cases where the test sample material is graded greater than 3, the test material is not a blocker material or the concentration of the material needs to be lowered and reevaluated to determine if a lower level has a malodor blocker functionality.
  • Method for Assigning the BI to Test Sample
  • The first step in the method for assigning a BI to a test sample material on the BI reference scale is to create the BI reference swatches. The swatches for the scale are created by treating clean fabrics swatches with a known amount of a known volume of isovaleric acid solution at a known concentration. Fabric swatches for this test are white knit polycotton (4 inch×4 inch) swatches from EMC ordered as PC 50/50. The supplier is instructed to strip the swatches first, stripping involves washing twice with a fragrance-free detergent and rinsing three times.
  • Making the BI Reference Swatches
  • Make one solution of 0.08% isovaleric acid using 50%/50% EtOH/water as the diluent. The BI scale contains one clean swatch with no malodor applied. Three other swatches each have a different volume of the 0.08% isovaleric acid applied. Pipette 2 μL of the 0.08% isovaleric acid solution to one clean swatch, 5 μL of the 0.08% isovaleric acid solution to the next swatch and 20 μL of isovaleric acid to the final clean swatch. These solutions are pipetted to the middle of the swatches. This will create a sensory scale of three swatches with three different odor levels based on the volume of the 0.08% isovaleric acid solution pipetted onto the swatch. After drying for 30 minutes in a vented hood, the swatches are wrapped in aluminum foil to prevent odor contamination to the treated swatch. A clean untreated swatch is also included as the lowest anchor point of reference for malodor strength on the BI scale. The BI reference scale swatches should be used within 0.5 to 12 hours and discarded after 12 hours. The swatches are used as scale anchor points when graders evaluate a test sample(s) and are assigned a Blocker Index (BI) as show in Table 12.
  • At least four perfumers/expert graders are used to rank the isovaleric acid swatches in the BI scale. The perfumer/expert grader needs to demonstrate adequate discrimination on the scale. The perfumer/expert grader is asked to rank order swatches according to a scale between 0 and 3. The panel of graders must demonstrate statistical differences between the swatches as seen in Table 10.
  • TABLE 10
    Results from six perfumers/expert graders to create the BI scale.
    Expert Grader Std
    BI Swatch 1 2 3 4 5 Ave Dev.
    0 Control: stripped swatch 0 0 0 0 0 0 0
    NIL isovaleric acid
    1 Stripped swatch with 2 μL 0.5 2.0 1.0 1.0 0.5 1.0 0.5
    0.08% isovaleric acid
    2 Stripped swatch with 5 μL 2.0 2.5 2.0 2.0 2.0 2.1 0.2
    0.08% isovaleric acid
    3 Stripped swatch with 20 μL 3.0 3.0 3.0 3.0 2.5 2.8 0.2
    0.08% isovaleric acid
  • The expert graders must demonstrate a full range of 2.5 over the 4 swatches to be acceptably discriminating. The panel of expert graders must also demonstrated the ability to statistically discriminate between swatches in the scale. Expert grader #2 did not demonstrate the ability to discriminate between the swatches and is eliminated from the panel, see Table 11.
  • TABLE 11
    This table demonstrates acceptable expert graders
    with an acceptable range and the panel meets the
    requirement for discriminating statistics.
    Expert Grader Std
    BI Swatch 1 3 4 5 Ave Dev.
    0 Control: stripped swatch 0 0 0 0 0 0
    NIL isovaleric acid
    1 Stripped swatch with 2 μL 0.5 1.0 1.0 0.5 0.8 0.3
    0.08% isovaleric acid
    2 Stripped swatch with 5 μL 2.0 2.0 2.0 2.0 2.0 0
    0.08% isovaleric acid
    3 Stripped swatch with 20 μL 3.0 3.0 3.0 2.5 2.9 0.2
    0.08% isovaleric acid
  • The reference swatches represent the 0, 1, 2, and 3 BIs on the BI reference scale, Table 12. The expert grader should familiarizes him/herself with the strength of the odor on the BI reference swatches by sniffing each one starting at 0 (the lowest odor strength) and ending at 3 (the highest odor strength). This should be done prior to evaluating the swatch treated with the test material.
  • TABLE 12
    Swatch treatments comprising the Blocker Index (BI) reference scale.
    Swatch/treatment Wt. of isovaleric acid BI
    Clean fabric swatch w/ 20 μL 0.08%  16 mg isovaleric acid 3
    isovaleric acid
    Clean fabric swatch w/ 5 μL 0.08%   4 mg isovaleric acid 2
    isovaleric acid
    Clean fabric swatch w/ 2 μL 0.08% 1.6 mg isovaleric acid 1
    isovaleric acid
    Clean fabric swatch NIL isovaleric acid NIL isovaleric acid 0

    Making the Malodorous Swatch and Treating it with a Test Material
  • To evaluate the BI, the test material is applied to a malodorous swatch to determine how well the test material blocks the malodor. The malodorous swatch is made by treating a clean swatch with 20 μL of a 0.08% solution of isovaleric acid. Dry the malodorous swatch treated with isovaleric acid in a vented hood for 30 minutes. After drying the malodorous swatch a known concentration of test material solution, between 1 ppm and 100 ppm is pipetted onto the malodorous swatch. Apply the test material solution right on top of the spot where the isovaleric acid solution was applied making an about 1 cm diameter spot. Just like the BI reference swatches, the isovaleric acid+test material swatch is dried in a vented hood for 30 minutes and then wrapped in aluminum foil to prevent contamination. The isovaleric acid+test material swatches and the BI reference swatches should be made within 2 hrs. of each other. The isovaleric acid+test material swatch must be used between 1-12 hours just like the reference swatches. It is sometimes necessary to evaluate several levels of the test material between about 1 and about 100 ppm to determine the BI.
  • Assigning the BI to the Test Material
  • At least two perfumers/expert graders are used to assign the BI to the test sample. The expert grader smells the isovaleric acid+test material swatch by holding that swatch one inch from their nose with their nose centered over the area where the Test sample was pipetted on to the fabric and then assigns the isovaleric acid+test material swatch a BI based on ranking its odor strength against the odor strength of the swatches in the BI reference scale. The test sample swatch is assigned a BI at or between numbers on the BI in table. In cases where the isovaleric acid+test material swatch odor is greater than 3 on the BI reference scale, this indicates the material is not a blocker or the concentration of the test material needs to be lowered to achieve its blocker functionality.
  • Malodor Reduction Compounds with FFI and BI Grades Based on the Aforementioned
  • Table
    Ref # CAS# log P Name Conc FFI BI
    281 54830-99-8 3.11 3a,4,5,6,7,7a-hexahydro-4,7- 10 ppm 0 2.0
    methano-1H-indenyl acetate 50 ppm 0.5 2.0
    677 139504-68-0 3.75 1-((2-(tert- 10 ppm 0 2.3
    butyl)cyclohexyl)oxy)butan-2-ol 50 ppm 1.8 2.0
    962 55066-48-3 3.17 3-methyl-5-phenylpentan-1-ol 10 ppm 0 2.3
    50 ppm 0.5 1.7
    261 173445-65-3 3.29 3-(3,3-dimethyl-2,3-dihydro-1H- 10 ppm 0 1.8
    inden-5-yl)propanal 50 ppm 1.3 1.3
    1139 87731-18-8 2.11 (Z)-cyclooct-4-en-1-yl methyl 10 ppm 0 2.0
    carbonate 50 ppm 1.0 2.7
    4430-31-3 1.43 3,4,4a,5,6,7,8,8a-octahydrochromen- 10 ppm 0 2.0
    2-one 50 ppm 0 2.0
    204 40379-24-6 3.89 7-methyloctyl acetate 10 ppm 0 2.0
    50 ppm 0 2.7
    1005 93981-50-1 5.59 ethyl (2,3,6-trimethylcyclohexyl) 50 ppm 0.5 2.6
    carbonate
    391 106-33-2 5.73 Ethyl laurate 50 ppm 0.3 2.2
    1148 1139-30-6 4.06 Caryophyllene Oxide 50 ppm 0.5 2.3
    524 13877-91-3 4.31 3,7-Dimethyl-1,3,6-Octatriene(cis-β 50 ppm 0 2.8
    3338-55-4 ocimene 70%)
    1149 23787-90-8 4 1,3,4,6,7,8alpha-hexahydro- 10 ppm 0 1.5
    1,1,5,5-tetramethyl-2H-2,4alpha- 50 ppm 0.8 2.3
    methanophtalen-8(5H)-one
    112-42-5 4.62 Undecanol 50 ppm 0.8 2.3
    174 112-53-8 5.17 1-dodecanol 50 ppm 0.5 2.3
    98-52-2 2.78 4-tert-butyl cyclohexane 10 ppm 0 2.0
    50 ppm 0.3 2.0
    109 112-39-0 6.41 Methyl palmitate 10 ppm 2.0
  • Malodor Control Compounds with Improved Performance at Lower Levels.
  • Below are some non-limiting examples of preferred behavior by which the malodor control compound gives improved malodor control at lower concentration. These nonlimiting data provide additional compelling data that malodor is being blocked, not masked.
  • Table
    Ref # CAS# Name Conc FFI BI
    N/A 68912-13-0 8,8-dimethyl-3a,4,5,6,7,7a- 10 ppm 0 1.5
    hexahydro-1H-4,7- 50 ppm 0 2.2
    methanoinden-6-yl propionate
    N/A TBD 4,8-dimethyl-1-(methylethyl)- 10 ppm 2.0
    7-oxybiciclo [4.3.0]nonane 50 ppm 0.3 2.2

    about 0.001 Fragrance Fidelity
    • 868686868686868686868686868686868686868686868686868686868686868686868686868686 868686868686868686868686868686868686868686868686868686868686868686868686868686 868686868686868686868686868686868686
    Retesting Malodor Reduction Compounds at Lower Levels.
  • The example below demonstrates that while a malodor control compound could fail to demonstrate odor blocking (BI>2.5) at a higher concentration it should be retested at a lower concentration to determine if it passes.
  • Table
    Ref # CAS # Name Conc FFI BI
    N/A 173445-65-3 1H-Indene-5-propanal, 2,3- 10 ppm 0 1.5
    dihydro-3,3-dimethyl- 50 ppm 0.5 2.7
  • EXAMPLE 1 Compositions Comprising Malodor Reduction Compounds
  • In the present invention blends enable more potent malodor reduction because blends are useful at a higher % of the product composition before becoming olfactively noticeable. Below are non-limiting examples of malodor reduction compounds.
  • % wt. Active
    Component CAS# A B C D E
    2,2,8,8-tetramethyl-octahydro-1H- 29461-14-1 35-45 15-25  5-20 10-30 15-25
    2,4a-methanonapthalene-10-one
    1H-Indene-ar-propanal, 2,3- 300371-33-9 10-20  1-30 NIL  5-10 1-5
    dihydro-1,1-dimethyl-
    Hexadecanoic acid, (2E)-3,7- 3681-73-0 35-45 10-25 NIL 30-40 35-50
    dimethyl-2,6-octadien-1-yl ester
    1-Pentanol-3-methyl-5-phenyl 55066-48-3 10-20 10-25  2-10  5-17 10
    4,7-Methano-1H-inden-5-ol, 171102-41-3 0-5 10-25 NIL 1-6 1-5
    3a,4,5,6,7,7a-hexahydro-, 5-acetate
    4,8-dimethyl-1-(methylethyl)-7- N/A 0-5 NIL NIL NIL 1-5
    oxybiciclo [4.3.0]nonane
    (3Z)-3,7-dimethylocta-1,3,6-triene 3338-55-4 NIL NIL 10-20 2-5 NIL
    1H-Indene-5-propanal, 2,3- 173445-65-3 NIL NIL NIL 7.5-16   1-15
    dihydro-3,3-dimethyl-
    3,4,4a,5,6,7,8,8a- 4430-31-3 NIL NIL NIL 3-7  1-15
    octahydrochromen-2-one
    1-(2-tert- 139504-68-0 NIL NIL NIL 0.25-1.5  NIL
    butylcyclohexyl)oxybutan-2-ol
    ethyl (2,3,6-trimethylcyclohexyl) 93981-50-1 NIL NIL 15-30 NIL  2
    carbonate
    benzyl 2-hydroxypropanoate 2051-96-9 NIL NIL 2-5 NIL NIL
    (3,5-dimethylcyclohex-3-en-1- 67634-16-6 NIL NIL  5-30 NIL NIL
    yl)methanol
    2-Dodecanol 10203-28-8 NIL 0.25-1   NIL 0.5-3 NIL
  • EXAMPLE 2 Compositions Comprising Malodor Reduction Compounds
  • % wt. Active
    Ingredient CAS # A B C B D E
    (E)-1-(2,6,6-trimethyl-1- 127-42-4  4 8 2 8  3 2
    cyclohex-2-enyl)pent-1-en-3-
    one
    ethyl dodecanoate 106-33-2 NIL 1 NIL 3 NIL NIL
    3a,4,5,6,7,7a-hexahydro-1H- 68912-13-0  8 30 1 4  1 3.5
    4,7-methanoinden-1-yl
    propanoate
    [1R-(1R*,4R*,6R*,10S*)]- 1139-30-6 NIL 0.3 2 0.5 NIL 0.5
    4,12,12-trimethyl-9-
    methylene-5-
    oxatricyclo[8.2.0.04,6]dodecane
    (8E)-cyclohexadec-8-en-1-one 3100-36-5 NIL 5 NIL 7 NIL NIL
    3,5,5-trimethylhexyl acetate 58430-94-7 25 15 50  35 60 56
    ethyl (2,3,6- 93981-50-1 NIL 1 NIL 5 NIL NIL
    trimethylcyclohexyl)
    carbonate
    2,4-dimethyl-4,4a,5,9b- 27606-09-3 25 10 15  15 16 15
    tetrahydroindeno[1,2-
    d][1,3]dioxine
    2,2,7,7- 23787-90-8  8 9 5 7  5 5
    tetramethyltricyclo[6.2.1.01,6]
    undecan-5-one
    (3,5-dimethylcyclohex-3-en- 67634-16-6 NIL 0.7 NIL 0.5 NIL NIL
    1-yl)methanol
    3-(7,7-dimethyl-4- 33885-52-8 30 20 25  15 15 18
    bicyclo[3.1.1]hept-3-enyl)-
    2,2-dimethylpropanal
    Total 100  100 100  100 100  100
  • EXAMPLE 3 Malodor Reduction Composition
  • % wt. Active
    Ingredient CAS # A B C
    5-Cyclohexadecen-1-One 37609-25-9 15.0 2.00 2.00
    decahydro-2,2,7,7,8,9,9- 476332-65-7 0.005 0.01 0.01
    heptamethylindeno(4,3a-b)furan
    2,3-Dihydro-5,6-dimethoxy-2-(4- 33704-61-9 0.3 0.5 0.5
    piperidinylmethylene)-1H-inden-1-one
    Cedryl Methyl Ether 19870-74-7 6.0 10.0 4.0
    Trans-4-Decenal 65405-70-1 0.005 0.002 0.002
    Decyl Aldehyde 112-31-2 3.74 2.0 2.0
    3-methyl cyclopentadecenone 63314-79-4 0.4 1.0 1.0
    Diphenyl Oxide 101-84-8 0.5 1.0 1.0
    3a,4,5,6,7,7a-hexahydro-4,7-methano- 54830-99-8 5.0 8.0 8.0
    1H-indenyl acetate
    3a,4,5,6,7,7a-hexahydro-1H-4,7- 68912-13-0 6.0 8.0 8.0
    methanoinden-1-yl propanoate
    2-(5-methyl-2-propan-2-yl-8- 68901-32-6 10.0 15.0 15.0
    bicyclo[2.2.2]oct-5-enyl)-1,3-dioxolane
    (E)-3,7-dimethyl-2,6- 3681-73-0 10.0 10.0 16.0
    octadienylhexadecanoate
    Iso Nonyl Acetate 58430-94-7 6.65 8.0 3.0
    2,2,7,7- 23787-90-8 10.0 8.0 8.0
    tetramethyltricyclo[6.2.1.01,6]undecan-5-one
    (1-Methyl-2-(1,2,2- 198404-98-7 0.1 0.3 0.3
    trimethylbicyclo[3.1.0]-hex-3-
    ylmethyl)cyclopropyl)methanol
    Lauric Aldehyde 112-54-9 0.625 1.0 0.7
    Methyl Iso Eugenol 93-16-3 18.000 10.0 13.0
    Methyl hexadecanoate 112-39-00 3.000 10.0 12.0
    2,3-dihydro-1,1-1H-dimethyl-indene-ar- 300371-33-9 0.400 0.0 0.3
    propanal
    4-tert-butylcyclohexanol 98-52-2 0.400 0.1 0.1
    2-isobutyl-4-hydroxy-4- 63500-71-0 1.600 2.0 2.0
    methyltetrahydropyran
    Undecyl Aldehyde 112-44-7 1.725 2.888 1.888
    Undecylenic Aldehyde 112-45-8 0.550 0.2 1.2
    Total 100 100.0 100.0
  • EXAMPLE 4.1-4.5 Deodorant Example with Malodor Reducing Composition
  • An example of Deodorant compositions prepared with malodor reduction composition, according to the compositions shown in Example 1 to 3.
  • Ingredient 4.1 4.2 4.3 4.4 4.5
    Product Form Solid Solid Solid Solid Aerosol
    Deodorant Deodor- Deodor- Deodor- Deodorant
    Control ant ant ant or Body
    Spray
    dipropylene glycol 48 48 20 30 20
    propylene glycol 19.3 19.3 22
    tripopylene glycol 25
    Glycerine 10
    PEG-8 20
    Propylene Glycol 3 1.4 1.4
    Myristyl Ether
    ethanol QS
    Water QS QS QS QS
    sodium stearate 5.4 5.4 5.5 5.5
    tetra sodium EDTA 0.5 0.5 0.05 0.05
    sodium hydroxide 0.04 0.04
    triclosan 0.3 0.3
    Neat Perfume 2.8 2.8 2 1.5 1.5
    Malodor reducing 0.7 1.0 0.5 0.35
    composition
    Blue 1 0.0009 0.0009
    Propellant (1,1 40
    difluoroethane)
    QS - Indicates that this material is used to bring the total to 100%.
  • EXAMPLES 5.1-5.6 Antiperspirant Examples with Malodor Reducing Composition
  • An example of Antiperspirant compositions prepared with malodor reduction composition, according to the compositions shown in Example 1-3.
  • 5.1 5.2 5.3 5.4 5.5 5.6
    Invisible Invisible Invisible Soft Soft Soft
    Solid Solid Solid Solid Solid Solid
    Aluminum 24 24 24 26.5 26.5 26.5
    Zirconium
    Trichlorohydrex
    Glycine Powder
    Cyclopentasiloxane Q.S Q.S. Q.S. Q.S. Q.S. Q.S.
    Dimethicone 5 5 5
    CO-1897 Stearyl 14 14 14
    Alcohol NF
    Hydrogenated 3.85 3.85 3.85
    Castor Oil MP80
    Deodorized
    Behenyl Alcohol 0.2 0.2 0.2
    Tribehenin 4.5 4.5 4.5
    C 18-36 acid 1.125 1.125 1.125
    triglyceride
    C12-15 Alkyl 9.5 9.5 5
    Benzoate
    PPG-14 Butyl 6.5 6.5 0.5 0.5 0.5
    Ether
    Phenyl 3 3
    Trimethicone
    White Petrolatum 3 3 3 3
    Mineral Oil 1.0 1.0 1.0
    Free (Neat) 1.0 0.75 2.0 0.75 1.0 1.25
    Perfume
    Malodor reducing 0.25 0.35 0.175 0.25 0.1
    composition
    Beta-Cyclodextrin 3.0 3.0
    complexed with
    Malodor reducing
    composition
    Talc Imperial 250 3.0 3.0 3.0
    USP
    Polyacrylate 1.9
    Microcapsule
    loaded with
    Malodor reducing
    composition
    QS - indicates that this material is used to bring the total to 100%.
  • EXAMPLE 6.1-6.5 Clear Gel Antiperspirant Examples with Malodor Reducing Composition
  • An example of Antiperspirant compositions prepared with malodor reduction composition, according to the compositions shown in Example 1-3.
  • 6.1 6.2 6.3 6.4 6.5
    Clear Gel Clear Gel Clear Gel Clear Gel Clear Gel
    Antiperspirant Antiperspirant Antiperspirant Antiperspirant Antiperspirant
    Aluminum 20 18.5 20 18 10
    Zirconium
    Octachlorohydrex
    Gly
    Water Q.S Q.S. Q.S. Q.S. Q.S.
    Ethanol 5.5 8 6 6.5 5
    Propylene Glycol 5.3 5 7 5.5 8
    DC 5225c - 7.8 9 6.5 7 8
    Cyclopentasiloxane
    & PEG/PPG-
    18/18
    Dimethicone
    Dimethicone 5.6 4.5 5.8 5 4.1
    Cyclopentasiloxane 2.6 3 1 3 2.5
    Free (Neat) 1.0 0.75 2.0 0.75 1.0
    Perfume
    Malodor reducing 0.25 0.35 0.175 0.25
    composition
    QS - indicates that this material is used to bring the total to 100%.
  • The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”
  • Every document cited herein, including any cross referenced or related patent or application, is hereby incorporated herein by reference in its entirety unless expressly excluded or otherwise limited. The citation of any document is not an admission that it is prior art with respect to any invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches, suggests, or discloses any such invention. Further, to the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
  • While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is, therefore, intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.

Claims (16)

What is claimed:
1. An antiperspirant and/or deodorant composition comprising, based on total composition weight,
a) a sum total of from about 0.0001% to about 2%, preferably from about 0.0001% to about 0.75%, more preferably from about 0.001% to about 0.5%, most preferably from about 0.007% to about 0.25% of 1 or more malodor reduction materials, preferably 1 to about 75 malodor reduction materials, more preferably 1 to about 50 malodor reduction materials, more preferably 1 to about 35 malodor reduction materials, most preferably 1 to about 20 malodor reduction materials, each of said malodor reduction materials having a MORV of at least 0.5, preferably from 0.5 to 10, more preferably from 1 to 10, most preferably from 1 to 5, and preferably each of said malodor reduction materials having a Universal MORV, or said sum total of malodor reduction materials having a Blocker Index of less than 3, more preferable less than about 2.5 even more preferably less than about 2 and still more preferably less than about 1 and most preferably 0 and/or a Blocker Index average of 3 to about 0.001; and
b) from about 0% to about 12%, preferably from about 0% to about 8%, more preferably from about 0.1% to about 4%, of one or more perfume raw materials having a MORV of less than 0.5, preferably less than 0, more preferably less than −2, most preferably less than −5;
c) from about 0.1% to about 99%, preferably from about 1% to about 80%, more preferably from about 5% to about 55%, most preferably from about 10% to about 50% of a solvent, preferably said solvent is selected from cyclopentasiloxane, ethanol, water, propylene glycol, dipropylene glycol, and mixtures thereof;
d) from about 0% to about 30%, preferably from about 0% to about 20%, more preferably from about 0.1% to about 4%, most preferably from about 0.1% to about 4% of a material selected from the group consisting of a structurant, a residue masker, an antimicrobial, and mixtures thereof.
2. An antiperspirant and/or deodorant composition according to claim 1, wherein said sum total of malodor reduction materials has a Blocker Index of less than 3, more preferable less than about 2.5 even more preferably less than about 2 and still more preferably less than about 1 and most preferably 0 and/or a Blocker Index average of 3 to about 0.001.
3. An antiperspirant and/or deodorant composition according to any preceding claim, wherein each of said malodor reduction materials has a MORV of at least 0.5, preferably from 0.5 to 10, more preferably from 1 to 10, most preferably from 1 to 5, and preferably each of said malodor reduction materials having a Universal MORV.
4. An antiperspirant and/or deodorant composition according to any preceding claim wherein, said sum total of malodor reduction materials has a Fragrance Fidelity Index average of 3 to about 0.001 Fragrance Fidelity Index, preferably each malodor reduction material in said sum total of malodor reduction materials has a Fragrance Fidelity Index of less than 3, preferably less than 2, more preferably less than 1 and most preferably each malodor reduction material in said sum total of malodor reduction materials has a Fragrance Fidelity Index of 0.
5. An antiperspirant and/or deodorant composition according to any preceding claim, wherein said malodor reduction materials are selected from the group consisting of 2-ethylhexyl(Z)-(3-(4-methoxyphenyl)acrylate; 2,4-dimethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolane; 1,1-dimethoxynon-2-yne; 2-(p-tolyl)propan-2-ol; 3-methoxy-7,7-dimethyl-10-methylenebicyclo[4.3.1]decane; methoxycyclododecane; 1,1-dimethoxycyclododecane; (Z)-tridec-2-enenitrile; (2-hydroxy-4-methoxyphenyl)(phenyl)methanone; 2,4a,5,8a-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl formate; 4-methyl-1-oxaspiro[5.5]undecan-4-ol; 7-methyl-2H-benzo[b][1,4]dioxepin-3(4H)-one; 1,8-dioxacycloheptadecan-9-one; 4-(tert-pentyl)cyclohexan-1-one; 2-methoxy-1,1′-biphenyl; 3a,5,6,7,8,8b-hexahydro-2,2,6,6,7,8,8-heptamethyl-4H-indeno(4,5-d)-1,3-dioxole; 7-isopropyl-8,8-dimethyl-6,10-dioxaspiro[4.5]decane; octyl furan-2-carboxylate; octyl acetate; 2-heptyl-4-methyl-1,3-dioxolane; octanal; 1,1-dimethoxyoctane; 7-methyl-3-methyleneocta-1,6-diene; 2-methyl-6-methyleneoct-7-en-2-ol; 2-methyl-6-methyleneoct-7-en-2-yl acetate; tetradecanal; 4-methoxy-6-prop-2-enyl-1,3-benzodioxole; tetradecanenitrile; 2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydronaphthalen-1-ol; (E)-2,6-dimethylocta-5,7-dien-2-ol; (E)-2,7-dimethylocta-1,5,7-trien-3-ol; 2-((1S,5R)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethyl acetate; (4R,4aS,6R)-4,4a-dimethyl-6-(prop-1-en-2-yl)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one; nonan-1-ol; nonanal; 12-methyl-14-tetradec-9-enolide; N-ethyl-2-isopropyl-5-methylcyclohexane-1-carboxamide; 1-(3-methylbenzofuran-2-yl)ethan-1-one; 2-methoxynaphthalene; (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; (Z)-3,7-dimethylocta-2,6-dien-1-ol; 1-ethyl-3-methoxytricyclo[2.2.1.02,6]heptane; methyl(E)-non-2-enoate; 10-isopropyl-2,7-dimethyl-1-oxaspiro[4.5]deca-3,6-diene; 2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentan-1-one; 6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde; (E)-4-(2,2,3,6-tetramethylcyclohexyl)but-3-en-2-one; (4-(4-methylpent-3-en-1-yl)cyclohex-3-en-1-yl)methyl acetate; 2-(tert-butyl)-4,5,6-trimethyl-1,3-phenylene dinitrite; 1,7-dioxacycloheptadecan-8-one; 1-(4-(tert-butyl)-2,6-dimethyl-3,5-dinitrophenyl)ethan-1-one; 1-(tert-butyl)-2-methoxy-4-methyl-3,5-dinitrobenzene; 3-methylcyclopentadecan-1-one; (E)-3-methylcyclopentadec-4-en-1-one; 3-methyl-4-phenylbutan-2-ol; 1-(4-isopropylcyclohexyl)ethan-1-ol; (E)-dec-5-enoic acid; methyl non-2-ynoate; 2-methyldecanal; 6,6-dimethoxy-2,5,5-trimethylhex-2-ene; 4-phenylbutan-2-ol; methyl stearate; 1,1-dimethoxy-2-methylundecane; undecan-2-one; 2-methylundecanal; methyl tetradecanoate; methyl(9Z,12Z)-octadeca-9,12-dienoate; 1-hydroxydecan-3-one; (Z)-1,2-dimethoxy-4-(prop-1-en-1-yl)benzene; methyl palmitate; 4-allyl-1,2-dimethoxybenzene; methyl 2-((1R,2R)-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)acetate; methyl 2-(3-oxo-2-pentylcyclopentyl)acetate; 1-methyl-2-phenoxybenzene; methyl cinnamate; 1-allyl-4-methoxybenzene; 1-(naphthalen-2-yl)ethan-1-one; methyl oct-2-ynoate; methyl 2,6,6-trimethylcyclohex-2-ene-1-carboxylate; 7-methoxy-3,7-dimethyloctanal; 7-isopropyl-10-methyl-1,5-dioxaspiro[5.5]undecan-3-ol; octahydro-1H-4,7-methanoindene-1-carbaldehyde; 3-(3-(tert-butyl)phenyl)-2-methylpropanal; (E)-4-(4,8-dimethylnona-3,7-dien-1-yl)pyridine; (E)-trideca-3,12-dienenitrile; 2,2-dimethyl-3-(m-tolyl)propan-1-ol; 2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine; 8-isopropyl-6-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde; 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; (S)-1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; (Z)-3-hexen-1-yl-2-cyclopenten-1-one; 3,7-dimethylocta-1,6-dien-3-yl octanoate; 3,7-dimethylocta-1,6-dien-3-yl isobutyrate; 3,7-dimethylocta-1,6-dien-3-yl benzoate; 3,7-dimethylocta-1,6-dien-3-yl 2-aminobenzoate; 2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol; 6-methyl-2-(oxiran-2-yl)hept-5-en-2-ol; (2Z,6E)-3,7-dimethylnona-2,6-dienenitrile; 3-(4-methylcyclohex-3-en-1-yl)butanal; (2,5-dimethyl-1,3-dihydroinden-2-yl)methanol; 3-(4-(tert-butyl)phenyl)-2-methylpropanal; (E)-1-(1-methoxypropoxy)hex-3-ene; (E)-1-(1-ethoxyethoxy)hex-3-ene; (1S,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-ol; dodecan-1-ol; dodecyl acetate; dodecanoic acid; 5-hexyl-5-methyldihydrofuran-2(3H)-one; dodecanal; 3,6-dimethylhexahydrobenzofuran-2(3H)-one; 4-(1-ethoxyvinyl)-3,3,5,5-tetramethylcyclohexan-1-one; ((3S,3aR,6R,8aS)-7,7-dimethyl-8-methyleneoctahydro-1H-3a,6-methanoazulen-3-yl)methanol; 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane; (1-methyl-2-((1,2,2-trimethylbicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methanol; 2-propylheptanenitrile; (E)-6-(pent-3-en-1-yl)tetrahydro-2H-pyran-2-one; 2-hexylcyclopentan-1-one; 2-methyl-4-phenyl-1,3-dioxolane; 2,6,9,10-tetramethyl-1-oxaspiro(4.5)deca-3,6-diene; (1R,2S,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol; isopropyl palmitate; isopropyl tetradecanoate; isopropyl dodecanoate; 4,9-dimethoxy-7H-furo[3,2-g]chromen-7-one; (E)-cyclohexadec-8-en-1-one; (2S,5S)-2-isopropyl-5-methylcyclohexan-1-one; 2-hexylcyclopent-2-en-1-one; (2S,5S)-2-isopropyl-5-methylcyclohexan-1-one; 4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde; (Z)-1-(benzyloxy)-2-methoxy-4-(prop-1-en-1-yl)benzene; 1-((2S,3S)-2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethan-1-one; 2,5,6-trimethylcyclohex-3-ene-1-carbaldehyde; 6-(sec-butyl)quinoline; 2-(cyclohexyloxy)-1,7,7-trimethylbicyclo[2.2.1]heptane; (1R,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propionate; (1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl isobutyrate; 4-((2R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)cyclohexan-1-ol; (1R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 2-(4-isopropylcyclohexa-1,4-dien-1-yl)ethyl formate; isopentyl(E)-undec-6-enoate; isopentyl dodecanoate; (E)-oxacycloheptadec-10-en-2-one; (E)-non-2-enenitrile; (E)-8-(1H-indol-1-yl)-2,6-dimethyloct-7-en-2-ol; 8,8-di(1H-indol-1-yl)-2,6-dimethyloctan-2-ol; 4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine; 3,7-dimethyloctane-1,7-diol; 2-cyclododecylpropan-1-ol; 3-methyl-5-phenylpentanenitrile; 3-phenylpropan-1-ol; (1,1-dimethoxypropan-2-yl)benzene; 5-ethyl-4-hydroxy-2-methylfuran-3(2H)-one; 2,3-dihydro-3,3-dimethyl-1H-indene-5-propanal; 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal; hexyl octanoate; hexyl hexanoate; (Z)-2-benzylideneoctanal; hexyl benzoate; (Z)-hex-1-en-1-yl(Z)-2-methylbut-2-enoate; (E)-3,7-dimethylocta-2,6-dien-1-yl palmitate; oxacycloheptadecan-2-one; 2-butyl-4,4,6-trimethyl-1,3-dioxane; ethyl(1R,2R,3R,4R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl propionate; 5-(diethoxymethyl)benzo[d][1,3]dioxole; 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal; (E)-oxacyclohexadec-13-en-2-one; 6-butyl-2,4-dimethyl-3,6-dihydro-2H-pyran; 2-((3S,5R,8S)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl)propan-2-ol; 1-(2,6,6-trimethylcyclohex-2-en-1-yl)pentan-3-one; ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate; (1Z,5Z)-1,5-dimethyl-8-(propan-2-ylidene)cyclodeca-1,5-diene; (1E,6E)-8-isopropyl-1-methyl-5-methylenecyclodeca-1,6-diene; (E)-3,7-dimethylocta-2,6-dien-1-yl 2-phenylacetate; (E)-3,7-dimethylocta-2,6-dien-1-yl 2-phenylacetate; (6E,10E)-3,7,11,15-tetramethylhexadeca-1,6,10,14-tetraen-3-ol; (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)cyclopentan-1-one; 5-heptyldihydrofuran-2(3H)-one; 1-methyl-4-(propan-2-ylidene)cyclohexyl acetate; 1-methyl-4-(propan-2-ylidene)cyclohexan-1-ol; 5-pentyldihydrofuran-2(3H)-one; (1R,4aR,8aS)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 5-[(Z)-hex-3-enyl]oxolan-2-one; (Z)-4-(2,2-dimethyl-6-methylenecyclohexyl)but-3-en-2-one; (4aS,9aR)-3,5,5,9-tetramethyl-2,4a,5,6,7,9a-hexahydro-1H-benzo[7]annulene; (1R,3aR,4R,7R)-1,4-dimethyl-7-(prop-1-en-2-yl)-1,2,3,3a,4,5,6,7-octahydroazulene; 2-((2R,4aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol; 5-octyldihydrofuran-2(3H)-one; (Z)-1-(2,2-dimethyl-6-methylenecyclohexyl)but-2-en-1-one; 5-hexyldihydrofuran-2(3H)-one; (1R,4aS,8aS)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one; 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene; furan-2-ylmethyl octanoate; furan-2-ylmethyl hexanoate; furan-2-ylmethyl heptanoate; 2-methyldecanenitrile; 8,8-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; ethyl(3aR,4S,7R,7aR)-octahydro-3aH-4,7-methanoindene-3a-carboxylate; diethyl cyclohexane-1,4-dicarboxylate; (6-isopropyl-9-methyl-1,4-dioxaspiro[4.5]decan-2-yl)methanol; 2-isobutyl-4-methyltetrahydro-2H-pyran-4-ol; undec-10-enenitrile; (Z)-6-ethylideneoctahydro-2H-5,8-methanochromen-2-one; 3-(2-ethylphenyl)-2,2-dimethylpropanal; (E)-4,8-dimethyldeca-4,9-dienal; (E)-4-((3aR,4R,7R,7aR)-1,3a,4,6,7,7a-hexahydro-5H-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 8,8-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 2-heptylcyclopentan-1-one; 1-ethoxyethoxy Cyclododecane; 3-cyclohexene-1-carboxylic acid, 2,6,6-trimethyl-, methyl ester; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; oxacyclohexadecan-2-one; (E)-cyclopentadec-4-en-1-one; 1-cyclopentadec-4-en-1-one; 2-methoxy-4-(4-methylenetetrahydro-2H-pyran-2-yl)phenol; 4-allyl-2-methoxyphenyl acetate; 4-allyl-2-methoxyphenol; ethyl 3-methyl-3-phenyloxirane-2-carboxylate; 1,4-dioxacycloheptadecane-5,17-dione; ethyl undec-10-enoate; ethyl palmitate; ethyl nonanoate; ethyl tetradecanoate; (E)-3,7-dimethylnona-1,6-dien-3-ol; ethyl dodecanoate; nonan-3-one; ethyl decanoate; ethyl 6,6-dimethyl-2-methylenecyclohex-3-ene-1-carboxylate; ethyl 3-phenyloxirane-2-carboxylate; 6-ethyl-2,10,10-trimethyl-1-oxaspiro[4.5]deca-3,6-diene; 2-((1R,3S,4S)-4-methyl-3-(prop-1-en-2-yl)-4-vinylcyclohexyl)propan-2-ol; (2-(1-ethoxyethoxy)ethyl)benzene; (E)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol; (2R,3S,4R)-2,3,4,5-tetrahydroxypentanal; (E)-4-((3aS,7aS)-octahydro-5H-4,7-methanoinden-5-ylidene)butanal; 1,1-dimethoxydodecane; (R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; 2-(2-hydroxypropoxy)propan-1-ol; 7,9-dimethylspiro[5.5]undecan-3-one; oxydibenzene; diphenylmethane; 2-methyl-1-phenylpropan-2-yl butyrate; 2,6-dimethyloct-7-en-4-one; octahydro-1H-4,7-methanoinden-5-yl acetate; 2-methyl-5-(prop-1-en-2-yl)cyclohexyl acetate; 2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-ol; 3,7-dimethyloct-6-en-3-ol; methyl 2-hexyl-3-oxocyclopentane-1-carboxylate; dibutylsulfane; 1,2-diphenylethane; 6-hexyltetrahydro-2H-pyran-2-one; (3R,4R)-1-isopropyl-4-methyl-3-(prop-1-en-2-yl)-4-vinylcyclohex-1-ene; (3S,3aS,5R)-3,8-dimethyl-5-(prop-1-en-2-yl)-1,2,3,3a,4,5,6,7-octahydroazulene; 6-heptyltetrahydro-2H-pyran-2-one; 6-pentyltetrahydro-2H-pyran-2-one; (1S,8aR)-4,7-dimethyl-1-(propan-2-yl)-1,2,3,5,6,8a-hexahydronaphthalene; (Z)-1-((1R,2S)-2,6,6-trimethylcyclohex-3-en-1-yl)but-2-en-1-one; (1S,8aS)-1-isopropyl-4,7-dimethyl-1,2,3,5,6,8a-hexahydronaphthalene; 3,7,7-trimethylbicyclo[4.1.0]hept-3-ene; dec-9-en-1-ol; decyl propionate; 1,1-diethoxydecane; decahydronaphthalen-2-ol; 1-cyclohexylethyl(E)-but-2-enoate; 3-(4-isopropylphenyl)-2-methylpropanal; cyclotetradecane; cyclopentadecanone; cyclohexyl 2-hydroxybenzoate; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl butyrate; 1,4-dioxacyclohexadecane-5,16-dione; 8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carbaldehyde; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl isobutyrate; (5R,6R)-3,6-dimethyl-5-(prop-1-en-2-yl)-6-vinyl-4,5,6,7-tetrahydrobenzofuran; (4-isopropylphenyl)methanol; 1-(benzofuran-2-yl)ethan-1-one; 2-(3-phenylpropyl)pyridine; dodecanenitrile; (E)-cycloheptadec-9-en-1-one; 3-(4-methylcyclohex-3-en-1-yl)but-3-en-1-yl acetate; 3-(4-methylcyclohex-3-en-1-yl)butan-1-ol; (E)-3-methyl-5-phenylpent-2-enenitrile; (E)-2-(2,6-dimethylhepta-1,5-dien-1-yl)-4-methyl-1,3-dioxolane; (E)-1,1-dimethoxy-3,7-dimethylocta-2,6-diene; (E)-1,1-diethoxy-3,7-dimethylocta-2,6-diene; (E)-3,7-dimethylocta-1,3,6-triene; (1R,4R,6S)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane; (E)-oxacycloheptadec-11-en-2-one; (Z)-non-6-en-1-ol; (1R,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-ol; (Z)-dec-4-enal; (E)-hex-3-en-1-yl(E)-hex-3-enoate; (Z)-hex-3-en-1-yl 2-hydroxybenzoate; (Z)-hex-3-en-1-yl benzoate; (Z)-hex-3-en-1-yl 2-methylbutanoate; (3Z,6Z)-nona-3,6-dien-1-ol; cinnamyl propionate; cinnamyl isobutyrate; cinnamyl formate; cinnamyl cinnamate; cinnamyl acetate; (E)-3-phenylprop-2-en-1-ol; hexadecan-1-ol; (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one; 2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butanal; (3aR,5aR,9aR,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; 1,6-dioxacycloheptadecan-7-one; 1-(6-(tert-butyl)-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethan-1-one; (3R,3aR,6S,7S,8aS)-6-methoxy-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulene; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-3-yl formate; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-6-yl acetate; (4Z,8Z)-1,5,9-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-6-ol; 5-methyl-1-(2,2,3-trimethylcyclopent-3-en-1-yl)-6-oxabicyclo[3.2.1]octane; 5-methyl-1-(2,2,3-trimethylcyclopent-3-en-1-yl)-6-oxabicyclo[3.2.1]octane; 1,1,2,3,3-pentamethyl-1,2,3,5,6,7-hexahydro-4H-inden-4-one; (Z)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-3-en-5-yl acetate; (1S,2S,5R,8S)-4,4,8-trimethyltricyclo[6.3.1.02,5]dodecan-1-ol; 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl acetate; octanenitrile; octan-1-ol; octanoic acid; decanoic acid; decanal; 3-(4-methoxyphenyl)-2-methylpropanal; 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione; 2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane; ethyl 2-methyl-4-oxo-6-pentylcyclohex-2-ene-1-carboxylate; 2,6-di-tert-butyl-4-methylphenol; butyl stearate; 1-butoxy-1-oxopropan-2-yl butyrate; butyl undec-10-enoate; 2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)butan-1-ol; 3-(4-(tert-butyl)phenyl)propanal; (1S,2S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl isobutyrate; 1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 2-ethoxy-2,6,6-trimethyl-9-methylenebicyclo[3.3.1]nonane; (ethoxymethoxy)cyclododecane; (E)-1-methyl-4-(6-methylhept-5-en-2-ylidene)cyclohex-1-ene; 3,3,6,7-tetramethyloctahydro-2H-chromene; (5R,10R)-6,10-dimethyl-2-(propan-2-ylidene)spiro[4.5]dec-6-en-8-one; 1-methyl-4-(prop-1-en-2-yl)cyclohexyl acetate; 1-methyl-4-(prop-1-en-2-yl)cyclohexan-1-ol; (2Z,6E)-2,6-dimethyl-10-methylenedodeca-2,6,11-trienal; (R)-3-methylene-6-((S)-6-methylhept-5-en-2-yl)cyclohex-1-ene; (4aR,7R,8aS)-4a-methyl-1-methylene-7-(prop-1-en-2-yl)decahydronaphthalene; (Z)-2-methyl-5-((1S,2R,4R)-2-methyl-3-methylenebicyclo[2.2.1]heptan-2-yl)pent-2-en-1-ol; 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane; 2-ethoxynaphthalene; (1S,4R,7R)-1,4,9,9-tetramethyl-1,2,3,4,5,6,7,8-octahydro-4,7-methanoazulene; (1aS,5aR,9aR)-1a,5,5,7-tetramethyl-1a,2,3,4,5,5a,8,9-octahydrobenzo[1,7]cyclohepta[1,2-b]oxirene; (R)-3,5,5,9-tetramethyl-2,4a,5,6,7,8-hexahydro-1H-benzo[7]annulene; (1S,4S)-1,4-dimethyl-7-(propan-2-ylidene)-1,2,3,4,5,6,7,8-octahydroazulene; (2,2-dimethoxyethyl)benzene; (E)-7,11-dimethyl-3-methylenedodeca-1,6,10-triene; (1R,2S,6S,7S,8S)-8-isopropyl-1-methyl-3-methylenetricyclo[4.4.0.02,7]decane; (3R,3aS,7S,8aS)-3,8,8-trimethyl-6-methyleneoctahydro-1H-3a,7-methanoazulene; (1R,9S,Z)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene; (S)-4-methyl-1-((S)-6-methylhept-5-en-2-yl)cyclohex-3-en-1-ol; (Z)-4-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl)but-3-en-2-one; 4-methoxy-7H-furo[3,2-g]chromen-7-one; 2-methyl-4-phenylbutan-2-ol; benzyl dodecanoate; 2-methyl-1-phenylpropan-2-ol; benzyl cinnamate; benzyl benzoate; benzophenone; 7-isopentyl-2H-benzo[b][1,4]dioxepin-3(4H)-one; 2′ -isopropyl-1,7,7-trimethylspiro[bicyclo[2.2.1]heptane-2,4′-[1,3]dioxane]/A; 4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbonitrile; methyl(E)-2-((7-hydroxy-3,7-dimethyloctylidene)amino)benzoate; 4-methoxybenzyl 2-phenylacetate; methyl(E)-octa-4,7-dienoate; pentyl(Z)-3-phenylacrylate; (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; (4aR,5R,7aS,9R)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole; 2,5,5-trimethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-ol; 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol; 1-((2-(tert-butyl)cyclohexyl)oxy)butan-2-ol; (3S,5aR,7aS,11aS,11bR)-3,8,8,11a-tetramethyldodecahydro-5H-3,5a-epoxynaphtho[2,1-c]oxepine; 2,2,6,6,7,8,8-heptamethyldecahydro-2H-indeno[4,5-b]furan; 2,2,7,7,8,9,9-heptamethyldecahydroindeno[4,3a-b]furan; 2-(sec-butyl)-1-vinylcyclohexyl acetate; (1S,4R,5R)-1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one; (4R,4aS)-4,4a-dimethyl-6-(propan-2-ylidene)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one; 2-(4-methylcyclohex-3-en-1-yl)propan-2-yl propionate; (2Z,6E,9E)-2,6,10-trimethyldodeca-2,6,9,11-tetraenal; (2R,4aR,8aR)-4a,8-dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 1,7-dimethyl-7-(4-methylpent-3-en-1-yl)tricyclo[2.2.1.02,6]heptane; (E)-5-(2,3-dimethyltricyclo[2.2.1.02,6]heptan-3-yl)-2-methylpent-2-en-1-ol; (1R,3aS,7S,8aR)-1,4,9,9-tetramethyl-2,3,6,7,8,8a-hexahydro-1H-3a,7-methanoazulene; 1-(5,5-dimethylcyclohex-1-en-1-yl)pent-4-en-1-one; (1S,4aS,8aR)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; (R,Z)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)pent-1-en-3-one; 1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; (Z)-4-(2,5,6,6-tetramethylcyclohex-2-en-1-yl)but-3-en-2-one; (1Z,4E,8Z)-2,6,6,9-tetramethylcycloundeca-1,4,8-triene; (4aR,8S,9aS)-3,5,5,8-tetramethyl-9-methylene-2,4a,5,6,7,8,9,9a-octahydro-1H-benzo[7]annulene; (1aR,4R,4aR,7bS)-1,1,4,7-tetramethyl-1a,2,3,4,4a,5,6,7b-octahydro-1H-cyclopropa[e]azulene; 1,4-dimethyl-7-(prop-1-en-2-yl)-1,2,3,4,5,6,7,8-octahydroazulene; (3E,6E)-3,7,11-trimethyldodeca-1,3,6,10-tetraene; 7,7-dimethyl-2-methylenebicyclo[2.2.1]heptane; 2-((2R,4aR,8aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl)propan-2-ol; (R)-1-methyl-4-(6-methylhept-5-en-2-yl)benzene; (3aR,3bR,4S,7R,7aS)-4-isopropyl-7-methyl-3a,3b,4,5,6,7-hexahydro-1H-cyclopenta[1,3]cyclopropa[1,2]benzene; (1aS,2aR,3R,5aS,7R,7aR)-3,6,6,7a-tetramethyloctahydro-2H-2a,7-methanoazuleno[5,6-b]oxirene; (1R,4S,4aR,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; (1S,4aR,8aR)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; (R)-2-((R)-4-methylcyclohex-3-en-1-yl)hex-5-en-2-ol; (Z)-1-methyl-4-(6-methylhepta-2,5-dien-2-yl)cyclohex-1-ene; 2,6-dimethyl-6-(4-methylpent-3-en-1-yl)bicyclo[3.1.1]hept-2-ene; (E)-2-benzylideneheptan-1-ol; (E)-2-benzylideneheptyl acetate; (Z)-(2-(diethoxymethyl)hept-1-en-1-yl)benzene; (E)-2-benzylideneheptanal; (1S,4aR,8aS)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; (3R,5aS,9aR)-2,2,5a,9-tetramethyl-3,4,5,5a,6,7-hexahydro-2H-3,9a-methanobenzo[b]oxepine; 1-methyl-4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde; 1-phenylpentan-2-ol; 3-methyl-1-phenylpentan-3-ol; 2,3,4-trimethoxybenzaldehyde; 2,4,5-trimethoxybenzaldehyde; 2,4,6-trimethoxybenzaldehyde; Trans,Trans-2,4-Nonadienal; 2,6,10-trimethylundecanal; alpha-4-Dimethyl benzenepropanal; allyl 3-cyclohexylpropanoate; allyl 2-(isopentyloxy)acetate; (1aR,4aS,7R,7aR,7bS)-1,1,7-trimethyl-4-methylenedecahydro-1H-cyclopropa[e]azulene; (E)-undec-9-enal; methyl(E)-2-(((3,5-dimethylcyclohex-3-en-1-yl)methylene)amino)benzoate; 2,6,10-trimethylundec-9-enal; (7,7,8,8-tetramethyloctahydro-2,3b-methanocyclopenta[1,3]cyclopropa[1,2]benzen-4-yl)methyl acetate; nonyl acetate; (2-(1-propoxyethoxy)ethyl)benzene; 1-(1-propoxyethoxy)propane; ((1-(2-methoxyethoxy)ethoxy)methyl)benzene; (Z)-2-(4-methylbenzylidene)heptanal; dec-9-enal; (Z)-oxacycloheptadec-8-en-2-one; 7-methoxy-2H-chromen-2-one; (2S,4aR,8aR)-4a,8-dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 2-((2S,4aR,8aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl)propan-2-ol; 1-(3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one; 6-isopropylquinoline; 3-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)propanal; 6,10,14-trimethylpentadecan-2-one; 2-methyl-5-(prop-1-en-2-yl)-2-vinyltetrahydrofuran; (E)-cyclohexadec-5-en-1-one; 1-isopropyl-4-methylcyclohex-3-en-1-ol; 1-phenylpent-4-en-1-one; 1-isopropyl-4-methylcyclohex-3-en-1-ol; 3,6-dimethyl-4,5,6,7-tetrahydrobenzofuran; 4-(4-methoxyphenyl)butan-2-one; (1aR,2S,4aS)-2,4a,8,8-tetramethyloctahydrocyclopropa[d]naphthalen-3(1H)-one; (E)-3-propylideneisobenzofuran-1(3H)-one; (Z)-dodec-2-enal; 3-methyl-5-phenylpentanal; (E)-hex-3-en-1-yl 3-methylbutanoate; 3,6-dimethyloctan-3-yl acetate; 3,4,5-trimethoxybenzaldehyde; 3-(4-isopropylphenyl)propanal; (Z)-undec-2-enenitrile; (E)-undec-2-enal; (2E,6E)-nona-2,6-dienal; phenethyl butyrate; (Z)-3-(furan-2-yl)-2-phenylacrylaldehyde; 2-phenoxyethan-1-ol; (Z)-non-2-enal; nonan-2-ol; nonan-2-one; 2-isobutylquinoline; (E)-2-hexylidenecyclopentan-1-one; 2-heptyltetrahydrofuran; (E)-dec-2-enal; (2E,6E)-nona-2,6-dienal; (2E,6E)-nona-2,6-dien-1-ol; 2,6-dimethyloctanal; decan-1-ol; (E)-hept-1-en-1-yl acetate; undec-10-en-1-ol; undec-10-enal; 2-((2R,4aS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol; 1-isopropyl-4-methyl-7-thiabicyclo[2.2.1]heptane; (3E,5Z)-undeca-1,3,5-triene; 3,7-dimethyloct-6-en-3-ol; 1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 1,1,2,3,3-pentamethyl-2,3-dihydro-1H-indene; (Z)-6,10-dimethylundeca-5,9-dien-2-yl acetate; (Z)-dodec-3-enal; (S)-5-heptyldihydrofuran-2(3H)-one; (R)-5-heptyldihydrofuran-2(3H)-one; (E)-6,10-dimethylundeca-5,9-dien-2-yl acetate; (Z)-3-methyl-5-phenylpent-2-enenitrile; (2S,5S,6S)-2,6,10,10-tetramethyl-1-oxaspiro[4.5]decan-6-ol; (2E)-3-methyl-5-phenyl-2-pentenenitrile; (1S,2S,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-ol; (2S,5R)-2-isopropyl-5-methylcyclohexan-1-one; (R,E)-2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 2-(8-isopropyl-6-methylbicyclo[2.2.2]oct-5-en-2-yl)-1,3-dioxolane; (E)-4-(2,2-dimethyl-6-methylenecyclohexyl)-3-methylbut-3-en-2-one; 3-(3-isopropylphenyl)butanal; 3-(1-ethoxyethoxy)-3,7-dimethylocta-1,6-diene; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; 2-((3S,3aS,5R)-3,8-dimethyl-1,2,3,3a,4,5,6,7-octahydroazulen-5-yl)propan-2-ol; benzyl 2-phenylacetate; 2-hydroxy-1,2-diphenylethan-1-one; (E)-1,2,4-trimethoxy-5-(prop-1-en-1-yl)benzene; 3-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-2,2-dimethylpropanal; 2-methyl-5-(6-methylhept-5-en-2-yl)bicyclo[3.1.0]hex-2-ene; 1-(1,1,2,3,3,6-hexamethyl-2,3-dihydro-1H-inden-5-yl)ethan-1-one; 2-(m-tolyl)ethan-1-ol; (3E,6E)-nona-3,6-dien-1-ol; (E)-tridec-2-enal; (1R,4S,4aS,6R,8aS)-4,8a,9,9-tetramethyloctahydro-1,6-methanonaphthalen-1(2H)-ol; p-tolyl isobutyrate; p-tolyl hexanoate; 5-hexyl-4-methyldihydrofuran-2(3H)-one; ethyl(2Z,4E)-deca-2,4-dienoate; 2,4-dimethyl-6-phenyl-3,6-dihydro-2H-pyran; 2-cyclohexylidene-2-phenylacetonitrile; 4-(prop-1-en-2-yl)cyclohex-1-ene-1-carbaldehyde; (4-(prop-1-en-2-yl)cyclohex-1-en-1-yl)methyl acetate; (4-(prop-1-en-2-yl)cyclohex-1-en-1-yl)methanol; (2-isopropoxyethyl)benzene; 2-cyclohexylhepta-1,6-dien-3-one; (2-(cyclohexyloxy)ethyl)benzene; phenethyl 2-methylbutanoate; 2-phenylethan-1-ol; phenethyl 2-phenylacetate; 3-methyl-5-phenylpentan-1-ol; phenyl benzoate; phenethyl benzoate; 2-benzyl-1,3-dioxolane; 2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)acetaldehyde; 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-ol; 4-(benzo[d][1,3]dioxol-5-yl)butan-2-one; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl pivalate; (4aR,8aS)-7-methyloctahydro-1,4-methanonaphthalen-6(2H)-one; 4-isopropyl-1-methylcyclohex-3-en-1-ol; (E)-3,3-dimethyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol; 1-methyl-4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde; propane-1,2-diol; p-tolyl 2-phenylacetate; Ethyl 2,4,7-decatrienoate; 2-benzyl-4,4,6-trimethyl-1,3-dioxane; 2,4-dimethyl-4-phenyltetrahydrofuran; (2R,4a′R,8a′R)-3,7′-dimethyl-3′,4′,4a′,5′,8′,8a′-hexahydro-1′H-spiro[oxirane-2,2′-[1,4]methanonaphthalene]; (Z)-6-ethylideneoctahydro-2H-5,8-methanochromene; 2-((S)-1-((S)-3,3-dimethylcyclohexyl)ethoxy)-2-oxoethyl propionate; methyl 2,2-dimethyl-6-methylenecyclohexane-1-carboxylate; 2-methyl-5-phenylpentan-1-ol; 4-methyl-2-phenyl-3,6-dihydro-2H-pyran; (1S,3R,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexan-3-ol; 5-allylbenzo[d][1,3]dioxole; 2,2,7,9-tetramethylspiro(5.5)undec-8-en-1-one; 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol; (Z)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; (E)-2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 5-methoxyoctahydro-1H-4,7-methanoindene-2-carbaldehyde; 5-methoxyoctahydro-1H-4,7-methanoindene-2-carbaldehyde; 1-(3-hydroxy-3-methylpent-4-en-1-yl)-2,5,5,8a-tetramethyldecahydronaphthalen-2-ol; (4aR,6aS,10aS,10bR)-3,4a,7,7,10a-pentamethyl-4a,5,6,6a,7,8,9,10,10a,10b-decahydro-1H-benzo[f]chromene; (4aR,8aR)-4a,8-dimethyl-2-(propan-2-ylidene)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl cyclopropanecarboxylate; 3-(4-isobutylphenyl)-2-methylpropanal; (1aR,4aR,7S,7aR,7bR)-1,1,7-trimethyl-4-methylenedecahydro-1H-cyclopropa[e]azulen-7-ol; (1R,3R,6R)-2′,2′,3,7,7-pentamethylspiro[bicyclo[4.1.0]heptane-2,5′-[1,3]dioxane]; 2-methyl-1,5-dioxaspiro[5.5]undecane; 1-(spiro[4.5]dec-7-en-7-yl)pent-4-en-1-one; 2-(4-methylthiazol-5-yl)ethan-1-ol; 2-(heptan-3-yl)-1,3-dioxolane; (Z)-dodec-4-enal; (1S,4S,4aR,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; (1S,4S,4aR,8aS)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; 3-methyl-2-pentylcyclopentan-1-one; 2,6,10,10-tetramethyl-1-oxaspiro[4.5]dec-6-ene; 2-(2-mercaptopropan-2-yl)-5-methylcyclohexan-1-one; (1aR,4aS)-2,4a,8,8-tetramethyl-1,1a,4,4a,5,6,7,8-octahydrocyclopropa[d]naphthalene; 1-isopropyl-2-methoxy-4-methylbenzene; 1-(2,2,6-trimethylcyclohexyl)hexan-3-ol; (2Z,4E)-nona-2,4-dienal; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; (2E,6Z)-nona-2,6-dienal; (Z)-dec-2-enal; (E)-non-2-enal; (3E,6Z)-nona-3,6-dien-1-ol; (E)-dec-4-enal; (Z)-oxacycloheptadec-8-en-2-one; (Z)-3,7-dimethylocta-1,3,6-triene; (Z)-3,7-dimethylocta-1,3,6-triene; (E)-3,7-dimethylocta-2,6-dien-1-ol; methyl 2-((1S,2S)-3-oxo-2-pentylcyclopentyl)acetate; 7-(1,1-Dimethylethyl)-2H-1,5-benzodioxepin-3(4H)-one; (1R-(1alpha,3alpha,4aalpha))-2,3,4,4a,5,6-hexahydro-2,2-dimethyl-1,3-methanonaphthalen-7(1H)-one; tridecan-1-ol; triethyl 2-hydroxypropane-1,2,3-tricarboxylate; methyl 2-((1-hydroxy-3-phenylbutyl)amino)benzoate; 1-((2E,5Z,9Z)-2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethan-1-one; decahydro-2,6,6,7,8,8-hexamethyl-2h-indeno(4,5-b)furan; 13-methyl oxacyclopentadec-10-en-2-one; undecanal; (E)-4-methyldec-3-en-5-ol; (3R,4aS,5R)-4a,5-dimethyl-3-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene; 2-((2R,8R,8aS)-8,8a-dimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)propan-2-ol; 4-formyl-2-methoxyphenyl isobutyrate; (Z)-2-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-enal; methyl 2,4-dihydroxy-3,6-dimethylbenzoate; 1-methoxy-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoindene; methyl(Z)-2-((3-(4-(tert-butyl)phenyl)-2-methylpropylidene)amino)benzoate; (Z)-hex-3-en-1-yl isobutyrate; 2,4,6-trimethyl-4-phenyl-1,3-dioxane; 1-((3R,3aR,7R,8aS)-3,6,8,8-tetramethyl-2,3,4,7,8,8a-hexahydro-1H-3a,7-methanoazulen-5-yl)ethan-1-one; methyl(Z)-2-(((2,4-dimethylcyclohex-3-en-1-yl)methylene)amino)benzoate; 4,8-dimethyl-2-(propan-2-ylidene)-1,2,3,3a,4,5,6,8a-octahydroazulen-6-ol; 4,8-dimethyl-2-(propan-2-ylidene)-1,2,3,3a,4,5,6,8a-octahydroazulen-6-yl acetate; decahydro-3H-spiro[furan-2,5′-[4,7]methanoindene]; (2Z,6E)-nona-2,6-dienenitrile; (Z)-cyclooct-4-en-1-yl methyl carbonate; (1aR,4S,4aS,7R,7aS,7bS)-1,1,4,7-tetramethyldecahydro-1H-cyclopropa[e]azulen-4-ol; 3,5,5,6,7,8,8-heptamethyl-5,6,7,8-tetrahydronaphthalene-2-carbonitrile; (1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1′-cyclohexan]-2′-en-4′-one; 1′,1′,5′,5′-tetramethylhexahydro-2′H,5′H-spiro[[1,3]dioxolane-2,8′-[2,4a]methanonaphthalene]; (2′S,4a′S,8a′S)-1′,1′,5′,5′-tetramethylhexahydro-2′H,5′H-spiro[[1,3]dioxolane-2,8′-[2,4a]methanonaphthalene]; 4-(4-hydroxy-3-methoxyphenyl)butan-2-one; (1R,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,7,8,8a-hexahydronaphthalene; 2,4-dimethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolane; 3a,5,6,7,8,8b-hexahydro-2,2,6,6,7,8,8-heptamethyl-4H-indeno(4,5-d)-1,3-dioxole; 2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine; (1-methyl-2-((1,2,2-trimethylbicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methanol; 2-(cyclohexyloxy)-1,7,7-trimethylbicyclo[2.2.1]heptane; 4-((2R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)cyclohexan-1-ol; 8,8-di(1H-indol-1-yl)-2,6-dimethyloctan-2-ol; (7,7,8,8-tetramethyloctahydro-2,3b-methanocyclopenta[1,3]cyclopropa[1,2]benzen-4-yl)methanol; 8,8-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; (E)-4-((3aR,4R,7R,7aR)-1,3a,4,6,7,7a-hexahydro-5H-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; (3R,3aR,6S,7S,8aS)-6-methoxy-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulene; (1R,2S,6S,7S,8S)-8-isopropyl-1-methyl-3-methylenetricyclo[4.4.0.02,7]decane; 2′-isopropyl-1,7,7-trimethylspiro[bicyclo[2.2.1]heptane-2,4′-[1,3]dioxane]; (4aR,5R,7aS,9R)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole; (3S,5aR,7aS,11aS,11bR)-3,8,8,11a-tetramethyldodecahydro-5H-3,5a-epoxynaphtho[2,1-c]oxepine; 2,2,6,6,7,8,8-heptamethyldecahydro-2H-indeno[4,5-b]furan; (1aS,2aR,3R,5aS,7R,7aR)-3,6,6,7a-tetramethyloctahydro-2H-2a,7-methanoazuleno[5,6-b]oxirene; (7,7,8,8-tetramethyloctahydro-2,3b-methanocyclopenta[1,3]cyclopropa[1,2]benzen-4-yl)methyl acetate; 1-(3-hydroxy-3-methylpent-4-en-1-yl)-2,5,5,8a-tetramethyldecahydronaphthalen-2-ol; decahydro-2,6,6,7,8,8-hexamethyl-2h-indeno(4,5-b)furan; 2-ethylhexyl(Z)-3-(4-methoxyphenyl)acrylate; methoxycyclododecane; 1-ethoxy-4-(tert-pentyl)cyclohexane; (2-hydroxy-4-methoxyphenyl)(phenyl)methanone; (3Z)-1-(2-buten-1-yloxy)-3-hexene; 4-(2-methoxypropan-2-yl)-1-methylcyclohex-1-ene; 4-(tert-pentyl)cyclohexan-1-one; 3-methoxy-3,7-dimethylocta-1,6-diene; 7-isopropyl-8,8-dimethyl-6,10-dioxaspiro[4.5]decane; (E)-3-(2-methoxyphenyl)acrylaldehyde; 3,7-dimethyloctanal; 1,1-dimethoxyoctane; 2-methyl-6-methyleneoct-7-en-2-ol; 4-methoxy-6-prop-2-enyl-1,3-benzodioxole; tetradecanenitrile; (E)-2,7-dimethylocta-1,5,7-trien-3-ol; 3,3-Dimethyl-5(2,2,3-Trimethyl-3-Cyclopenten-1yl)-4-Penten-2-ol; hexyl 2-hydroxybenzoate; hexyl(Z)-but-2-enoate; (Z)-3,7-dimethylocta-2,6-dien-1-yl formate; (Z)-3,7-dimethylocta-2,6-dien-1-ol; 1-ethyl-3-methoxytricyclo[2.2.1.02,6]heptane; 10-isopropyl-2,7-dimethyl-1-oxaspiro[4.5]deca-3,6-diene; 6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde; (E)-4-(2,2,3,6-tetramethylcyclohexyl)but-3-en-2-one; (Z)-1-(2,6,6-trimethylcyclohex-1-en-1-yl)pent-1-en-3-one; (E)-2,2-dimethyl-3-(3-methylpenta-2,4-dien-1-yl)oxirane; 3-methylcyclopentadecan-1-one; (E)-3,7-dimethylocta-4,6-dien-3-ol; 3-methyl-4-phenylbutan-2-ol; 1-(4-isopropylcyclohexyl)ethan-1-ol; (Z)-hex-3-en-1-yl cyclopropanecarboxylate; (E)-dec-5-enoic acid; 1-phenylethyl propionate; methyl 2-phenylacetate; 4-phenylbutan-2-ol; methyl stearate; methyl(9Z,12Z)-octadeca-9,12-dienoate; 1-hydroxydecan-3-one; 2-methyl-6-oxaspiro[4.5]decan-7-one; (Z)-1,2-dimethoxy-4-(prop-1-en-1-yl)benzene; methyl palmitate; 4-allyl-1,2-dimethoxybenzene; methyl(Z)-3,7-dimethylocta-2,6-dienoate; 1-methyl-2-phenoxybenzene; 2-ethoxy-4-(methoxymethyl)phenol; methyl 2-cyclopentylideneacetate; 1-allyl-4-methoxybenzene; 6-methoxy-2,6-dimethylheptanal; 7-methoxy-3,7-dimethyloctanal; ((1s,4s)-4-isopropylcyclohexyl)methanol; 3-(3-(tert-butyl)phenyl)-2-methylpropanal; (E)-4-(4,8-dimethylnona-3,7-dien-1-yl)pyridine; (E)-trideca-3,12-dienenitrile; 2,2-dimethyl-3-(m-tolyl)propan-1-ol; 8-isopropyl-6-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde; 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; (Z)-3-hexen-1-yl-2-cyclopenten-1-one; 3,7-dimethylocta-1,6-dien-3-yl propionate; 3,7-dimethylocta-1,6-dien-3-yl octanoate; 3,7-dimethylocta-1,6-dien-3-yl formate; 3,7-dimethylocta-1,6-dien-3-yl butyrate; 3,7-dimethylocta-1,6-dien-3-yl benzoate; 3,7-dimethylocta-1,6-dien-3-yl 2-aminobenzoate; 3,7-dimethylocta-1,6-dien-3-yl acetate; 3,7-dimethylocta-1,6-dien-3-ol; 3-(4-methylcyclohex-3-en-1-yl)butanal; 3-(4-(tert-butyl)phenyl)-2-methylpropanal; (Z)-hex-3-en-1-yl methyl carbonate; 4-methylquinoline; (E)-1-(1-methoxypropoxy)hex-3-ene; 2-Methyl-5-(1-methylethenyl)-2-cyclohexenone; dodecanal; 2,2-dimethyl-5-phenylhexanenitrile; (E)-6-(pent-3-en-1-yl)tetrahydro-2H-pyran-2-one; 2-hexylcyclopentan-1-one; (Z)-4-(6,6-dimethylcyclohex-2-en-1-yl)-3-methylbut-3-en-2-one; 2,6,9,10-tetramethyl-1-oxaspiro(4.5)deca-3,6-diene; 4-methylpent-1-en-3-ol; isopropyl palmitate; isopropyl dodecanoate; isopropyl 2-methylbutanoate; 4-methylpent-4-en-2-yl isobutyrate; 7-methyloctyl acetate; 7-methyloctan-1-ol; 4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde; (Z)-2-methoxy-4-(prop-1-en-1-yl)phenyl acetate; (Z)-2-methoxy-4-(prop-1-en-1-yl)phenol; (1R,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propionate; (1R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; 2-(4-isopropylcyclohexa-1,4-dien-1-yl)ethyl formate; isopentyl(E)-undec-6-enoate; isopentyl octanoate; isopentyl dodecanoate; isopentyl isobutyrate; (E)-oxacycloheptadec-10-en-2-one; 8,8-di(1H-indol-1-yl)-2,6-dimethyloctan-2-ol; 2-cyclododecylpropan-1-ol; 3-phenylpropan-1-ol; 3-phenylpropanoic acid; (1,1-dimethoxypropan-2-yl)benzene; 2-phenylpropan-1-ol; hexyl propionate; hexyl butyrate; hexyl 2-methylbutanoate; hexyl furan-2-carboxylate; oxacycloheptadecan-2-one; heptan-1-ol; heptyl acetate; heptanal; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl propionate; 5-(diethoxymethyl)benzo[d][1,3]dioxole; benzo[d][1,3]dioxole-5-carbaldehyde; 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal; (E)-oxacyclohexadec-13-en-2-one; 6-butyl-2,4-dimethyl-3,6-dihydro-2H-pyran; 2-((3S,5R,8S)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl)propan-2-ol; 1-(2,6,6-trimethylcyclohex-2-en-1-yl)pentan-3-one; (1Z,5Z)-1,5-dimethyl-8-(propan-2-ylidene)cyclodeca-1,5-diene; (E)-3,7-dimethylocta-2,6-dien-1-yl 2-phenylacetate; (E)-3,7-dimethylocta-2,6-dien-1-yl 2-phenylacetate; (Z)-3,7-dimethylocta-2,6-dienenitrile; (E)-3,7-dimethylocta-2,6-dien-1-yl formate; (E)-3,7-dimethylocta-2,6-dien-1-yl octanoate; (E)-3,7-dimethylocta-2,6-dien-1-yl benzoate; (E)-3,7-dimethylocta-2,6-dienal; N,2-dimethyl-N-phenylbutanamide; 1-isopropyl-4-methylcyclohexa-1,4-diene; (1R,4aR,8aS)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 5-[(Z)-hex-3-enyl]oxolan-2-one; (4aS,9aR)-3,5,5,9-tetramethyl-2,4a,5,6,7,9a-hexahydro-1H-benzo[7]annulene; (Z)-1-(2,2-dimethyl-6-methylenecyclohexyl)but-2-en-1-one; (1R,4aS,8aS)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one; furan-2-ylmethyl octanoate; furan-2-ylmethyl hexanoate; furan-2-ylmethyl heptanoate; ethyl (3aR,4S,7R,7aR)-octahydro-3aH-4,7-methanoindene-3a-carboxylate; 2-(sec-butyl)cyclohexan-1-one; 3-(2-ethylphenyl)-2,2-dimethylpropanal; 2-(tert-butyl)cyclohexyl ethyl carbonate; 3-(2-ethylphenyl)-2,2-dimethylpropanal; (E)-4,8-dimethyldeca-4,9-dienal; 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 2-heptylcyclopentan-1-one; 1-ethoxyethoxy Cyclododecane; (Z)-5-methylhept-2-en-4-one; 1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol; oxacyclohexadecan-2-one; (E)-cyclopentadec-4-en-1-one; 1-cyclopentadec-4-en-1-one; 4-allyl-2-methoxyphenyl acetate; 4-allyl-2-methoxyphenol; 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane; ethyl 3-methyl-3-phenyloxirane-2-carboxylate; 1,4-dioxacycloheptadecane-5,17-dione; 2-ethoxy-4-formylphenyl acetate; ethyl undec-10-enoate; ethyl palmitate; ethyl octanoate; ethyl tetradecanoate; (E)-3,7-dimethylnona-1,6-dien-3-ol; ethyl cinnamate; ethyl 3-phenyloxirane-2-carboxylate; ethyl 2-cyclohexylpropanoate; 6-ethyl-2,10,10-trimethyl-1-oxaspiro[4.5]deca-3,6-diene; (2R,3S,4R)-2,3,4,5-tetrahydroxypentanal; (E)-4-((3aS,7aS)-octahydro-5H-4,7-methanoinden-5-ylidene)butanal; (2R,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-one; 4-methyl-2-phenyltetrahydro-2H-pyran; oxydibenzene; diphenylmethane; 2-methyl-1-phenylpropan-2-yl butyrate; 2,6-dimethyloct-7-en-2-ol; 3-methyl-2-pentylcyclopent-2-en-1-one; 3,3,5-trimethylcyclohexan-1-one; 2-methoxy-4-propylphenol; chroman-2-one; 2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-one; 2-methyl-5-(prop-1-en-2-yl)cyclohexyl acetate; 2-(4-methylcyclohexyl)propan-2-yl acetate; 4-(2,6,6-trimethylcyclohex-2-en-1-yl)butan-2-one; (oxybis(methylene))dibenzene; dibutyl phthalate; 1,2-diphenylethane; (3R,4R)-1-isopropyl-4-methyl-3-(prop-1-en-2-yl)-4-vinylcyclohex-1-ene; (1S,8aR)-4,7-dimethyl-1-(propan-2-yl)-1,2,3,5,6,8a-hexahydronaphthalene; (1S,8aS)-1-isopropyl-4,7-dimethyl-1,2,3,5,6,8a-hexahydronaphthalene; 2-pentylcyclopentan-1-one; decyl 2-aminobenzoate; decahydronaphthalen-2-ol; methyl(1s,4s)-1,4-dimethylcyclohexane-1-carboxylate; 3-(4-isopropylphenyl)-2-methylpropanal; cyclotetradecane; cyclopentadecanone; 2-cyclohexylethyl acetate; cyclohexyl 2-hydroxybenzoate; 1,4-dioxacyclohexadecane-5,16-dione; (4-isopropylphenyl)methanol; 2-methoxy-4-methylphenol; (3Z,5Z)-2,6-dimethylocta-1,3,5,7-tetraene; 4-cyclohexyl-2-methylbutan-2-ol; 2-(3-phenylpropyl)pyridine; 3-(4-methylcyclohex-3-en-1-yl)but-3-en-1-yl acetate; 3-(4-methylcyclohex-3-en-1-yl)butan-1-ol; 2-benzyl-2-methylbut-3-enenitrile; 3,7-dimethyloct-6-enenitrile; 3,7-dimethyloct-6-en-1-yl 2-phenylacetate; 3,7-dimethyloct-6-en-1-yl formate; 3,7-dimethyloct-6-en-1-yl benzoate; 3,7-dimethyloct-6-en-1-ol; 3,7-dimethyloct-6-enal; (E)-3,7-dimethylocta-2,6-dienal; (1R,2S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane; (Z)-3-methyl-2-(pent-2-en-1-yl)cyclopent-2-en-1-one; (E)-2-methoxy-4-(prop-1-en-1-yl)phenol; (E)-oxacycloheptadec-11-en-2-one; (Z)-non-6-en-1-ol; (Z)-hex-3-en-1-yl pentanoate; (E)-hex-3-en-1-yl(E)-2-methylbut-2-enoate; (Z)-hex-3-en-1-yl 2-hydroxybenzoate; (Z)-hex-3-en-1-yl propionate; (Z)-hex-3-en-1-yl butyrate; (Z)-hex-3-en-1-yl benzoate; (Z)-hex-3-en-1-ol; (Z)-hex-3-en-1-yl 2-methylbutanoate; (Z)-hex-2-en-1-ol; cinnamonitrile; cinnamyl isobutyrate; cinnamaldehyde; (E)-3-phenylprop-2-en-1-ol; cinnamonitrile; 4-chloro-3,5-dimethylphenol; hexadecan-1-ol; (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one; 2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butanal; (3aR,5aR,9aR,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; (4Z,8Z)-1,5,9-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene; 5-methyl-1-(2,2,3-trimethylcyclopent-3-en-1-yl)-6-oxabicyclo[3.2.1]octane; 1,1,2,3,3-pentamethyl-1,2,3,5,6,7-hexahydro-4H-inden-4-one; 5-isopropyl-2-methylphenol; 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; 2-(2-ethoxyethoxy)ethan-1-ol; hexan-1-ol; 2-(2,2,3-trimethylcyclopent-3-en-1-yl)acetonitrile; 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one; 2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane; 2,6-di-tert-butyl-4-methylphenol; butyl stearate; butyl undec-10-enoate; 2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)butan-1-ol; (E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-2-enal; 1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate; (1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol; 3,3,6,7-tetramethyloctahydro-2H-chromene; 6,6-dimethylspiro[bicyclo[3.1.1]heptane-2,2′-oxirane]; 3-isopropyl-6-methylenecyclohex-1-ene; 2-ethoxynaphthalene; (R)-3,5,5,9-tetramethyl-2,4a,5,6,7,8-hexahydro-1H-benzo[7]annulene; (1S,4S)-1,4-dimethyl-7-(propan-2-ylidene)-1,2,3,4,5,6,7,8-octahydroazulene; (1R,9S,Z)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene; (Z)-4-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl)but-3-en-2-one; 4-methoxy-7H-furo[3,2-g]chromen-7-one; 4-phenylbutan-2-one; benzyl 2-hydroxybenzoate; benzyl dodecanoate; benzyl 3-methylbutanoate; benzyl isobutyrate; benzyl cinnamate; benzyl butyrate; phenylmethanol; benzyl benzoate; 1-(3,3-dimethylcyclohexyl)ethyl formate; 4-methoxybenzyl acetate; 4-methoxybenzyl formate; (Z)-1-methoxy-4-(prop-1-en-1-yl)benzene; pentyl benzoate; (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; 2,5,5-trimethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-ol; 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol; 2-(sec-butyl)-1-vinylcyclohexyl acetate; (1S,4R,5R)-1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one; 2-(4-methylcyclohex-3-en-1-yl)propan-2-yl propionate; 2-(4-methylcyclohex-3-en-1-yl)propan-2-yl acetate; 1,7-dimethyl-7-(4-methylpent-3-en-1-yl)tricyclo[2.2.1.02,6]heptane; 1-(5,5-dimethylcyclohex-1-en-1-yl)pent-4-en-1-one; (1S,4aS,8aR)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; 4-cyclohexylbutan-2-ol; (R,Z)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)pent-1-en-3-one; (E)-2-methyl-3-phenylacrylaldehyde; (Z)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; (Z)-4-(2,5,6,6-tetramethylcyclohex-2-en-1-yl)but-3-en-2-one; (1Z,4E,8Z)-2,6,6,9-tetramethylcycloundeca-1,4,8-triene; (4aR,8S,9aS)-3,5,5,8-tetramethyl-9-methylene-2,4a,5,6,7,8,9,9a-octahydro-1H-benzo[7]annulene; (1R,4S,4aR,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; (1S,4aR,8aR)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; (R)-2-((R)-4-methylcyclohex-3-en-1-yl)hex-5-en-2-ol; (E)-2-benzylideneheptyl acetate; (1S,4aR,8aS)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; 1-phenylpentan-2-ol; 4-methoxy-2,5-dimethylfuran-3(2H)-one; alpha-4-Dimethyl benzenepropanal; allyl 2-phenoxyacetate; (2-(allyloxy)ethyl)benzene; allyl heptanoate; allyl 3-cyclohexylpropanoate; N-ethyl-N-(m-tolyl)propionamide; 2,6,10-trimethylundec-9-enal; 3-hydroxybutan-2-one; 1-(4-methoxyphenyl)ethan-1-one; (Z)-2-(4-methylbenzylidene)heptanal; (Z)-oxacycloheptadec-8-en-2-one; 7-methoxy-2H-chromen-2-one; 6-methylquinoline; 6,8-dimethylnonan-2-ol; 6,10,14-trimethylpentadecan-2-one; 5-methylheptan-3-one; 4-vinylphenol; 1-phenylpent-4-en-1-one; (E)-3-(4-hydroxy-3-methoxyphenyl)acrylaldehyde; 4-ethyl-2-methoxyphenol; 5-methyl-5-phenylhexan-3-one; 4-(4-methoxyphenyl)butan-2-one; (E)-3-propylideneisobenzofuran-1(3H)-one; (Z)-dodec-2-enal; 3-methyl-5-phenylpentanal; 3-methyl-4-phenyl-1H-pyrazole; 3-methylcyclopentane-1,2-dione; 3-methoxy-5-methylphenol; 3-methoxy-3-methylbutan-1-ol; (E)-hex-3-en-1-ol; 3,7-dimethyl-2-methyleneoct-6-enal; 3,7-dimethyloctan-1-ol; (Z)-undec-2-enenitrile; (E)-undec-2-enal; phenethyl acetate; (Z)-3-(furan-2-yl)-2-phenylacrylaldehyde; phenethyl propionate; 2-pentylcyclopentan-1-ol; (2S,4S)-2-heptyl-2,4-dimethyl-1,3-dioxolane; nonan-2-ol; 2-(sec-butyl)-3-methoxypyrazine; 2-isopropyl-N,2,3-trimethylbutanamide; (E)-2-isopropyl-5-methylhex-2-enal; 2-isopropyl-4-methylthiazole; (E)-2-hexylidenecyclopentan-1-one; (E)-hex-2-en-1-ol; 2-butoxyethan-1-ol; (2E,6E)-nona-2,6-dien-1-ol; 1-isopropyl-4-methyl-7-oxabicyclo[2.2.1]heptane; 1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 1,1,2,3,3-pentamethyl-2,3-dihydro-1H-indene; (Z)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one; (Z)-6,10-dimethylundeca-5,9-dien-2-yl acetate; (Z)-hept-3-en-1-yl acetate; (1S,5S)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one; (R)-3,7-dimethylocta-1,6-dien-3-ol; 3,7-dimethyloct-6-enal; (E)-6,10-dimethylundeca-5,9-dien-2-yl acetate; (R)-3,7-dimethyloct-6-enal; (2S,5S,6S)-2,6,10,10-tetramethyl-1-oxaspiro[4.5]decan-6-ol; 3,7-dimethyloct-6-en-1-ol; 3,7-dimethyloct-6-en-1-ol; (1R,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene; (S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; (1S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene; methyl 2-methylbutanoate; hexyl(Z)-2-methylbut-2-enoate; 2-(8-isopropyl-6-methylbicyclo[2.2.2]oct-5-en-2-yl)-1,3-dioxolane; 3-(3-isopropylphenyl)butanal; allyl 2-(cyclohexyloxy)acetate; 2-((3S,3aS,5R)-3,8-dimethyl-1,2,3,3a,4,5,6,7-octahydroazulen-5-yl)propan-2-ol; 1,5-dimethylbicyclo[3.2.1]octan-8-one oxime; benzyl 2-phenylacetate; 2-hydroxy-1,2-diphenylethan-1-one; (E)-tridec-2-enal; 1-phenylvinyl acetate; p-tolyl isobutyrate; p-tolyl hexanoate; p-cymene; 5-hexyl-4-methyldihydrofuran-2(3H)-one; 2-cyclohexylidene-2-phenylacetonitrile; 4-(prop-1-en-2-yl)cyclohex-1-ene-1-carbaldehyde; (4-(prop-1-en-2-yl)cyclohex-1-en-1-yl)methyl acetate; (4-(prop-1-en-2-yl)cyclohex-1-en-1-yl)methanol; (2-(cyclohexyloxy)ethyl)benzene; phenethyl 2-methylbutanoate; phenethyl formate; phenethyl isobutyrate; phenethyl 2-phenylacetate; phenethyl(Z)-2-methylbut-2-enoate; phenyl benzoate; phenethyl benzoate; phenethyl methacrylate; 2-(4-isopropylphenyl)acetaldehyde; 1,2-dimethyl-3-(prop-1-en-2-yl)cyclopentan-1-ol; 1-(4-methoxyphenyl)propan-2-one; (2Z,5Z)-5,6,7-trimethylocta-2,5-dien-4-one; 1-methoxy-4-propylbenzene; 2-(4-(tert-butyl)phenyl)acetaldehyde; 4-(tert-pentyl)cyclohexan-1-ol; p-tolyl 2-phenylacetate; Ethyl 2,4,7-decatrienoate; 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene; 4-(4-hydroxyphenyl)butan-2-one; 2-benzyl-4,4,6-trimethyl-1,3-dioxane; 3,7-dimethyloct-7-en-1-ol; ethyl(2,3,6-trimethylcyclohexyl)carbonate; (Z)-6-ethylideneoctahydro-2H-5,8-methanochromene; 2-((S)-1-((S)-3,3-dimethylcyclohexyl)ethoxy)-2-oxoethyl propionate; methyl 2,2-dimethyl-6-methylenecyclohexane-1-carboxylate; 1-(3,3-dimethylcyclohexyl)ethyl acetate; (S)-3,7-dimethylocta-1,6-dien-3-ol; 1-isopropyl-4-methylenebicyclo[3.1.0]hexane; 5-isopropyl-2-methylbicyclo[3.1.0]hexan-2-ol; (1S,3R,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexan-3-ol; 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol; 5-methoxyoctahydro-1H-4,7-methanoindene-2-carbaldehyde; propyl (S)-2-(tert-pentyloxy)propanoate; (4aR,8aR)-4a,8-dimethyl-2-(propan-2-ylidene)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl cyclopropanecarboxylate; (1R,3R,6R)-2′,2′,3,7,7-pentamethylspiro[bicyclo[4.1.0]heptane-2,5′-[1,3]dioxanel; 1-oxaspiro(4,5)decan-2-one; (Z)-5-methylheptan-3-one oxime; 1-phenylethyl acetate; (1S,4S,4aR,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; (1S,4S,4aR,8aS)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; 3,7-dimethyloctanal; 4-(2,2,6-trimethylcyclohexyl)butan-2-ol; 3-methyl-2-pentylcyclopentan-1-one; 3,7-dimethyloctan-3-ol; 3,7-dimethyloctan-3-yl acetate; 2,6,10,10-tetramethyl-1-oxaspiro[4.5]dec-6-ene; ethyl(1R,6S)-2,2,6-trimethylcyclohexane-1-carboxylate; 2-isopropyl-5-methylphenol; 1-isopropyl-2-methoxy-4-methylbenzene; 1-(2,2,6-trimethylcyclohexyl)hexan-3-ol; (E)-hex-2-en-1-ol; (1R,2S)-2-(tert-butyl)cyclohexan-1-ol; (Z)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one; (Z)-oxacycloheptadec-8-en-2-one; (Z)-1-methoxy-4-(prop-1-en-1-yl)benzene; cinnamic acid; (2R,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-one; (E)-3,7-dimethylocta-2,6-dien-1-ol; (Z)-2-methoxy-4-(prop-1-en-1-yl)phenol; 2,2,2-trichloro-1-phenylethyl acetate; triethyl 2-hydroxypropane-1,2,3-tricarboxylate; methyl 2-((1-hydroxy-3-phenylbutyl)amino)benzoate; 1-((2E,5Z,9Z)-2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethan-1-one; 2-mercapto-2-methylpentan-1-ol; 13-methyl oxacyclopentadec-10-en-2-one; undecanal; (E)-4-methyldec-3-en-5-ol; (3R,4aS,5R)-4a,5-dimethyl-3-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene; 4-formyl-2-methoxyphenyl acetate; 4-formyl-2-methoxyphenyl isobutyrate; (Z)-2-ethoxy-5-(prop-1-en-1-yl)phenol; 2,2,5-trimethyl-5-pentylcyclopentan-1-one; (Z)-2-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-enal; 3,4-dimethoxybenzaldehyde; (1R,5R)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one; 1-methoxy-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoindene; 2-(tert-butyl)cyclohexan-1-ol; cis-(4-tert-butylcyclohexyl) acetate; 4-(tert-butyl)cyclohexyl acetate; 2,4-diethoxy-5-methylpyrimidine; 4-methyl-4-phenylpentan-2-yl acetate; 4,8-dimethyl-2-(propan-2-ylidene)-1,2,3,3a,4,5,6,8a-octahydroazulen-6-ol; (Z)-cyclooct-4-en-1-yl methyl carbonate; (Z)-1-((2-methylallyl)oxy)hex-3-ene; 4-(4-hydroxy-3-methoxyphenyl)butan-2-one; (1R,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,7,8,8a-hexahydronaphthalene; 4,5-epoxy-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undecane; 1,3,4,6,7,8alpha-hexahydro-1,1,5,5-tetramethyl-2H-2,4alpha-methanophtalen-8(5H)-one preferably said malodor reduction materials are selected from the group consisting of 2-ethylhexyl(Z)-3-(4-methoxyphenyl)acrylate; 2,4-dimethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolane; 1,1-dimethoxynon-2-yne; 2-(p-tolyl)propan-2-ol; 3-methoxy-7,7-dimethyl-10-methylenebicyclo[4.3.1]decane; methoxycyclododecane; 1,1-dimethoxycyclododecane; (Z)-tridec-2-enenitrile; (2-hydroxy-4-methoxyphenyl)(phenyl)methanone; 2,4a,5,8a-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl formate; 4-methyl-1-oxaspiro[5.5]undecan-4-ol; 7-methyl-2H-benzo[b][1,4]dioxepin-3(4H)-one; 1,8-dioxacycloheptadecan-9-one; 4-(tert-pentyl)cyclohexan-1-one; 2-methoxy-1,1′-biphenyl; 3a,5,6,7,8,8b-hexahydro-2,2,6,6,7,8,8-heptamethyl-4H-indeno(4,5-d)-1,3-dioxole; 7-isopropyl-8,8-dimethyl-6,10-dioxaspiro[4.5]decane; octyl furan-2-carboxylate; octyl acetate; 2-heptyl-4-methyl-1,3-dioxolane; octanal; 1,1-dimethoxyoctane; 7-methyl-3-methyleneocta-1,6-diene; 2-methyl-6-methyleneoct-7-en-2-ol; 2-methyl-6-methyleneoct-7-en-2-yl acetate; tetradecanal; 4-methoxy-6-prop-2-enyl-1,3-benzodioxole; tetradecanenitrile; 2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydronaphthalen-1-ol; (E)-2,6-dimethylocta-5,7-dien-2-ol; (E)-2,7-dimethylocta-1,5,7-trien-3-ol; 2-((1S,5R)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethyl acetate; (4R,4aS,6R)-4,4a-dimethyl-6-(prop-1-en-2-yl)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one; nonan-1-ol; nonanal; 12-methyl-14-tetradec-9-enolide; N-ethyl-2-isopropyl-5-methylcyclohexane-1-carboxamide; 1-(3-methylbenzofuran-2-yl)ethan-1-one; 2-methoxynaphthalene; (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; (Z)-3,7-dimethylocta-2,6-dien-1-ol; 1-ethyl-3-methoxytricyclo[2.2.1.02,6]heptane; methyl(E)-non-2-enoate; 10-isopropyl-2,7-dimethyl-1-oxaspiro[4.5]deca-3,6-diene; 2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentan-1-one; 6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde; (E)-4-(2,2,3,6-tetramethylcyclohexyl)but-3-en-2-one; (4-(4-methylpent-3-en-1-yl)cyclohex-3-en-1-yl)methyl acetate; 2-(tert-butyl)-4,5,6-trimethyl-1,3-phenylene dinitrite; 1,7-dioxacycloheptadecan-8-one; 1-(4-(tert-butyl)-2,6-dimethyl-3,5-dinitrophenyl)ethan-1-one; 1-(tert-butyl)-2-methoxy-4-methyl-3,5-dinitrobenzene; 3-methylcyclopentadecan-1-one; (E)-3-methylcyclopentadec-4-en-1-one; 3-methyl-4-phenylbutan-2-ol; 1-(4-isopropylcyclohexyl)ethan-1-ol; (E)-dec-5-enoic acid; methyl non-2-ynoate; 2-methyldecanal; 6,6-dimethoxy-2,5,5-trimethylhex-2-ene; 4-phenylbutan-2-ol; methyl stearate; 1,1-dimethoxy-2-methylundecane; undecan-2-one; 2-methylundecanal; methyl tetradecanoate; methyl(9Z,12Z)-octadeca-9,12-dienoate; 1-hydroxydecan-3-one; (Z)-1,2-dimethoxy-4-(prop-1-en-1-yl)benzene; methyl palmitate; 4-allyl-1,2-dimethoxybenzene; methyl 2-((1R,2R)-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)acetate; methyl 2-(3-oxo-2-pentylcyclopentyl)acetate; 1-methyl-2-phenoxybenzene; methyl cinnamate; 1-allyl-4-methoxybenzene; 1-(naphthalen-2-yl)ethan-1-one; methyl oct-2-ynoate; methyl 2,6,6-trimethylcyclohex-2-ene-1-carboxylate; 7-methoxy-3,7-dimethyloctanal; 7-isopropyl-10-methyl-1,5-dioxaspiro[5.5]undecan-3-ol; octahydro-1H-4,7-methanoindene-1-carbaldehyde; 3-(3-(tert-butyl)phenyl)-2-methylpropanal; (E)-4-(4,8-dimethylnona-3,7-dien-1-yl)pyridine; (E)-trideca-3,12-dienenitrile; 2,2-dimethyl-3-(m-tolyl)propan-1-ol; 2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine; 8-isopropyl-6-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde; 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; (S)-1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; (Z)-3-hexen-1-yl-2-cyclopenten-1-one; 3,7-dimethylocta-1,6-dien-3-yl octanoate; 3,7-dimethylocta-1,6-dien-3-yl isobutyrate; 3,7-dimethylocta-1,6-dien-3-yl benzoate; 3,7-dimethylocta-1,6-dien-3-yl 2-aminobenzoate; 2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol; 6-methyl-2-(oxiran-2-yl)hept-5-en-2-ol; (2Z,6E)-3,7-dimethylnona-2,6-dienenitrile; 3-(4-methylcyclohex-3-en-1-yl)butanal; (2,5-dimethyl-1,3-dihydroinden-2-yl)methanol; 3-(4-(tert-butyl)phenyl)-2-methylpropanal; (E)-1-(1-methoxypropoxy)hex-3-ene; (E)-1-(1-ethoxyethoxy)hex-3-ene; (1S,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-ol; dodecan-1-ol; dodecyl acetate; dodecanoic acid; 5-hexyl-5-methyldihydrofuran-2(3H)-one; dodecanal; 3,6-dimethylhexahydrobenzofuran-2(3H)-one; 4-(1-ethoxyvinyl)-3,3,5,5-tetramethylcyclohexan-1-one; ((3S,3aR,6R,8aS)-7,7-dimethyl-8-methyleneoctahydro-1H-3a,6-methanoazulen-3-yl)methanol; 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane; (1-methyl-2-((1,2,2-trimethylbicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methanol; 2-propylheptanenitrile; (E)-6-(pent-3-en-1-yl)tetrahydro-2H-pyran-2-one; 2-hexylcyclopentan-1-one; 2-methyl-4-phenyl-1,3-dioxolane; 2,6,9,10-tetramethyl-1-oxaspiro(4.5)deca-3,6-diene; (1R,2S,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol; isopropyl palmitate; isopropyl tetradecanoate; isopropyl dodecanoate; 4,9-dimethoxy-7H-furo[3,2-g]chromen-7-one; (E)-cyclohexadec-8-en-1-one; (2S,5S)-2-isopropyl-5-methylcyclohexan-1-one; 2-hexylcyclopent-2-en-1-one; (2S,5S)-2-isopropyl-5-methylcyclohexan-1-one; 4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde; (Z)-1-(benzyloxy)-2-methoxy-4-(prop-1-en-1-yl)benzene; 1-((2S,3S)-2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethan-1-one; 2,5,6-trimethylcyclohex-3-ene-1-carbaldehyde; 6-(sec-butyl)quinoline; 2-(cyclohexyloxy)-1,7,7-trimethylbicyclo[2.2.1]heptane; (1R,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propionate; (1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl isobutyrate; 4-((2R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)cyclohexan-1-ol; (1R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 2-(4-isopropylcyclohexa-1,4-dien-1-yl)ethyl formate; isopentyl(E)-undec-6-enoate; isopentyl dodecanoate; (E)-oxacycloheptadec-10-en-2-one; (E)-non-2-enenitrile; (E)-8-(1H-indol-1-yl)-2,6-dimethyloct-7-en-2-ol; 8,8-di(1H-indol-1-yl)-2,6-dimethyloctan-2-ol; 4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine; 3,7-dimethyloctane-1,7-diol; 2-cyclododecylpropan-1-ol; 3-methyl-5-phenylpentanenitrile; 3-phenylpropan-1-ol; (1,1-dimethoxypropan-2-yl)benzene; 5-ethyl-4-hydroxy-2-methylfuran-3(2H)-one; 2,3-dihydro-3,3-dimethyl-1H-indene-5-propanal; 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal; hexyl octanoate; hexyl hexanoate; (Z)-2-benzylideneoctanal; hexyl benzoate; (Z)-hex-1-en-1-yl(Z)-2-methylbut-2-enoate; (E)-3,7-dimethylocta-2,6-dien-1-yl palmitate; oxacycloheptadecan-2-one; 2-butyl-4,4,6-trimethyl-1,3-dioxane; ethyl(1R,2R,3R,4R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl propionate; 5-(diethoxymethyl)benzo[d][1,3]dioxole; 3-(benzo[d][1,3]dioxol-5-yl)-2-methylpropanal; (E)-oxacyclohexadec-13-en-2-one; 6-butyl-2,4-dimethyl-3,6-dihydro-2H-pyran; 2-((3S,5R,8S)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl)propan-2-ol; 1-(2,6,6-trimethylcyclohex-2-en-1-yl)pentan-3-one; ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate; (1Z,5Z)-1,5-dimethyl-8-(propan-2-ylidene)cyclodeca-1,5-diene; (1E,6E)-8-isopropyl-1-methyl-5-methylenecyclodeca-1,6-diene; (E)-3,7-dimethylocta-2,6-dien-1-yl 2-phenylacetate; (E)-3,7-dimethylocta-2,6-dien-1-yl 2-phenylacetate; (6E,10E)-3,7,11,15-tetramethylhexadeca-1,6,10,14-tetraen-3-ol; (E)-2-(3,7-dimethylocta-2,6-dien-1-yl)cyclopentan-1-one; 5-heptyldihydrofuran-2(3H)-one; 1-methyl-4-(propan-2-ylidene)cyclohexyl acetate; 1-methyl-4-(propan-2-ylidene)cyclohexan-1-ol; 5-pentyldihydrofuran-2(3H)-one; (1R,4aR,8aS)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 5-[(Z)-hex-3-enyl]oxolan-2-one; (Z)-4-(2,2-dimethyl-6-methylenecyclohexyl)but-3-en-2-one; (4aS,9aR)-3,5,5,9-tetramethyl-2,4a,5,6,7,9a-hexahydro-1H-benzo[7]annulene; (1R,3aR,4R,7R)-1,4-dimethyl-7-(prop-1-en-2-yl)-1,2,3,3a,4,5,6,7-octahydroazulene; 2-((2R,4aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol; 5-octyldihydrofuran-2(3H)-one; (Z)-1-(2,2-dimethyl-6-methylenecyclohexyl)but-2-en-1-one; 5-hexyldihydrofuran-2(3H)-one; (1R,4aS,8aS)-1-isopropyl-7-methyl-4-methylene-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one; 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene; furan-2-ylmethyl octanoate; furan-2-ylmethyl hexanoate; furan-2-ylmethyl heptanoate; 2-methyldecanenitrile; 8,8-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; ethyl(3aR,4S,7R,7aR)-octahydro-3aH-4,7-methanoindene-3a-carboxylate; diethyl cyclohexane-1,4-dicarboxylate; (6-isopropyl-9-methyl-1,4-dioxaspiro[4.5]decan-2-yl)methanol; 2-isobutyl-4-methyltetrahydro-2H-pyran-4-ol; undec-10-enenitrile; (Z)-6-ethylideneoctahydro-2H-5,8-methanochromen-2-one; 3-(2-ethylphenyl)-2,2-dimethylpropanal; (E)-4,8-dimethyldeca-4,9-dienal; (E)-4-((3aR,4R,7R,7aR)-1,3a,4,6,7,7a-hexahydro-5H-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 8,8-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 2-heptylcyclopentan-1-one; 1-ethoxyethoxy Cyclododecane; 3-cyclohexene-1-carboxylic acid, 2,6,6-trimethyl-, methyl ester; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; oxacyclohexadecan-2-one; (E)-cyclopentadec-4-en-1-one; 1-cyclopentadec-4-en-1-one; 2-methoxy-4-(4-methylenetetrahydro-2H-pyran-2-yl)phenol; 4-allyl-2-methoxyphenyl acetate; 4-allyl-2-methoxyphenol; ethyl 3-methyl-3-phenyloxirane-2-carboxylate; 1,4-dioxacycloheptadecane-5,17-dione; ethyl undec-10-enoate; ethyl palmitate; ethyl nonanoate; ethyl tetradecanoate; (E)-3,7-dimethylnona-1,6-dien-3-ol; ethyl dodecanoate; nonan-3-one; ethyl decanoate; ethyl 6,6-dimethyl-2-methylenecyclohex-3-ene-1-carboxylate; ethyl 3-phenyloxirane-2-carboxylate; 6-ethyl-2,10,10-trimethyl-1-oxaspiro[4.5]deca-3,6-diene; 2-((1R,3S,4S)-4-methyl-3-(prop-1-en-2-yl)-4-vinylcyclohexyl)propan-2-ol; (2-(1-ethoxyethoxy)ethyl)benzene; (E)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol; (2R,3S,4R)-2,3,4,5-tetrahydroxypentanal; (E)-4-((3aS,7aS)-octahydro-5H-4,7-methanoinden-5-ylidene)butanal; 1,1-dimethoxydodecane; (R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; 2-(2-hydroxypropoxy)propan-1-ol; 7,9-dimethylspiro[5.5]undecan-3-one; oxydibenzene; diphenylmethane; 2-methyl-1-phenylpropan-2-yl butyrate; 2,6-dimethyloct-7-en-4-one; octahydro-1H-4,7-methanoinden-5-yl acetate; 2-methyl-5-(prop-1-en-2-yl)cyclohexyl acetate; 2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-ol; 3,7-dimethyloct-6-en-3-ol; methyl 2-hexyl-3-oxocyclopentane-1-carboxylate; dibutylsulfane; 1,2-diphenylethane; 6-hexyltetrahydro-2H-pyran-2-one; (3R,4R)-1-isopropyl-4-methyl-3-(prop-1-en-2-yl)-4-vinylcyclohex-1-ene; (3S,3aS,5R)-3,8-dimethyl-5-(prop-1-en-2-yl)-1,2,3,3a,4,5,6,7-octahydroazulene; 6-heptyltetrahydro-2H-pyran-2-one; 6-pentyltetrahydro-2H-pyran-2-one; (1S,8aR)-4,7-dimethyl-1-(propan-2-yl)-1,2,3,5,6,8a-hexahydronaphthalene; (Z)-1-((1R,2S)-2,6,6-trimethylcyclohex-3-en-1-yl)but-2-en-1-one; (1S,8aS)-1-isopropyl-4,7-dimethyl-1,2,3,5,6,8a-hexahydronaphthalene; 3,7,7-trimethylbicyclo[4.1.0]hept-3-ene; dec-9-en-1-ol; decyl propionate; 1,1-diethoxydecane; decahydronaphthalen-2-ol; 1-cyclohexylethyl(E)-but-2-enoate; 3-(4-isopropylphenyl)-2-methylpropanal; cyclotetradecane; cyclopentadecanone; cyclohexyl 2-hydroxybenzoate; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl butyrate; 1,4-dioxacyclohexadecane-5,16-dione; 8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carbaldehyde; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl isobutyrate; (5R,6R)-3,6-dimethyl-5-(prop-1-en-2-yl)-6-vinyl-4,5,6,7-tetrahydrobenzofuran; (4-isopropylphenyl)methanol; 1-(benzofuran-2-yl)ethan-1-one; 2-(3-phenylpropyl)pyridine; dodecanenitrile; (E)-cycloheptadec-9-en-1-one; 3-(4-methylcyclohex-3-en-1-yl)but-3-en-1-yl acetate; 3-(4-methylcyclohex-3-en-1-yl)butan-1-ol; (E)-3-methyl-5-phenylpent-2-enenitrile; (E)-2-(2,6-dimethylhepta-1,5-dien-1-yl)-4-methyl-1,3-dioxolane; (E)-1,1-dimethoxy-3,7-dimethylocta-2,6-diene; (E)-1,1-diethoxy-3,7-dimethylocta-2,6-diene; (E)-3,7-dimethylocta-1,3,6-triene; (1R,4R,6S)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane; (E)-oxacycloheptadec-11-en-2-one; (Z)-non-6-en-1-ol; (1R,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-ol; (Z)-dec-4-enal; (E)-hex-3-en-1-yl(E)-hex-3-enoate; (Z)-hex-3-en-1-yl 2-hydroxybenzoate; (Z)-hex-3-en-1-yl benzoate; (Z)-hex-3-en-1-yl 2-methylbutanoate; (3Z,6Z)-nona-3,6-dien-1-ol; cinnamyl propionate; cinnamyl isobutyrate; cinnamyl formate; cinnamyl cinnamate; cinnamyl acetate; (E)-3-phenylprop-2-en-1-ol; hexadecan-1-ol; (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one; 2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butanal; (3aR,5aR,9aR,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; 1,6-dioxacycloheptadecan-7-one; 1-(6-(tert-butyl)-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethan-1-one; (3R,3aR,6S,7S,8aS)-6-methoxy-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulene; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-3-yl formate; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-6-yl acetate; (4Z,8Z)-1,5,9-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-6-ol; 5-methyl-1-(2,2,3-trimethylcyclopent-3-en-1-yl)-6-oxabicyclo[3.2.1]octane; 5-methyl-1-(2,2,3-trimethylcyclopent-3-en-1-yl)-6-oxabicyclo[3.2.1]octane; 1,1,2,3,3-pentamethyl-1,2,3,5,6,7-hexahydro-4H-inden-4-one; (Z)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-3-en-5-yl acetate; (1S,2S,5R,8S)-4,4,8-trimethyltricyclo[6.3.1.02,5]dodecan-1-ol; 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl acetate; octanenitrile; octan-1-ol; octanoic acid; decanoic acid; decanal; 3-(4-methoxyphenyl)-2-methylpropanal; 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione; 2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane; ethyl 2-methyl-4-oxo-6-pentylcyclohex-2-ene-1-carboxylate; 2,6-di-tert-butyl-4-methylphenol; butyl stearate; 1-butoxy-1-oxopropan-2-yl butyrate; butyl undec-10-enoate; 2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)butan-1-ol; 3-(4-(tert-butyl)phenyl)propanal; (1S,2S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl isobutyrate; 1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 2-ethoxy-2,6,6-trimethyl-9-methylenebicyclo[3.3.1]nonane; (ethoxymethoxy)cyclododecane; (E)-1-methyl-4-(6-methylhept-5-en-2-ylidene)cyclohex-1-ene; 3,3,6,7-tetramethyloctahydro-2H-chromene; (5R,10R)-6,10-dimethyl-2-(propan-2-ylidene)spiro[4.5]dec-6-en-8-one; 1-methyl-4-(prop-1-en-2-yl)cyclohexyl acetate; 1-methyl-4-(prop-1-en-2-yl)cyclohexan-1-ol; (2Z,6E)-2,6-dimethyl-10-methylenedodeca-2,6,11-trienal; (R)-3-methylene-6-((S)-6-methylhept-5-en-2-yl)cyclohex-1-ene; (4aR,7R,8aS)-4a-methyl-1-methylene-7-(prop-1-en-2-yl)decahydronaphthalene; (Z)-2-methyl-5-((1S,2R,4R)-2-methyl-3-methylenebicyclo[2.2.1]heptan-2-yl)pent-2-en-1-ol; 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane; 2-ethoxynaphthalene; (1S,4R,7R)-1,4,9,9-tetramethyl-1,2,3,4,5,6,7,8-octahydro-4,7-methanoazulene; (1aS,5aR,9aR)-1a,5,5,7-tetramethyl-1a,2,3,4,5,5a,8,9-octahydrobenzo[1,7]cyclohepta[1,2-b]oxirene; (R)-3,5,5,9-tetramethyl-2,4a,5,6,7,8-hexahydro-1H-benzo[7]annulene; (1S,4S)-1,4-dimethyl-7-(propan-2-ylidene)-1,2,3,4,5,6,7,8-octahydroazulene; (2,2-dimethoxyethyl)benzene; (E)-7,11-dimethyl-3-methylenedodeca-1,6,10-triene; (1R,2S,6S,7S,8S)-8-isopropyl-1-methyl-3-methylenetricyclo[4.4.0.02,7]decane; (3R,3aS,7S,8aS)-3,8,8-trimethyl-6-methyleneoctahydro-1H-3a,7-methanoazulene; (1R,9S,Z)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene; (S)-4-methyl-1-((S)-6-methylhept-5-en-2-yl)cyclohex-3-en-1-ol; (Z)-4-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl)but-3-en-2-one; 4-methoxy-7H-furo[3,2-g]chromen-7-one; 2-methyl-4-phenylbutan-2-ol; benzyl dodecanoate; 2-methyl-1-phenylpropan-2-ol; benzyl cinnamate; benzyl benzoate; benzophenone; 7-isopentyl-2H-benzo[b][1,4]dioxepin-3(4H)-one; 2′-isopropyl-1,7,7-trimethylspiro[bicyclo[2.2.1]heptane-2,4′-[1,3]dioxane]/A; 4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbonitrile; methyl(E)-2-((7-hydroxy-3,7-dimethyloctylidene)amino)benzoate; 4-methoxybenzyl 2-phenylacetate; methyl(E)-octa-4,7-dienoate; pentyl(Z)-3-phenylacrylate; (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; (4aR,5R,7aS,9R)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole; 2,5,5-trimethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-ol; 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol; 1-((2-(tert-butyl)cyclohexyl)oxy)butan-2-ol; (3S,5aR,7aS,11aS,11bR)-3,8,8,11a-tetramethyldodecahydro-5H-3,5a-epoxynaphtho[2,1-c]oxepine; 2,2,6,6,7,8,8-heptamethyldecahydro-2H-indeno[4,5-b]furan; 2,2,7,7,8,9,9-heptamethyldecahydroindeno[4,3a-b]furan; 2-(sec-butyl)-1-vinylcyclohexyl acetate; (1S,4R,5R)-1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one; (4R,4aS)-4,4a-dimethyl-6-(propan-2-ylidene)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one; 2-(4-methylcyclohex-3-en-1-yl)propan-2-yl propionate; (2Z,6E,9E)-2,6,10-trimethyldodeca-2,6,9,11-tetraenal; (2R,4aR,8aR)-4a,8-dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 1,7-dimethyl-7-(4-methylpent-3-en-1-yl)tricyclo[2.2.1.02,6]heptane; (E)-5-(2,3-dimethyltricyclo[2.2.1.02,6]heptan-3-yl)-2-methylpent-2-en-1-ol; (1R,3aS,7S,8aR)-1,4,9,9-tetramethyl-2,3,6,7,8,8a-hexahydro-1H-3a,7-methanoazulene; 1-(5,5-dimethylcyclohex-1-en-1-yl)pent-4-en-1-one; (1S,4aS,8aR)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; (R,Z)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)pent-1-en-3-one; 1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; (Z)-4-(2,5,6,6-tetramethylcyclohex-2-en-1-yl)but-3-en-2-one; (1Z,4E,8Z)-2,6,6,9-tetramethylcycloundeca-1,4,8-triene; (4aR,8S,9aS)-3,5,5,8-tetramethyl-9-methylene-2,4a,5,6,7,8,9,9a-octahydro-1H-benzo[7]annulene; (1aR,4R,4aR,7bS)-1,1,4,7-tetramethyl-1a,2,3,4,4a,5,6,7b-octahydro-1H-cyclopropa[e]azulene; 1,4-dimethyl-7-(prop-1-en-2-yl)-1,2,3,4,5,6,7,8-octahydroazulene; (3E,6E)-3,7,11-trimethyldodeca-1,3,6,10-tetraene; 7,7-dimethyl-2-methylenebicyclo[2.2.1]heptane; 2-((2R,4aR,8aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl)propan-2-ol; (R)-1-methyl-4-(6-methylhept-5-en-2-yl)benzene; (3aR,3bR,4S,7R,7aS)-4-isopropyl-7-methyl-3a,3b,4,5,6,7-hexahydro-1H-cyclopenta[1,3]cyclopropa[1,2]benzene; (1aS,2aR,3R,5aS,7R,7aR)-3,6,6,7a-tetramethyloctahydro-2H-2a,7-methanoazuleno[5,6-b]oxirene; (1R,4S,4aR,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; (1S,4aR,8aR)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; (R)-2-((R)-4-methylcyclohex-3-en-1-yl)hex-5-en-2-ol; (Z)-1-methyl-4-(6-methylhepta-2,5-dien-2-yl)cyclohex-1-ene; 2,6-dimethyl-6-(4-methylpent-3-en-1-yl)bicyclo[3.1.1]hept-2-ene; (E)-2-benzylideneheptan-1-ol; (E)-2-benzylideneheptyl acetate; (Z)-(2-(diethoxymethyl)hept-1-en-1-yl)benzene; (E)-2-benzylideneheptanal; (1S,4aR,8aS)-1-isopropyl-4,7-dimethyl-1,2,4a,5,6,8a-hexahydronaphthalene; (3R,5aS,9aR)-2,2,5a,9-tetramethyl-3,4,5,5a,6,7-hexahydro-2H-3,9a-methanobenzo[b]oxepine; 1-methyl-4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde; 1-phenylpentan-2-ol; 3-methyl-1-phenylpentan-3-ol; 2,3,4-trimethoxybenzaldehyde; 2,4,5-trimethoxybenzaldehyde; 2,4,6-trimethoxybenzaldehyde; Trans,Trans-2,4-Nonadienal; 2,6,10-trimethylundecanal; alpha-4-Dimethyl benzenepropanal; allyl 3-cyclohexylpropanoate; allyl 2-(isopentyloxy)acetate; (1aR,4aS,7R,7aR,7bS)-1,1,7-trimethyl-4-methylenedecahydro-1H-cyclopropa[e]azulene; (E)-undec-9-enal; methyl(E)-2-(((3,5-dimethylcyclohex-3-en-1-yl)methylene)amino)benzoate; 2,6,10-trimethylundec-9-enal; (7,7,8,8-tetramethyloctahydro-2,3b-methanocyclopenta[1,3]cyclopropa[1,2]benzen-4-yl)methyl acetate; nonyl acetate; (2-(1-propoxyethoxy)ethyl)benzene; 1-(1-propoxyethoxy)propane; ((1-(2-methoxyethoxy)ethoxy)methyl)benzene; (Z)-2-(4-methylbenzylidene)heptanal; dec-9-enal; (Z)-oxacycloheptadec-8-en-2-one; 7-methoxy-2H-chromen-2-one; (2S,4aR,8aR)-4a,8-dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 2-((2S,4aR,8aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl)propan-2-ol; 1-(3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one; 6-isopropylquinoline; 3-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)propanal; 6,10,14-trimethylpentadecan-2-one; 2-methyl-5-(prop-1-en-2-yl)-2-vinyltetrahydrofuran; (E)-cyclohexadec-5-en-1-one; 1-isopropyl-4-methylcyclohex-3-en-1-ol; 1-phenylpent-4-en-1-one; 1-isopropyl-4-methylcyclohex-3-en-1-ol; 3,6-dimethyl-4,5,6,7-tetrahydrobenzofuran; 4-(4-methoxyphenyl)butan-2-one; (1aR,2S,4aS)-2,4a,8,8-tetramethyloctahydrocyclopropa[d]naphthalen-3(1H)-one; (E)-3-propylideneisobenzofuran-1(3H)-one; (Z)-dodec-2-enal; 3-methyl-5-phenylpentanal; (E)-hex-3-en-1-yl 3-methylbutanoate; 3,6-dimethyloctan-3-yl acetate; 3,4,5-trimethoxybenzaldehyde; 3-(4-isopropylphenyl)propanal; (Z)-undec-2-enenitrile; (E)-undec-2-enal; (2E,6E)-nona-2,6-dienal; phenethyl butyrate; (Z)-3-(furan-2-yl)-2-phenylacrylaldehyde; 2-phenoxyethan-1-ol; (Z)-non-2-enal; nonan-2-ol; nonan-2-one; 2-isobutylquinoline; (E)-2-hexylidenecyclopentan-1-one; 2-heptyltetrahydrofuran; (E)-dec-2-enal; (2E,6E)-nona-2,6-dienal; (2E,6E)-nona-2,6-dien-1-ol; 2,6-dimethyloctanal; decan-1-ol; (E)-hept-1-en-1-yl acetate; undec-10-en-1-ol; undec-10-enal; 2-((2R,4aS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol; 1-isopropyl-4-methyl-7-thiabicyclo[2.2.1]heptane; (3E,5Z)-undeca-1,3,5-triene; 3,7-dimethyloct-6-en-3-ol; 1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl acetate; 1,1,2,3,3-pentamethyl-2,3-dihydro-1H-indene; (Z)-6,10-dimethylundeca-5,9-dien-2-yl acetate; (Z)-dodec-3-enal; (S)-5-heptyldihydrofuran-2(3H)-one; (R)-5-heptyldihydrofuran-2(3H)-one; (E)-6,10-dimethylundeca-5,9-dien-2-yl acetate; (Z)-3-methyl-5-phenylpent-2-enenitrile; (2S,5S,6S)-2,6,10,10-tetramethyl-1-oxaspiro[4.5]decan-6-ol; (2E)-3-methyl-5-phenyl-2-pentenenitrile; (1S,2S,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-ol; (2S,5R)-2-isopropyl-5-methylcyclohexan-1-one; (R,E)-2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 2-(8-isopropyl-6-methylbicyclo[2.2.2]oct-5-en-2-yl)-1,3-dioxolane; (E)-4-(2,2-dimethyl-6-methylenecyclohexyl)-3-methylbut-3-en-2-one; 3-(3-isopropylphenyl)butanal; 3-(1-ethoxyethoxy)-3,7-dimethylocta-1,6-diene; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; 2-((3S,3aS,5R)-3,8-dimethyl-1,2,3,3a,4,5,6,7-octahydroazulen-5-yl)propan-2-ol; benzyl 2-phenylacetate; 2-hydroxy-1,2-diphenylethan-1-one; (E)-1,2,4-trimethoxy-5-(prop-1-en-1-yl)benzene; 3-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-2,2-dimethylpropanal; 2-methyl-5-(6-methylhept-5-en-2-yl)bicyclo[3.1.0]hex-2-ene; 1-(1,1,2,3,3,6-hexamethyl-2,3-dihydro-1H-inden-5-yl)ethan-1-one; 2-(m-tolyl)ethan-1-ol; (3E,6E)-nona-3,6-dien-1-ol; (E)-tridec-2-enal; (1R,4S,4aS,6R,8aS)-4,8a,9,9-tetramethyloctahydro-1,6-methanonaphthalen-1(2H)-ol; p-tolyl isobutyrate; p-tolyl hexanoate; 5-hexyl-4-methyldihydrofuran-2(3H)-one; ethyl(2Z,4E)-deca-2,4-dienoate; 2,4-dimethyl-6-phenyl-3,6-dihydro-2H-pyran; 2-cyclohexylidene-2-phenylacetonitrile; 4-(prop-1-en-2-yl)cyclohex-1-ene-1-carbaldehyde; (4-(prop-1-en-2-yl)cyclohex-1-en-1-yl)methyl acetate; (4-(prop-1-en-2-yl)cyclohex-1-en-1-yl)methanol; (2-isopropoxyethyl)benzene; 2-cyclohexylhepta-1,6-dien-3-one; (2-(cyclohexyloxy)ethyl)benzene; phenethyl 2-methylbutanoate; 2-phenylethan-1-ol; phenethyl 2-phenylacetate; 3-methyl-5-phenylpentan-1-ol; phenyl benzoate; phenethyl benzoate; 2-benzyl-1,3-dioxolane; 2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)acetaldehyde; 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-ol; 4-(benzo[d][1,3]dioxol-5-yl)butan-2-one; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl pivalate; (4aR,8aS)-7-methyloctahydro-1,4-methanonaphthalen-6(2H)-one; 4-isopropyl-1-methylcyclohex-3-en-1-ol; (E)-3,3-dimethyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol; 1-methyl-4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde; propane-1,2-diol; p-tolyl 2-phenylacetate; Ethyl 2,4,7-decatrienoate; 2-benzyl-4,4,6-trimethyl-1,3-dioxane; 2,4-dimethyl-4-phenyltetrahydrofuran; (2R,4a′R,8a′R)-3,7′-dimethyl-3′,4′,4a′,5′,8′,8a′-hexahydro-1′H-spiro[oxirane-2,2′-[1,4]methanonaphthalene]; (Z)-6-ethylideneoctahydro-2H-5,8-methanochromene; 2-((S)-1-((S)-3,3-dimethylcyclohexyl)ethoxy)-2-oxoethyl propionate; methyl 2,2-dimethyl-6-methylenecyclohexane-1-carboxylate; 2-methyl-5-phenylpentan-1-ol; 4-methyl-2-phenyl-3,6-dihydro-2H-pyran; (1S,3R,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexan-3-ol; 5-allylbenzo[d][1,3]dioxole; 2,2,7,9-tetramethylspiro(5.5)undec-8-en-1-one; 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol; (Z)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; (E)-2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 5-methoxyoctahydro-1H-4,7-methanoindene-2-carbaldehyde; 5-methoxyoctahydro-1H-4,7-methanoindene-2-carbaldehyde; 1-(3-hydroxy-3-methylpent-4-en-1-yl)-2,5,5,8a-tetramethyldecahydronaphthalen-2-ol; (4aR,6aS,10aS,10bR)-3,4a,7,7,10a-pentamethyl-4a,5,6,6a,7,8,9,10,10a,10b-decahydro-1H-benzo[f]chromene; (4aR,8aR)-4a,8-dimethyl-2-(propan-2-ylidene)-1,2,3,4,4a,5,6,8a-octahydronaphthalene; 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropyl cyclopropanecarboxylate; 3-(4-isobutylphenyl)-2-methylpropanal; (1aR,4aR,7S,7aR,7bR)-1,1,7-trimethyl-4-methylenedecahydro-1H-cyclopropa[e]azulen-7-ol; (1R,3R,6R)-2′,2′,3,7,7-pentamethylspiro[bicyclo[4.1.0]heptane-2,5′-[1,3]dioxane]; 2-methyl-1,5-dioxaspiro[5.5]undecane; 1-(spiro[4.5]dec-7-en-7-yl)pent-4-en-1-one; 2-(4-methylthiazol-5-yl)ethan-1-ol; 2-(heptan-3-yl)-1,3-dioxolane; (Z)-dodec-4-enal; (1S,4S,4aR,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; (1S,4S,4aR,8aS)-4-isopropyl-1,6-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol; 3-methyl-2-pentylcyclopentan-1-one; 2,6,10,10-tetramethyl-1-oxaspiro[4.5]dec-6-ene; 2-(2-mercaptopropan-2-yl)-5-methylcyclohexan-1-one; (1aR,4aS)-2,4a,8,8-tetramethyl-1,1a,4,4a,5,6,7,8-octahydrocyclopropa[d]naphthalene; 1-isopropyl-2-methoxy-4-methylbenzene; 1-(2,2,6-trimethylcyclohexyl)hexan-3-ol; (2Z,4E)-nona-2,4-dienal; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; (2E,6Z)-nona-2,6-dienal; (Z)-dec-2-enal; (E)-non-2-enal; (3E,6Z)-nona-3,6-dien-1-ol; (E)-dec-4-enal; (Z)-oxacycloheptadec-8-en-2-one; (Z)-3,7-dimethylocta-1,3,6-triene; (Z)-3,7-dimethylocta-1,3,6-triene; (E)-3,7-dimethylocta-2,6-dien-1-ol; methyl 2-((1S,2S)-3-oxo-2-pentylcyclopentyl)acetate; 7-(1,1-Dimethylethyl)-2H-1,5-benzodioxepin-3(4H)-one; (1R-(1alpha,3alpha,4aalpha))-2,3,4,4a,5,6-hexahydro-2,2-dimethyl-1,3-methanonaphthalen-7(1H)-one; tridecan-1-ol; triethyl 2-hydroxypropane-1,2,3-tricarboxylate; methyl 2-((1-hydroxy-3-phenylbutyl)amino)benzoate; 1-((2E,5Z,9Z)-2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethan-1-one; decahydro-2,6,6,7,8,8-hexamethyl-2h-indeno(4,5-b)furan; 13-methyl oxacyclopentadec-10-en-2-one; undecanal; (E)-4-methyldec-3-en-5-ol; (3R,4aS,5R)-4a,5-dimethyl-3-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene; 2-((2R,8R,8aS)-8,8a-dimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)propan-2-ol; 4-formyl-2-methoxyphenyl isobutyrate; (Z)-2-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-enal; methyl 2,4-dihydroxy-3,6-dimethylbenzoate; 1-methoxy-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoindene; methyl(Z)-2-((3-(4-(tert-butyl)phenyl)-2-methylpropylidene)amino)benzoate; (Z)-hex-3-en-1-yl isobutyrate; 2,4,6-trimethyl-4-phenyl-1,3-dioxane; 1-((3R,3aR,7R,8aS)-3,6,8,8-tetramethyl-2,3,4,7,8,8a-hexahydro-1H-3a,7-methanoazulen-5-yl)ethan-1-one; methyl(Z)-2-(((2,4-dimethylcyclohex-3-en-1-yl)methylene)amino)benzoate; 4,8-dimethyl-2-(propan-2-ylidene)-1,2,3,3a,4,5,6,8a-octahydroazulen-6-ol; 4,8-dimethyl-2-(propan-2-ylidene)-1,2,3,3a,4,5,6,8a-octahydroazulen-6-yl acetate; decahydro-3H-spiro[furan-2,5′-[4,7]methanoindene]; (2Z,6E)-nona-2,6-dienenitrile; (Z)-cyclooct-4-en-1-yl methyl carbonate; (1aR,4S,4aS,7R,7aS,7bS)-1,1,4,7-tetramethyldecahydro-1H-cyclopropa[e]azulen-4-ol; 3,5,5,6,7,8,8-heptamethyl-5,6,7,8-tetrahydronaphthalene-2-carbonitrile; (1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1′-cyclohexan]-2′-en-4′-one; 1′,1′,5′,5′-tetramethylhexahydro-2′H,5′H-spiro[[1,3]dioxolane-2,8′-[2,4a]methanonaphthalene]; (2′S,4a′S,8a′S)-1′,1′,5′,5′-tetramethylhexahydro-2′H,5′H-spiro[[1,3]dioxolane-2,8′-[2,4a]methanonaphthalene]; 4-(4-hydroxy-3-methoxyphenyl)butan-2-one; (1R,8aR)-4-isopropyl-1,6-dimethyl-1,2,3,7,8,8a-hexahydronaphthalene; 2,4-dimethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolane; 3a,5,6,7,8,8b-hexahydro-2,2,6,6,7,8,8-heptamethyl-4H-indeno(4,5-d)-1,3-dioxole; 2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine; (1-methyl-2-((1,2,2-trimethylbicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methanol; 2-(cyclohexyloxy)-1,7,7-trimethylbicyclo[2.2.1]heptane; 4-((2R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)cyclohexan-1-ol; 8,8-di(1H-indol-1-yl)-2,6-dimethyloctan-2-ol; (7,7,8,8-tetramethyloctahydro-2,3b-methanocyclopenta[1,3]cyclopropa[1,2]benzen-4-yl)methanol; 8,8-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; (E)-4-((3aR,4R,7R,7aR)-1,3a,4,6,7,7a-hexahydro-5H-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; (3R,3aR,6S,7S,8aS)-6-methoxy-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulene; (1R,2S,6S,7S,8S)-8-isopropyl-1-methyl-3-methylenetricyclo[4.4.0.02,7]decane; 2′-isopropyl-1,7,7-trimethylspiro[bicyclo[2.2.1]heptane-2,4′-[1,3]dioxane]; (4aR,5R,7aS,9R)-2,2,5,8,8,9a-hexamethyloctahydro-4H-4a,9-methanoazuleno[5,6-d][1,3]dioxole; (3S,5aR,7aS,11aS,11bR)-3,8,8,11a-tetramethyldodecahydro-5H-3,5a-epoxynaphtho[2,1-c]oxepine; 2,2,6,6,7,8,8-heptamethyldecahydro-2H-indeno[4,5-b]furan; (1aS,2aR,3R,5aS,7R,7aR)-3,6,6,7a-tetramethyloctahydro-2H-2a,7-methanoazuleno[5,6-b]oxirene; (7,7,8,8-tetramethyloctahydro-2,3b-methanocyclopenta[1,3]cyclopropa[1,2]benzen-4-yl)methyl acetate; 1-(3-hydroxy-3-methylpent-4-en-1-yl)-2,5,5,8a-tetramethyldecahydronaphthalen-2-ol; decahydro-2,6,6,7,8,8-hexamethyl-2h-indeno(4,5-b)furan; 4,5-epoxy-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undecane; 1,3,4,6,7,8alpha-hexahydro-1,1,5,5-tetramethyl-2H-2,4alpha-methanophtalen-8(5H)-one, more preferably said malodor reduction materials are selected from the group consisting of 3-methoxy-7,7-dimethyl-10-methylenebicyclo[4.3.1]decane; 2,4a,5,8a-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl formate; 2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydronaphthalen-1-ol; (4R,4aS,6R)-4,4a-dimethyl-6-(prop-1-en-2-yl)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one; ((3S,3aR,6R,8aS)-7,7-dimethyl-8-methyleneoctahydro-1H-3a,6-methanoazulen-3-yl)methanol; 4,9-dimethoxy-7H-furo[3,2-g]chromen-7-one; (E)-cyclohexadec-8-en-1-one; (Z)-1-(benzyloxy)-2-methoxy-4-(prop-1-en-1-yl)benzene; 1-((2S,3S)-2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethan-1-one; (1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl isobutyrate; 2,3-dihydro-3,3-dimethyl-1H-indene-5-propanal; 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; 2-((2R,4aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol; 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene; (Z)-6-ethylideneoctahydro-2H-5,8-methanochromen-2-one; 8,8-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; octahydro-1H-4,7-methanoinden-5-yl acetate; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl butyrate; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl isobutyrate; (5R,6R)-3,6-dimethyl-5-(prop-1-en-2-yl)-6-vinyl-4,5,6,7-tetrahydrobenzofuran; (E)-cycloheptadec-9-en-1-one; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-3-yl formate; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-6-yl acetate; (3R,3aS,6R,7R,8aS)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-6-ol; 5-methyl-1-(2,2,3-trimethylcyclopent-3-en-1-yl)-6-oxabicyclo[3.2.1]octane; (Z)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-3-en-5-yl acetate; (1S,2S,5R,8S)-4,4,8-trimethyltricyclo[6.3.1.02,5]dodecan-1-ol; (1S,2S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl isobutyrate; (Z)-2-methyl-5-((1S,2R,4R)-2-methyl-3-methylenebicyclo[2.2.1]heptan-2-yl)pent-2-en-1-ol; (1S,4R,7R)-1,4,9,9-tetramethyl-1,2,3,4,5,6,7,8-octahydro-4,7-methanoazulene; (1aS,5aR,9aR)-1a,5,5,7-tetramethyl-1a,2,3,4,5,5a,8,9-octahydrobenzo[1,7]cyclohepta[1,2-b]oxirene; (2,2-dimethoxyethyl)benzene; (3R,3aS,7S,8aS)-3,8,8-trimethyl-6-methyleneoctahydro-1H-3a,7-methanoazulene; 4-methoxybenzyl 2-phenylacetate; 2,2,7,7,8,9,9-heptamethyldecahydroindeno[4,3a-b]furan; (4R,4aS)-4,4a-dimethyl-6-(propan-2-ylidene)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one; (E)-5-(2,3-dimethyltricyclo[2.2.1.02,6]heptan-3-yl)-2-methylpent-2-en-1-ol; (1R,3aS,7S,8aR)-1,4,9,9-tetramethyl-2,3,6,7,8,8a-hexahydro-1H-3a,7-methanoazulene; (1aR,4R,4aR,7bS)-1,1,4,7-tetramethyl-1a,2,3,4,4a,5,6,7b-octahydro-1H-cyclopropa[e]azulene; 2-((2R,4aR,8aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl)propan-2-ol; (3aR,3bR,4S,7R,7aS)-4-isopropyl-7-methyl-3a,3b,4,5,6,7-hexahydro-1H-cyclopenta[1,3]cyclopropa[1,2]benzene; (3R,5aS,9aR)-2,2,5a,9-tetramethyl-3,4,5,5a,6,7-hexahydro-2H-3,9a-methanobenzo[b]oxepine; (1aR,4aS,7R,7aR,7bS)-1,1,7-trimethyl-4-methylenedecahydro-1H-cyclopropa[e]azulene; 2-((2S,4aR,8aR)-4a,8-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl)propan-2-ol; 1-(3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one; (E)-cyclohexadec-5-en-1-one; (1aR,2S,4aS)-2,4a,8,8-tetramethyloctahydrocyclopropa[d]naphthalen-3(1H)-one; 2-((2R,4aS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; 1-(1,1,2,3,3,6-hexamethyl-2,3-dihydro-1H-inden-5-yl)ethan-1-one; (1R,4S,4aS,6R,8aS)-4,8a,9,9-tetramethyloctahydro-1,6-methanonaphthalen-1(2H)-ol; 3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-ylpivalate; (2R,4a′R,8a′R)-3,7′-dimethyl-3′,4′,4a′,5′,8′,8a′-hexahydro-1′H-spiro[oxirane-2,2′-[1,4]methanonaphthalene]; 2,2,7,9-tetramethylspiro(5.5)undec-8-en-1-one; (Z)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 5-methoxyoctahydro-1H-4,7-methanoindene-2-carbaldehyde; (4aR,6aS,10aS,10bR)-3,4a,7,7,10a-pentamethyl-4a,5,6,6a,7,8,9,10,10a,10b-decahydro-1H-benzo[f]chromene; (1aR,4aR,7S,7aR,7bR)-1,1,7-trimethyl-4-methylenedecahydro-1H-cyclopropa[e]azulen-7-ol; 1-(spiro[4.5]dec-7-en-7-yl)pent-4-en-1-one; (1aR,4aS)-2,4a,8,8-tetramethyl-1,1a,4,4a,5,6,7,8-octahydrocyclopropa[d]naphthalene; (1R-(1alpha,3alpha,4aalpha))-2,3,4,4a,5,6-hexahydro-2,2-dimethyl-1,3-methanonaphthalen-7(1H)-one; 2-((2R,8R,8aS)-8,8a-dimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)propan-2-ol; 1-((3R,3aR,7R,8aS)-3,6,8,8-tetramethyl-2,3,4,7,8,8a-hexahydro-1H-3a,7-methanoazulen-5-yl)ethan-1-one; methyl(Z)-2-(((2,4-dimethylcyclohex-3-en-1-yl)methylene)amino)benzoate; 4,8-dimethyl-2-(propan-2-ylidene)-1,2,3,3a,4,5,6,8a-octahydroazulen-6-yl acetate; decahydro-3H-spiro[furan-2,5′-[4,7]methanoindene]; (1aR,4S,4aS,7R,7aS,7bS)-1,1,4,7-tetramethyldecahydro-1H-cyclopropa[e]azulen-4-ol; 3,5,5,6,7,8,8-heptamethyl-5,6,7,8-tetrahydronaphthalene-2-carbonitrile; (1S,2S,3S,5R)-2,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,1′-cyclohexan]-2′-en-4′-one; 1′,1′,5′,5′-tetramethylhexahydro-2′H,5′H-spiro[[1,3]dioxolane-2,8′-[2,4a]methanonaphthalene]; (2′S,4a′S,8a′S)-1′,1′,5′,5′-tetramethylhexahydro-2′H,5′H-spiro[[1,3]dioxolane-2,8′-[2,4a]methanonaphthalene]; (7,7,8,8-tetramethyloctahydro-2,3b-methanocyclopenta[1,3]cyclopropa[1,2]benzen-4-yl)methanol; 4,5-epoxy-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undecane; 1,3,4,6,7,8alpha-hexahydro-1,1,5,5-tetramethyl-2H-2,4alpha-methanophtalen-8(5H)-one, most preferably said malodor reduction materials are selected from the group consisting of (E)-cyclohexadec-5-en-1-one; 2,2,7,7,8,9,9-heptamethyldecahydroindeno[4,3a-b]furan; 2,3-dihydro-3,3-dimethyl-1H-indene-5-propanal; 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal; 4,5-epoxy-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undecane; 1,3,4,6,7,8alpha-hexahydro-1,1,5,5-tetramethyl-2H-2,4alpha-methanophtalen-8(5H)-one and mixtures thereof.
6. An antiperspirant and/or deodorant composition according to any preceding claim, said composition comprising one or more perfume raw materials.
7. An antiperspirant and/or deodorant composition according to any preceding claim wherein, said sum total of malodor reduction materials has an average boiling point, based on the weight percent of each malodor reduction material in said sum total of malodor reduction materials, of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.; preferably 25%, more preferably 50%, more preferably 75%, most preferably each of said malodor reduction materials in said sum total of malodor reduction materials has a of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.
8. An antiperspirant and/or deodorant composition according to any preceding claim wherein, said combination of said sum total of malodor reduction materials and said one or more perfume raw materials combined has an average boiling point, based on the weight percent of each malodor reduction material in said sum total of malodor reduction materials, of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.; preferably 25%, more preferably 50%, more preferably 75%, most preferably each of said malodor reduction materials in said sum total of malodor reduction materials and each of said one or more perfume raw materials has a boiling point of from about 160° C. to about 400° C., preferably from about 180° C. to about 400° C.
9. An antiperspirant and/or deodorant composition according to any preceding claim wherein, the ratio of said one or more perfume raw materials to said sum total of malodor reduction material being from about 500:1 to about 1:1, preferably from about 50:1 to about 1:1, more preferably from about 20:1 to about 1:1, most preferably from about 2:1 to about 1:1.
10. An antiperspirant and/or deodorant composition according to any preceding claim, wherein less than 10%, preferably less than 5%, more preferably less than 1% of said malodor reduction materials and said one or more perfume raw materials, based on total combined weight of malodor reduction materials and said one or more perfume raw materials comprise an ionone moiety.
11. An antiperspirant and/or deodorant composition according to any preceding claim, wherein said malodor reduction materials are not a material selected from the group consisting of geranyl nitrile; helional; nonanal; linalool; (S)-(+)-linalool; (R)-(−)-linalool; nerol; tetrahydrolinalool; 2-phenylethyl acetate; eugenol; ethyl linalool; allyl heptoate; agrumen nitrile; citronitrile; 2,2-dimethyl-3-(m-tolyl)propan-1-ol; 2-methyl-5-phenylpentan-1-ol; dodecanenitrile; 2-heptylcyclopentan-1-one; methyl nonyl acetaldehyde; 3-(2-ethylphenyl)-2,2-dimethylpropanal; (Z)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one; (R,E)-2-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 4-(tert-butyl)cyclohexyl acetate; 1-cyclohexylethyl(E)-but-2-enoate; allyl 2-(cyclohexyloxy)acetate; alpha terpinyl acetate; beta terpinyl acetate; gamma terpinyl acetate; methyl dodecyl ether; 2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine; cinnamyl isobutyrate; (E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-2-enal; gamma methyl ionone; ethyl 2,3,6-trimethyl cyclohexyl carbonate ethyl 2,3,6-trimethyl cyclohexyl carbonate; Citral diethyl acetal; Dimethoxycyclododecane; 1-((2S,3S)-2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethan-1-one; oxacyclohexadecan-2-one; 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene; Ethylene brassylate; Methyl(Z)-2-((3-(4-(tert-butyl)phenyl)-2-methylpropylidene)amino)benzoate; 4,7-Methano-1H-inden-5-ol, 3a,4,5,6,7,7a-hexahydro-, 5-acetate; cedryl methyl ether; vetivert acetate; 1-((3R,3aR,7R,8aS)-3,6,8,8-tetramethyl-2,3,4,7,8,8a-hexahydro-1H-3a,7-methanoazulen-5-yl)ethan-1-one; Benzophenone; Farnesol; trans,trans-farnesol; 3-(3-isopropylphenyl)butanal; 2,6,10-trimethylundec-9-enal; 3-(4-(tert-butyl)phenyl)propanal; 3-(4-isopropylphenyl)-2-methylpropanal; Citronellal (1); Citronellal (d); (E)-4,8-dimethyldeca-4,9-dienal; Pino Acetaldehyde; 3-(4-(tert-butyl)phenyl)-2-methylpropanal; Cinnamic aldehyde; Citral; Geranial; MethoxyMelonal; o-methoxycinnamaldehyde; (E)-4-((3aS,7aS)-octahydro-5H-4,7-methanoinden-5-ylidene)butanal; Methyl Octyl Acetaldehyde; 3-(4-methoxyphenyl)-2-methylpropanal; 5-methoxyoctahydro-1H-4,7-methanoindene-2-carbaldehyde; Iso Cyclocitral; Octanal; 2-Undecenal; 10-Undecenal; Trans-trans-2,6-Nonadienal; Trans-2,cis-6-nondienal; Heliotropin; Hexyl Cinnamic aldehyde; p-methyl-alpha-pentylcinnamaldehyde; Alpha-methyl cinnamaldehyde; 3,4-dimethoxybenzaldehyde; Myrtenal; Perillaldehyde; Maceal; Methyl palmitate; Methyl iso eugenol and mixtures thereof.
12. An antiperspirant and/or deodorant composition according to any preceding claim, said composition being a antiperspirant composition, said antiperspirant composition comprising a total of, based on total antiperspirant composition weight, from about 0.1% to about 7% of one or more of said malodor reduction materials and, optionally, from about 1% to about 25% of an aluminum salt antiperspirant active.
13. An antiperspirant and/or deodorant composition according to any preceding claim, said composition being anhydrous antiperspirant composition, said anhydrous antiperspirant composition comprising a total of, based on total antiperspirant composition weight, from about 0.1% to about 7% of one or more of said malodor reduction materials and from about 1% to about 25% of an antiperspirant actives selected from the group consisting of astringent metallic salts, preferably inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof, more preferably aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof.
14. An antiperspirant and/or deodorant composition according to any preceding claim, said composition comprising an adjunct ingredient selected from the group consisting of clay mineral powders, pearl pigments, organic powders, emulsifiers, distributing agents, pharmaceutical active, topical active, preservatives, surfactants and mixtures thereof.
15. A deodorant method of controlling malodors comprising: contacting a situs comprising a malodor and/or a situs that will become malodorous with a care antiperspirant and/or deodorant composition selected from the group consisting of the antiperspirant and/or deodorant composition of claims 1 to 14.
16. The method of claim 15 wherein, said situs comprises an underarm and said contacting step comprises contacting said underarm with a sufficient amount of Applicants' antiperspirant and/or deodorant composition containing said sum of malodor reduction materials to provide said underarm with a level of malodor reduction materials of at least 0.0001 mg of malodor reduction material per underarm, preferably from about 0.0001 mg of malodor reduction material per underarm to about 10 mg of malodor reduction material per underarm, more preferably from about 0.001 mg of malodor reduction material per underarm about 5 mg of malodor reduction material per underarm, most preferably from about 0.01 of malodor reduction material per underarm to about 0.2 mg of malodor reduction material per underarm.
US14/865,048 2014-09-26 2015-09-25 Antiperspirant and deodorant compositions comprising malodor reduction compositions Abandoned US20160089317A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/865,048 US20160089317A1 (en) 2014-09-26 2015-09-25 Antiperspirant and deodorant compositions comprising malodor reduction compositions
US15/597,376 US20170249407A1 (en) 2014-09-26 2017-05-17 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions
US15/597,391 US20170249408A1 (en) 2014-09-26 2017-05-17 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462055844P 2014-09-26 2014-09-26
US201562143862P 2015-04-07 2015-04-07
US14/865,048 US20160089317A1 (en) 2014-09-26 2015-09-25 Antiperspirant and deodorant compositions comprising malodor reduction compositions

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US15/597,376 Division US20170249407A1 (en) 2014-09-26 2017-05-17 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions
US15/597,391 Division US20170249408A1 (en) 2014-09-26 2017-05-17 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions

Publications (1)

Publication Number Publication Date
US20160089317A1 true US20160089317A1 (en) 2016-03-31

Family

ID=54256860

Family Applications (20)

Application Number Title Priority Date Filing Date
US14/864,994 Abandoned US20160090555A1 (en) 2014-09-26 2015-09-25 Cleaning and/or treatment compositions comprising malodor reduction compositions
US14/865,010 Abandoned US20160090556A1 (en) 2014-09-26 2015-09-25 Products comprising malodor reduction materials
US14/865,056 Abandoned US20170333591A9 (en) 2014-09-26 2015-09-25 Absorbent article comprising malodor reduction compositions
US14/865,048 Abandoned US20160089317A1 (en) 2014-09-26 2015-09-25 Antiperspirant and deodorant compositions comprising malodor reduction compositions
US14/864,927 Abandoned US20160089464A1 (en) 2014-09-26 2015-09-25 Malodor reduction compositions
US14/865,099 Abandoned US20160090557A1 (en) 2014-09-26 2015-09-25 Substrates comprising malodor reduction compositions
US14/865,412 Abandoned US20160090558A1 (en) 2014-09-26 2015-09-25 Delivery systems comprising malodor reduction compositions
US14/865,257 Active 2036-03-14 US11334694B2 (en) 2014-09-26 2015-09-25 Personal care compositions comprising malodor reduction compositions
US14/864,973 Abandoned US20160092661A1 (en) 2014-09-26 2015-09-25 Method of making perfumed goods
US14/865,066 Active US10113140B2 (en) 2014-09-26 2015-09-25 Freshening compositions and devices comprising same
US14/865,089 Active US10552557B2 (en) 2014-09-26 2015-09-25 Freshening compositions and devices comprising same
US15/196,081 Abandoned US20160306909A1 (en) 2014-09-26 2016-06-29 Method of making perfumed goods
US15/407,477 Abandoned US20170119917A1 (en) 2014-09-26 2017-01-17 Malodor reduction compositions
US15/421,642 Abandoned US20170137753A1 (en) 2014-09-26 2017-02-01 Delivery systems comprising malodor reduction compositions
US15/421,481 Abandoned US20170137752A1 (en) 2014-09-26 2017-02-01 Products comprising malodor reduction materials
US15/432,957 Abandoned US20170255725A1 (en) 2014-09-26 2017-02-15 Substrates comprising malodor reduction compositions
US15/597,391 Abandoned US20170249408A1 (en) 2014-09-26 2017-05-17 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions
US15/597,376 Abandoned US20170249407A1 (en) 2014-09-26 2017-05-17 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions
US15/708,205 Active 2036-04-16 US11334695B2 (en) 2014-09-26 2017-09-19 Antiperspirant and deodorant compositions comprising malodor reduction compositions
US15/716,544 Abandoned US20180066210A1 (en) 2014-09-26 2017-09-27 Delivery systems comprising malodor reduction compositions

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US14/864,994 Abandoned US20160090555A1 (en) 2014-09-26 2015-09-25 Cleaning and/or treatment compositions comprising malodor reduction compositions
US14/865,010 Abandoned US20160090556A1 (en) 2014-09-26 2015-09-25 Products comprising malodor reduction materials
US14/865,056 Abandoned US20170333591A9 (en) 2014-09-26 2015-09-25 Absorbent article comprising malodor reduction compositions

Family Applications After (16)

Application Number Title Priority Date Filing Date
US14/864,927 Abandoned US20160089464A1 (en) 2014-09-26 2015-09-25 Malodor reduction compositions
US14/865,099 Abandoned US20160090557A1 (en) 2014-09-26 2015-09-25 Substrates comprising malodor reduction compositions
US14/865,412 Abandoned US20160090558A1 (en) 2014-09-26 2015-09-25 Delivery systems comprising malodor reduction compositions
US14/865,257 Active 2036-03-14 US11334694B2 (en) 2014-09-26 2015-09-25 Personal care compositions comprising malodor reduction compositions
US14/864,973 Abandoned US20160092661A1 (en) 2014-09-26 2015-09-25 Method of making perfumed goods
US14/865,066 Active US10113140B2 (en) 2014-09-26 2015-09-25 Freshening compositions and devices comprising same
US14/865,089 Active US10552557B2 (en) 2014-09-26 2015-09-25 Freshening compositions and devices comprising same
US15/196,081 Abandoned US20160306909A1 (en) 2014-09-26 2016-06-29 Method of making perfumed goods
US15/407,477 Abandoned US20170119917A1 (en) 2014-09-26 2017-01-17 Malodor reduction compositions
US15/421,642 Abandoned US20170137753A1 (en) 2014-09-26 2017-02-01 Delivery systems comprising malodor reduction compositions
US15/421,481 Abandoned US20170137752A1 (en) 2014-09-26 2017-02-01 Products comprising malodor reduction materials
US15/432,957 Abandoned US20170255725A1 (en) 2014-09-26 2017-02-15 Substrates comprising malodor reduction compositions
US15/597,391 Abandoned US20170249408A1 (en) 2014-09-26 2017-05-17 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions
US15/597,376 Abandoned US20170249407A1 (en) 2014-09-26 2017-05-17 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions
US15/708,205 Active 2036-04-16 US11334695B2 (en) 2014-09-26 2017-09-19 Antiperspirant and deodorant compositions comprising malodor reduction compositions
US15/716,544 Abandoned US20180066210A1 (en) 2014-09-26 2017-09-27 Delivery systems comprising malodor reduction compositions

Country Status (10)

Country Link
US (20) US20160090555A1 (en)
EP (10) EP3197510A1 (en)
JP (10) JP6923439B2 (en)
KR (2) KR102008588B1 (en)
CN (8) CN106716482A (en)
AR (1) AR105148A1 (en)
CA (9) CA2959691A1 (en)
MX (7) MX2017003971A (en)
WO (11) WO2016049407A1 (en)
ZA (1) ZA201701449B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170172872A1 (en) * 2015-12-17 2017-06-22 Henkel Ag & Co. Kgaa Propellant-free deodorants and/or antiperspirants having specific preservative-agent combinations
WO2018053344A1 (en) * 2016-09-16 2018-03-22 University Of Florida Research Foundation, Inc. Sweetness enhancing volatile compositions and methods of increasing perceived sweetness of a comestible
US10113140B2 (en) 2014-09-26 2018-10-30 The Procter & Gamble Company Freshening compositions and devices comprising same
US10179887B1 (en) * 2017-07-14 2019-01-15 International Flavors & Fragrances Inc. Organoleptic compounds
US10240108B2 (en) 2015-10-19 2019-03-26 The Procter & Gamble Company Particles for malodor reduction
US10610473B2 (en) 2016-03-24 2020-04-07 The Procter And Gamble Company Hair care compositions comprising malodor reduction compositions
US11352588B2 (en) 2018-04-02 2022-06-07 Kao Corporation Musk-like composition
US11679065B2 (en) 2020-02-27 2023-06-20 The Procter & Gamble Company Compositions with sulfur having enhanced efficacy and aesthetics
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11819474B2 (en) 2020-12-04 2023-11-21 The Procter & Gamble Company Hair care compositions comprising malodor reduction materials
US11904036B2 (en) 2017-10-10 2024-02-20 The Procter & Gamble Company Sulfate free clear personal cleansing composition comprising low inorganic salt
US11980679B2 (en) 2019-12-06 2024-05-14 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11085009B2 (en) * 2012-10-12 2021-08-10 International Flavors & Fragrances Inc. Enhanced deposition of ethyl vanillin or vanillin with friable microcapsules
EP2981245B1 (en) 2013-04-05 2023-03-01 The Procter & Gamble Company Personal care composition comprising a pre-emulsified formulation
US10806688B2 (en) 2014-10-03 2020-10-20 The Procter And Gamble Company Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation
US9993404B2 (en) 2015-01-15 2018-06-12 The Procter & Gamble Company Translucent hair conditioning composition
TWI769972B (en) * 2015-01-19 2022-07-11 日商花王股份有限公司 Water-absorbent resin composition and method for producing the same, absorbent article and method for producing the same, and method for producing a material for absorbent articles
EP3262233A1 (en) 2015-02-25 2018-01-03 The Procter and Gamble Company Fibrous structures comprising a surface softening composition
JP6663174B2 (en) * 2015-06-08 2020-03-11 大日本除蟲菊株式会社 Pharmaceutical compositions, pest control incense sticks, and preparations for heat evaporation
CN107809994A (en) 2015-06-30 2018-03-16 宝洁公司 Include the composition of multiple microcapsules colonies
CN107847768A (en) * 2015-06-30 2018-03-27 宝洁公司 For the method for the composition for preparing multiple colonies comprising microcapsules
US11773351B2 (en) 2015-06-30 2023-10-03 The Procter & Gamble Company Compositions containing multiple populations of microcapsules
EP3623527A1 (en) 2015-07-10 2020-03-18 The Procter & Gamble Company Fabric care composition comprising metathesized unsaturated polyol esters
US11352587B2 (en) * 2015-09-08 2022-06-07 Symrise Ag Fragrance mixtures
GB201521861D0 (en) * 2015-12-11 2016-01-27 Givaudan Sa Improvements in or relating to organic compounds
MX2018008913A (en) 2016-01-20 2019-05-06 Procter & Gamble Hair conditioning composition comprising monoalkyl glyceryl ether.
US11851631B2 (en) * 2016-02-24 2023-12-26 Takasago International Corporation Household product delivering cooling sensations
US20190054200A1 (en) * 2016-02-24 2019-02-21 Takasago International Corporation Household product delivering warming and/or tingling sensations
US10457900B2 (en) * 2016-05-20 2019-10-29 The Proctor & Gamble Company Detergent composition comprising an alkyl ether sulfate-rich surfactant system and coated encapsulates
US10494592B2 (en) * 2016-05-20 2019-12-03 The Procter & Gamble Company Detergent composition comprising anionic/nonionic/cationic surfactant system and encapsulates
US20170355933A1 (en) * 2016-06-09 2017-12-14 The Procter & Gamble Company Cleaning compositions including nuclease enzyme and malodor reduction materials
FR3052665B1 (en) * 2016-06-16 2018-06-08 Expressions Parfumees MIXTURE COMPRISING AT LEAST DIHYDRO-5-PENTYL-2 (3H) -FURANONE AND 2,4-DIMETHYL-4-PHENYLTETRAHYDROFURAN AND USE THEREOF FOR HAMBLING
GB2551395A (en) 2016-06-17 2017-12-20 Reckitt Benckiser (Brands) Ltd Atomiser system for dispensing a fragrance
US11097031B2 (en) 2016-08-01 2021-08-24 The Procter & Gamble Company Phase-stable, sprayable freshening compositions comprising suspended particles
WO2018026625A1 (en) * 2016-08-01 2018-02-08 The Procter & Gamble Company Sprayable freshening product comprising suspended particles and methods of freshening the air or a surface with the same
US10143764B2 (en) * 2016-08-01 2018-12-04 The Procter & Gamble Company Phase-stable, sprayable freshening compositions comprising suspended particles
US10076583B2 (en) * 2016-08-01 2018-09-18 The Procter & Gamble Company Phase-stable, sprayable freshening compositions comprising suspended particles and methods of freshening the air or a surface with the same
PL3279303T3 (en) * 2016-08-04 2019-08-30 The Procter & Gamble Company Water-soluble unit dose article comprising an amphoteric surfactant
US10894932B2 (en) 2016-08-18 2021-01-19 The Procter & Gamble Company Fabric care composition comprising glyceride copolymers
DE102016219295A1 (en) * 2016-09-26 2018-03-29 Henkel Ag & Co. Kgaa Continuous process for the preparation of perfume-containing fused bodies
EP3301160A1 (en) * 2016-10-03 2018-04-04 The Procter & Gamble Company Low ph laundry detergent composition
CN109890950A (en) 2016-11-01 2019-06-14 宝洁公司 Leuco colorants as bluing agents in laundry care compositions
WO2018085390A1 (en) 2016-11-01 2018-05-11 Milliken & Company Leuco colorants as bluing agents in laundry care compositions
CN109890949B (en) 2016-11-01 2021-10-01 宝洁公司 Leuco colorants as bluing agents in laundry care compositions, packages, kits and methods thereof
MX2019005825A (en) 2016-11-18 2019-07-10 Procter & Gamble Fabric treatment compositions and methods for providing a benefit.
US20180142188A1 (en) * 2016-11-18 2018-05-24 The Procter & Gamble Company Fabric treatment compositions having polymers and fabric softening actives and methods for providing a benefit
CN109982725A (en) * 2016-11-18 2019-07-05 弗门尼舍有限公司 The perception to excrement stench is limited or eliminated using volatile component
US10870816B2 (en) 2016-11-18 2020-12-22 The Procter & Gamble Company Fabric treatment compositions having low calculated cationic charge density polymers and fabric softening actives and methods for providing a benefit
CA3051268C (en) 2016-11-21 2022-11-29 Bell Flavors & Fragrances, Inc. Malodor counteractant composition and methods
GB201703706D0 (en) 2017-03-08 2017-04-19 Givaudan Sa Improvements in or relating to organic compounds
MX2019013063A (en) 2017-05-05 2020-02-05 Symrise Ag Composition for odour improvement.
JP6895804B2 (en) * 2017-05-29 2021-06-30 花王株式会社 Hardener composition for molding
JP2020525602A (en) 2017-07-06 2020-08-27 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company Silicone compound
WO2019010265A1 (en) 2017-07-06 2019-01-10 The Procter & Gamble Company Silicone compounds
US20190029928A1 (en) * 2017-07-31 2019-01-31 The Procter & Gamble Company Fibrous Structures Comprising Malodor Reduction Compositions
US11802258B2 (en) * 2017-09-25 2023-10-31 Takasago International Corporation Perfume precursor
WO2019061375A1 (en) * 2017-09-30 2019-04-04 The Procter & Gamble Company Method and apparatus for visual demonstration of malodor control benefit of consumer products
US20190194579A1 (en) 2017-10-12 2019-06-27 The Procter & Gamble Company Leuco colorants as bluing agents in laundry care compositions
WO2019075146A1 (en) 2017-10-12 2019-04-18 The Procter & Gamble Company Leuco colorants as bluing agents in laundry care composition
TWI715878B (en) 2017-10-12 2021-01-11 美商美力肯及公司 Leuco colorants and compositions
EP3694980A1 (en) 2017-10-12 2020-08-19 The Procter and Gamble Company Leuco colorants in combination with a second whitening agent as bluing agents in laundry care compositions
JP7230043B2 (en) 2017-11-01 2023-02-28 ミリケン・アンド・カンパニー Leuco compounds, colorant compounds, and compositions containing them
US11744785B2 (en) 2017-11-22 2023-09-05 Firmenich Sa Use of volatile compositions to limit or eliminate the perception of malodor
BR112020007987A2 (en) * 2017-11-22 2020-10-20 Firmenich S.A. Spiro compounds as neutralizing ingredients for bad odor
JP7460981B2 (en) * 2017-11-29 2024-04-03 山本香料株式会社 Odor modulating agent for modulating the odor of asphalt, sludge, sewage, ginkgo, compost, marine animals, vegetables, food waste, or paint, and method for modulating the odor of asphalt, sludge, sewage, ginkgo, compost, marine animals, vegetables, food waste, or paint
KR101988012B1 (en) * 2017-12-12 2019-06-11 한국콜마주식회사 Composition for masking raw-material smell of cosmetic composition
US10792384B2 (en) 2017-12-15 2020-10-06 The Procter & Gamble Company Rolled fibrous structures comprising encapsulated malodor reduction compositions
JP6973220B2 (en) * 2018-03-20 2021-11-24 日油株式会社 Deodorant for asphalt
GB201805435D0 (en) * 2018-04-03 2018-05-16 Givaudan Sa Improvements in or relating to organic compounds
US10699960B2 (en) 2018-06-27 2020-06-30 Taiwan Semiconductor Manufacturing Co., Ltd. Methods for improving interlayer dielectric layer topography
EP3814463A1 (en) 2018-06-29 2021-05-05 Ecolab USA Inc. Formula design for a solid laundry fabric softener
EP3814462A1 (en) * 2018-06-29 2021-05-05 The Procter & Gamble Company Cleaning compositions comprising esteramines
US20210171865A1 (en) * 2018-07-19 2021-06-10 Lonza, Llc Detergent Composition
US11806448B2 (en) 2018-07-31 2023-11-07 Arylessence, Inc. Freshening compositions comprising controlled release modulators
EP3611247B1 (en) 2018-08-14 2021-03-10 The Procter & Gamble Company Fabric treatment compositions comprising benefit agent capsules
EP3611245B1 (en) * 2018-08-14 2021-03-10 The Procter & Gamble Company Liquid fabric treatment compositions comprising brightener
EP3848442A1 (en) 2018-08-14 2021-07-14 The Procter & Gamble Company Fabric treatment compositions comprising benefit agent capsules
CN109135960B (en) * 2018-09-29 2021-05-04 广州立白企业集团有限公司 Application of polymer as protease stabilizer in detergent and detergent composition
US11732218B2 (en) 2018-10-18 2023-08-22 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US20200123475A1 (en) * 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
US20200123319A1 (en) * 2018-10-18 2020-04-23 Milliken & Company Polyethyleneimine compounds containing n-halamine and derivatives thereof
US11299591B2 (en) 2018-10-18 2022-04-12 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11518963B2 (en) * 2018-10-18 2022-12-06 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11466122B2 (en) * 2018-10-18 2022-10-11 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
WO2020104009A1 (en) * 2018-11-19 2020-05-28 Symrise Ag Jasmol
US20200170906A1 (en) * 2018-12-04 2020-06-04 The Procter & Gamble Company Hair care composition for cleansing and refreshing the hair and the scalp
MX2021012399A (en) 2019-04-12 2021-12-10 Ecolab Usa Inc Antimicrobial multi-purpose cleaner and methods of making and using the same.
JP7385999B2 (en) * 2019-05-24 2023-11-24 株式会社 資生堂 Personal care compositions and malodor control methods
US12011517B2 (en) 2019-10-10 2024-06-18 The Procter & Gamble Company Air freshening product
KR102130972B1 (en) * 2019-10-22 2020-07-07 한국화학연구원 Deodorant composition and deodorant comprising same
EP3822334A1 (en) 2019-11-18 2021-05-19 The Procter & Gamble Company Process of reducing malodors on fabrics
WO2021110770A1 (en) * 2019-12-04 2021-06-10 Firmenich Sa Fragrance dispensing emanating substrate and method
CN110917867A (en) * 2019-12-20 2020-03-27 烟台欧顺生物科技有限公司 Preparation method of odor remover of microbial exopolysaccharide and seaweed polysaccharide composite
TWI726626B (en) * 2020-02-19 2021-05-01 大陸商廣州市創韋照明燈具有限公司 Sugar-containing aqueous solution formula suitable for producing smoke and method of using sugar-containing aqueous solution to produce smoke
CN115151340A (en) * 2020-02-28 2022-10-04 杰富意矿物股份有限公司 Composite body
WO2021203207A1 (en) * 2020-04-09 2021-10-14 Tyromer Inc. Method and system for odour abatement in rubber processing
JP2023526020A (en) 2020-06-05 2023-06-20 ザ プロクター アンド ギャンブル カンパニー Detergent composition containing branched surfactant
US20220056371A1 (en) * 2020-08-18 2022-02-24 Ap Goldshield Llc 3-in one fabric conditioners and softeners comprising antimicrobial agents
BR112023004156A2 (en) 2020-09-22 2023-04-04 Swimc Llc COATING COMPOSITION, COATED ARTICLE, AND METHOD FOR PRODUCING A COATING COMPOSITION
WO2022093189A1 (en) 2020-10-27 2022-05-05 Milliken & Company Compositions comprising leuco compounds and colorants
CN112611823A (en) * 2020-11-18 2021-04-06 上海和黄药业有限公司 Method for detecting main active ingredients of borneol and artificial musk in medicinal preparation
EP4438065A2 (en) 2020-12-09 2024-10-02 Symrise AG A mixture comprising 1,2-alkanediols
US11560534B2 (en) * 2020-12-15 2023-01-24 Henkel Ag & Co. Kgaa Surfactant compositions for improved transparency of DADMAC-acrylamide co-polymers
US11505766B2 (en) 2020-12-15 2022-11-22 Henkel Ag & Co. Kgaa Surfactant compositions for improved transparency of DADMAC-acrylic acid co-polymers
KR102579965B1 (en) * 2021-02-03 2023-09-19 한국콜마주식회사 Perfume composition for expressing the fragrance of bugleweed clove fennel aroma tea
EP4347573A1 (en) 2021-05-26 2024-04-10 The Procter & Gamble Company Pro-benefit-agent compounds with heterocyclic moieties
JP2024523167A (en) * 2021-06-03 2024-06-28 フイルメニツヒ ソシエテ アノニム Composition for controlling, reducing or eliminating malodors associated with plastic materials - Patents.com
EP4376793A1 (en) * 2021-07-28 2024-06-05 Shear/Kershman Laboratories, Inc. Reduced odor formaldehyde-containing antiseptic lotion
JP2024531182A (en) * 2021-08-13 2024-08-29 エンカプシス エルエルシー Amine-containing natural substance-based disintegrating delivery particles
CN113841707B (en) * 2021-10-26 2022-07-05 中国热带农业科学院环境与植物保护研究所 Application of trans-farnesol as synergist in preventing and treating litchi downy blight
GB202204394D0 (en) * 2022-03-28 2022-05-11 Codikoat Ltd Antimicrobial and/or antiviral materials
EP4321604A1 (en) 2022-08-08 2024-02-14 The Procter & Gamble Company A fabric and home care composition comprising surfactant and a polyester
WO2024074830A1 (en) * 2022-10-05 2024-04-11 Codikoat Ltd Antimicrobial and/or antiviral materials
WO2024094800A1 (en) 2022-11-04 2024-05-10 The Procter & Gamble Company Fabric and home care composition
WO2024094778A1 (en) 2022-11-04 2024-05-10 Clariant International Ltd Polyesters
WO2024094803A1 (en) 2022-11-04 2024-05-10 The Procter & Gamble Company Fabric and home care composition
WO2024119298A1 (en) 2022-12-05 2024-06-13 The Procter & Gamble Company Fabric and home care composition comprising a polyalkylenecarbonate compound
WO2024129520A1 (en) 2022-12-12 2024-06-20 The Procter & Gamble Company Fabric and home care composition
EP4386074A1 (en) 2022-12-16 2024-06-19 The Procter & Gamble Company Fabric and home care composition
EP4411059A3 (en) 2023-02-06 2024-08-21 Kraton Polymers Nederland B.V. Compositions and methods for odor control
GB202303310D0 (en) 2023-03-07 2023-04-19 Joulium Energy Ltd Working fluid composition
WO2024213536A1 (en) * 2023-04-13 2024-10-17 Givaudan Sa Fragrance composition
EP4458932A1 (en) 2023-05-04 2024-11-06 The Procter & Gamble Company A fabric and home care composition
EP4458933A1 (en) 2023-05-05 2024-11-06 The Procter & Gamble Company A fabric and home care composition comprising a propoxylated polyol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080176780A1 (en) * 2006-09-04 2008-07-24 Takasago International Corporation Encapsulation of bulky fragrance molecules
US20110098209A1 (en) * 2009-01-29 2011-04-28 Johan Smets Encapsulates
US20110245134A1 (en) * 2010-04-06 2011-10-06 Johan Smets Encapsulates

Family Cites Families (170)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438091A (en) 1943-09-06 1948-03-16 American Cyanamid Co Aspartic acid esters and their preparation
US2528378A (en) 1947-09-20 1950-10-31 John J Mccabe Jr Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same
US2658072A (en) 1951-05-17 1953-11-03 Monsanto Chemicals Process of preparing amine sulfonates and products obtained thereof
US2809971A (en) 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US3236733A (en) 1963-09-05 1966-02-22 Vanderbilt Co R T Method of combatting dandruff with pyridinethiones metal salts detergent compositions
US3761418A (en) 1967-09-27 1973-09-25 Procter & Gamble Detergent compositions containing particle deposition enhancing agents
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
US3716498A (en) 1971-04-02 1973-02-13 Int Flavors & Fragrances Inc Novel fragrance compositions
US3753196A (en) 1971-10-05 1973-08-14 Kulite Semiconductor Products Transducers employing integral protective coatings and supports
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4049792A (en) 1973-06-26 1977-09-20 The Procter & Gamble Company Antiperspirant stick
FR2259587A1 (en) 1974-02-04 1975-08-29 Procter & Gamble Zirconium or hafnium oxyhalide anti-perspirant cpds - used in compsns with aluminium cpds and amino acids
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB1567947A (en) 1976-07-02 1980-05-21 Unilever Ltd Esters of quaternised amino-alcohols for treating fabrics
US4120948A (en) 1976-11-29 1978-10-17 The Procter & Gamble Company Two phase antiperspirant compositions
US4237155A (en) 1979-04-30 1980-12-02 The Procter & Gamble Company Articles and methods for treating fabrics
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
DE3068546D1 (en) 1979-11-07 1984-08-16 Procter & Gamble Antiperspirant compositions
US4379753A (en) 1980-02-07 1983-04-12 The Procter & Gamble Company Hair care compositions
US4345080A (en) 1980-02-07 1982-08-17 The Procter & Gamble Company Pyridinethione salts and hair care compositions
US4323683A (en) 1980-02-07 1982-04-06 The Procter & Gamble Company Process for making pyridinethione salts
US4470982A (en) 1980-12-22 1984-09-11 The Procter & Gamble Company Shampoo compositions
GR76237B (en) 1981-08-08 1984-08-04 Procter & Gamble
JPS604598A (en) * 1983-06-22 1985-01-11 ライオン株式会社 Deodorant detergent composition
GB2144992A (en) 1983-08-16 1985-03-20 Gillette Co Antiperspirants
JPS62205200A (en) * 1986-03-03 1987-09-09 花王株式会社 Aromatic liquid bleaching composition
US5942217A (en) 1997-06-09 1999-08-24 The Procter & Gamble Company Uncomplexed cyclodextrin compositions for odor control
US4973416A (en) 1988-10-14 1990-11-27 The Procter & Gamble Company Liquid laundry detergent in water-soluble package
US5019375A (en) 1989-03-14 1991-05-28 The Procter & Gamble Company Low residue antiperspirant creams
US4985238A (en) 1989-03-14 1991-01-15 The Procter & Gamble Company Low residue antiperspirant sticks
US5104646A (en) 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5106609A (en) 1990-05-01 1992-04-21 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
DE4015849A1 (en) 1990-05-17 1991-11-21 Henkel Kgaa QUATERNED ESTERS
JP3560989B2 (en) * 1991-11-08 2004-09-02 クウエスト・インターナシヨナル・ベー・ベー Fragrance composition
CZ277194A3 (en) 1992-05-12 1995-05-17 Procter & Gamble Anti-perspirant rod-like jellylike preparation
EP0571677A1 (en) 1992-05-29 1993-12-01 Unilever Plc Aqueous parfume oil microemulsions
JPH06220495A (en) * 1993-01-25 1994-08-09 Lion Corp Liquid bleach composition
US5486303A (en) 1993-08-27 1996-01-23 The Procter & Gamble Company Process for making high density detergent agglomerates using an anhydrous powder additive
PL318553A1 (en) * 1994-08-12 1997-06-23 Procter & Gamble Compositions for attenuation of unpleasant odour impression from surfaces on non-living bodies
US5714137A (en) 1994-08-12 1998-02-03 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
US5670475A (en) 1994-08-12 1997-09-23 The Procter & Gamble Company Composition for reducing malodor impression of inanimate surfaces
HU218030B (en) 1994-08-12 2000-05-28 The Procter & Gamble Co. Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces and use thereof
US5879584A (en) 1994-09-10 1999-03-09 The Procter & Gamble Company Process for manufacturing aqueous compositions comprising peracids
US5516448A (en) 1994-09-20 1996-05-14 The Procter & Gamble Company Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate
US5691297A (en) 1994-09-20 1997-11-25 The Procter & Gamble Company Process for making a high density detergent composition by controlling agglomeration within a dispersion index
US5489392A (en) 1994-09-20 1996-02-06 The Procter & Gamble Company Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties
US5534179A (en) 1995-02-03 1996-07-09 Procter & Gamble Detergent compositions comprising multiperacid-forming bleach activators
US5574005A (en) 1995-03-07 1996-11-12 The Procter & Gamble Company Process for producing detergent agglomerates from high active surfactant pastes having non-linear viscoelastic properties
US5569645A (en) 1995-04-24 1996-10-29 The Procter & Gamble Company Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties
US5597936A (en) 1995-06-16 1997-01-28 The Procter & Gamble Company Method for manufacturing cobalt catalysts
US5565422A (en) 1995-06-23 1996-10-15 The Procter & Gamble Company Process for preparing a free-flowing particulate detergent composition having improved solubility
US5576282A (en) 1995-09-11 1996-11-19 The Procter & Gamble Company Color-safe bleach boosters, compositions and laundry methods employing same
US5800897A (en) * 1996-01-25 1998-09-01 Eastman Chemical Company Air freshener composition containing a fiber pad
JPH1017894A (en) * 1996-07-04 1998-01-20 Kao Corp Liquid bleaching composition
US5902570A (en) 1996-10-29 1999-05-11 Procter & Gamble Company Antiperspirant cream compositions having improved rheology
ES2245020T3 (en) 1997-03-07 2005-12-16 THE PROCTER &amp; GAMBLE COMPANY IMPROVED METHODS OF PRODUCING MACROPOLICICLES WITH CROSSED BRIDGE.
US6656923B1 (en) 1997-06-09 2003-12-02 The Procter & Gamble Company Uncomplexed cyclodextrin compositions for odor and wrinkle control
US6180121B1 (en) * 1998-03-05 2001-01-30 Colgate-Palmolive Company Fragrance enhancing compositions for cosmetic products
GB9809772D0 (en) 1998-05-07 1998-07-08 Quest Int Perfume composition
ES2289771T3 (en) 1998-06-15 2008-02-01 THE PROCTER &amp; GAMBLE COMPANY PERFUME COMPOSITIONS.
US6413920B1 (en) 1998-07-10 2002-07-02 Procter & Gamble Company Amine reaction compounds comprising one or more active ingredient
GB9821693D0 (en) * 1998-10-06 1998-12-02 Humphries Martyn Improvements in or relating to insect repellents
US5976514A (en) 1998-11-20 1999-11-02 Procter & Gamble Company Low-irritation antiperspirant and deodorant compositions containing a volatile, nonpolar hydrocarbon liquid
BR9915688A (en) 1998-11-25 2001-08-07 Procter & Gamble Enhanced non-complexed cyclodextrin compositions for odor control
AU2026100A (en) 1998-11-30 2000-06-19 Procter & Gamble Company, The Process for preparing cross-bridged tetraaza macrocycles
JP2000178586A (en) * 1998-12-17 2000-06-27 Lion Corp Detergent composition for automatic vessel washer
US6488943B1 (en) 1999-04-13 2002-12-03 The Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
JP3617613B2 (en) * 1999-06-30 2005-02-09 ライオン株式会社 Liquid detergent composition
JP2001011497A (en) * 1999-06-30 2001-01-16 Lion Corp Liquid detergent product filled in thin-wall plastic bottle
EP1067173A1 (en) * 1999-07-08 2001-01-10 The Procter & Gamble Company Process for producing particles of amine reaction product
DE69920676D1 (en) * 1999-07-08 2004-11-04 Procter & Gamble Process for the preparation of amine reaction product particles
US6386392B1 (en) 1999-11-02 2002-05-14 The Procter & Gamble Company Reservoirs for use with cleaning devices
US6814088B2 (en) 1999-09-27 2004-11-09 The Procter & Gamble Company Aqueous compositions for treating a surface
US6716805B1 (en) 1999-09-27 2004-04-06 The Procter & Gamble Company Hard surface cleaning compositions, premoistened wipes, methods of use, and articles comprising said compositions or wipes and instructions for use resulting in easier cleaning and maintenance, improved surface appearance and/or hygiene under stress conditions such as no-rinse
JP2003501558A (en) * 1999-11-18 2003-01-14 ザ、プロクター、エンド、ギャンブル、カンパニー Improved uncomplexed cyclodextrin compositions for odor control
JP3566171B2 (en) * 2000-03-09 2004-09-15 花王株式会社 Liquid detergent composition
EP1283858B8 (en) * 2000-05-24 2007-02-28 The Procter & Gamble Company A fabric softening composition comprising a malodor controlling agent
US20040028551A1 (en) 2000-07-27 2004-02-12 Kvietok Frank Andrej Methods for emitting volatile compositions
US6610648B2 (en) * 2000-12-22 2003-08-26 Givaudan Sa Malodor counteractant compositions
CA2437720C (en) * 2001-02-14 2007-12-18 The Procter & Gamble Company Automatic dishwashing compositions comprising diacyl peroxide bleach and blooming perfume
JP2002336337A (en) * 2001-05-14 2002-11-26 Lion Corp Deodorizing antifoulant
DE10132003A1 (en) 2001-07-03 2003-01-30 Merz & Co Gmbh & Co Fat (oil) -containing agent containing onion extract, its production and its use for the care, prevention or treatment of damaged skin tissue, in particular scars
JP2003082398A (en) * 2001-09-11 2003-03-19 Lion Corp Detergent product
JP2003171688A (en) * 2001-12-05 2003-06-20 Lion Corp Neutral liquid detergent composition
JP2003176497A (en) * 2001-12-10 2003-06-24 Lion Corp Cleanser composition for glass
JP2003268398A (en) * 2002-03-15 2003-09-25 Lion Corp Liquid bleaching composition
US6722529B2 (en) * 2002-04-15 2004-04-20 Michael J. Ceppaluni Air flow scent enhancer
AU2003239145A1 (en) 2002-04-17 2003-11-03 Playtex Products, Inc. Disposable cassette for incremental withdrawal of tubular plastic with malodor-counteractant capacity
JP4579509B2 (en) * 2002-08-09 2010-11-10 花王株式会社 Fragrance composition
WO2004021850A2 (en) 2002-09-09 2004-03-18 The Procter & Gamble Company Fluid delivery mechanism
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
US8187580B2 (en) * 2002-11-01 2012-05-29 The Procter & Gamble Company Polymeric assisted delivery using separate addition
US7202198B2 (en) 2003-06-10 2007-04-10 International Flavors & Fragrances Inc. Substituted phenolic composition and process for using same for inhibiting malodours
US20050003975A1 (en) * 2003-06-18 2005-01-06 Browne Yvonne Bridget Blooming soap bars
US7365043B2 (en) 2003-06-27 2008-04-29 The Procter & Gamble Co. Lipophilic fluid cleaning compositions capable of delivering scent
DE10330865A1 (en) 2003-07-09 2005-01-27 Symrise Gmbh & Co. Kg 4,8-dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one as fragrances
AR045608A1 (en) * 2003-09-08 2005-11-02 Colgate Palmolive Co TRANSPARENT GEL ANTITRANSPIRANTE WITH LOW GLYCOL CONTENT
US20080032245A1 (en) 2003-11-11 2008-02-07 Vapor Fuel Technologies, Llc Fuel utilization
AU2004294842B2 (en) 2003-12-04 2010-05-13 Kyowa Kirin Co., Ltd. Medicine containing genetically modified antibody against chemokine receptor CCR4
US7524809B2 (en) 2004-02-27 2009-04-28 The Procter & Gamble Company Multiple use fabric conditioning composition with improved perfume
DE102004023720A1 (en) 2004-05-11 2005-12-08 Henkel Kgaa Use of cyclodextrin compounds or their salts as aromatic agents or agents for releasing aroma in aqueous/solid washing-, cleaning- or deodorizing- agents, which are useful as e.g. kitchen cleaners and room fresheners
US20050276831A1 (en) 2004-06-10 2005-12-15 Dihora Jiten O Benefit agent containing delivery particle
JP4129645B2 (en) * 2004-08-30 2008-08-06 ライオン株式会社 Shampoo composition
JP4694171B2 (en) * 2004-10-07 2011-06-08 ライオン株式会社 Hair rinse composition for non-aerosol foam discharge container and non-aerosol foam discharge hair rinse product
BRPI0517313A (en) 2004-10-20 2008-10-07 Firmenich & Cie oil-containing composition, consumable article, method for imparting, enhancing, enhancing or modifying properties, process for preparing a composition, and oil solubilization system
US8058500B2 (en) * 2005-05-06 2011-11-15 Kimberly-Clark Worldwide, Inc. Malodor reduction patch
US20070003499A1 (en) 2005-06-30 2007-01-04 The Gillette Company Particulate enhanced efficacy antiperspirant salt with raised pH
JP5038656B2 (en) * 2005-11-18 2012-10-03 花王株式会社 Deodorant composition
JP5138169B2 (en) * 2005-12-27 2013-02-06 ライオン株式会社 Liquid bleach composition
WO2007100501A2 (en) * 2006-02-28 2007-09-07 Appleton Papers Inc. Benefit agent containing delivery particle
JP4243867B2 (en) * 2006-03-29 2009-03-25 ライオン株式会社 Rosmarinic acid-containing composition
US7832681B2 (en) 2006-04-26 2010-11-16 Johnson James H Dispenser for coiled materials
US20070275866A1 (en) * 2006-05-23 2007-11-29 Robert Richard Dykstra Perfume delivery systems for consumer goods
CN101501174B (en) * 2006-05-23 2013-08-21 宝洁公司 Perfume delivery systems for consumer goods
US20080003245A1 (en) * 2006-06-30 2008-01-03 Beiersdorf Ag Use of octyl salicylate in cosmetic preparations containing 1,3-dihydroxyacetone
DE102006056320A1 (en) * 2006-11-21 2008-05-29 Beiersdorf Ag Cosmetic formulation with glucosylglycerides and selected perfumes
EP1936438B1 (en) 2006-12-20 2010-03-10 Agfa Graphics N.V. Flexographic printing forme precursor for laser engraving
US8059787B2 (en) 2007-01-26 2011-11-15 Koninklijke Philips Electronics N.V. Spectrum-preserving heel effect compensation filter made from the same material as anode plate
MX2009008576A (en) 2007-02-09 2009-08-18 Procter & Gamble Perfume systems.
DE102007019369A1 (en) 2007-04-23 2008-10-30 Henkel Ag & Co. Kgaa Photocatalytic material-containing particles
DE102007028024A1 (en) 2007-06-14 2008-12-18 Beiersdorf Ag Cosmetic or dermatological preparations containing molecular oxygen and perfume substances
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
CN101101299A (en) * 2007-06-25 2008-01-09 华东理工大学 Parallel-tandem mode identification method and its uses in machine scent
US7550416B2 (en) * 2007-06-27 2009-06-23 The Procter & Gamble Company Perfumed household products and methods for preserving perfume integrity and extending fragrance life
GB2450727A (en) * 2007-07-05 2009-01-07 Irish Skincare Ltd Perfumed silicone microemulsion
GB0718532D0 (en) 2007-09-22 2007-10-31 Unilever Plc Improvements relating to fabric treatment compositions
CN102123742A (en) * 2008-02-22 2011-07-13 宝洁公司 Absorbent article comprising lotion composition comprising a cooling agent
US20090312223A1 (en) 2008-06-13 2009-12-17 Conopco, Inc., D/B/A Unilever Method of Controlling Structure and Rheology of Low Active Liquid Cleansers by Selecting Perfume Components
KR100905419B1 (en) 2008-09-11 2009-07-02 연세대학교 산학협력단 Uses of sesquiterpene derivatives
DE102009001570A1 (en) 2009-03-16 2010-09-23 Henkel Ag & Co. Kgaa Lilial surrogate
US8709337B2 (en) 2009-04-16 2014-04-29 The Procter & Gamble Company Method for delivering a volatile material
US8931711B2 (en) 2009-04-16 2015-01-13 The Procter & Gamble Company Apparatus for delivering a volatile material
CA2758384A1 (en) 2009-05-15 2010-11-18 The Procter & Gamble Company Perfume systems
CN102905682A (en) 2009-06-18 2013-01-30 宝洁公司 Personal care composition comprising a synthetic cationic polymer
WO2010020892A2 (en) * 2009-07-07 2010-02-25 The Procter & Gamble Company Property-space similarity modeling
WO2011059952A1 (en) * 2009-11-12 2011-05-19 Q Therapeutics, Inc. Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells
JP5782046B2 (en) * 2009-12-17 2015-09-24 ザ プロクター アンド ギャンブルカンパニー Freshening composition comprising malodor binding polymer and malodor control component
EP3309245A1 (en) * 2009-12-18 2018-04-18 The Procter & Gamble Company Encapsulates
CN102811699A (en) * 2010-04-06 2012-12-05 宝洁公司 Encapsulates
US20110269657A1 (en) 2010-04-28 2011-11-03 Jiten Odhavji Dihora Delivery particles
US9186642B2 (en) * 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US8322631B2 (en) 2010-05-10 2012-12-04 The Procter & Gamble Company Trigger pump sprayer having favorable particle size distribution with specified liquids
JP5419799B2 (en) * 2010-05-21 2014-02-19 花王株式会社 Liquid detergent composition for floors
US8741275B2 (en) 2010-06-04 2014-06-03 Robetet, Inc. Malodor neutralizing compositions comprising undecylenic acid or citric acid
US9174229B2 (en) 2010-06-11 2015-11-03 The Procter & Gamble Company Dispenser having non-frustro-conical funnel wall
CN105919832A (en) 2010-06-11 2016-09-07 宝洁公司 Compositions For Treating Skin
PL2585569T3 (en) 2010-06-22 2017-03-31 The Procter And Gamble Company Perfume systems
JP5692844B2 (en) 2010-09-24 2015-04-01 高砂香料工業株式会社 Deodorant composition for sulfides
JP5711385B2 (en) * 2010-12-08 2015-04-30 ザ プロクター アンド ギャンブルカンパニー Non-fragrance and low-fragrance malodor control composition and method
ES2819073T3 (en) * 2011-01-27 2021-04-14 Robertet Inc Malodor neutralizing compositions comprising bornyl acetate or isobornyl acetate
US20120219610A1 (en) 2011-02-28 2012-08-30 Smith Iii Edward Dewey Bar Compositions Comprising Platelet Zinc Pyrithione
US20120230936A1 (en) * 2011-03-09 2012-09-13 The Dial Corporation Gel air freshener with improved length-of-life and method for producing same
ES2698049T3 (en) 2011-04-04 2019-01-30 Procter & Gamble Article for home care
DE102011006982A1 (en) 2011-04-07 2012-10-11 Beiersdorf Ag Preparations with a long-lasting floral scent without 4- (4-hydroxy-4-methylpentyl) -3-cyclohexenecarboxaldehyde
US20120258150A1 (en) 2011-04-11 2012-10-11 Holly Balasubramanian Rauckhorst Particles comprising volatile materials and particle gas saturated solution processes for making same
US9296550B2 (en) 2013-10-23 2016-03-29 The Procter & Gamble Company Recyclable plastic aerosol dispenser
WO2012162331A2 (en) * 2011-05-26 2012-11-29 The Procter & Gamble Company Compositions comprising an efficient perfume bloom
WO2013018805A1 (en) * 2011-08-01 2013-02-07 山本香料株式会社 Fragrance for suppressing fecal odor, microcapsulated fragrance using same, textile having fecal odor suppressing capability, pellet for suppressing fecal odor, microcapsulated fragrance misting spray, and spray for suppressing fecal odor
WO2013025761A1 (en) 2011-08-15 2013-02-21 The Procter & Gamble Company Conformable personal care articles
MX2014011397A (en) * 2012-04-10 2014-11-25 Procter & Gamble Malodor reduction compositions.
US9320407B2 (en) 2012-06-04 2016-04-26 The Procter & Gamble Company Floor cleaning appliance having disposable floor sheets and method of cleaning a floor therewith
CN102901779B (en) * 2012-09-13 2014-07-23 中国烟草总公司郑州烟草研究院 Discrimination method for caramel sweet taste characteristics of tobacco leaf based on flavor components
JP6247540B2 (en) * 2013-01-11 2017-12-13 大日本除蟲菊株式会社 Mosquito coil
EP2757146B1 (en) * 2013-01-22 2018-01-03 The Procter & Gamble Company Treatment compositions comprising microcapsules, primary or secondary amines, and formaldehyde scavengers
EP2832441B1 (en) 2013-07-29 2019-09-11 Takasago International Corporation Microcapsules
AU2015223492B2 (en) 2014-02-28 2020-01-16 Kimberly-Clark Worldwide, Inc. Easy open bundled packaged goods
MX2017003971A (en) 2014-09-26 2017-06-30 Procter & Gamble Delivery systems comprising malodor reduction compositions.
WO2018100411A1 (en) 2016-11-30 2018-06-07 Arcelormittal Electrical connection device for a photovoltaic system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080176780A1 (en) * 2006-09-04 2008-07-24 Takasago International Corporation Encapsulation of bulky fragrance molecules
US8609600B2 (en) * 2006-09-04 2013-12-17 Takasago International Corporation Encapsulation of bulky fragrance molecules
US20110098209A1 (en) * 2009-01-29 2011-04-28 Johan Smets Encapsulates
US20110245134A1 (en) * 2010-04-06 2011-10-06 Johan Smets Encapsulates

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
McGinley et al. Performance Verification of Air Freshener Products and Other Odour Control Devices for Indoor Air Quality Malodours. Presented at The 8th Workshop on Odour and Emissions of Plastic Materials Universität Kassel Institut für Werkstofftechnik Kassel, Germany: 27-28 March 2006. 13p. *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10113140B2 (en) 2014-09-26 2018-10-30 The Procter & Gamble Company Freshening compositions and devices comprising same
US10552557B2 (en) 2014-09-26 2020-02-04 The Procter & Gamble Company Freshening compositions and devices comprising same
US10240108B2 (en) 2015-10-19 2019-03-26 The Procter & Gamble Company Particles for malodor reduction
US20170172872A1 (en) * 2015-12-17 2017-06-22 Henkel Ag & Co. Kgaa Propellant-free deodorants and/or antiperspirants having specific preservative-agent combinations
US11197810B2 (en) 2016-03-24 2021-12-14 The Procter And Gamble Company Hair care compositions comprising malodor reduction compositions
US11197809B2 (en) 2016-03-24 2021-12-14 The Procter And Gamble Company Hair care compositions comprising malodor reduction compositions
US10610473B2 (en) 2016-03-24 2020-04-07 The Procter And Gamble Company Hair care compositions comprising malodor reduction compositions
US11744273B2 (en) 2016-09-16 2023-09-05 University Of Florida Research Foundation, Incorporated Sweetness enhancing volatile compositions and methods of increasing perceived sweetness of a comestible
WO2018053344A1 (en) * 2016-09-16 2018-03-22 University Of Florida Research Foundation, Inc. Sweetness enhancing volatile compositions and methods of increasing perceived sweetness of a comestible
US10179887B1 (en) * 2017-07-14 2019-01-15 International Flavors & Fragrances Inc. Organoleptic compounds
US11904036B2 (en) 2017-10-10 2024-02-20 The Procter & Gamble Company Sulfate free clear personal cleansing composition comprising low inorganic salt
US11992540B2 (en) 2017-10-10 2024-05-28 The Procter & Gamble Company Sulfate free personal cleansing composition comprising low inorganic salt
US11352588B2 (en) 2018-04-02 2022-06-07 Kao Corporation Musk-like composition
US11980679B2 (en) 2019-12-06 2024-05-14 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
US11679065B2 (en) 2020-02-27 2023-06-20 The Procter & Gamble Company Compositions with sulfur having enhanced efficacy and aesthetics
US11819474B2 (en) 2020-12-04 2023-11-21 The Procter & Gamble Company Hair care compositions comprising malodor reduction materials
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants

Also Published As

Publication number Publication date
JP2017535628A (en) 2017-11-30
CA2959695A1 (en) 2016-03-31
CA2959691A1 (en) 2016-03-31
US20170249408A1 (en) 2017-08-31
US10113140B2 (en) 2018-10-30
JP6923439B2 (en) 2021-08-18
US20170255725A1 (en) 2017-09-07
US20170137752A1 (en) 2017-05-18
US11334694B2 (en) 2022-05-17
WO2016049389A1 (en) 2016-03-31
WO2016049395A1 (en) 2016-03-31
US20160296656A1 (en) 2016-10-13
US20160089465A1 (en) 2016-03-31
JP2017536859A (en) 2017-12-14
JP2019162428A (en) 2019-09-26
US20160092661A1 (en) 2016-03-31
CN107073154A (en) 2017-08-18
US11334695B2 (en) 2022-05-17
US20190155975A9 (en) 2019-05-23
KR101971378B1 (en) 2019-04-22
EP3197510A1 (en) 2017-08-02
MX2017003971A (en) 2017-06-30
WO2016049397A1 (en) 2016-03-31
EP3197422A1 (en) 2017-08-02
US20170119917A1 (en) 2017-05-04
CA2959432A1 (en) 2016-03-31
US20160090555A1 (en) 2016-03-31
US20160090558A1 (en) 2016-03-31
CA2959555A1 (en) 2016-03-31
WO2016049407A1 (en) 2016-03-31
US20170249407A1 (en) 2017-08-31
WO2016049393A1 (en) 2016-03-31
KR20170042328A (en) 2017-04-18
US20180066210A1 (en) 2018-03-08
WO2016049458A1 (en) 2016-03-31
WO2016049398A1 (en) 2016-03-31
CA2959434A1 (en) 2016-03-31
EP3197507A1 (en) 2017-08-02
JP2017531469A (en) 2017-10-26
JP2019123883A (en) 2019-07-25
CA2960394A1 (en) 2016-03-31
JP2017531468A (en) 2017-10-26
CA2959546A1 (en) 2016-03-31
EP3197426A1 (en) 2017-08-02
EP3197511A1 (en) 2017-08-02
EP3197425A1 (en) 2017-08-02
CN106714848A (en) 2017-05-24
CN106687148A (en) 2017-05-17
US20160089462A1 (en) 2016-03-31
KR20170042329A (en) 2017-04-18
WO2016049396A1 (en) 2016-03-31
WO2016049394A1 (en) 2016-03-31
WO2016049455A1 (en) 2016-03-31
US20160090557A1 (en) 2016-03-31
JP2017537173A (en) 2017-12-14
CN106687099A (en) 2017-05-17
EP3197424A1 (en) 2017-08-02
US20180004875A1 (en) 2018-01-04
MX2017003970A (en) 2017-06-30
CA2959697A1 (en) 2016-03-31
EP3197509A1 (en) 2017-08-02
KR102008588B1 (en) 2019-08-07
CN106714849A (en) 2017-05-24
EP3197508A1 (en) 2017-08-02
CN106716482A (en) 2017-05-24
US20170333591A9 (en) 2017-11-23
CN107073153A (en) 2017-08-18
ZA201701449B (en) 2018-12-19
US20160089464A1 (en) 2016-03-31
CA2960390A1 (en) 2016-03-31
AR105148A1 (en) 2017-09-13
CN107001995A (en) 2017-08-01
MX2017003965A (en) 2017-05-30
CA2959434C (en) 2023-01-10
EP3197423A1 (en) 2017-08-02
US20160089318A1 (en) 2016-03-31
US20170137753A1 (en) 2017-05-18
JP2017537058A (en) 2017-12-14
JP7328058B2 (en) 2023-08-16
JP2017530122A (en) 2017-10-12
MX2017003968A (en) 2017-06-30
US10552557B2 (en) 2020-02-04
US20160090556A1 (en) 2016-03-31
WO2016049404A1 (en) 2016-03-31
MX2017003966A (en) 2017-06-30
MX2017003967A (en) 2017-07-07
MX2017003969A (en) 2017-06-30
US20160306909A1 (en) 2016-10-20
JP2020000884A (en) 2020-01-09

Similar Documents

Publication Publication Date Title
US20170249408A1 (en) Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions
US9814661B2 (en) Fragrance compositions
JP7431295B2 (en) Deodorant containing zinc neodecanoate
CA3000818A1 (en) Particles for malodor reduction
US20180334637A1 (en) Fragrance Compositions and Uses Thereof
US10792384B2 (en) Rolled fibrous structures comprising encapsulated malodor reduction compositions
US20190029928A1 (en) Fibrous Structures Comprising Malodor Reduction Compositions
WO2022084548A1 (en) Compositions to limit or eliminate the perception of sweat malodor

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE PROCTER & GAMBLE COMPANY, OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CETTI, JONATHAN ROBERT;FRANKENBACH, GAYLE MARIE;HORENZIAK, STEVEN ANTHONY;AND OTHERS;SIGNING DATES FROM 20150928 TO 20150930;REEL/FRAME:036714/0901

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STPP Information on status: patent application and granting procedure in general

Free format text: TC RETURN OF APPEAL

STCV Information on status: appeal procedure

Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION